data_1rfo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rfo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.585 ' CD1' ' HA ' ' C' ' 4' ' ' PRO . 5.5 m-30 . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 111.925 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.754 HG22 ' NE ' ' A' ' 15' ' ' ARG . 4.5 pt -91.4 153.63 44.34 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.644 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.458 ' O ' ' NE1' ' A' ' 20' ' ' TRP . 11.2 Cg_endo -86.25 153.42 9.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.723 2.282 . . . . 0.0 111.308 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.653 ' OE2' ' NH2' ' B' ' 15' ' ' ARG . 1.1 tp10 -58.21 142.34 47.85 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.475 ' O ' ' NH2' ' B' ' 15' ' ' ARG . . . -87.21 160.77 48.05 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.166 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.562 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 43.9 Cg_exo -54.65 152.06 29.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.102 2.535 . . . . 0.0 112.958 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.548 ' HG3' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -111.63 57.76 0.63 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.165 0.507 . . . . 0.0 111.135 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -105.48 16.15 25.96 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.699 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' B' ' 16' ' ' LYS . . . 79.98 14.08 81.22 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.81 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.511 ' CG ' HD22 ' A' ' 22' ' ' LEU . 3.0 mt-30 -107.11 157.73 17.62 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 117.156 0.478 . . . . 0.0 110.47 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.804 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -98.86 136.21 39.19 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.485 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.772 ' O ' HG22 ' B' ' 14' ' ' VAL . 66.2 m-85 -120.43 149.1 42.91 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.391 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.757 HG21 ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -111.25 157.14 12.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.779 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -106.19 107.3 18.24 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 118.134 -1.426 . . . . 0.0 110.645 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.698 ' HG2' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -137.3 140.58 41.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.592 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.698 ' CG ' ' HG2' ' A' ' 16' ' ' LYS . 0.4 OUTLIER 45.21 45.65 9.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 177.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 61.82 16.81 52.98 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.383 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -133.71 162.34 32.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 118.124 0.962 . . . . 0.0 111.574 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.779 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 73.4 m95 -93.94 114.1 26.24 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.471 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.757 ' O ' HG21 ' A' ' 14' ' ' VAL . 2.4 m -107.19 132.66 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.295 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.511 HD22 ' CG ' ' A' ' 11' ' ' GLN . 4.4 mt -53.11 121.83 8.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.766 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.49 HD23 ' CD1' ' B' ' 26' ' ' PHE . 1.8 tp -60.09 -45.73 91.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.904 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.4 p -50.54 -26.28 5.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.962 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.2 m -67.5 -19.08 65.28 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.725 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.762 ' O ' ' CD2' ' C' ' 27' ' ' LEU . 12.7 m-85 -98.2 2.66 48.61 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.168 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 1.012 HD21 ' O ' ' B' ' 26' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.309 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.555 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 4.6 m-85 -130.89 141.64 50.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.985 0.422 . . . . 0.0 111.165 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.583 ' CG2' ' HE ' ' B' ' 15' ' ' ARG . 6.4 pt -88.69 158.59 47.81 Favored Pre-proline 0 CA--C 1.515 -0.372 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 96.9 Cg_endo -88.48 150.21 6.41 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.984 2.456 . . . . 0.0 110.463 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.651 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 0.4 OUTLIER -57.54 149.19 21.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.935 -176.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.59 ' N ' ' HG3' ' B' ' 5' ' ' GLU . . . -91.0 152.55 44.39 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.195 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.702 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 6.2 Cg_exo -48.14 153.18 2.99 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.337 2.692 . . . . 0.0 113.251 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.51 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.9 OUTLIER -111.56 66.62 0.63 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.934 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -110.65 11.25 22.8 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.265 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.48 8.06 88.03 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.148 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . 0.662 ' OE1' HD23 ' B' ' 22' ' ' LEU . 2.6 mm-40 -102.03 151.76 21.76 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.813 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -93.13 134.79 34.93 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.527 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.702 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 55.5 m-85 -119.85 151.54 38.7 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.021 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -113.72 159.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-N 113.61 -1.632 . . . . 0.0 106.832 175.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.938 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -103.7 107.9 18.96 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.489 1.137 . . . . 0.0 109.323 -176.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.804 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -135.82 131.81 35.87 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.036 -1.893 . . . . 0.0 111.432 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.601 ' OD1' ' O ' ' B' ' 16' ' ' LYS . 0.1 OUTLIER 47.8 46.86 18.52 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 177.027 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.464 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 62.39 16.44 54.47 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 114.172 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -133.46 161.44 34.56 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 117.967 0.884 . . . . 0.0 111.702 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' TRP . . . . . 0.938 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 84.8 m95 -94.09 117.15 29.69 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.503 ' O ' HG12 ' B' ' 14' ' ' VAL . 5.4 t -114.63 136.6 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.196 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.071 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.662 HD23 ' OE1' ' B' ' 11' ' ' GLN . 2.8 mt -54.02 125.34 18.47 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.016 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.58 HD23 ' CG ' ' C' ' 26' ' ' PHE . 1.8 tp -56.75 -35.5 68.7 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.082 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' SER . . . . . 0.494 ' HA ' ' HB2' ' B' ' 27' ' ' LEU . 2.0 p -63.62 -19.59 64.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.021 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 23.6 m -70.51 -20.45 62.83 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 1.012 ' O ' HD21 ' A' ' 27' ' ' LEU . 96.2 m-85 -101.12 18.77 18.95 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-O 122.218 1.009 . . . . 0.0 108.328 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.742 HD23 ' O ' ' C' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.363 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.279 -0.329 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 2' ' ' TYR . . . . . 0.618 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.3 m-30 -102.23 159.6 15.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 111.682 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . 0.738 HG21 ' NE ' ' C' ' 15' ' ' ARG . 3.3 pt -86.97 154.73 55.4 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.806 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.585 ' HA ' ' CD1' ' A' ' 2' ' ' TYR . 9.9 Cg_endo -83.22 148.13 13.06 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.437 2.091 . . . . 0.0 110.856 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.66 ' OE2' ' NH2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -58.09 143.53 43.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' ALA . . . . . 0.587 ' HB3' ' CG ' ' C' ' 20' ' ' TRP . . . -83.77 167.46 28.1 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.268 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' PRO . . . . . 0.498 ' HD2' ' CD2' ' C' ' 13' ' ' TYR . 28.7 Cg_exo -59.04 151.5 65.68 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.042 2.495 . . . . 0.0 112.547 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -112.03 48.82 0.95 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.046 0.45 . . . . 0.0 111.581 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' ASP . . . . . 0.476 ' CG ' ' HG3' ' C' ' 11' ' ' GLN . 19.0 p-10 -104.94 19.35 20.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.088 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.465 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.65 14.27 81.36 Favored Glycine 0 C--O 1.229 -0.158 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.34 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' GLN . . . . . 0.564 ' C ' ' HB2' ' A' ' 16' ' ' LYS . 7.1 mt-30 -105.1 141.15 37.17 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.499 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -90.91 135.33 33.81 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.268 0.556 . . . . 0.0 110.981 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.524 ' HB3' ' HB3' ' C' ' 20' ' ' TRP . 70.9 m-85 -119.3 152.79 36.12 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.615 1.198 . . . . 0.0 112.637 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' VAL . . . . . 0.741 HG21 ' O ' ' C' ' 21' ' ' VAL . 0.6 OUTLIER -113.37 145.82 18.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 112.624 -2.08 . . . . 0.0 106.35 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.764 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -95.01 115.47 27.46 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.906 -178.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . 0.813 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 1.9 tttt -151.05 125.46 9.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.989 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . 0.51 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 0.3 OUTLIER 58.64 44.44 17.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.984 0.421 . . . . 0.0 111.462 177.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.482 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.8 16.42 51.56 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.996 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -133.73 161.94 33.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.032 0.916 . . . . 0.0 111.679 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' TRP . . . . . 0.764 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 92.1 m95 -97.58 115.18 27.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.485 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.741 ' O ' HG21 ' C' ' 14' ' ' VAL . 6.4 t -110.06 137.59 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-O 121.596 0.712 . . . . 0.0 110.296 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' LEU . . . . . 0.424 HD22 ' HB3' ' C' ' 11' ' ' GLN . 1.3 mt -56.59 127.3 30.65 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.66 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . 0.536 ' CD2' ' CG ' ' A' ' 26' ' ' PHE . 7.7 tp -59.16 -35.61 73.83 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.139 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 80.6 p -64.01 -19.88 65.5 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 122.12 -0.362 . . . . 0.0 110.977 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 73.3 m -67.63 -18.36 64.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' PHE . . . . . 0.742 ' O ' HD23 ' B' ' 27' ' ' LEU . 76.6 m-85 -101.88 9.37 40.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.426 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.762 ' CD2' ' O ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.478 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.846 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 22.9 m-85 . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 120.936 0.398 . . . . 0.0 111.667 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.49 ' CG2' ' HA ' ' C' ' 5' ' ' GLU . 1.0 OUTLIER -97.32 160.05 29.8 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.833 177.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 21.1 Cg_endo -82.47 145.77 13.41 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.034 1.823 . . . . 0.0 111.401 176.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.573 ' CB ' HG22 ' B' ' 3' ' ' ILE . 3.4 tt0 -57.61 142.6 44.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.006 -1.452 . . . . 0.0 113.76 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 20' ' ' TRP . . . -85.03 163.92 43.8 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.557 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 37.8 Cg_exo -57.31 151.13 54.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.979 2.453 . . . . 0.0 112.853 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 45.4 mtm-85 -112.32 58.26 0.64 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.44 15.55 21.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.737 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.741 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 78.79 14.58 81.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.695 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.676 ' O ' ' HB2' ' B' ' 16' ' ' LYS . 7.7 mm-40 -102.83 141.32 35.84 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -91.52 133.39 35.55 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.784 0.802 . . . . 0.0 112.54 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.576 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 70.2 m-85 -118.66 151.42 37.98 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.961 1.363 . . . . 0.0 113.048 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -111.04 155.34 12.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 178.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.887 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.49 108.52 20.08 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.364 -177.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.65 ' HE3' ' O ' ' C' ' 10' ' ' GLY . 0.0 OUTLIER -136.73 120.72 17.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.65 -1.613 . . . . 0.0 111.977 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 0.4 OUTLIER 59.2 45.88 13.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 177.119 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.609 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 63.6 14.15 53.62 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.991 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -131.38 159.95 36.47 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 118.329 1.064 . . . . 0.0 111.429 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.887 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 93.0 m95 -97.53 114.77 26.72 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.882 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 10.5 t -111.37 139.73 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-O 121.718 0.771 . . . . 0.0 110.032 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 12' ' ' ALA . 3.7 mt -56.72 128.02 34.4 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.618 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.528 HD21 ' CG ' ' B' ' 26' ' ' PHE . 3.0 tp -61.5 -42.99 99.64 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.897 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.421 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -63.54 -18.59 64.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.738 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.0 m -69.69 -19.11 63.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.815 ' O ' ' CD2' ' C' ' 27' ' ' LEU . 96.3 m-85 -97.77 3.6 50.01 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.756 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.949 ' CD2' ' O ' ' B' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.483 ' HA ' ' H ' ' A' ' 5' ' ' GLU . 4.8 m-85 -133.65 129.58 37.05 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.634 0.254 . . . . 0.0 110.595 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.573 HG22 ' CB ' ' A' ' 5' ' ' GLU . 3.5 pt -85.45 155.63 59.6 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.905 ' HD2' HH21 ' B' ' 15' ' ' ARG . 83.4 Cg_endo -83.39 160.22 14.94 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.638 2.226 . . . . 0.0 112.648 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.522 ' HA ' HG22 ' C' ' 3' ' ' ILE . 19.2 tt0 -60.74 143.08 55.15 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.578 ' HB1' ' CD1' ' B' ' 20' ' ' TRP . . . -84.72 169.61 16.05 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.568 -1.197 . . . . 0.0 112.053 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.441 ' CD ' ' HB2' ' B' ' 6' ' ' ALA . 12.2 Cg_exo -71.04 153.89 62.83 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.826 3.017 . . . . 0.0 113.064 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' C' ' 17' ' ' ASP . 1.7 mpp_? -112.0 84.56 1.98 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.297 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.32 6.57 4.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.338 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.841 ' O ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.15 14.74 81.43 Favored Glycine 0 CA--C 1.509 -0.29 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.512 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . 0.595 ' O ' ' HB2' ' C' ' 16' ' ' LYS . 0.4 OUTLIER -103.9 144.08 31.99 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.44 ' HB1' ' HB ' ' C' ' 14' ' ' VAL . . . -90.57 135.88 33.42 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.541 0.686 . . . . 0.0 110.404 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.6 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 43.5 m-85 -118.92 152.15 36.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.491 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.563 ' CG1' HG23 ' B' ' 21' ' ' VAL . 0.5 OUTLIER -105.55 158.79 5.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 175.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.905 HH21 ' HD2' ' B' ' 4' ' ' PRO . 0.0 OUTLIER -107.66 105.82 15.87 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 118.581 -1.248 . . . . 0.0 107.688 176.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.741 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -138.06 124.68 20.89 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.164 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 2.8 t0 58.92 43.79 17.49 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.322 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.19 12.69 38.96 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 119.243 -0.754 . . . . 0.0 114.529 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.495 ' C ' ' NH1' ' B' ' 15' ' ' ARG . 0.1 OUTLIER -127.43 154.72 44.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.113 1.456 . . . . 0.0 111.382 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' TRP . . . . . 0.886 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 76.2 m95 -93.74 113.41 25.46 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.563 HG23 ' CG1' ' B' ' 14' ' ' VAL . 1.4 m -108.61 132.85 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 CA-C-O 121.626 0.727 . . . . 0.0 111.282 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.586 HD23 ' CG ' ' B' ' 11' ' ' GLN . 1.8 mt -53.75 122.06 9.16 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.216 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.522 HD21 ' CB ' ' C' ' 26' ' ' PHE . 1.1 tp -57.61 -34.99 69.86 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.6 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 16.7 m -61.65 -16.58 49.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.434 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 31.7 m -69.78 -18.15 63.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.949 ' O ' ' CD2' ' A' ' 27' ' ' LEU . 8.8 m-85 -99.71 -11.4 20.9 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.449 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.62 HD13 ' O ' ' C' ' 26' ' ' PHE . 9.4 mt . . . . . 0 C--O 1.249 1.043 0 O-C-N 120.751 -1.218 . . . . 0.0 110.896 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 CA-C-O 119.861 -0.411 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 2' ' ' TYR . . . . . 0.584 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.6 m-30 -116.85 150.39 38.47 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.614 0.707 . . . . 0.0 111.241 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . 0.691 HG21 ' NE ' ' C' ' 15' ' ' ARG . 2.4 pt -87.31 156.85 53.92 Favored Pre-proline 0 CA--C 1.506 -0.748 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.846 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 20.7 Cg_endo -87.8 152.96 7.35 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 122.153 1.902 . . . . 0.0 112.335 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.49 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 4.2 tt0 -57.38 141.45 47.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.086 -1.415 . . . . 0.0 113.321 -177.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' ALA . . . . . 0.601 ' HB2' ' NH1' ' A' ' 15' ' ' ARG . . . -84.97 160.51 55.14 Favored Pre-proline 0 N--CA 1.455 -0.211 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.306 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.99 151.52 49.25 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.921 2.414 . . . . 0.0 112.22 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' ARG . . . . . . . . . . . . . 20.7 mtm105 -111.57 70.37 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.407 0.623 . . . . 0.0 111.08 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -113.34 17.23 18.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.038 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.65 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 74.0 15.37 79.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.616 -1.278 . . . . 0.0 112.264 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' GLN . . . . . 0.784 ' OE1' HD13 ' C' ' 22' ' ' LEU . 0.1 OUTLIER -113.91 152.47 30.75 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.011 0.434 . . . . 0.0 110.977 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.574 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -92.75 136.19 33.45 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.583 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 70.4 m-85 -119.85 156.76 30.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.949 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' VAL . . . . . 0.537 HG23 ' HB ' ' C' ' 21' ' ' VAL . 0.0 OUTLIER -108.64 155.62 9.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 176.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.735 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.96 107.67 18.79 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 118.34 -1.344 . . . . 0.0 107.789 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . 0.841 ' HE2' ' O ' ' B' ' 10' ' ' GLY . 0.0 OUTLIER -136.57 124.49 22.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.978 -1.465 . . . . 0.0 111.381 -179.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' B' ' 8' ' ' ARG . 0.2 OUTLIER 58.71 45.34 15.92 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 176.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.43 ' C ' ' CZ ' ' C' ' 15' ' ' ARG . . . 63.02 16.42 57.46 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.907 -0.663 . . . . 0.0 114.475 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -134.65 161.08 36.12 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.289 1.044 . . . . 0.0 111.227 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' TRP . . . . . 0.735 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 91.2 m95 -97.28 115.04 26.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.527 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.537 ' HB ' HG23 ' C' ' 14' ' ' VAL . 21.5 t -107.92 141.2 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 121.767 0.794 . . . . 0.0 110.028 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' LEU . . . . . 0.784 HD13 ' OE1' ' C' ' 11' ' ' GLN . 1.6 mt -57.78 124.2 18.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.302 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . 0.762 HD23 ' CD2' ' A' ' 26' ' ' PHE . 25.8 tp -58.82 -52.15 66.97 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.33 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 41.8 t -43.64 -26.79 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.434 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -68.19 -18.65 64.65 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.585 0.707 . . . . 0.0 109.623 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' PHE . . . . . 0.62 ' O ' HD13 ' B' ' 27' ' ' LEU . 81.0 m-85 -99.65 -3.7 32.52 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.81 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.815 ' CD2' ' O ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.241 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.531 ' CD1' ' HA ' ' C' ' 4' ' ' PRO . 4.1 m-30 . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 120.634 0.254 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.661 HD12 ' CZ2' ' A' ' 20' ' ' TRP . 4.2 pt -91.75 161.53 33.65 Favored Pre-proline 0 CA--C 1.509 -0.603 0 CA-C-O 121.024 0.44 . . . . 0.0 111.582 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 33.2 Cg_endo -89.06 151.65 5.73 Favored 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 122.274 1.983 . . . . 0.0 110.686 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.629 ' OE2' ' NH2' ' B' ' 15' ' ' ARG . 0.5 OUTLIER -57.44 142.72 42.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.873 -177.036 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.588 ' HA ' ' CD1' ' A' ' 20' ' ' TRP . . . -84.39 165.07 40.29 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.524 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.484 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 28.5 Cg_exo -61.16 154.01 60.7 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 123.512 2.808 . . . . 0.0 113.202 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.411 ' CG ' ' HA ' ' B' ' 17' ' ' ASP . 2.0 mtp85 -112.04 69.98 0.7 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.262 0.553 . . . . 0.0 111.155 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -113.84 14.83 18.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.051 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.536 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 79.36 15.12 80.6 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.851 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.882 ' CG ' HD23 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -115.28 150.91 35.47 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.733 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -91.54 136.49 33.09 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.771 0.796 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.605 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 51.8 m-85 -117.43 151.65 36.62 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.344 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.854 HG21 ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -112.87 152.9 14.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.747 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.04 107.32 18.23 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 118.962 -1.095 . . . . 0.0 108.503 -177.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.715 ' HE3' ' O ' ' C' ' 10' ' ' GLY . 0.6 OUTLIER -137.01 125.04 22.82 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 113.382 -1.736 . . . . 0.0 111.132 -178.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.519 ' HA ' ' HG3' ' C' ' 8' ' ' ARG . 0.2 OUTLIER 57.87 45.36 18.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.485 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 62.35 14.07 46.55 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 114.352 0.501 . . . . 0.0 114.352 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -131.0 161.93 30.89 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 117.889 0.845 . . . . 0.0 111.897 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.747 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 82.5 m95 -96.42 113.91 25.53 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.952 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.854 ' O ' HG21 ' A' ' 14' ' ' VAL . 11.7 t -111.91 139.18 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 121.726 0.775 . . . . 0.0 110.034 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.882 HD23 ' CG ' ' A' ' 11' ' ' GLN . 2.1 mt -55.52 126.76 26.61 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.078 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 23' ' ' LEU . 2.9 tp -59.91 -42.78 94.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.307 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.3 m -62.97 -19.15 64.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 25' ' ' THR . 18.7 m -69.7 -18.31 63.53 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.631 ' CG ' ' CD2' ' C' ' 23' ' ' LEU . 84.1 m-85 -97.54 2.05 49.66 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.574 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.953 ' CD1' ' O ' ' B' ' 26' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.072 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.588 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 3.7 m-85 -129.51 143.32 50.78 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.738 0.304 . . . . 0.0 110.988 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.626 ' CG2' ' HE ' ' B' ' 15' ' ' ARG . 2.6 pt -89.44 158.34 46.04 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-O 120.999 0.428 . . . . 0.0 112.139 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.713 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 92.2 Cg_endo -87.22 151.58 8.06 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.72 2.28 . . . . 0.0 111.075 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.848 ' HA ' ' CG2' ' C' ' 3' ' ' ILE . 0.8 OUTLIER -57.69 142.41 45.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.253 -177.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -83.72 166.67 32.84 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.462 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.491 ' HD2' ' CE2' ' B' ' 13' ' ' TYR . 22.2 Cg_exo -62.76 151.12 85.67 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.448 2.765 . . . . 0.0 112.588 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.549 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -112.79 60.52 0.64 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.985 0.421 . . . . 0.0 111.891 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -106.01 15.24 26.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.239 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.516 ' C ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.48 14.48 81.3 Favored Glycine 0 CA--C 1.506 -0.487 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.81 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' C' ' 16' ' ' LYS . 0.0 OUTLIER -113.19 152.83 29.24 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.484 0.659 . . . . 0.0 109.744 178.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.569 ' HB1' ' CZ ' ' C' ' 26' ' ' PHE . . . -92.83 136.26 33.4 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.89 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.764 ' O ' HG22 ' C' ' 14' ' ' VAL . 58.4 m-85 -119.2 152.59 36.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.457 1.123 . . . . 0.0 112.265 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.873 HG23 ' O ' ' B' ' 21' ' ' VAL . 0.7 OUTLIER -112.49 155.84 13.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 113.122 -1.854 . . . . 0.0 106.214 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.951 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.14 107.1 17.9 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.884 -1.127 . . . . 0.0 108.92 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.733 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -136.79 124.02 21.81 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.505 -1.679 . . . . 0.0 111.792 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.411 ' HA ' ' CG ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 57.11 45.99 19.85 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.306 176.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.534 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 61.92 14.41 45.08 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.381 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.73 161.72 31.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.524 1.162 . . . . 0.0 111.803 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' TRP . . . . . 0.951 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 81.2 m95 -96.84 114.41 26.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.441 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.873 ' O ' HG23 ' B' ' 14' ' ' VAL . 10.6 t -111.16 142.4 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 121.768 0.794 . . . . 0.0 110.613 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' B' ' 11' ' ' GLN . 1.4 mt -56.82 122.68 12.75 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.399 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.528 HD23 ' CD2' ' C' ' 26' ' ' PHE . 2.8 tp -57.57 -43.18 84.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.87 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -19.28 65.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.944 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 4.1 m -67.72 -18.76 65.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.953 ' O ' ' CD1' ' A' ' 27' ' ' LEU . 87.4 m-85 -95.92 -16.11 21.96 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.325 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.57 HD11 ' O ' ' C' ' 26' ' ' PHE . 1.8 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.275 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.052 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 2' ' ' TYR . . . . . 0.713 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.5 m-30 -100.62 160.97 13.92 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.775 0.321 . . . . 0.0 111.798 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . 0.848 ' CG2' ' HA ' ' B' ' 5' ' ' GLU . 7.4 pt -87.75 160.75 46.49 Favored Pre-proline 0 CA--C 1.516 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.624 ' O ' ' NE1' ' C' ' 20' ' ' TRP . 69.8 Cg_endo -92.38 144.09 2.6 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 122.614 2.209 . . . . 0.0 111.432 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.641 ' OE2' HG23 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -58.05 142.84 45.52 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -176.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' ALA . . . . . 0.512 ' N ' ' HG3' ' C' ' 5' ' ' GLU . . . -87.37 156.69 53.81 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.814 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' PRO . . . . . 0.475 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 52.0 Cg_exo -49.61 153.69 5.18 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.111 2.541 . . . . 0.0 113.238 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' ARG . . . . . 0.519 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -111.64 64.73 0.62 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.368 0.604 . . . . 0.0 111.03 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -112.05 14.18 20.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.526 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.715 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.29 13.95 82.18 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.363 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' GLN . . . . . 0.609 ' CG ' HD22 ' C' ' 22' ' ' LEU . 1.3 mm-40 -106.25 155.01 19.92 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -96.63 134.43 39.87 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.402 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.475 ' CE2' ' HD2' ' C' ' 7' ' ' PRO . 50.2 m-85 -118.79 155.21 31.54 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.071 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' VAL . . . . . 0.764 HG22 ' O ' ' B' ' 13' ' ' TYR . 0.4 OUTLIER -118.87 160.79 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.867 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.23 107.71 18.84 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.482 1.134 . . . . 0.0 110.766 -176.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' B' ' 11' ' ' GLN . 0.0 OUTLIER -137.05 127.25 26.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.474 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . 0.549 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 1.1 m-20 55.79 45.97 23.29 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.61 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 60.54 15.37 39.51 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' C' ' 16' ' ' LYS . 0.0 OUTLIER -133.61 162.0 33.11 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.277 1.038 . . . . 0.0 111.043 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' TRP . . . . . 0.867 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 91.9 m95 -98.49 122.84 42.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.299 0.571 . . . . 0.0 110.732 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.509 ' O ' HG13 ' C' ' 14' ' ' VAL . 12.8 t -117.5 138.44 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.673 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' LEU . . . . . 0.609 HD22 ' CG ' ' C' ' 11' ' ' GLN . 1.5 mt -55.61 125.61 21.8 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.874 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . 0.631 ' CD2' ' CG ' ' A' ' 26' ' ' PHE . 7.8 tp -57.15 -35.18 69.22 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.921 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -15.1 59.6 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.502 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 4.0 m -72.8 -18.93 61.42 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' PHE . . . . . 0.57 ' O ' HD11 ' B' ' 27' ' ' LEU . 92.0 m-85 -99.1 -6.95 27.42 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.607 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.497 HD13 ' HB3' ' A' ' 26' ' ' PHE . 58.4 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.899 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.679 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 8.4 m-30 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.51 HD11 ' CZ2' ' A' ' 20' ' ' TRP . 5.6 pt -100.96 159.11 30.43 Favored Pre-proline 0 CA--C 1.508 -0.648 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.097 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 39.2 Cg_endo -86.58 152.92 8.95 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 121.623 1.549 . . . . 0.0 112.043 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.669 ' OE2' ' HA2' ' B' ' 18' ' ' GLY . 0.4 OUTLIER -57.25 143.24 40.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.753 -177.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.674 ' HA ' ' CD1' ' A' ' 20' ' ' TRP . . . -85.72 165.7 33.72 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.92 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.476 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 24.8 Cg_exo -58.85 151.07 67.36 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.957 2.438 . . . . 0.0 112.355 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.33 63.84 0.61 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.192 0.52 . . . . 0.0 111.25 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -110.27 13.34 23.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.592 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.19 8.94 87.15 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.394 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.615 ' OE1' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -102.4 151.14 22.62 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.227 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.677 ' HB3' HG13 ' B' ' 14' ' ' VAL . . . -92.1 136.26 33.32 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.606 0.717 . . . . 0.0 110.189 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.542 ' CE1' HD21 ' A' ' 22' ' ' LEU . 52.9 m-85 -119.09 154.28 33.44 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.711 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.615 ' HB ' HG21 ' A' ' 21' ' ' VAL . 1.8 t -115.41 156.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.904 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -106.06 107.85 19.07 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.407 1.099 . . . . 0.0 110.46 -176.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.644 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 0.0 OUTLIER -138.2 126.75 23.44 Favored 'General case' 0 C--O 1.23 0.044 0 CA-C-N 113.062 -1.881 . . . . 0.0 112.052 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.527 ' HA ' ' HG3' ' C' ' 8' ' ' ARG . 0.4 OUTLIER 55.46 45.3 25.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 176.274 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.528 ' H ' ' NH2' ' A' ' 15' ' ' ARG . . . 62.1 15.59 50.69 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.568 -0.573 . . . . 0.0 114.528 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -134.33 162.97 30.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.498 1.149 . . . . 0.0 111.37 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.904 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 89.1 m95 -94.58 120.12 34.31 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.397 0.617 . . . . 0.0 110.792 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.615 HG21 ' HB ' ' A' ' 14' ' ' VAL . 1.6 m -115.69 131.35 68.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.949 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.615 HD12 ' OE1' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -51.09 123.87 10.29 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.786 -178.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' CD2' ' CG ' ' B' ' 26' ' ' PHE . 4.7 tp -57.43 -36.19 71.05 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.517 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.68 -21.18 66.52 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.949 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.0 m -70.1 -22.61 63.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.759 0.79 . . . . 0.0 108.97 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.603 ' CZ ' ' HB1' ' C' ' 12' ' ' ALA . 32.8 m-85 -97.87 -6.14 33.07 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.777 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.77 ' CD2' ' O ' ' B' ' 26' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.193 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.684 -0.166 . . . . 0.0 112.684 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.518 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 3.0 m-85 -130.48 138.61 50.35 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.861 0.362 . . . . 0.0 111.354 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.636 ' CG2' ' HE ' ' B' ' 15' ' ' ARG . 4.2 pt -88.89 159.65 45.32 Favored Pre-proline 0 N--CA 1.468 0.474 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 80.9 Cg_endo -91.05 152.59 3.86 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.875 2.383 . . . . 0.0 111.76 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.771 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 2.9 tt0 -58.39 142.8 47.27 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.458 ' HB1' ' CG ' ' B' ' 20' ' ' TRP . . . -88.33 146.23 37.44 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.597 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.481 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 11.4 Cg_exo -40.73 154.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.569 2.846 . . . . 0.0 113.678 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.94 65.0 0.62 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.818 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -110.77 18.54 19.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.304 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.459 ' HA2' ' OD2' ' C' ' 17' ' ' ASP . . . 75.6 7.83 83.54 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.564 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . 0.499 ' HB3' HD21 ' B' ' 22' ' ' LEU . 0.1 OUTLIER -105.5 151.16 24.62 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.289 0.566 . . . . 0.0 110.071 178.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.81 137.32 32.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.635 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.54 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 60.2 m-85 -120.44 154.34 35.33 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.665 1.221 . . . . 0.0 111.476 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.802 HG22 ' O ' ' B' ' 21' ' ' VAL . 0.2 OUTLIER -111.89 156.15 13.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 112.58 -2.1 . . . . 0.0 106.625 179.111 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.946 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.74 103.91 13.51 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.118 0.961 . . . . 0.0 109.178 -178.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.616 ' N ' HH11 ' B' ' 15' ' ' ARG . 0.0 OUTLIER -135.24 125.87 27.03 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.366 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.05 46.11 19.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.669 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 61.5 15.76 47.62 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 114.277 0.471 . . . . 0.0 114.277 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -133.36 161.91 33.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 117.904 0.852 . . . . 0.0 112.172 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' TRP . . . . . 0.946 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 83.9 m95 -95.86 114.73 26.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.215 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.802 ' O ' HG22 ' B' ' 14' ' ' VAL . 10.9 t -107.03 139.97 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.628 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' B' ' 11' ' ' GLN . 4.7 mt -58.04 124.33 18.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.326 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.658 HD23 ' CD2' ' C' ' 26' ' ' PHE . 35.6 tp -58.87 -39.98 82.99 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.523 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.2 m -62.77 -18.46 62.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.914 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m -68.25 -17.6 64.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.77 ' O ' ' CD2' ' A' ' 27' ' ' LEU . 90.0 m-85 -102.69 -15.82 16.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.261 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.47 HD13 ' O ' ' C' ' 26' ' ' PHE . 5.5 mt . . . . . 0 C--O 1.249 1.07 0 O-C-N 121.137 -0.977 . . . . 0.0 111.024 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 2' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.8 m-30 -96.09 161.72 13.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.333 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . 0.926 HG21 ' CZ ' ' C' ' 15' ' ' ARG . 2.9 pt -87.62 157.99 51.77 Favored Pre-proline 0 CA--C 1.512 -0.49 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.583 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 37.3 Cg_endo -89.65 146.09 4.84 Favored 'Trans proline' 0 N--CA 1.437 -1.853 0 C-N-CA 122.664 2.242 . . . . 0.0 111.336 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.542 ' OE2' ' NH1' ' A' ' 15' ' ' ARG . 1.1 tp10 -57.6 141.68 47.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' ALA . . . . . 0.554 ' H ' HH12 ' A' ' 15' ' ' ARG . . . -83.83 157.55 63.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.535 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' PRO . . . . . 0.427 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 51.8 Cg_exo -50.93 153.34 8.79 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.642 2.228 . . . . 0.0 112.769 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' ARG . . . . . 0.527 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 1.6 mpt_? -111.21 63.18 0.61 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.302 0.572 . . . . 0.0 110.645 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -107.96 13.97 25.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.252 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.62 10.23 86.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.397 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' GLN . . . . . 0.578 ' HB3' HD23 ' C' ' 22' ' ' LEU . 0.6 OUTLIER -106.7 152.27 24.01 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.644 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -93.36 137.94 32.18 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.274 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.616 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 61.8 m-85 -119.11 152.65 36.13 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.326 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' VAL . . . . . 0.703 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.1 OUTLIER -111.38 153.97 13.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 178.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.926 ' CZ ' HG21 ' C' ' 3' ' ' ILE . 0.0 OUTLIER -104.9 106.28 16.7 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.984 -177.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . 0.682 ' HE2' ' OD2' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -137.53 133.13 34.17 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 113.08 -1.873 . . . . 0.0 111.764 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . 0.682 ' OD2' ' HE2' ' C' ' 16' ' ' LYS . 0.4 OUTLIER 46.68 46.45 14.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.586 ' HA2' HH22 ' C' ' 15' ' ' ARG . . . 69.98 10.68 65.4 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.97 160.45 38.26 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.835 1.317 . . . . 0.0 112.349 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' TRP . . . . . 0.683 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 85.2 m95 -94.49 112.63 24.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.008 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.703 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.0 m -109.79 135.38 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.083 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' LEU . . . . . 0.578 HD23 ' HB3' ' C' ' 11' ' ' GLN . 1.3 mt -53.21 124.32 14.21 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.145 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . 0.572 ' O ' ' HG ' ' C' ' 27' ' ' LEU . 2.6 tp -58.23 -42.36 86.13 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.761 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -22.61 66.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.055 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 48.2 m -69.46 -18.95 63.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' PHE . . . . . 0.658 ' CD2' HD23 ' B' ' 23' ' ' LEU . 40.9 m-85 -100.34 -6.42 25.83 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.859 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.601 HD11 ' O ' ' A' ' 26' ' ' PHE . 2.6 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.661 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.769 ' CE2' ' HB2' ' C' ' 2' ' ' TYR . 0.4 OUTLIER . . . . . 0 CA--C 1.543 0.693 0 CA-C-O 119.912 -0.09 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.607 ' CG2' ' HE ' ' A' ' 15' ' ' ARG . 1.4 pt -104.74 158.96 30.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 37.2 Cg_endo -87.33 137.43 4.31 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.814 2.343 . . . . 0.0 111.802 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.737 ' OE2' ' NH2' ' B' ' 15' ' ' ARG . 2.9 tt0 -51.93 143.63 13.19 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.472 ' CB ' ' CG ' ' A' ' 20' ' ' TRP . . . -87.06 154.23 54.84 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.88 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.431 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 75.3 Cg_exo -51.73 157.34 5.57 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 123.613 2.875 . . . . 0.0 113.944 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -112.11 59.26 0.63 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.353 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -105.62 13.53 29.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.001 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' B' ' 16' ' ' LYS . . . 79.66 13.57 82.27 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.777 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.54 ' CG ' HD23 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -106.21 156.76 18.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 117.156 0.478 . . . . 0.0 109.734 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.837 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -98.2 134.29 41.46 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.591 0.71 . . . . 0.0 112.021 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.86 ' O ' HG22 ' B' ' 14' ' ' VAL . 68.6 m-85 -120.1 151.76 38.58 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.649 1.214 . . . . 0.0 111.888 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -112.98 157.76 13.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 113.105 -1.862 . . . . 0.0 106.566 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.972 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.56 106.05 16.39 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 118.579 -1.248 . . . . 0.0 109.437 -177.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.894 ' HG3' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -137.86 128.02 25.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.163 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.894 ' CG ' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 57.14 45.53 20.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 176.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.656 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 60.81 15.65 42.69 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.669 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -133.64 162.82 30.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.702 0.751 . . . . 0.0 111.767 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.972 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 84.0 m95 -97.21 110.83 23.3 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.948 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.734 ' O ' HG23 ' A' ' 14' ' ' VAL . 17.5 t -105.68 142.35 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.051 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.54 HD23 ' CG ' ' A' ' 11' ' ' GLN . 6.2 mt -56.41 124.56 18.53 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.057 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 23' ' ' LEU . 2.7 tp -58.73 -39.98 82.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.24 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.4 p -63.8 -18.89 64.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.205 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.7 m -69.13 -18.48 63.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.642 ' O ' HD11 ' C' ' 27' ' ' LEU . 86.5 m-85 -97.33 -3.32 40.69 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.612 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.698 HD13 ' O ' ' B' ' 26' ' ' PHE . 7.7 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.462 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.486 2.023 0 CA-C-O 120.315 -0.158 . . . . 0.0 112.826 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.627 ' HD2' ' HB3' ' A' ' 2' ' ' TYR . 3.1 m-30 -105.23 151.78 23.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.758 0.313 . . . . 0.0 111.549 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.813 HG22 ' NH2' ' B' ' 15' ' ' ARG . 5.8 pt -88.91 159.47 45.66 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.808 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 70.1 Cg_endo -87.21 151.79 8.09 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 122.29 1.993 . . . . 0.0 111.403 177.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.597 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 0.4 OUTLIER -57.32 143.34 40.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.144 -177.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.536 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -83.48 162.15 54.38 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.544 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.34 152.94 43.29 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.231 2.62 . . . . 0.0 112.98 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.507 ' HD3' ' N ' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -112.24 60.23 0.63 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.165 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -105.27 15.33 27.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.574 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.573 ' O ' ' HE3' ' C' ' 16' ' ' LYS . . . 79.56 14.85 80.73 Favored Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 120.203 -0.998 . . . . 0.0 112.824 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . 0.679 ' OE1' HD22 ' B' ' 22' ' ' LEU . 1.9 mm-40 -115.64 154.23 29.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.189 0.518 . . . . 0.0 110.585 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.639 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -93.43 134.18 35.94 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.391 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.502 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 74.6 m-85 -120.44 154.06 35.72 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.119 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -113.89 159.58 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 CA-C-N 113.368 -1.742 . . . . 0.0 106.634 176.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.881 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -103.2 107.31 18.07 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.74 -176.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.837 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -137.05 131.54 32.94 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 112.942 -1.936 . . . . 0.0 113.114 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.588 ' OD1' ' O ' ' B' ' 16' ' ' LYS . 0.5 OUTLIER 46.75 45.08 14.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.518 ' HA2' HH22 ' B' ' 15' ' ' ARG . . . 76.72 -3.38 55.96 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.395 -0.907 . . . . 0.0 114.748 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.24 161.36 27.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.863 0.831 . . . . 0.0 111.911 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' TRP . . . . . 0.881 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 91.5 m95 -93.7 114.66 27.0 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.285 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.419 ' O ' HG11 ' B' ' 14' ' ' VAL . 11.2 t -108.31 138.11 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 CA-C-O 121.898 0.856 . . . . 0.0 110.376 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.679 HD22 ' OE1' ' B' ' 11' ' ' GLN . 1.9 mt -53.77 124.05 14.11 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.223 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.561 HD11 ' CG ' ' C' ' 26' ' ' PHE . 0.2 OUTLIER -57.93 -44.19 86.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 18.0 t -48.42 -26.27 2.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.23 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 10.8 m -68.64 -19.1 64.4 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.245 0.545 . . . . 0.0 110.452 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.698 ' O ' HD13 ' A' ' 27' ' ' LEU . 81.6 m-85 -98.23 -4.47 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.64 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.584 HD12 ' O ' ' C' ' 26' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.103 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 2' ' ' TYR . . . . . 0.808 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.4 m-30 -100.49 167.59 10.27 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.789 0.328 . . . . 0.0 111.213 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . 0.733 HG21 ' CZ ' ' C' ' 15' ' ' ARG . 1.1 pt -102.55 157.95 32.71 Favored Pre-proline 0 CA--C 1.504 -0.819 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.276 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 9.7 Cg_endo -82.81 145.06 12.58 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 121.696 1.597 . . . . 0.0 111.577 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.656 ' OE2' ' HA2' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -57.55 143.01 42.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.309 -177.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' ALA . . . . . 0.599 ' HB1' ' CG ' ' C' ' 20' ' ' TRP . . . -84.09 170.37 14.14 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.306 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' PRO . . . . . 0.541 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 21.8 Cg_exo -61.8 149.06 91.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.772 2.315 . . . . 0.0 111.822 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -112.14 64.68 0.63 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.146 0.498 . . . . 0.0 110.882 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' ASP . . . . . 0.446 ' CG ' ' HG3' ' C' ' 11' ' ' GLN . 13.6 p-10 -121.28 23.02 10.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.505 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.575 ' C ' ' HE2' ' A' ' 16' ' ' LYS . . . 79.75 15.26 79.75 Favored Glycine 0 CA--C 1.508 -0.38 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.844 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' GLN . . . . . 0.464 ' C ' ' HB2' ' A' ' 16' ' ' LYS . 6.2 mt-30 -111.28 140.21 46.04 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 117.32 0.56 . . . . 0.0 110.837 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 26' ' ' PHE . . . -92.47 136.39 33.26 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.75 0.786 . . . . 0.0 110.785 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.541 ' CE2' ' HD2' ' C' ' 7' ' ' PRO . 69.1 m-85 -121.12 152.15 39.06 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.847 1.308 . . . . 0.0 112.32 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' VAL . . . . . 0.753 HG21 ' O ' ' C' ' 21' ' ' VAL . 0.0 OUTLIER -107.06 154.58 7.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 177.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.747 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.67 107.45 18.45 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.208 -178.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . 0.85 ' HG2' ' CG ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -137.1 134.45 36.46 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.106 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . 0.85 ' CG ' ' HG2' ' C' ' 16' ' ' LYS . 0.0 OUTLIER 48.45 45.6 20.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 176.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.428 ' O ' ' NH2' ' C' ' 15' ' ' ARG . . . 65.53 8.99 41.97 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -129.78 161.31 31.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.198 0.999 . . . . 0.0 111.358 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' TRP . . . . . 0.747 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 87.9 m95 -93.84 120.39 34.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.987 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.753 ' O ' HG21 ' C' ' 14' ' ' VAL . 11.1 t -113.0 137.79 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.549 0.69 . . . . 0.0 110.309 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.2 mt -57.6 127.64 33.05 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.981 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . 0.598 HD23 ' CB ' ' A' ' 26' ' ' PHE . 6.6 tp -58.79 -35.04 72.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.448 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -19.87 65.99 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 122.245 -0.285 . . . . 0.0 111.338 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -68.64 -18.25 64.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' PHE . . . . . 0.584 ' O ' HD12 ' B' ' 27' ' ' LEU . 93.3 m-85 -99.13 -7.78 26.14 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.011 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.642 HD11 ' O ' ' A' ' 26' ' ' PHE . 5.7 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.064 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.615 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 3.6 m-85 . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 120.539 0.209 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.775 HG22 ' CZ ' ' A' ' 15' ' ' ARG . 4.3 pt -94.39 157.72 36.89 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-O 120.974 0.416 . . . . 0.0 111.975 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 21.4 Cg_endo -88.19 147.07 6.52 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 122.596 2.198 . . . . 0.0 111.102 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.824 ' OE2' ' NH2' ' B' ' 15' ' ' ARG . 1.3 tt0 -58.14 143.02 45.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.644 -176.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.528 ' HB1' ' CG ' ' A' ' 20' ' ' TRP . . . -86.42 163.8 40.6 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.976 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.63 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 31.3 Cg_exo -56.74 152.93 39.19 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.832 2.355 . . . . 0.0 112.824 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.582 ' CZ ' ' H ' ' B' ' 18' ' ' GLY . 0.0 OUTLIER -112.07 63.86 0.62 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.48 0.657 . . . . 0.0 111.594 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -110.78 14.67 22.19 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.478 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.829 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 79.12 15.93 79.55 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.642 ' CG ' HD21 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -109.81 148.17 31.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.584 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -91.68 135.2 34.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.293 0.568 . . . . 0.0 112.178 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.778 ' O ' HG23 ' B' ' 14' ' ' VAL . 65.6 m-85 -117.59 148.34 42.01 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 123.026 1.393 . . . . 0.0 111.905 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -107.01 154.26 7.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 112.1 -2.318 . . . . 0.0 104.813 177.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.775 ' CZ ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -104.77 106.98 17.7 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 118.057 -1.457 . . . . 0.0 108.274 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' C' ' 11' ' ' GLN . 0.2 OUTLIER -137.63 124.39 21.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.681 -178.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.89 46.84 16.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.45 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 65.97 6.29 30.63 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.741 -0.743 . . . . 0.0 114.554 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -129.74 161.95 29.52 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 117.894 0.847 . . . . 0.0 111.819 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.754 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 87.9 m95 -95.89 119.76 34.97 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.363 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.559 ' O ' HG21 ' A' ' 14' ' ' VAL . 15.9 t -114.5 141.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 CA-C-O 121.702 0.763 . . . . 0.0 109.933 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.642 HD21 ' CG ' ' A' ' 11' ' ' GLN . 1.7 mt -57.61 126.94 29.56 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.81 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.612 ' CD1' HD13 ' C' ' 23' ' ' LEU . 1.3 tp -60.36 -45.16 94.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.983 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.466 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 52.8 p -63.43 -19.05 64.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.752 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 m -69.38 -19.28 63.83 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.75 ' O ' ' CD2' ' C' ' 27' ' ' LEU . 87.9 m-85 -97.26 -2.47 42.59 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.789 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.718 HD12 ' O ' ' B' ' 26' ' ' PHE . 1.5 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.414 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.551 ' HA ' ' H ' ' A' ' 5' ' ' GLU . 5.5 m-85 -134.98 131.62 37.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.495 0.188 . . . . 0.0 110.988 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.672 HG21 ' CG ' ' A' ' 5' ' ' GLU . 21.3 pt -85.16 156.46 60.16 Favored Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 120.695 0.283 . . . . 0.0 110.8 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 71.8 Cg_endo -87.25 155.99 8.17 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.47 2.113 . . . . 0.0 111.524 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.669 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 0.6 OUTLIER -57.68 143.53 41.26 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.201 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.733 ' HB3' ' CG ' ' B' ' 20' ' ' TRP . . . -86.67 153.7 55.58 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.653 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.738 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 3.1 Cg_exo -50.48 153.81 7.06 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.48 2.787 . . . . 0.0 113.401 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.554 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -111.73 73.66 0.83 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.571 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -114.72 11.04 16.75 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.705 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' C' ' 16' ' ' LYS . . . 78.99 14.99 81.37 Favored Glycine 0 CA--C 1.512 -0.144 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.583 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . 0.595 ' O ' ' HB2' ' C' ' 16' ' ' LYS . 0.0 OUTLIER -118.73 158.52 25.39 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.096 0.474 . . . . 0.0 110.536 179.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.6 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.54 135.83 33.73 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.392 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.738 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 51.3 m-85 -120.64 153.53 36.73 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-N 114.42 -1.264 . . . . 0.0 112.088 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -116.15 159.13 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 113.802 -1.544 . . . . 0.0 107.956 176.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.83 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.09 107.24 18.12 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 122.104 0.954 . . . . 0.0 110.23 -176.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.829 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -137.63 125.63 22.8 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.612 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.53 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 56.81 41.81 27.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.582 ' H ' ' CZ ' ' A' ' 8' ' ' ARG . . . 69.59 10.54 63.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.46 159.55 36.73 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 118.233 1.017 . . . . 0.0 111.881 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' TRP . . . . . 0.83 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 90.5 m95 -93.42 113.15 25.24 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.07 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 18.7 t -109.55 136.94 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.161 0 CA-C-O 121.815 0.817 . . . . 0.0 110.43 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.489 HD23 ' CG ' ' B' ' 11' ' ' GLN . 4.9 mt -51.56 123.11 9.2 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.031 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.743 HD21 ' CG ' ' C' ' 26' ' ' PHE . 7.3 tp -57.01 -36.03 69.93 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.545 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -63.04 -17.3 62.09 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.601 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 3.4 m -71.48 -19.59 62.19 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.718 ' O ' HD12 ' A' ' 27' ' ' LEU . 90.4 m-85 -99.34 -3.62 33.55 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.159 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.759 ' CD2' ' O ' ' C' ' 26' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.196 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' B' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.106 0 N-CA-C 112.688 -0.165 . . . . 0.0 112.688 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 2' ' ' TYR . . . . . 0.618 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.0 m-85 -127.14 147.14 50.19 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.923 0.362 . . . . 0.0 111.653 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . 0.768 HG21 ' CZ ' ' C' ' 15' ' ' ARG . 2.3 pt -87.04 157.89 53.57 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 121.004 0.431 . . . . 0.0 111.589 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 19.2 Cg_endo -87.86 148.54 7.07 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 122.33 2.02 . . . . 0.0 110.873 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.667 ' OE2' ' NH2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -57.59 143.38 41.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.584 -177.058 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' ALA . . . . . 0.515 ' N ' ' HG3' ' C' ' 5' ' ' GLU . . . -85.29 162.24 49.33 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.449 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' PRO . . . . . 0.49 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 32.3 Cg_exo -56.78 155.08 28.68 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.004 2.469 . . . . 0.0 113.171 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.78 79.02 1.21 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.458 0.647 . . . . 0.0 111.601 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -125.15 11.62 8.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.355 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.67 10.66 85.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.07 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' GLN . . . . . 0.784 ' OE1' HD12 ' C' ' 22' ' ' LEU . 0.6 OUTLIER -102.02 151.1 22.54 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.494 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -92.83 136.57 33.13 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.273 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.603 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 49.1 m-85 -117.99 155.42 30.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.554 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' B' ' 23' ' ' LEU . 4.4 t -123.93 134.9 65.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.807 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -80.59 109.14 14.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.998 0.904 . . . . 0.0 111.204 -175.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . 0.6 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -136.1 123.0 21.32 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 113.832 -1.531 . . . . 0.0 112.128 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . 0.554 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER 55.11 45.98 24.97 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 176.021 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.456 ' HA2' ' NH2' ' C' ' 15' ' ' ARG . . . 65.53 13.52 58.69 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 119.474 -0.626 . . . . 0.0 114.543 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' C' ' 16' ' ' LYS . 0.1 OUTLIER -133.05 161.41 34.44 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.488 1.144 . . . . 0.0 111.346 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' TRP . . . . . 0.807 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 82.3 m95 -93.35 116.19 28.75 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.087 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.539 HG22 ' HB ' ' C' ' 14' ' ' VAL . 1.7 m -108.29 129.57 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 CA-C-O 122.032 0.92 . . . . 0.0 111.25 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' LEU . . . . . 0.784 HD12 ' OE1' ' C' ' 11' ' ' GLN . 2.1 mt -51.42 123.45 9.78 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.62 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . 0.612 HD13 ' CD1' ' A' ' 23' ' ' LEU . 11.8 tp -60.37 -42.75 96.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.014 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -20.5 64.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.55 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 30.1 m -68.31 -18.59 64.55 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' PHE . . . . . 0.759 ' O ' ' CD2' ' B' ' 27' ' ' LEU . 52.8 m-85 -100.93 -8.77 22.17 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.073 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.75 ' CD2' ' O ' ' A' ' 26' ' ' PHE . 2.6 tp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.11 -0.947 . . . . 0.0 111.105 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.754 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 8.4 m-30 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 121.195 0.521 . . . . 0.0 111.86 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.596 HD13 ' CZ2' ' C' ' 20' ' ' TRP . 0.7 OUTLIER -92.74 159.59 35.92 Favored Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.501 178.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 43.1 Cg_endo -88.13 144.15 5.94 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.418 2.079 . . . . 0.0 111.487 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.654 ' OE2' ' NH2' ' B' ' 15' ' ' ARG . 0.6 OUTLIER -50.27 142.77 9.53 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.244 -178.195 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.541 ' HB3' ' CG ' ' A' ' 20' ' ' TRP . . . -87.13 166.24 27.2 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.563 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.516 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 34.5 Cg_exo -57.03 148.7 67.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.336 2.024 . . . . 0.0 111.627 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.416 ' HG2' ' N ' ' B' ' 18' ' ' GLY . 85.7 mtt180 -112.58 62.68 0.63 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.078 0.466 . . . . 0.0 111.928 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -114.78 18.07 16.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.135 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.887 ' O ' ' HE2' ' B' ' 16' ' ' LYS . . . 79.02 14.6 81.77 Favored Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.864 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.461 ' HB3' ' CD2' ' A' ' 22' ' ' LEU . 3.7 mm-40 -103.88 141.64 35.78 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -91.88 134.87 34.38 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.534 0.683 . . . . 0.0 110.914 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.876 ' O ' HG23 ' B' ' 14' ' ' VAL . 53.7 m-85 -120.04 149.75 41.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.409 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.599 HG23 ' CE2' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -104.61 156.64 5.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 176.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 1.022 HH11 ' HG3' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -105.86 115.76 30.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.644 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' C' ' 11' ' ' GLN . 1.0 OUTLIER -151.69 129.17 11.38 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.825 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.646 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 0.1 OUTLIER 54.89 42.24 31.26 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.718 177.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 62.44 16.45 54.73 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 119.358 -0.69 . . . . 0.0 114.742 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.646 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -131.87 161.62 32.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.801 1.301 . . . . 0.0 111.613 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.985 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 91.5 m95 -99.47 112.32 24.53 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.892 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.471 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 17.9 t -108.6 139.74 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.453 0.644 . . . . 0.0 109.652 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 11' ' ' GLN . 1.3 mt -55.79 126.71 26.78 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.935 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.526 ' CD2' ' CG ' ' B' ' 26' ' ' PHE . 3.3 tp -58.46 -39.49 80.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.164 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -19.14 64.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.046 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.3 m -70.12 -18.58 63.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.093 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.599 ' CE2' HG23 ' A' ' 14' ' ' VAL . 80.7 m-85 -97.25 -1.82 44.02 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.847 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 1.011 ' CD1' ' O ' ' B' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.048 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 CA-C-O 120.19 -0.228 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.504 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 4.4 m-85 -132.33 135.69 46.36 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 110.896 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.678 ' CG2' ' HE ' ' B' ' 15' ' ' ARG . 6.1 pt -87.19 159.31 51.14 Favored Pre-proline 0 CA--C 1.513 -0.462 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 92.0 Cg_endo -91.04 148.56 3.77 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 122.949 2.433 . . . . 0.0 111.376 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.779 ' OE2' ' HA2' ' C' ' 18' ' ' GLY . 0.9 OUTLIER -58.22 142.85 46.34 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.758 0.79 . . . . 0.0 112.959 -177.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.565 ' CB ' ' CG ' ' B' ' 20' ' ' TRP . . . -83.17 155.25 67.05 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.99 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.694 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 5.0 Cg_exo -45.75 152.7 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.743 2.962 . . . . 0.0 113.678 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' C' ' 17' ' ' ASP . 3.6 mtp180 -111.93 62.27 0.62 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.586 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -109.03 15.37 23.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.643 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.549 ' C ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.23 14.73 81.34 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.852 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . 0.636 ' O ' ' HB2' ' C' ' 16' ' ' LYS . 38.5 mm-40 -109.01 147.18 32.71 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 120.966 0.412 . . . . 0.0 110.508 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.607 ' HB1' ' CZ ' ' C' ' 26' ' ' PHE . . . -92.57 136.16 33.46 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.638 0.732 . . . . 0.0 109.469 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.694 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 50.7 m-85 -122.09 155.46 35.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.264 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 13' ' ' TYR . 1.5 p -114.93 159.81 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.477 175.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.986 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -102.95 114.42 28.7 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.133 0.968 . . . . 0.0 110.124 -176.225 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.887 ' HE2' ' O ' ' A' ' 10' ' ' GLY . 2.0 tttm -149.01 127.93 12.64 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.788 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 0.2 OUTLIER 56.29 45.25 23.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.444 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 62.13 14.13 45.22 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 119.484 -0.62 . . . . 0.0 114.196 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' B' ' 17' ' ' ASP . 0.1 OUTLIER -133.1 163.22 29.73 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.525 1.162 . . . . 0.0 112.011 -178.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' TRP . . . . . 0.986 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 92.5 m95 -97.65 113.02 24.68 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.204 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.588 ' O ' HG13 ' B' ' 14' ' ' VAL . 6.2 t -108.24 139.27 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 121.925 0.869 . . . . 0.0 110.333 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.522 ' CD2' ' HB3' ' B' ' 11' ' ' GLN . 3.8 mt -55.21 125.11 19.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.061 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.564 ' O ' HD12 ' B' ' 23' ' ' LEU . 3.8 tp -57.77 -39.4 77.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.521 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 29.8 t -63.23 -17.34 62.34 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.708 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 18.3 m -70.37 -20.27 62.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 1.011 ' O ' ' CD1' ' A' ' 27' ' ' LEU . 88.1 m-85 -96.89 -15.54 21.15 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.575 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.945 HD21 ' O ' ' C' ' 26' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.99 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 2' ' ' TYR . . . . . 0.643 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.1 m-30 -98.01 161.15 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.352 . . . . 0.0 111.524 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . 0.616 HG21 ' CD ' ' B' ' 5' ' ' GLU . 1.5 pt -90.09 158.4 44.2 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.765 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.754 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 43.7 Cg_endo -90.23 153.99 4.64 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 122.432 2.088 . . . . 0.0 112.285 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.519 ' OE2' ' HA2' ' A' ' 18' ' ' GLY . 1.1 tp10 -57.56 142.4 44.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.917 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' ALA . . . . . 0.845 ' H ' HH12 ' A' ' 15' ' ' ARG . . . -89.08 162.89 36.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 113.699 -1.592 . . . . 0.0 110.864 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' PRO . . . . . 0.479 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 31.8 Cg_exo -57.27 152.39 46.17 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.075 2.517 . . . . 0.0 113.52 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -111.77 67.75 0.65 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.128 0.489 . . . . 0.0 111.095 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' ASP . . . . . 0.516 ' OD1' ' HB2' ' C' ' 11' ' ' GLN . 6.1 p30 -116.72 12.98 15.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.107 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.492 ' HA2' ' NZ ' ' A' ' 16' ' ' LYS . . . 84.08 14.68 71.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.203 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' GLN . . . . . 0.592 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 19.1 mt-30 -110.79 150.56 28.94 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.492 0.663 . . . . 0.0 110.892 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . . . -92.52 136.87 32.85 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.477 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.574 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 59.3 m-85 -118.99 156.12 30.17 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.035 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' VAL . . . . . 0.871 HG22 ' O ' ' C' ' 21' ' ' VAL . 0.2 OUTLIER -115.25 157.04 16.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.946 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.63 115.31 30.03 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 122.045 0.926 . . . . 0.0 110.903 -176.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . 0.636 ' HB2' ' O ' ' B' ' 11' ' ' GLN . 0.5 OUTLIER -153.47 132.96 12.89 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.339 -178.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . 0.417 ' HA ' ' HG2' ' B' ' 8' ' ' ARG . 0.2 OUTLIER 55.17 45.04 26.77 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 176.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.779 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.21 16.84 50.5 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-O 119.382 -0.677 . . . . 0.0 114.167 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -137.33 164.63 28.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.661 1.231 . . . . 0.0 112.255 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' TRP . . . . . 0.946 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 90.3 m95 -96.49 115.11 26.89 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.162 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.871 ' O ' HG22 ' C' ' 14' ' ' VAL . 2.7 m -105.81 134.81 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.153 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' LEU . . . . . 0.472 ' CD2' ' HB3' ' C' ' 11' ' ' GLN . 3.5 mt -55.44 122.03 10.31 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . 0.56 ' CD2' ' CG ' ' A' ' 26' ' ' PHE . 4.5 tp -59.12 -38.24 79.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.498 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 28.7 t -62.44 -18.94 62.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.89 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' THR . . . . . 0.422 ' O ' HG22 ' C' ' 25' ' ' THR . 29.6 m -69.23 -18.03 63.84 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' PHE . . . . . 0.945 ' O ' HD21 ' B' ' 27' ' ' LEU . 70.9 m-85 -101.04 -10.62 20.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.466 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.503 HD11 ' HB3' ' A' ' 26' ' ' PHE . 25.4 mt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.873 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.689 ' HB3' ' O ' ' C' ' 3' ' ' ILE . 5.9 m-85 . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 121.287 0.565 . . . . 0.0 112.23 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.843 HG22 ' CZ ' ' A' ' 15' ' ' ARG . 3.5 pt -91.68 159.52 38.31 Favored Pre-proline 0 CA--C 1.51 -0.578 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.186 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 55.5 Cg_endo -84.58 139.71 7.91 Favored 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 121.17 1.247 . . . . 0.0 111.201 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.574 ' CB ' HG21 ' B' ' 3' ' ' ILE . 0.5 OUTLIER -47.97 143.03 4.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.59 -1.187 . . . . 0.0 113.87 -177.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.731 ' HA ' ' CD1' ' A' ' 20' ' ' TRP . . . -84.05 177.65 2.86 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.66 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.919 ' HB2' ' OD2' ' A' ' 9' ' ' ASP . 2.7 Cg_exo -75.5 155.23 40.64 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.576 2.851 . . . . 0.0 114.037 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' HG3' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -105.01 79.67 1.53 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 178.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.919 ' OD2' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -124.84 3.03 8.13 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.198 -178.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.49 0.36 83.61 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 119.571 -1.299 . . . . 0.0 111.188 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.803 ' O ' ' HB2' ' B' ' 16' ' ' LYS . 0.1 OUTLIER -101.69 151.76 21.64 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.475 ' HB1' ' HB ' ' B' ' 14' ' ' VAL . . . -91.48 137.94 31.97 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.439 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.615 ' CD2' ' HD2' ' A' ' 7' ' ' PRO . 47.5 m-85 -118.5 155.69 30.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.081 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.615 HG11 ' CD1' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -105.1 150.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.953 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.55 99.41 9.09 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.541 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 0.3 OUTLIER -136.0 125.73 25.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 112.777 -2.011 . . . . 0.0 113.172 -176.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.96 43.11 30.42 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.616 ' HA2' ' NH1' ' A' ' 15' ' ' ARG . . . 74.85 6.65 78.95 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.168 -1.015 . . . . 0.0 115.109 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.88 161.54 35.34 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.992 1.396 . . . . 0.0 112.396 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.953 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 97.3 m95 -94.32 115.25 27.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.651 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.562 ' C ' ' HD1' ' A' ' 13' ' ' TYR . 22.0 t -107.21 136.84 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 121.904 0.859 . . . . 0.0 108.791 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.662 HD23 ' OE1' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -53.92 122.64 10.47 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.321 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.59 HD22 ' CB ' ' B' ' 26' ' ' PHE . 4.9 tp -57.26 -36.06 70.52 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.683 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.442 ' HB2' HD11 ' A' ' 22' ' ' LEU . 25.9 m -61.47 -17.76 55.92 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.243 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 25' ' ' THR . 27.3 m -72.23 -18.39 61.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.615 ' CD1' HG11 ' A' ' 14' ' ' VAL . 88.9 m-85 -99.34 -10.54 22.18 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.332 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' B' ' 26' ' ' PHE . 9.3 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.689 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 119.733 -0.482 . . . . 0.0 111.972 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.626 ' CD2' ' HB2' ' A' ' 2' ' ' TYR . 3.6 m-85 -134.57 138.51 44.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.748 0.774 . . . . 0.0 110.809 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.574 HG21 ' CB ' ' A' ' 5' ' ' GLU . 0.8 OUTLIER -88.2 158.49 49.42 Favored Pre-proline 0 N--CA 1.47 0.528 0 CA-C-O 121.4 0.619 . . . . 0.0 112.621 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 87.8 Cg_endo -92.17 156.3 3.2 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 123.056 2.504 . . . . 0.0 111.232 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.847 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 0.7 OUTLIER -57.85 141.99 47.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -177.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.6 ' CB ' ' CD1' ' B' ' 20' ' ' TRP . . . -88.15 158.68 49.33 Favored Pre-proline 0 C--N 1.334 -0.103 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.361 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.476 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 10.1 Cg_endo -51.39 152.76 11.22 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.428 2.085 . . . . 0.0 111.68 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -114.85 67.95 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.471 0.653 . . . . 0.0 111.6 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -109.55 16.0 22.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.639 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.16 31.89 63.51 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.387 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . 0.634 ' O ' ' HA ' ' C' ' 16' ' ' LYS . 19.8 mm-40 -123.47 149.42 45.13 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.567 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.61 135.92 33.67 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.855 0.836 . . . . 0.0 111.66 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.538 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 80.7 m-85 -122.24 152.67 39.78 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 123.382 1.563 . . . . 0.0 112.654 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.49 HG23 ' O ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -106.99 156.69 7.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 111.266 -2.697 . . . . 0.0 105.93 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.931 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.19 105.55 15.64 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 118.76 -1.176 . . . . 0.0 108.13 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.803 ' HB2' ' O ' ' A' ' 11' ' ' GLN . 4.4 pttt -138.78 132.61 30.93 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 113.224 -1.807 . . . . 0.0 111.661 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.538 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 58.17 42.99 21.25 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 176.061 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.484 ' HA3' ' NH1' ' A' ' 8' ' ' ARG . . . 60.05 14.81 33.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.216 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -134.96 165.41 25.39 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 117.437 0.618 . . . . 0.0 111.842 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' TRP . . . . . 0.931 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 94.7 m95 -98.11 112.14 24.21 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.742 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.639 HG22 ' HG2' ' B' ' 16' ' ' LYS . 17.0 t -106.12 141.44 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 CA-C-O 121.848 0.833 . . . . 0.0 109.65 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.515 HD23 ' OE1' ' B' ' 11' ' ' GLN . 2.6 mt -57.27 127.72 33.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.999 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.575 HD22 ' CB ' ' C' ' 26' ' ' PHE . 5.7 tp -61.67 -40.04 93.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.579 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -19.77 66.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.176 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -68.32 -18.02 64.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.59 ' CB ' HD22 ' A' ' 23' ' ' LEU . 91.3 m-85 -99.29 -4.93 30.7 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.577 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.568 HD13 ' O ' ' C' ' 26' ' ' PHE . 4.5 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.227 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.714 -0.154 . . . . 0.0 112.714 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 2' ' ' TYR . . . . . 0.603 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.5 m-85 -120.3 146.57 45.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.932 0.396 . . . . 0.0 111.656 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . 0.689 ' O ' ' HB3' ' A' ' 2' ' ' TYR . 1.0 OUTLIER -92.11 158.65 39.03 Favored Pre-proline 0 CA--C 1.501 -0.926 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.592 178.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.684 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 75.7 Cg_endo -86.73 146.86 8.21 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.83 1.687 . . . . 0.0 112.426 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.579 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 1.8 tt0 -57.41 143.41 40.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 113.803 -1.544 . . . . 0.0 113.464 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' ALA . . . . . 0.491 ' CB ' ' CD1' ' C' ' 20' ' ' TRP . . . -85.3 153.36 59.17 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.411 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.85 153.69 5.75 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.142 2.561 . . . . 0.0 112.986 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' ARG . . . . . 0.42 ' NH2' ' OE1' ' C' ' 5' ' ' GLU . 8.8 mtt85 -112.79 57.28 0.66 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.914 0.388 . . . . 0.0 111.782 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' ASP . . . . . 0.478 ' OD1' ' HB2' ' C' ' 11' ' ' GLN . 2.5 p30 -105.63 18.71 21.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' A' ' 16' ' ' LYS . . . 80.0 10.51 85.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.604 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' GLN . . . . . 0.612 ' HA ' ' NE2' ' C' ' 11' ' ' GLN . 0.2 OUTLIER -103.85 154.09 20.0 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 117.669 0.734 . . . . 0.0 109.271 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -95.91 134.26 39.12 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.529 0.68 . . . . 0.0 111.82 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.69 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 51.4 m-85 -117.51 154.68 31.05 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.783 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' VAL . . . . . 0.621 ' HB ' HG21 ' C' ' 21' ' ' VAL . 1.7 t -118.36 156.7 20.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.867 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -104.99 108.25 19.67 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.941 -177.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . 0.634 ' HA ' ' O ' ' B' ' 11' ' ' GLN . 0.0 OUTLIER -136.38 121.18 18.58 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.621 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.55 45.93 18.6 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.029 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.559 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 62.31 14.6 48.7 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.629 0.612 . . . . 0.0 114.629 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -130.19 162.2 29.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.3 1.05 . . . . 0.0 111.737 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' TRP . . . . . 0.867 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 68.0 m95 -96.27 114.71 26.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.715 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.621 HG21 ' HB ' ' C' ' 14' ' ' VAL . 2.3 m -111.35 130.66 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.117 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' LEU . . . . . 0.484 HD23 ' HG3' ' C' ' 11' ' ' GLN . 1.2 mt -53.46 125.02 16.48 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.101 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . 0.789 HD23 ' O ' ' C' ' 23' ' ' LEU . 0.2 OUTLIER -60.38 -36.62 78.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.737 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.08 -19.5 64.47 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.203 -0.311 . . . . 0.0 110.829 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' THR . . . . . 0.425 HG23 ' O ' ' C' ' 25' ' ' THR . 51.7 m -69.04 -18.4 64.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' PHE . . . . . 0.575 ' CB ' HD22 ' B' ' 23' ' ' LEU . 59.1 m-85 -100.06 -8.94 23.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.317 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.584 HD13 ' O ' ' A' ' 26' ' ' PHE . 5.5 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.176 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.788 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 19.6 m-85 . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.792 0.329 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.744 HG22 ' CZ ' ' A' ' 15' ' ' ARG . 1.1 pt -92.12 158.01 40.01 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.193 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 10.3 Cg_endo -82.49 147.7 14.15 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 121.764 1.643 . . . . 0.0 110.605 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.59 ' HA ' ' CG2' ' B' ' 3' ' ' ILE . 0.6 OUTLIER -58.36 142.9 46.82 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -176.666 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.51 ' HA ' ' CD1' ' A' ' 20' ' ' TRP . . . -87.14 160.74 48.33 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.317 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.475 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 51.9 Cg_exo -55.06 153.63 25.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.332 2.688 . . . . 0.0 113.621 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 71.3 mtm-85 -112.03 83.15 1.74 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.45 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -128.42 13.5 6.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.66 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.669 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 78.79 13.36 83.21 Favored Glycine 0 CA--C 1.51 -0.253 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.819 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.656 ' O ' ' HB2' ' B' ' 16' ' ' LYS . 11.5 mt-30 -115.55 148.75 39.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.848 0.356 . . . . 0.0 110.112 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' B' ' 14' ' ' VAL . . . -90.88 138.52 31.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 122.131 0.967 . . . . 0.0 112.562 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.538 ' HB3' ' HB3' ' A' ' 20' ' ' TRP . 61.9 m-85 -118.57 152.77 35.38 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.395 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.866 HG11 ' O ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -114.46 157.22 15.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.785 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.91 104.26 13.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.798 0.809 . . . . 0.0 111.524 -176.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 1.1 tttt -135.39 128.38 31.49 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.204 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.486 ' HA ' ' CG ' ' C' ' 8' ' ' ARG . 0.2 OUTLIER 55.33 44.97 26.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 63.14 15.92 57.06 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 114.993 0.757 . . . . 0.0 114.993 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -132.33 158.57 41.57 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.575 1.188 . . . . 0.0 111.777 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.785 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 92.7 m95 -94.92 115.67 27.75 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.182 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.866 ' O ' HG11 ' A' ' 14' ' ' VAL . 14.2 t -111.21 141.24 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-O 121.693 0.759 . . . . 0.0 110.185 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.504 HD23 ' HB3' ' A' ' 11' ' ' GLN . 2.4 mt -57.29 125.37 22.47 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.596 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.797 HD21 ' CG ' ' B' ' 26' ' ' PHE . 7.4 tp -57.49 -35.48 70.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.45 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -63.97 -20.06 65.61 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.36 -0.213 . . . . 0.0 111.146 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 m -68.81 -18.09 64.12 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.35 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 1.228 ' O ' HD11 ' C' ' 27' ' ' LEU . 80.7 m-85 -95.9 -21.36 18.11 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.662 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.686 HD11 ' O ' ' B' ' 26' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.168 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 120.209 -0.217 . . . . 0.0 113.166 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 3.4 m-85 -120.97 143.58 48.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.983 0.391 . . . . 0.0 110.93 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.746 HG22 ' NE ' ' B' ' 15' ' ' ARG . 5.0 pt -86.97 158.19 53.42 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 120.953 0.406 . . . . 0.0 112.031 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 84.0 Cg_endo -91.59 153.21 3.52 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.49 2.127 . . . . 0.0 111.671 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.651 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 0.6 OUTLIER -58.26 143.48 44.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.701 -177.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.477 ' HB3' ' CG ' ' B' ' 20' ' ' TRP . . . -86.99 171.39 10.07 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.795 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.468 ' HD2' ' CD2' ' B' ' 13' ' ' TYR . 18.8 Cg_exo -64.46 151.89 83.75 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.443 2.762 . . . . 0.0 113.028 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.425 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.3 OUTLIER -111.91 49.61 0.89 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -99.93 14.92 28.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.471 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.599 ' O ' ' HD2' ' C' ' 16' ' ' LYS . . . 79.64 15.04 80.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.169 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . 0.482 HE21 ' HA ' ' B' ' 11' ' ' GLN . 1.8 mm-40 -103.52 146.82 27.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.676 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -94.28 133.76 37.48 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.954 0.883 . . . . 0.0 112.339 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.659 ' HA ' ' O ' ' B' ' 21' ' ' VAL . 74.8 m-85 -121.31 152.9 38.41 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 123.148 1.451 . . . . 0.0 112.354 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.7 HG23 ' O ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -113.22 158.01 13.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 111.766 -2.47 . . . . 0.0 106.264 178.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.746 ' NE ' HG22 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -104.29 107.4 18.29 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 118.845 -1.142 . . . . 0.0 108.779 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.669 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -136.81 125.23 23.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.432 -178.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 55.04 44.94 27.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 176.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.466 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 62.19 16.14 52.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 115.222 0.849 . . . . 0.0 115.222 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' B' ' 16' ' ' LYS . 0.0 OUTLIER -134.81 161.3 35.58 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 118.624 1.212 . . . . 0.0 111.575 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' TRP . . . . . 0.592 ' HB3' ' CG ' ' B' ' 13' ' ' TYR . 90.0 m95 -97.02 112.82 24.4 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.515 0.674 . . . . 0.0 110.495 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.7 ' O ' HG23 ' B' ' 14' ' ' VAL . 0.5 OUTLIER -110.59 153.3 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.572 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.968 179.036 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.482 ' CD2' ' O ' ' B' ' 12' ' ' ALA . 3.9 mt -67.98 126.76 30.49 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 113.503 -1.68 . . . . 0.0 114.89 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.538 HD11 ' O ' ' B' ' 23' ' ' LEU . 3.5 tp -60.72 -43.77 97.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.887 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 14.3 m -63.59 -16.85 62.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.421 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.411 ' O ' HG22 ' B' ' 25' ' ' THR . 13.2 m -69.66 -17.51 63.5 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.797 ' CG ' HD21 ' A' ' 23' ' ' LEU . 24.8 m-85 -100.61 -5.6 26.47 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.358 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.85 HD12 ' O ' ' C' ' 26' ' ' PHE . 15.3 mt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.251 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 CA-C-O 120.275 -0.18 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 2' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.6 m-85 -128.53 141.0 51.51 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.88 0.34 . . . . 0.0 111.015 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . 0.751 ' CG2' ' HE ' ' C' ' 15' ' ' ARG . 2.3 pt -88.54 157.58 49.56 Favored Pre-proline 0 CA--C 1.496 -1.113 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.236 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.788 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 20.8 Cg_endo -86.35 147.45 8.78 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.821 1.681 . . . . 0.0 111.856 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.631 ' OE2' ' NH2' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -57.8 143.16 43.19 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.944 -177.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' C' ' 5' ' ' GLU . . . -85.59 152.38 57.21 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.856 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' PRO . . . . . 0.425 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 72.0 Cg_exo -49.73 156.02 3.46 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.519 2.813 . . . . 0.0 113.88 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' ARG . . . . . 0.486 ' CG ' ' HA ' ' A' ' 17' ' ' ASP . 2.6 mtp85 -111.9 57.25 0.64 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.994 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -102.09 17.9 22.12 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.784 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.34 11.0 75.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.795 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' GLN . . . . . 0.489 ' HB3' HD22 ' C' ' 22' ' ' LEU . 86.8 mt-30 -106.49 151.86 24.41 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.62 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -92.41 137.17 32.59 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.999 0.904 . . . . 0.0 112.627 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.528 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 79.8 m-85 -120.99 158.22 28.23 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.807 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' VAL . . . . . 0.56 HG22 ' O ' ' B' ' 13' ' ' TYR . 0.1 OUTLIER -125.45 159.46 32.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 113.357 -1.747 . . . . 0.0 106.495 177.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.984 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -103.67 107.71 18.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 122.436 1.113 . . . . 0.0 110.743 -175.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . 0.676 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 0.2 OUTLIER -136.57 133.23 36.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.995 -1.911 . . . . 0.0 110.365 178.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . 0.596 ' OD1' ' O ' ' C' ' 16' ' ' LYS . 0.1 OUTLIER 48.31 46.17 20.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 177.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.493 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.48 16.21 49.22 Favored Glycine 0 N--CA 1.453 -0.194 0 N-CA-C 114.373 0.509 . . . . 0.0 114.373 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -131.57 159.1 39.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 117.756 0.778 . . . . 0.0 111.666 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' TRP . . . . . 0.984 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 87.9 m95 -93.67 109.35 21.0 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.418 0.627 . . . . 0.0 110.33 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' C' ' 13' ' ' TYR . 5.9 t -103.81 135.82 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.913 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' LEU . . . . . 0.489 HD22 ' HB3' ' C' ' 11' ' ' GLN . 7.2 mt -50.37 122.44 6.99 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.797 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . 0.497 HD11 ' O ' ' C' ' 23' ' ' LEU . 1.3 tp -58.02 -39.91 79.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.546 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 35.4 t -64.2 -17.46 63.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.476 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' C' ' 22' ' ' LEU . 5.2 m -70.11 -18.76 63.26 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' PHE . . . . . 0.85 ' O ' HD12 ' B' ' 27' ' ' LEU . 89.7 m-85 -98.09 0.86 46.89 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.6 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 1.228 HD11 ' O ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.257 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.771 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 15.4 m-85 . . . . . 0 CA--C 1.531 0.218 0 CA-C-O 121.577 0.703 . . . . 0.0 112.382 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.593 HG21 ' HE ' ' A' ' 15' ' ' ARG . 1.1 pt -104.7 159.71 28.43 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.33 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.603 ' HA ' ' CD1' ' B' ' 2' ' ' TYR . 13.9 Cg_endo -81.4 144.94 14.68 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.047 1.831 . . . . 0.0 111.716 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.49 ' HG3' HG21 ' B' ' 3' ' ' ILE . 22.5 tt0 -57.04 142.02 43.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 113.995 -1.457 . . . . 0.0 114.094 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.78 157.24 52.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.388 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 51.0 Cg_exo -54.54 151.14 32.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.977 2.451 . . . . 0.0 112.436 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 24.4 mtm180 -112.51 57.76 0.65 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.971 0.415 . . . . 0.0 112.051 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.05 18.66 19.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.792 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.779 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 80.17 14.95 79.71 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.906 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.683 ' C ' ' HB2' ' B' ' 16' ' ' LYS . 8.4 mt-30 -106.6 141.12 38.4 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.538 ' HA ' ' CB ' ' B' ' 16' ' ' LYS . . . -91.47 135.53 33.77 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 122.004 0.907 . . . . 0.0 112.102 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.759 ' CE1' HD22 ' A' ' 22' ' ' LEU . 56.4 m-85 -119.57 153.21 35.78 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.794 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -118.32 147.58 21.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.726 ' NH2' ' HA2' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -93.64 107.68 19.51 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.678 -1.209 . . . . 0.0 110.405 -177.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.673 ' HB2' ' C ' ' C' ' 11' ' ' GLN . 0.0 OUTLIER -138.21 124.97 21.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.519 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.776 ' HA ' ' CB ' ' C' ' 8' ' ' ARG . 0.8 OUTLIER 60.97 45.84 9.03 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 176.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.726 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 61.37 14.75 42.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.643 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -137.15 164.25 28.9 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 117.983 0.892 . . . . 0.0 112.198 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.697 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 81.4 m95 -93.11 116.2 28.81 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.188 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.793 ' O ' HG22 ' A' ' 14' ' ' VAL . 1.4 m -107.04 128.25 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.717 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.759 HD22 ' CE1' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -52.21 121.86 7.6 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.985 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.922 HD22 ' CG ' ' B' ' 26' ' ' PHE . 15.8 tp -58.44 -44.97 89.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.508 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 m -48.08 -26.32 1.79 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.324 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -67.02 -18.84 65.55 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.489 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 1.029 ' O ' HD21 ' C' ' 27' ' ' LEU . 61.5 m-85 -98.75 -5.03 32.11 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.143 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.836 ' CD1' ' O ' ' B' ' 26' ' ' PHE . 1.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.091 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' TYR . . . . . 0.603 ' CD1' ' HA ' ' A' ' 4' ' ' PRO . 2.7 m-85 -129.03 135.61 49.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.796 0.298 . . . . 0.0 111.345 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.49 HG21 ' HG3' ' A' ' 5' ' ' GLU . 11.8 pt -86.97 155.84 55.25 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-O 120.993 0.425 . . . . 0.0 111.926 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.779 ' HD2' HH21 ' B' ' 15' ' ' ARG . 90.3 Cg_endo -86.93 154.25 8.53 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.427 2.752 . . . . 0.0 111.965 178.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.576 ' HA ' ' CG2' ' C' ' 3' ' ' ILE . 3.2 tt0 -58.48 143.46 45.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.472 ' HB1' ' CG ' ' B' ' 20' ' ' TRP . . . -86.9 158.16 53.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.12 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.415 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 19.0 Cg_endo -58.23 158.1 23.44 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.526 2.817 . . . . 0.0 113.106 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' C' ' 17' ' ' ASP . 1.3 mpp_? -112.22 74.6 0.87 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.294 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.41 8.24 10.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.698 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.713 ' O ' ' HE3' ' C' ' 16' ' ' LYS . . . 78.72 22.84 65.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.287 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . 0.713 ' OE1' HD21 ' B' ' 22' ' ' LEU . 56.2 mt-30 -116.32 145.4 43.21 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.548 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -91.83 134.82 34.41 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.065 0.936 . . . . 0.0 111.503 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.655 ' CE1' HD22 ' B' ' 22' ' ' LEU . 52.2 m-85 -120.27 153.01 36.97 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.132 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.783 HG21 ' O ' ' B' ' 21' ' ' VAL . 0.2 OUTLIER -113.23 154.14 14.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 112.727 -2.033 . . . . 0.0 105.716 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.817 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -106.22 100.63 10.15 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.257 1.027 . . . . 0.0 111.136 -176.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.779 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -134.66 126.71 29.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 113.347 -1.752 . . . . 0.0 110.847 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 38.4 t70 60.12 43.42 14.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.85 12.77 29.99 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.565 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.445 ' C ' ' NH1' ' B' ' 15' ' ' ARG . 28.0 mt-10 -128.56 160.03 33.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.09 0.945 . . . . 0.0 111.45 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' TRP . . . . . 0.817 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 81.9 m95 -95.14 116.19 28.41 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.301 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.783 ' O ' HG21 ' B' ' 14' ' ' VAL . 9.8 t -112.0 134.98 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.211 0 CA-C-O 121.746 0.784 . . . . 0.0 109.735 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.713 HD21 ' OE1' ' B' ' 11' ' ' GLN . 0.1 OUTLIER -52.71 124.94 15.15 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.821 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.649 HD21 ' CD2' ' C' ' 26' ' ' PHE . 18.2 tp -57.68 -38.35 75.01 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.256 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 25.6 t -62.66 -18.5 62.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.742 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 1.5 m -68.95 -17.88 64.01 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.922 ' CG ' HD22 ' A' ' 23' ' ' LEU . 81.4 m-85 -101.88 -12.69 18.06 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.673 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.611 HD12 ' O ' ' C' ' 26' ' ' PHE . 13.5 mt . . . . . 0 C--O 1.25 1.087 0 O-C-N 121.103 -0.998 . . . . 0.0 111.367 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.071 0 N-CA-C 112.815 -0.114 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 2' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.7 m-85 -121.91 145.98 47.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.732 0.266 . . . . 0.0 111.344 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . 0.667 HG22 ' CZ ' ' C' ' 15' ' ' ARG . 3.8 pt -85.46 150.11 53.4 Favored Pre-proline 0 CA--C 1.514 -0.415 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 10.9 Cg_endo -81.89 150.41 16.2 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.817 1.678 . . . . 0.0 111.203 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.492 ' HG2' HH21 ' C' ' 8' ' ' ARG . 6.2 tt0 -58.04 142.39 46.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.503 -1.226 . . . . 0.0 113.102 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' ALA . . . . . 0.569 ' HB2' ' NH1' ' A' ' 15' ' ' ARG . . . -88.57 165.06 29.79 Favored Pre-proline 0 C--O 1.231 0.127 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.873 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' PRO . . . . . 0.45 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 24.7 Cg_exo -59.06 146.22 95.03 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.525 2.15 . . . . 0.0 110.679 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' ARG . . . . . 0.776 ' CB ' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -113.85 58.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.109 0.48 . . . . 0.0 111.5 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' C' ' 11' ' ' GLN . 6.8 p-10 -104.27 21.84 15.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.387 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' GLY . . . . . 0.615 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 78.88 12.7 83.89 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.226 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' GLN . . . . . 0.673 ' C ' ' HB2' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -113.02 143.05 44.97 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.685 ' HB1' ' CZ ' ' A' ' 26' ' ' PHE . . . -90.6 138.26 31.7 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.948 0.88 . . . . 0.0 111.852 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.58 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 60.4 m-85 -118.33 150.35 39.64 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.572 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' VAL . . . . . 0.632 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.3 OUTLIER -110.71 154.2 12.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.707 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.73 108.13 19.49 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.651 -1.22 . . . . 0.0 109.944 -177.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . 0.713 ' HE3' ' O ' ' B' ' 10' ' ' GLY . 0.0 OUTLIER -136.89 121.63 18.61 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.942 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' B' ' 8' ' ' ARG . 8.8 t70 58.56 45.75 15.8 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.55 ' HA2' ' NH2' ' C' ' 15' ' ' ARG . . . 63.97 15.71 58.6 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 115.064 0.786 . . . . 0.0 115.064 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -132.42 161.66 33.09 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.703 1.251 . . . . 0.0 112.118 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' TRP . . . . . 0.707 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 89.4 m95 -96.95 115.15 26.93 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.143 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.632 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.4 m -114.67 131.83 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.139 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' LEU . . . . . 0.571 HD21 ' CG ' ' C' ' 11' ' ' GLN . 2.1 mt -51.48 127.31 19.71 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.235 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' A' ' 26' ' ' PHE . 3.5 tp -59.87 -44.01 94.42 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.677 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -65.63 -22.26 66.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.934 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 16.6 m -69.29 -18.41 63.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' PHE . . . . . 0.649 ' CD2' HD21 ' B' ' 23' ' ' LEU . 42.9 m-85 -97.19 -0.31 47.07 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.555 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 1.029 HD21 ' O ' ' A' ' 26' ' ' PHE . 1.7 tp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.007 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.585 ' CD1' ' HA ' ' C' ' 4' ' ' PRO . 5.5 m-30 -102.52 160.93 14.13 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 111.925 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.754 HG22 ' NE ' ' A' ' 15' ' ' ARG . 4.5 pt -91.4 153.63 44.34 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.644 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.458 ' O ' ' NE1' ' A' ' 20' ' ' TRP . 11.2 Cg_endo -86.25 153.42 9.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.723 2.282 . . . . 0.0 111.308 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.653 ' OE2' ' NH2' ' B' ' 15' ' ' ARG . 1.1 tp10 -58.21 142.34 47.85 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.475 ' O ' ' NH2' ' B' ' 15' ' ' ARG . . . -87.21 160.77 48.05 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.166 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.562 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 43.9 Cg_exo -54.65 152.06 29.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.102 2.535 . . . . 0.0 112.958 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.548 ' HG3' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -111.63 57.76 0.63 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.165 0.507 . . . . 0.0 111.135 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -105.48 16.15 25.96 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.699 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' B' ' 16' ' ' LYS . . . 79.98 14.08 81.22 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.81 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.511 ' CG ' HD22 ' A' ' 22' ' ' LEU . 3.0 mt-30 -107.11 157.73 17.62 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 117.156 0.478 . . . . 0.0 110.47 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.804 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -98.86 136.21 39.19 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.485 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.772 ' O ' HG22 ' B' ' 14' ' ' VAL . 66.2 m-85 -120.43 149.1 42.91 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.391 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.757 HG21 ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -111.25 157.14 12.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.779 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -106.19 107.3 18.24 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 118.134 -1.426 . . . . 0.0 110.645 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.698 ' HG2' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -137.3 140.58 41.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.592 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.698 ' CG ' ' HG2' ' A' ' 16' ' ' LYS . 0.4 OUTLIER 45.21 45.65 9.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 177.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 61.82 16.81 52.98 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.383 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -133.71 162.34 32.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 118.124 0.962 . . . . 0.0 111.574 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.779 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 73.4 m95 -93.94 114.1 26.24 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.471 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.757 ' O ' HG21 ' A' ' 14' ' ' VAL . 2.4 m -107.19 132.66 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.295 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.511 HD22 ' CG ' ' A' ' 11' ' ' GLN . 4.4 mt -53.11 121.83 8.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.766 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.49 HD23 ' CD1' ' B' ' 26' ' ' PHE . 1.8 tp -60.09 -45.73 91.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.904 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.4 p -50.54 -26.28 5.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.962 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.2 m -67.5 -19.08 65.28 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.725 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.762 ' O ' ' CD2' ' C' ' 27' ' ' LEU . 12.7 m-85 -98.2 2.66 48.61 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.168 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 1.012 HD21 ' O ' ' B' ' 26' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.309 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.555 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 4.6 m-85 -130.89 141.64 50.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.985 0.422 . . . . 0.0 111.165 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.583 ' CG2' ' HE ' ' B' ' 15' ' ' ARG . 6.4 pt -88.69 158.59 47.81 Favored Pre-proline 0 CA--C 1.515 -0.372 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 96.9 Cg_endo -88.48 150.21 6.41 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.984 2.456 . . . . 0.0 110.463 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.651 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 0.4 OUTLIER -57.54 149.19 21.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.935 -176.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.59 ' N ' ' HG3' ' B' ' 5' ' ' GLU . . . -91.0 152.55 44.39 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.195 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.702 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 6.2 Cg_exo -48.14 153.18 2.99 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.337 2.692 . . . . 0.0 113.251 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.51 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.9 OUTLIER -111.56 66.62 0.63 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.934 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -110.65 11.25 22.8 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.265 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.48 8.06 88.03 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.148 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . 0.662 ' OE1' HD23 ' B' ' 22' ' ' LEU . 2.6 mm-40 -102.03 151.76 21.76 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.813 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -93.13 134.79 34.93 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.527 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.702 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 55.5 m-85 -119.85 151.54 38.7 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.021 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -113.72 159.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-N 113.61 -1.632 . . . . 0.0 106.832 175.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.938 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -103.7 107.9 18.96 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.489 1.137 . . . . 0.0 109.323 -176.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.804 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -135.82 131.81 35.87 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.036 -1.893 . . . . 0.0 111.432 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.601 ' OD1' ' O ' ' B' ' 16' ' ' LYS . 0.1 OUTLIER 47.8 46.86 18.52 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 177.027 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.464 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 62.39 16.44 54.47 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 114.172 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -133.46 161.44 34.56 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 117.967 0.884 . . . . 0.0 111.702 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' TRP . . . . . 0.938 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 84.8 m95 -94.09 117.15 29.69 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.503 ' O ' HG12 ' B' ' 14' ' ' VAL . 5.4 t -114.63 136.6 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.196 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.071 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.662 HD23 ' OE1' ' B' ' 11' ' ' GLN . 2.8 mt -54.02 125.34 18.47 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.016 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.58 HD23 ' CG ' ' C' ' 26' ' ' PHE . 1.8 tp -56.75 -35.5 68.7 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.082 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.494 ' HA ' ' HB2' ' B' ' 27' ' ' LEU . 2.0 p -63.62 -19.59 64.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.021 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 23.6 m -70.51 -20.45 62.83 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 1.012 ' O ' HD21 ' A' ' 27' ' ' LEU . 96.2 m-85 -101.12 18.77 18.95 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-O 122.218 1.009 . . . . 0.0 108.328 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.742 HD23 ' O ' ' C' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.363 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.279 -0.329 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' TYR . . . . . 0.618 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.3 m-30 -102.23 159.6 15.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 111.682 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . 0.738 HG21 ' NE ' ' C' ' 15' ' ' ARG . 3.3 pt -86.97 154.73 55.4 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.806 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.585 ' HA ' ' CD1' ' A' ' 2' ' ' TYR . 9.9 Cg_endo -83.22 148.13 13.06 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.437 2.091 . . . . 0.0 110.856 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.66 ' OE2' ' NH2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -58.09 143.53 43.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.587 ' HB3' ' CG ' ' C' ' 20' ' ' TRP . . . -83.77 167.46 28.1 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.268 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' PRO . . . . . 0.498 ' HD2' ' CD2' ' C' ' 13' ' ' TYR . 28.7 Cg_exo -59.04 151.5 65.68 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.042 2.495 . . . . 0.0 112.547 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -112.03 48.82 0.95 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.046 0.45 . . . . 0.0 111.581 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' ASP . . . . . 0.476 ' CG ' ' HG3' ' C' ' 11' ' ' GLN . 19.0 p-10 -104.94 19.35 20.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.088 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.465 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.65 14.27 81.36 Favored Glycine 0 C--O 1.229 -0.158 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.34 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' GLN . . . . . 0.564 ' C ' ' HB2' ' A' ' 16' ' ' LYS . 7.1 mt-30 -105.1 141.15 37.17 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.499 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -90.91 135.33 33.81 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.268 0.556 . . . . 0.0 110.981 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.524 ' HB3' ' HB3' ' C' ' 20' ' ' TRP . 70.9 m-85 -119.3 152.79 36.12 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.615 1.198 . . . . 0.0 112.637 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' VAL . . . . . 0.741 HG21 ' O ' ' C' ' 21' ' ' VAL . 0.6 OUTLIER -113.37 145.82 18.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 112.624 -2.08 . . . . 0.0 106.35 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.764 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -95.01 115.47 27.46 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.906 -178.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . 0.813 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 1.9 tttt -151.05 125.46 9.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.989 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . 0.51 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 0.3 OUTLIER 58.64 44.44 17.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.984 0.421 . . . . 0.0 111.462 177.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.482 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.8 16.42 51.56 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.996 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -133.73 161.94 33.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.032 0.916 . . . . 0.0 111.679 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . 0.764 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 92.1 m95 -97.58 115.18 27.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.485 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.741 ' O ' HG21 ' C' ' 14' ' ' VAL . 6.4 t -110.06 137.59 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-O 121.596 0.712 . . . . 0.0 110.296 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' LEU . . . . . 0.424 HD22 ' HB3' ' C' ' 11' ' ' GLN . 1.3 mt -56.59 127.3 30.65 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.66 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . 0.536 ' CD2' ' CG ' ' A' ' 26' ' ' PHE . 7.7 tp -59.16 -35.61 73.83 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.139 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 80.6 p -64.01 -19.88 65.5 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 122.12 -0.362 . . . . 0.0 110.977 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 73.3 m -67.63 -18.36 64.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' PHE . . . . . 0.742 ' O ' HD23 ' B' ' 27' ' ' LEU . 76.6 m-85 -101.88 9.37 40.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.426 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.762 ' CD2' ' O ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.478 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.67 ' O ' ' HA ' ' C' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 119.45 -0.639 . . . . 0.0 112.209 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.846 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 22.9 m-85 -135.3 165.13 26.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 117.933 0.867 . . . . 0.0 111.667 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.49 ' CG2' ' HA ' ' C' ' 5' ' ' GLU . 1.0 OUTLIER -97.32 160.05 29.8 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.833 177.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 21.1 Cg_endo -82.47 145.77 13.41 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.034 1.823 . . . . 0.0 111.401 176.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.573 ' CB ' HG22 ' B' ' 3' ' ' ILE . 3.4 tt0 -57.61 142.6 44.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.006 -1.452 . . . . 0.0 113.76 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 20' ' ' TRP . . . -85.03 163.92 43.8 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.557 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 37.8 Cg_exo -57.31 151.13 54.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.979 2.453 . . . . 0.0 112.853 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 45.4 mtm-85 -112.32 58.26 0.64 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.44 15.55 21.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.737 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.741 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 78.79 14.58 81.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.695 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.676 ' O ' ' HB2' ' B' ' 16' ' ' LYS . 7.7 mm-40 -102.83 141.32 35.84 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -91.52 133.39 35.55 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.784 0.802 . . . . 0.0 112.54 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.576 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 70.2 m-85 -118.66 151.42 37.98 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.961 1.363 . . . . 0.0 113.048 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -111.04 155.34 12.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 178.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.887 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.49 108.52 20.08 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.364 -177.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.65 ' HE3' ' O ' ' C' ' 10' ' ' GLY . 0.0 OUTLIER -136.73 120.72 17.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.65 -1.613 . . . . 0.0 111.977 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 0.4 OUTLIER 59.2 45.88 13.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 177.119 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.609 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 63.6 14.15 53.62 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.991 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -131.38 159.95 36.47 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 118.329 1.064 . . . . 0.0 111.429 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.887 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 93.0 m95 -97.53 114.77 26.72 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.882 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 10.5 t -111.37 139.73 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-O 121.718 0.771 . . . . 0.0 110.032 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 12' ' ' ALA . 3.7 mt -56.72 128.02 34.4 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.618 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.528 HD21 ' CG ' ' B' ' 26' ' ' PHE . 3.0 tp -61.5 -42.99 99.64 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.897 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.421 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -63.54 -18.59 64.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.738 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.0 m -69.69 -19.11 63.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.815 ' O ' ' CD2' ' C' ' 27' ' ' LEU . 96.3 m-85 -97.77 3.6 50.01 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.756 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.949 ' CD2' ' O ' ' B' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.483 ' HA ' ' H ' ' A' ' 5' ' ' GLU . 4.8 m-85 -133.65 129.58 37.05 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.634 0.254 . . . . 0.0 110.595 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.573 HG22 ' CB ' ' A' ' 5' ' ' GLU . 3.5 pt -85.45 155.63 59.6 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.905 ' HD2' HH21 ' B' ' 15' ' ' ARG . 83.4 Cg_endo -83.39 160.22 14.94 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.638 2.226 . . . . 0.0 112.648 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.522 ' HA ' HG22 ' C' ' 3' ' ' ILE . 19.2 tt0 -60.74 143.08 55.15 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.578 ' HB1' ' CD1' ' B' ' 20' ' ' TRP . . . -84.72 169.61 16.05 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.568 -1.197 . . . . 0.0 112.053 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.441 ' CD ' ' HB2' ' B' ' 6' ' ' ALA . 12.2 Cg_exo -71.04 153.89 62.83 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.826 3.017 . . . . 0.0 113.064 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' C' ' 17' ' ' ASP . 1.7 mpp_? -112.0 84.56 1.98 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.297 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.32 6.57 4.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.338 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.841 ' O ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.15 14.74 81.43 Favored Glycine 0 CA--C 1.509 -0.29 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.512 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . 0.595 ' O ' ' HB2' ' C' ' 16' ' ' LYS . 0.4 OUTLIER -103.9 144.08 31.99 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.44 ' HB1' ' HB ' ' C' ' 14' ' ' VAL . . . -90.57 135.88 33.42 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.541 0.686 . . . . 0.0 110.404 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.6 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 43.5 m-85 -118.92 152.15 36.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.491 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.563 ' CG1' HG23 ' B' ' 21' ' ' VAL . 0.5 OUTLIER -105.55 158.79 5.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 175.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.905 HH21 ' HD2' ' B' ' 4' ' ' PRO . 0.0 OUTLIER -107.66 105.82 15.87 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 118.581 -1.248 . . . . 0.0 107.688 176.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.741 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -138.06 124.68 20.89 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.164 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 2.8 t0 58.92 43.79 17.49 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.322 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.19 12.69 38.96 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 119.243 -0.754 . . . . 0.0 114.529 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.495 ' C ' ' NH1' ' B' ' 15' ' ' ARG . 0.1 OUTLIER -127.43 154.72 44.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.113 1.456 . . . . 0.0 111.382 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' TRP . . . . . 0.886 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 76.2 m95 -93.74 113.41 25.46 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.563 HG23 ' CG1' ' B' ' 14' ' ' VAL . 1.4 m -108.61 132.85 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 CA-C-O 121.626 0.727 . . . . 0.0 111.282 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.586 HD23 ' CG ' ' B' ' 11' ' ' GLN . 1.8 mt -53.75 122.06 9.16 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.216 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.522 HD21 ' CB ' ' C' ' 26' ' ' PHE . 1.1 tp -57.61 -34.99 69.86 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.6 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 16.7 m -61.65 -16.58 49.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.434 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 31.7 m -69.78 -18.15 63.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.949 ' O ' ' CD2' ' A' ' 27' ' ' LEU . 8.8 m-85 -99.71 -11.4 20.9 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.449 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.62 HD13 ' O ' ' C' ' 26' ' ' PHE . 9.4 mt . . . . . 0 C--O 1.249 1.043 0 O-C-N 120.751 -1.218 . . . . 0.0 110.896 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 CA-C-O 119.861 -0.411 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' TYR . . . . . 0.584 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.6 m-30 -116.85 150.39 38.47 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.614 0.707 . . . . 0.0 111.241 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . 0.691 HG21 ' NE ' ' C' ' 15' ' ' ARG . 2.4 pt -87.31 156.85 53.92 Favored Pre-proline 0 CA--C 1.506 -0.748 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.846 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 20.7 Cg_endo -87.8 152.96 7.35 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 122.153 1.902 . . . . 0.0 112.335 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.49 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 4.2 tt0 -57.38 141.45 47.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.086 -1.415 . . . . 0.0 113.321 -177.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.601 ' HB2' ' NH1' ' A' ' 15' ' ' ARG . . . -84.97 160.51 55.14 Favored Pre-proline 0 N--CA 1.455 -0.211 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.306 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.99 151.52 49.25 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.921 2.414 . . . . 0.0 112.22 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' ARG . . . . . . . . . . . . . 20.7 mtm105 -111.57 70.37 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.407 0.623 . . . . 0.0 111.08 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -113.34 17.23 18.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.038 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.65 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 74.0 15.37 79.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.616 -1.278 . . . . 0.0 112.264 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' GLN . . . . . 0.784 ' OE1' HD13 ' C' ' 22' ' ' LEU . 0.1 OUTLIER -113.91 152.47 30.75 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.011 0.434 . . . . 0.0 110.977 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.574 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -92.75 136.19 33.45 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.583 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 70.4 m-85 -119.85 156.76 30.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.949 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' VAL . . . . . 0.537 HG23 ' HB ' ' C' ' 21' ' ' VAL . 0.0 OUTLIER -108.64 155.62 9.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 176.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.735 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.96 107.67 18.79 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 118.34 -1.344 . . . . 0.0 107.789 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . 0.841 ' HE2' ' O ' ' B' ' 10' ' ' GLY . 0.0 OUTLIER -136.57 124.49 22.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.978 -1.465 . . . . 0.0 111.381 -179.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' B' ' 8' ' ' ARG . 0.2 OUTLIER 58.71 45.34 15.92 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 176.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.43 ' C ' ' CZ ' ' C' ' 15' ' ' ARG . . . 63.02 16.42 57.46 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.907 -0.663 . . . . 0.0 114.475 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -134.65 161.08 36.12 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.289 1.044 . . . . 0.0 111.227 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . 0.735 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 91.2 m95 -97.28 115.04 26.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.527 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.537 ' HB ' HG23 ' C' ' 14' ' ' VAL . 21.5 t -107.92 141.2 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 121.767 0.794 . . . . 0.0 110.028 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' LEU . . . . . 0.784 HD13 ' OE1' ' C' ' 11' ' ' GLN . 1.6 mt -57.78 124.2 18.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.302 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . 0.762 HD23 ' CD2' ' A' ' 26' ' ' PHE . 25.8 tp -58.82 -52.15 66.97 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.33 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 41.8 t -43.64 -26.79 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.434 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -68.19 -18.65 64.65 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.585 0.707 . . . . 0.0 109.623 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' PHE . . . . . 0.62 ' O ' HD13 ' B' ' 27' ' ' LEU . 81.0 m-85 -99.65 -3.7 32.52 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.81 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.815 ' CD2' ' O ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.241 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' C' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.531 ' CD1' ' HA ' ' C' ' 4' ' ' PRO . 4.1 m-30 -110.83 153.38 25.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.634 0.254 . . . . 0.0 111.409 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.661 HD12 ' CZ2' ' A' ' 20' ' ' TRP . 4.2 pt -91.75 161.53 33.65 Favored Pre-proline 0 CA--C 1.509 -0.603 0 CA-C-O 121.024 0.44 . . . . 0.0 111.582 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 33.2 Cg_endo -89.06 151.65 5.73 Favored 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 122.274 1.983 . . . . 0.0 110.686 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.629 ' OE2' ' NH2' ' B' ' 15' ' ' ARG . 0.5 OUTLIER -57.44 142.72 42.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.873 -177.036 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.588 ' HA ' ' CD1' ' A' ' 20' ' ' TRP . . . -84.39 165.07 40.29 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.524 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.484 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 28.5 Cg_exo -61.16 154.01 60.7 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 123.512 2.808 . . . . 0.0 113.202 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.411 ' CG ' ' HA ' ' B' ' 17' ' ' ASP . 2.0 mtp85 -112.04 69.98 0.7 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.262 0.553 . . . . 0.0 111.155 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -113.84 14.83 18.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.051 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.536 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 79.36 15.12 80.6 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.851 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.882 ' CG ' HD23 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -115.28 150.91 35.47 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.733 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -91.54 136.49 33.09 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.771 0.796 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.605 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 51.8 m-85 -117.43 151.65 36.62 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.344 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.854 HG21 ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -112.87 152.9 14.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.747 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.04 107.32 18.23 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 118.962 -1.095 . . . . 0.0 108.503 -177.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.715 ' HE3' ' O ' ' C' ' 10' ' ' GLY . 0.6 OUTLIER -137.01 125.04 22.82 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 113.382 -1.736 . . . . 0.0 111.132 -178.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.519 ' HA ' ' HG3' ' C' ' 8' ' ' ARG . 0.2 OUTLIER 57.87 45.36 18.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.485 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 62.35 14.07 46.55 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 114.352 0.501 . . . . 0.0 114.352 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -131.0 161.93 30.89 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 117.889 0.845 . . . . 0.0 111.897 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.747 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 82.5 m95 -96.42 113.91 25.53 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.952 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.854 ' O ' HG21 ' A' ' 14' ' ' VAL . 11.7 t -111.91 139.18 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 121.726 0.775 . . . . 0.0 110.034 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.882 HD23 ' CG ' ' A' ' 11' ' ' GLN . 2.1 mt -55.52 126.76 26.61 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.078 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 23' ' ' LEU . 2.9 tp -59.91 -42.78 94.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.307 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.3 m -62.97 -19.15 64.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 25' ' ' THR . 18.7 m -69.7 -18.31 63.53 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.631 ' CG ' ' CD2' ' C' ' 23' ' ' LEU . 84.1 m-85 -97.54 2.05 49.66 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.574 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.953 ' CD1' ' O ' ' B' ' 26' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.072 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.588 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 3.7 m-85 -129.51 143.32 50.78 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.738 0.304 . . . . 0.0 110.988 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.626 ' CG2' ' HE ' ' B' ' 15' ' ' ARG . 2.6 pt -89.44 158.34 46.04 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-O 120.999 0.428 . . . . 0.0 112.139 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.713 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 92.2 Cg_endo -87.22 151.58 8.06 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.72 2.28 . . . . 0.0 111.075 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.848 ' HA ' ' CG2' ' C' ' 3' ' ' ILE . 0.8 OUTLIER -57.69 142.41 45.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.253 -177.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -83.72 166.67 32.84 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.462 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.491 ' HD2' ' CE2' ' B' ' 13' ' ' TYR . 22.2 Cg_exo -62.76 151.12 85.67 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.448 2.765 . . . . 0.0 112.588 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.549 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -112.79 60.52 0.64 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.985 0.421 . . . . 0.0 111.891 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -106.01 15.24 26.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.239 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.516 ' C ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.48 14.48 81.3 Favored Glycine 0 CA--C 1.506 -0.487 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.81 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' C' ' 16' ' ' LYS . 0.0 OUTLIER -113.19 152.83 29.24 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.484 0.659 . . . . 0.0 109.744 178.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.569 ' HB1' ' CZ ' ' C' ' 26' ' ' PHE . . . -92.83 136.26 33.4 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.89 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.764 ' O ' HG22 ' C' ' 14' ' ' VAL . 58.4 m-85 -119.2 152.59 36.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.457 1.123 . . . . 0.0 112.265 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.873 HG23 ' O ' ' B' ' 21' ' ' VAL . 0.7 OUTLIER -112.49 155.84 13.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 113.122 -1.854 . . . . 0.0 106.214 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.951 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.14 107.1 17.9 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.884 -1.127 . . . . 0.0 108.92 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.733 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -136.79 124.02 21.81 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.505 -1.679 . . . . 0.0 111.792 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.411 ' HA ' ' CG ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 57.11 45.99 19.85 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.306 176.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.534 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 61.92 14.41 45.08 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.381 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.73 161.72 31.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.524 1.162 . . . . 0.0 111.803 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' TRP . . . . . 0.951 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 81.2 m95 -96.84 114.41 26.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.441 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.873 ' O ' HG23 ' B' ' 14' ' ' VAL . 10.6 t -111.16 142.4 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 121.768 0.794 . . . . 0.0 110.613 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' B' ' 11' ' ' GLN . 1.4 mt -56.82 122.68 12.75 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.399 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.528 HD23 ' CD2' ' C' ' 26' ' ' PHE . 2.8 tp -57.57 -43.18 84.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.87 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -19.28 65.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.944 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 4.1 m -67.72 -18.76 65.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.953 ' O ' ' CD1' ' A' ' 27' ' ' LEU . 87.4 m-85 -95.92 -16.11 21.96 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.325 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.57 HD11 ' O ' ' C' ' 26' ' ' PHE . 1.8 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.275 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.052 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' TYR . . . . . 0.713 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.5 m-30 -100.62 160.97 13.92 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.775 0.321 . . . . 0.0 111.798 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . 0.848 ' CG2' ' HA ' ' B' ' 5' ' ' GLU . 7.4 pt -87.75 160.75 46.49 Favored Pre-proline 0 CA--C 1.516 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.624 ' O ' ' NE1' ' C' ' 20' ' ' TRP . 69.8 Cg_endo -92.38 144.09 2.6 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 122.614 2.209 . . . . 0.0 111.432 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.641 ' OE2' HG23 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -58.05 142.84 45.52 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -176.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.512 ' N ' ' HG3' ' C' ' 5' ' ' GLU . . . -87.37 156.69 53.81 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.814 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' PRO . . . . . 0.475 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 52.0 Cg_exo -49.61 153.69 5.18 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.111 2.541 . . . . 0.0 113.238 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' ARG . . . . . 0.519 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -111.64 64.73 0.62 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.368 0.604 . . . . 0.0 111.03 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -112.05 14.18 20.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.526 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.715 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.29 13.95 82.18 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.363 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' GLN . . . . . 0.609 ' CG ' HD22 ' C' ' 22' ' ' LEU . 1.3 mm-40 -106.25 155.01 19.92 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -96.63 134.43 39.87 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.402 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.475 ' CE2' ' HD2' ' C' ' 7' ' ' PRO . 50.2 m-85 -118.79 155.21 31.54 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.071 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' VAL . . . . . 0.764 HG22 ' O ' ' B' ' 13' ' ' TYR . 0.4 OUTLIER -118.87 160.79 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.867 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.23 107.71 18.84 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.482 1.134 . . . . 0.0 110.766 -176.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' B' ' 11' ' ' GLN . 0.0 OUTLIER -137.05 127.25 26.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.474 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . 0.549 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 1.1 m-20 55.79 45.97 23.29 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.61 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 60.54 15.37 39.51 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' C' ' 16' ' ' LYS . 0.0 OUTLIER -133.61 162.0 33.11 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.277 1.038 . . . . 0.0 111.043 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . 0.867 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 91.9 m95 -98.49 122.84 42.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.299 0.571 . . . . 0.0 110.732 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.509 ' O ' HG13 ' C' ' 14' ' ' VAL . 12.8 t -117.5 138.44 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.673 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' LEU . . . . . 0.609 HD22 ' CG ' ' C' ' 11' ' ' GLN . 1.5 mt -55.61 125.61 21.8 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.874 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . 0.631 ' CD2' ' CG ' ' A' ' 26' ' ' PHE . 7.8 tp -57.15 -35.18 69.22 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.921 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -15.1 59.6 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.502 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 4.0 m -72.8 -18.93 61.42 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' PHE . . . . . 0.57 ' O ' HD11 ' B' ' 27' ' ' LEU . 92.0 m-85 -99.1 -6.95 27.42 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.607 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.497 HD13 ' HB3' ' A' ' 26' ' ' PHE . 58.4 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.899 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' C' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.679 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 8.4 m-30 -103.29 167.02 10.08 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.51 HD11 ' CZ2' ' A' ' 20' ' ' TRP . 5.6 pt -100.96 159.11 30.43 Favored Pre-proline 0 CA--C 1.508 -0.648 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.097 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 39.2 Cg_endo -86.58 152.92 8.95 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 121.623 1.549 . . . . 0.0 112.043 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.669 ' OE2' ' HA2' ' B' ' 18' ' ' GLY . 0.4 OUTLIER -57.25 143.24 40.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.753 -177.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.674 ' HA ' ' CD1' ' A' ' 20' ' ' TRP . . . -85.72 165.7 33.72 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.92 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.476 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 24.8 Cg_exo -58.85 151.07 67.36 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.957 2.438 . . . . 0.0 112.355 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.33 63.84 0.61 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.192 0.52 . . . . 0.0 111.25 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -110.27 13.34 23.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.592 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.19 8.94 87.15 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.394 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.615 ' OE1' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -102.4 151.14 22.62 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.227 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.677 ' HB3' HG13 ' B' ' 14' ' ' VAL . . . -92.1 136.26 33.32 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.606 0.717 . . . . 0.0 110.189 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.542 ' CE1' HD21 ' A' ' 22' ' ' LEU . 52.9 m-85 -119.09 154.28 33.44 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.711 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.615 ' HB ' HG21 ' A' ' 21' ' ' VAL . 1.8 t -115.41 156.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.904 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -106.06 107.85 19.07 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.407 1.099 . . . . 0.0 110.46 -176.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.644 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 0.0 OUTLIER -138.2 126.75 23.44 Favored 'General case' 0 C--O 1.23 0.044 0 CA-C-N 113.062 -1.881 . . . . 0.0 112.052 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.527 ' HA ' ' HG3' ' C' ' 8' ' ' ARG . 0.4 OUTLIER 55.46 45.3 25.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 176.274 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.528 ' H ' ' NH2' ' A' ' 15' ' ' ARG . . . 62.1 15.59 50.69 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.568 -0.573 . . . . 0.0 114.528 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -134.33 162.97 30.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.498 1.149 . . . . 0.0 111.37 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.904 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 89.1 m95 -94.58 120.12 34.31 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.397 0.617 . . . . 0.0 110.792 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.615 HG21 ' HB ' ' A' ' 14' ' ' VAL . 1.6 m -115.69 131.35 68.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.949 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.615 HD12 ' OE1' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -51.09 123.87 10.29 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.786 -178.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' CD2' ' CG ' ' B' ' 26' ' ' PHE . 4.7 tp -57.43 -36.19 71.05 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.517 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.68 -21.18 66.52 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.949 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.0 m -70.1 -22.61 63.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.759 0.79 . . . . 0.0 108.97 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.603 ' CZ ' ' HB1' ' C' ' 12' ' ' ALA . 32.8 m-85 -97.87 -6.14 33.07 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.777 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.77 ' CD2' ' O ' ' B' ' 26' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.193 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.684 -0.166 . . . . 0.0 112.684 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.518 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 3.0 m-85 -130.48 138.61 50.35 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.861 0.362 . . . . 0.0 111.354 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.636 ' CG2' ' HE ' ' B' ' 15' ' ' ARG . 4.2 pt -88.89 159.65 45.32 Favored Pre-proline 0 N--CA 1.468 0.474 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 80.9 Cg_endo -91.05 152.59 3.86 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.875 2.383 . . . . 0.0 111.76 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.771 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 2.9 tt0 -58.39 142.8 47.27 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.458 ' HB1' ' CG ' ' B' ' 20' ' ' TRP . . . -88.33 146.23 37.44 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.597 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.481 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 11.4 Cg_exo -40.73 154.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.569 2.846 . . . . 0.0 113.678 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.94 65.0 0.62 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.818 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -110.77 18.54 19.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.304 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.459 ' HA2' ' OD2' ' C' ' 17' ' ' ASP . . . 75.6 7.83 83.54 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.564 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . 0.499 ' HB3' HD21 ' B' ' 22' ' ' LEU . 0.1 OUTLIER -105.5 151.16 24.62 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.289 0.566 . . . . 0.0 110.071 178.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.81 137.32 32.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.635 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.54 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 60.2 m-85 -120.44 154.34 35.33 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.665 1.221 . . . . 0.0 111.476 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.802 HG22 ' O ' ' B' ' 21' ' ' VAL . 0.2 OUTLIER -111.89 156.15 13.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 112.58 -2.1 . . . . 0.0 106.625 179.111 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.946 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.74 103.91 13.51 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.118 0.961 . . . . 0.0 109.178 -178.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.616 ' N ' HH11 ' B' ' 15' ' ' ARG . 0.0 OUTLIER -135.24 125.87 27.03 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.366 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.05 46.11 19.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.669 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 61.5 15.76 47.62 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 114.277 0.471 . . . . 0.0 114.277 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -133.36 161.91 33.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 117.904 0.852 . . . . 0.0 112.172 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' TRP . . . . . 0.946 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 83.9 m95 -95.86 114.73 26.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.215 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.802 ' O ' HG22 ' B' ' 14' ' ' VAL . 10.9 t -107.03 139.97 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.628 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' B' ' 11' ' ' GLN . 4.7 mt -58.04 124.33 18.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.326 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.658 HD23 ' CD2' ' C' ' 26' ' ' PHE . 35.6 tp -58.87 -39.98 82.99 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.523 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.2 m -62.77 -18.46 62.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.914 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m -68.25 -17.6 64.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.77 ' O ' ' CD2' ' A' ' 27' ' ' LEU . 90.0 m-85 -102.69 -15.82 16.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.261 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.47 HD13 ' O ' ' C' ' 26' ' ' PHE . 5.5 mt . . . . . 0 C--O 1.249 1.07 0 O-C-N 121.137 -0.977 . . . . 0.0 111.024 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.8 m-30 -96.09 161.72 13.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.333 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . 0.926 HG21 ' CZ ' ' C' ' 15' ' ' ARG . 2.9 pt -87.62 157.99 51.77 Favored Pre-proline 0 CA--C 1.512 -0.49 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.583 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 37.3 Cg_endo -89.65 146.09 4.84 Favored 'Trans proline' 0 N--CA 1.437 -1.853 0 C-N-CA 122.664 2.242 . . . . 0.0 111.336 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.542 ' OE2' ' NH1' ' A' ' 15' ' ' ARG . 1.1 tp10 -57.6 141.68 47.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.554 ' H ' HH12 ' A' ' 15' ' ' ARG . . . -83.83 157.55 63.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.535 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' PRO . . . . . 0.427 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 51.8 Cg_exo -50.93 153.34 8.79 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.642 2.228 . . . . 0.0 112.769 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' ARG . . . . . 0.527 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 1.6 mpt_? -111.21 63.18 0.61 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.302 0.572 . . . . 0.0 110.645 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -107.96 13.97 25.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.252 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.62 10.23 86.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.397 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' GLN . . . . . 0.578 ' HB3' HD23 ' C' ' 22' ' ' LEU . 0.6 OUTLIER -106.7 152.27 24.01 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.644 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -93.36 137.94 32.18 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.274 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.616 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 61.8 m-85 -119.11 152.65 36.13 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.326 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' VAL . . . . . 0.703 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.1 OUTLIER -111.38 153.97 13.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 178.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.926 ' CZ ' HG21 ' C' ' 3' ' ' ILE . 0.0 OUTLIER -104.9 106.28 16.7 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.984 -177.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . 0.682 ' HE2' ' OD2' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -137.53 133.13 34.17 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 113.08 -1.873 . . . . 0.0 111.764 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . 0.682 ' OD2' ' HE2' ' C' ' 16' ' ' LYS . 0.4 OUTLIER 46.68 46.45 14.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.586 ' HA2' HH22 ' C' ' 15' ' ' ARG . . . 69.98 10.68 65.4 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.97 160.45 38.26 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.835 1.317 . . . . 0.0 112.349 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . 0.683 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 85.2 m95 -94.49 112.63 24.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.008 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.703 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.0 m -109.79 135.38 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.083 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' LEU . . . . . 0.578 HD23 ' HB3' ' C' ' 11' ' ' GLN . 1.3 mt -53.21 124.32 14.21 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.145 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . 0.572 ' O ' ' HG ' ' C' ' 27' ' ' LEU . 2.6 tp -58.23 -42.36 86.13 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.761 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -22.61 66.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.055 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 48.2 m -69.46 -18.95 63.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' PHE . . . . . 0.658 ' CD2' HD23 ' B' ' 23' ' ' LEU . 40.9 m-85 -100.34 -6.42 25.83 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.859 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.601 HD11 ' O ' ' A' ' 26' ' ' PHE . 2.6 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.661 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.972 ' O ' ' HA ' ' C' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.123 0 CA-C-O 120.02 -0.322 . . . . 0.0 112.676 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.769 ' CE2' ' HB2' ' C' ' 2' ' ' TYR . 0.4 OUTLIER -138.67 146.24 41.37 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.112 0.565 . . . . 0.0 110.921 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.607 ' CG2' ' HE ' ' A' ' 15' ' ' ARG . 1.4 pt -104.74 158.96 30.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 37.2 Cg_endo -87.33 137.43 4.31 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.814 2.343 . . . . 0.0 111.802 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.737 ' OE2' ' NH2' ' B' ' 15' ' ' ARG . 2.9 tt0 -51.93 143.63 13.19 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.472 ' CB ' ' CG ' ' A' ' 20' ' ' TRP . . . -87.06 154.23 54.84 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.88 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.431 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 75.3 Cg_exo -51.73 157.34 5.57 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 123.613 2.875 . . . . 0.0 113.944 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -112.11 59.26 0.63 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.353 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -105.62 13.53 29.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.001 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' B' ' 16' ' ' LYS . . . 79.66 13.57 82.27 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.777 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.54 ' CG ' HD23 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -106.21 156.76 18.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 117.156 0.478 . . . . 0.0 109.734 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.837 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -98.2 134.29 41.46 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.591 0.71 . . . . 0.0 112.021 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.86 ' O ' HG22 ' B' ' 14' ' ' VAL . 68.6 m-85 -120.1 151.76 38.58 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.649 1.214 . . . . 0.0 111.888 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -112.98 157.76 13.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 113.105 -1.862 . . . . 0.0 106.566 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.972 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.56 106.05 16.39 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 118.579 -1.248 . . . . 0.0 109.437 -177.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.894 ' HG3' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -137.86 128.02 25.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.163 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.894 ' CG ' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 57.14 45.53 20.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 176.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.656 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 60.81 15.65 42.69 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.669 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -133.64 162.82 30.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.702 0.751 . . . . 0.0 111.767 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.972 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 84.0 m95 -97.21 110.83 23.3 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.948 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.734 ' O ' HG23 ' A' ' 14' ' ' VAL . 17.5 t -105.68 142.35 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.051 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.54 HD23 ' CG ' ' A' ' 11' ' ' GLN . 6.2 mt -56.41 124.56 18.53 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.057 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 23' ' ' LEU . 2.7 tp -58.73 -39.98 82.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.24 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.4 p -63.8 -18.89 64.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.205 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.7 m -69.13 -18.48 63.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.642 ' O ' HD11 ' C' ' 27' ' ' LEU . 86.5 m-85 -97.33 -3.32 40.69 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.612 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.698 HD13 ' O ' ' B' ' 26' ' ' PHE . 7.7 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.462 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.486 2.023 0 CA-C-O 120.315 -0.158 . . . . 0.0 112.826 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.627 ' HD2' ' HB3' ' A' ' 2' ' ' TYR . 3.1 m-30 -105.23 151.78 23.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.758 0.313 . . . . 0.0 111.549 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.813 HG22 ' NH2' ' B' ' 15' ' ' ARG . 5.8 pt -88.91 159.47 45.66 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.808 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 70.1 Cg_endo -87.21 151.79 8.09 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 122.29 1.993 . . . . 0.0 111.403 177.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.597 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 0.4 OUTLIER -57.32 143.34 40.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.144 -177.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.536 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -83.48 162.15 54.38 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.544 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.34 152.94 43.29 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.231 2.62 . . . . 0.0 112.98 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.507 ' HD3' ' N ' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -112.24 60.23 0.63 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.165 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -105.27 15.33 27.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.574 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.573 ' O ' ' HE3' ' C' ' 16' ' ' LYS . . . 79.56 14.85 80.73 Favored Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 120.203 -0.998 . . . . 0.0 112.824 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . 0.679 ' OE1' HD22 ' B' ' 22' ' ' LEU . 1.9 mm-40 -115.64 154.23 29.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.189 0.518 . . . . 0.0 110.585 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.639 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -93.43 134.18 35.94 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.391 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.502 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 74.6 m-85 -120.44 154.06 35.72 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.119 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -113.89 159.58 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 CA-C-N 113.368 -1.742 . . . . 0.0 106.634 176.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.881 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -103.2 107.31 18.07 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.74 -176.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.837 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -137.05 131.54 32.94 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 112.942 -1.936 . . . . 0.0 113.114 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.588 ' OD1' ' O ' ' B' ' 16' ' ' LYS . 0.5 OUTLIER 46.75 45.08 14.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.518 ' HA2' HH22 ' B' ' 15' ' ' ARG . . . 76.72 -3.38 55.96 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.395 -0.907 . . . . 0.0 114.748 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.24 161.36 27.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.863 0.831 . . . . 0.0 111.911 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' TRP . . . . . 0.881 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 91.5 m95 -93.7 114.66 27.0 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.285 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.419 ' O ' HG11 ' B' ' 14' ' ' VAL . 11.2 t -108.31 138.11 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 CA-C-O 121.898 0.856 . . . . 0.0 110.376 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.679 HD22 ' OE1' ' B' ' 11' ' ' GLN . 1.9 mt -53.77 124.05 14.11 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.223 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.561 HD11 ' CG ' ' C' ' 26' ' ' PHE . 0.2 OUTLIER -57.93 -44.19 86.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 18.0 t -48.42 -26.27 2.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.23 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 10.8 m -68.64 -19.1 64.4 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.245 0.545 . . . . 0.0 110.452 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.698 ' O ' HD13 ' A' ' 27' ' ' LEU . 81.6 m-85 -98.23 -4.47 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.64 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.584 HD12 ' O ' ' C' ' 26' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.103 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' TYR . . . . . 0.808 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.4 m-30 -100.49 167.59 10.27 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.789 0.328 . . . . 0.0 111.213 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . 0.733 HG21 ' CZ ' ' C' ' 15' ' ' ARG . 1.1 pt -102.55 157.95 32.71 Favored Pre-proline 0 CA--C 1.504 -0.819 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.276 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.972 ' HA ' ' O ' ' A' ' 1' ' ' GLY . 9.7 Cg_endo -82.81 145.06 12.58 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 121.696 1.597 . . . . 0.0 111.577 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.656 ' OE2' ' HA2' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -57.55 143.01 42.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.309 -177.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.599 ' HB1' ' CG ' ' C' ' 20' ' ' TRP . . . -84.09 170.37 14.14 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.306 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' PRO . . . . . 0.541 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 21.8 Cg_exo -61.8 149.06 91.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.772 2.315 . . . . 0.0 111.822 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -112.14 64.68 0.63 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.146 0.498 . . . . 0.0 110.882 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' ASP . . . . . 0.446 ' CG ' ' HG3' ' C' ' 11' ' ' GLN . 13.6 p-10 -121.28 23.02 10.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.505 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.575 ' C ' ' HE2' ' A' ' 16' ' ' LYS . . . 79.75 15.26 79.75 Favored Glycine 0 CA--C 1.508 -0.38 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.844 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' GLN . . . . . 0.464 ' C ' ' HB2' ' A' ' 16' ' ' LYS . 6.2 mt-30 -111.28 140.21 46.04 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 117.32 0.56 . . . . 0.0 110.837 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 26' ' ' PHE . . . -92.47 136.39 33.26 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.75 0.786 . . . . 0.0 110.785 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.541 ' CE2' ' HD2' ' C' ' 7' ' ' PRO . 69.1 m-85 -121.12 152.15 39.06 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.847 1.308 . . . . 0.0 112.32 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' VAL . . . . . 0.753 HG21 ' O ' ' C' ' 21' ' ' VAL . 0.0 OUTLIER -107.06 154.58 7.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 177.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.747 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.67 107.45 18.45 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.208 -178.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . 0.85 ' HG2' ' CG ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -137.1 134.45 36.46 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.106 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . 0.85 ' CG ' ' HG2' ' C' ' 16' ' ' LYS . 0.0 OUTLIER 48.45 45.6 20.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 176.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.428 ' O ' ' NH2' ' C' ' 15' ' ' ARG . . . 65.53 8.99 41.97 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -129.78 161.31 31.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.198 0.999 . . . . 0.0 111.358 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . 0.747 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 87.9 m95 -93.84 120.39 34.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.987 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.753 ' O ' HG21 ' C' ' 14' ' ' VAL . 11.1 t -113.0 137.79 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.549 0.69 . . . . 0.0 110.309 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.2 mt -57.6 127.64 33.05 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.981 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . 0.598 HD23 ' CB ' ' A' ' 26' ' ' PHE . 6.6 tp -58.79 -35.04 72.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.448 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -19.87 65.99 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 122.245 -0.285 . . . . 0.0 111.338 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -68.64 -18.25 64.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' PHE . . . . . 0.584 ' O ' HD12 ' B' ' 27' ' ' LEU . 93.3 m-85 -99.13 -7.78 26.14 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.011 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.642 HD11 ' O ' ' A' ' 26' ' ' PHE . 5.7 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.064 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' O ' ' CA ' ' C' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.487 2.098 0 N-CA-C 112.359 -0.297 . . . . 0.0 112.359 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.615 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 3.6 m-85 -121.79 150.96 41.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.971 0.385 . . . . 0.0 111.04 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.775 HG22 ' CZ ' ' A' ' 15' ' ' ARG . 4.3 pt -94.39 157.72 36.89 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-O 120.974 0.416 . . . . 0.0 111.975 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 21.4 Cg_endo -88.19 147.07 6.52 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 122.596 2.198 . . . . 0.0 111.102 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.824 ' OE2' ' NH2' ' B' ' 15' ' ' ARG . 1.3 tt0 -58.14 143.02 45.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.644 -176.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.528 ' HB1' ' CG ' ' A' ' 20' ' ' TRP . . . -86.42 163.8 40.6 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.976 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.63 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 31.3 Cg_exo -56.74 152.93 39.19 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.832 2.355 . . . . 0.0 112.824 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.582 ' CZ ' ' H ' ' B' ' 18' ' ' GLY . 0.0 OUTLIER -112.07 63.86 0.62 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.48 0.657 . . . . 0.0 111.594 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -110.78 14.67 22.19 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.478 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.829 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 79.12 15.93 79.55 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.642 ' CG ' HD21 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -109.81 148.17 31.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.584 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -91.68 135.2 34.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.293 0.568 . . . . 0.0 112.178 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.778 ' O ' HG23 ' B' ' 14' ' ' VAL . 65.6 m-85 -117.59 148.34 42.01 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 123.026 1.393 . . . . 0.0 111.905 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -107.01 154.26 7.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 112.1 -2.318 . . . . 0.0 104.813 177.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.775 ' CZ ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -104.77 106.98 17.7 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 118.057 -1.457 . . . . 0.0 108.274 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' C' ' 11' ' ' GLN . 0.2 OUTLIER -137.63 124.39 21.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.681 -178.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.89 46.84 16.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.45 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 65.97 6.29 30.63 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.741 -0.743 . . . . 0.0 114.554 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -129.74 161.95 29.52 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 117.894 0.847 . . . . 0.0 111.819 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.754 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 87.9 m95 -95.89 119.76 34.97 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.363 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.559 ' O ' HG21 ' A' ' 14' ' ' VAL . 15.9 t -114.5 141.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 CA-C-O 121.702 0.763 . . . . 0.0 109.933 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.642 HD21 ' CG ' ' A' ' 11' ' ' GLN . 1.7 mt -57.61 126.94 29.56 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.81 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.612 ' CD1' HD13 ' C' ' 23' ' ' LEU . 1.3 tp -60.36 -45.16 94.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.983 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.466 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 52.8 p -63.43 -19.05 64.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.752 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 m -69.38 -19.28 63.83 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.75 ' O ' ' CD2' ' C' ' 27' ' ' LEU . 87.9 m-85 -97.26 -2.47 42.59 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.789 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.718 HD12 ' O ' ' B' ' 26' ' ' PHE . 1.5 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.414 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.551 ' HA ' ' H ' ' A' ' 5' ' ' GLU . 5.5 m-85 -134.98 131.62 37.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.495 0.188 . . . . 0.0 110.988 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.672 HG21 ' CG ' ' A' ' 5' ' ' GLU . 21.3 pt -85.16 156.46 60.16 Favored Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 120.695 0.283 . . . . 0.0 110.8 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 71.8 Cg_endo -87.25 155.99 8.17 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.47 2.113 . . . . 0.0 111.524 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.669 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 0.6 OUTLIER -57.68 143.53 41.26 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.201 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.733 ' HB3' ' CG ' ' B' ' 20' ' ' TRP . . . -86.67 153.7 55.58 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.653 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.738 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 3.1 Cg_exo -50.48 153.81 7.06 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.48 2.787 . . . . 0.0 113.401 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.554 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -111.73 73.66 0.83 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.571 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -114.72 11.04 16.75 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.705 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' C' ' 16' ' ' LYS . . . 78.99 14.99 81.37 Favored Glycine 0 CA--C 1.512 -0.144 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.583 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . 0.595 ' O ' ' HB2' ' C' ' 16' ' ' LYS . 0.0 OUTLIER -118.73 158.52 25.39 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.096 0.474 . . . . 0.0 110.536 179.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.6 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.54 135.83 33.73 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.392 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.738 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 51.3 m-85 -120.64 153.53 36.73 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-N 114.42 -1.264 . . . . 0.0 112.088 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -116.15 159.13 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 113.802 -1.544 . . . . 0.0 107.956 176.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.83 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.09 107.24 18.12 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 122.104 0.954 . . . . 0.0 110.23 -176.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.829 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -137.63 125.63 22.8 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.612 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.53 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 56.81 41.81 27.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.582 ' H ' ' CZ ' ' A' ' 8' ' ' ARG . . . 69.59 10.54 63.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.46 159.55 36.73 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 118.233 1.017 . . . . 0.0 111.881 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' TRP . . . . . 0.83 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 90.5 m95 -93.42 113.15 25.24 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.07 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 18.7 t -109.55 136.94 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.161 0 CA-C-O 121.815 0.817 . . . . 0.0 110.43 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.489 HD23 ' CG ' ' B' ' 11' ' ' GLN . 4.9 mt -51.56 123.11 9.2 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.031 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.743 HD21 ' CG ' ' C' ' 26' ' ' PHE . 7.3 tp -57.01 -36.03 69.93 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.545 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -63.04 -17.3 62.09 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.601 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 3.4 m -71.48 -19.59 62.19 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.718 ' O ' HD12 ' A' ' 27' ' ' LEU . 90.4 m-85 -99.34 -3.62 33.55 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.159 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.759 ' CD2' ' O ' ' C' ' 26' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.196 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' B' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.106 0 N-CA-C 112.688 -0.165 . . . . 0.0 112.688 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' TYR . . . . . 0.618 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.0 m-85 -127.14 147.14 50.19 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.923 0.362 . . . . 0.0 111.653 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . 0.768 HG21 ' CZ ' ' C' ' 15' ' ' ARG . 2.3 pt -87.04 157.89 53.57 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 121.004 0.431 . . . . 0.0 111.589 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 19.2 Cg_endo -87.86 148.54 7.07 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 122.33 2.02 . . . . 0.0 110.873 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.667 ' OE2' ' NH2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -57.59 143.38 41.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.584 -177.058 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.515 ' N ' ' HG3' ' C' ' 5' ' ' GLU . . . -85.29 162.24 49.33 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.449 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' PRO . . . . . 0.49 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 32.3 Cg_exo -56.78 155.08 28.68 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.004 2.469 . . . . 0.0 113.171 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.78 79.02 1.21 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.458 0.647 . . . . 0.0 111.601 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -125.15 11.62 8.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.355 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.67 10.66 85.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.07 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' GLN . . . . . 0.784 ' OE1' HD12 ' C' ' 22' ' ' LEU . 0.6 OUTLIER -102.02 151.1 22.54 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.494 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -92.83 136.57 33.13 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.273 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.603 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 49.1 m-85 -117.99 155.42 30.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.554 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' B' ' 23' ' ' LEU . 4.4 t -123.93 134.9 65.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.807 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -80.59 109.14 14.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.998 0.904 . . . . 0.0 111.204 -175.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . 0.6 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -136.1 123.0 21.32 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 113.832 -1.531 . . . . 0.0 112.128 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . 0.554 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER 55.11 45.98 24.97 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 176.021 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.456 ' HA2' ' NH2' ' C' ' 15' ' ' ARG . . . 65.53 13.52 58.69 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 119.474 -0.626 . . . . 0.0 114.543 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' C' ' 16' ' ' LYS . 0.1 OUTLIER -133.05 161.41 34.44 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.488 1.144 . . . . 0.0 111.346 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . 0.807 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 82.3 m95 -93.35 116.19 28.75 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.087 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.539 HG22 ' HB ' ' C' ' 14' ' ' VAL . 1.7 m -108.29 129.57 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 CA-C-O 122.032 0.92 . . . . 0.0 111.25 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' LEU . . . . . 0.784 HD12 ' OE1' ' C' ' 11' ' ' GLN . 2.1 mt -51.42 123.45 9.78 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.62 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . 0.612 HD13 ' CD1' ' A' ' 23' ' ' LEU . 11.8 tp -60.37 -42.75 96.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.014 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -20.5 64.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.55 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 30.1 m -68.31 -18.59 64.55 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' PHE . . . . . 0.759 ' O ' ' CD2' ' B' ' 27' ' ' LEU . 52.8 m-85 -100.93 -8.77 22.17 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.073 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.75 ' CD2' ' O ' ' A' ' 26' ' ' PHE . 2.6 tp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.11 -0.947 . . . . 0.0 111.105 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 119.814 -0.437 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.754 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 8.4 m-30 -108.92 162.37 14.27 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.839 0.819 . . . . 0.0 111.86 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.596 HD13 ' CZ2' ' C' ' 20' ' ' TRP . 0.7 OUTLIER -92.74 159.59 35.92 Favored Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.501 178.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 43.1 Cg_endo -88.13 144.15 5.94 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.418 2.079 . . . . 0.0 111.487 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.654 ' OE2' ' NH2' ' B' ' 15' ' ' ARG . 0.6 OUTLIER -50.27 142.77 9.53 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.244 -178.195 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.541 ' HB3' ' CG ' ' A' ' 20' ' ' TRP . . . -87.13 166.24 27.2 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.563 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.516 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 34.5 Cg_exo -57.03 148.7 67.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.336 2.024 . . . . 0.0 111.627 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.416 ' HG2' ' N ' ' B' ' 18' ' ' GLY . 85.7 mtt180 -112.58 62.68 0.63 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.078 0.466 . . . . 0.0 111.928 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -114.78 18.07 16.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.135 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.887 ' O ' ' HE2' ' B' ' 16' ' ' LYS . . . 79.02 14.6 81.77 Favored Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.864 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.461 ' HB3' ' CD2' ' A' ' 22' ' ' LEU . 3.7 mm-40 -103.88 141.64 35.78 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -91.88 134.87 34.38 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.534 0.683 . . . . 0.0 110.914 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.876 ' O ' HG23 ' B' ' 14' ' ' VAL . 53.7 m-85 -120.04 149.75 41.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.409 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.599 HG23 ' CE2' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -104.61 156.64 5.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 176.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 1.022 HH11 ' HG3' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -105.86 115.76 30.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.644 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' C' ' 11' ' ' GLN . 1.0 OUTLIER -151.69 129.17 11.38 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.825 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.646 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 0.1 OUTLIER 54.89 42.24 31.26 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.718 177.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 62.44 16.45 54.73 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 119.358 -0.69 . . . . 0.0 114.742 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.646 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -131.87 161.62 32.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.801 1.301 . . . . 0.0 111.613 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.985 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 91.5 m95 -99.47 112.32 24.53 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.892 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.471 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 17.9 t -108.6 139.74 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.453 0.644 . . . . 0.0 109.652 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 11' ' ' GLN . 1.3 mt -55.79 126.71 26.78 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.935 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.526 ' CD2' ' CG ' ' B' ' 26' ' ' PHE . 3.3 tp -58.46 -39.49 80.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.164 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -19.14 64.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.046 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.3 m -70.12 -18.58 63.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.093 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.599 ' CE2' HG23 ' A' ' 14' ' ' VAL . 80.7 m-85 -97.25 -1.82 44.02 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.847 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 1.011 ' CD1' ' O ' ' B' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.048 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 CA-C-O 120.19 -0.228 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.504 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 4.4 m-85 -132.33 135.69 46.36 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 110.896 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.678 ' CG2' ' HE ' ' B' ' 15' ' ' ARG . 6.1 pt -87.19 159.31 51.14 Favored Pre-proline 0 CA--C 1.513 -0.462 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 92.0 Cg_endo -91.04 148.56 3.77 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 122.949 2.433 . . . . 0.0 111.376 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.779 ' OE2' ' HA2' ' C' ' 18' ' ' GLY . 0.9 OUTLIER -58.22 142.85 46.34 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.758 0.79 . . . . 0.0 112.959 -177.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.565 ' CB ' ' CG ' ' B' ' 20' ' ' TRP . . . -83.17 155.25 67.05 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.99 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.694 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 5.0 Cg_exo -45.75 152.7 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.743 2.962 . . . . 0.0 113.678 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' C' ' 17' ' ' ASP . 3.6 mtp180 -111.93 62.27 0.62 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.586 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -109.03 15.37 23.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.643 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.549 ' C ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.23 14.73 81.34 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.852 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . 0.636 ' O ' ' HB2' ' C' ' 16' ' ' LYS . 38.5 mm-40 -109.01 147.18 32.71 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 120.966 0.412 . . . . 0.0 110.508 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.607 ' HB1' ' CZ ' ' C' ' 26' ' ' PHE . . . -92.57 136.16 33.46 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.638 0.732 . . . . 0.0 109.469 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.694 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 50.7 m-85 -122.09 155.46 35.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.264 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 13' ' ' TYR . 1.5 p -114.93 159.81 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.477 175.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.986 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -102.95 114.42 28.7 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.133 0.968 . . . . 0.0 110.124 -176.225 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.887 ' HE2' ' O ' ' A' ' 10' ' ' GLY . 2.0 tttm -149.01 127.93 12.64 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.788 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 0.2 OUTLIER 56.29 45.25 23.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.444 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 62.13 14.13 45.22 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 119.484 -0.62 . . . . 0.0 114.196 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' B' ' 17' ' ' ASP . 0.1 OUTLIER -133.1 163.22 29.73 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.525 1.162 . . . . 0.0 112.011 -178.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' TRP . . . . . 0.986 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 92.5 m95 -97.65 113.02 24.68 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.204 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.588 ' O ' HG13 ' B' ' 14' ' ' VAL . 6.2 t -108.24 139.27 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 121.925 0.869 . . . . 0.0 110.333 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.522 ' CD2' ' HB3' ' B' ' 11' ' ' GLN . 3.8 mt -55.21 125.11 19.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.061 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.564 ' O ' HD12 ' B' ' 23' ' ' LEU . 3.8 tp -57.77 -39.4 77.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.521 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 29.8 t -63.23 -17.34 62.34 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.708 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 18.3 m -70.37 -20.27 62.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 1.011 ' O ' ' CD1' ' A' ' 27' ' ' LEU . 88.1 m-85 -96.89 -15.54 21.15 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.575 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.945 HD21 ' O ' ' C' ' 26' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.99 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' TYR . . . . . 0.643 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.1 m-30 -98.01 161.15 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.352 . . . . 0.0 111.524 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . 0.616 HG21 ' CD ' ' B' ' 5' ' ' GLU . 1.5 pt -90.09 158.4 44.2 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.765 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.754 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 43.7 Cg_endo -90.23 153.99 4.64 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 122.432 2.088 . . . . 0.0 112.285 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.519 ' OE2' ' HA2' ' A' ' 18' ' ' GLY . 1.1 tp10 -57.56 142.4 44.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.917 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.845 ' H ' HH12 ' A' ' 15' ' ' ARG . . . -89.08 162.89 36.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 113.699 -1.592 . . . . 0.0 110.864 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' PRO . . . . . 0.479 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 31.8 Cg_exo -57.27 152.39 46.17 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.075 2.517 . . . . 0.0 113.52 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -111.77 67.75 0.65 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.128 0.489 . . . . 0.0 111.095 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' ASP . . . . . 0.516 ' OD1' ' HB2' ' C' ' 11' ' ' GLN . 6.1 p30 -116.72 12.98 15.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.107 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.492 ' HA2' ' NZ ' ' A' ' 16' ' ' LYS . . . 84.08 14.68 71.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.203 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' GLN . . . . . 0.592 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 19.1 mt-30 -110.79 150.56 28.94 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.492 0.663 . . . . 0.0 110.892 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . . . -92.52 136.87 32.85 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.477 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.574 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 59.3 m-85 -118.99 156.12 30.17 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.035 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' VAL . . . . . 0.871 HG22 ' O ' ' C' ' 21' ' ' VAL . 0.2 OUTLIER -115.25 157.04 16.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.946 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.63 115.31 30.03 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 122.045 0.926 . . . . 0.0 110.903 -176.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . 0.636 ' HB2' ' O ' ' B' ' 11' ' ' GLN . 0.5 OUTLIER -153.47 132.96 12.89 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.339 -178.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . 0.417 ' HA ' ' HG2' ' B' ' 8' ' ' ARG . 0.2 OUTLIER 55.17 45.04 26.77 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 176.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.779 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.21 16.84 50.5 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-O 119.382 -0.677 . . . . 0.0 114.167 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -137.33 164.63 28.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.661 1.231 . . . . 0.0 112.255 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . 0.946 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 90.3 m95 -96.49 115.11 26.89 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.162 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.871 ' O ' HG22 ' C' ' 14' ' ' VAL . 2.7 m -105.81 134.81 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.153 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' LEU . . . . . 0.472 ' CD2' ' HB3' ' C' ' 11' ' ' GLN . 3.5 mt -55.44 122.03 10.31 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . 0.56 ' CD2' ' CG ' ' A' ' 26' ' ' PHE . 4.5 tp -59.12 -38.24 79.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.498 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 28.7 t -62.44 -18.94 62.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.89 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' THR . . . . . 0.422 ' O ' HG22 ' C' ' 25' ' ' THR . 29.6 m -69.23 -18.03 63.84 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' PHE . . . . . 0.945 ' O ' HD21 ' B' ' 27' ' ' LEU . 70.9 m-85 -101.04 -10.62 20.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.466 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.503 HD11 ' HB3' ' A' ' 26' ' ' PHE . 25.4 mt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.873 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 112.58 -0.208 . . . . 0.0 112.58 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.689 ' HB3' ' O ' ' C' ' 3' ' ' ILE . 5.9 m-85 -99.02 167.21 10.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 112.23 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.843 HG22 ' CZ ' ' A' ' 15' ' ' ARG . 3.5 pt -91.68 159.52 38.31 Favored Pre-proline 0 CA--C 1.51 -0.578 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.186 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 55.5 Cg_endo -84.58 139.71 7.91 Favored 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 121.17 1.247 . . . . 0.0 111.201 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.574 ' CB ' HG21 ' B' ' 3' ' ' ILE . 0.5 OUTLIER -47.97 143.03 4.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.59 -1.187 . . . . 0.0 113.87 -177.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.731 ' HA ' ' CD1' ' A' ' 20' ' ' TRP . . . -84.05 177.65 2.86 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.66 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.919 ' HB2' ' OD2' ' A' ' 9' ' ' ASP . 2.7 Cg_exo -75.5 155.23 40.64 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.576 2.851 . . . . 0.0 114.037 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' HG3' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -105.01 79.67 1.53 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 178.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.919 ' OD2' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -124.84 3.03 8.13 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.198 -178.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.49 0.36 83.61 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 119.571 -1.299 . . . . 0.0 111.188 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.803 ' O ' ' HB2' ' B' ' 16' ' ' LYS . 0.1 OUTLIER -101.69 151.76 21.64 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.475 ' HB1' ' HB ' ' B' ' 14' ' ' VAL . . . -91.48 137.94 31.97 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.439 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.615 ' CD2' ' HD2' ' A' ' 7' ' ' PRO . 47.5 m-85 -118.5 155.69 30.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.081 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.615 HG11 ' CD1' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -105.1 150.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.953 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.55 99.41 9.09 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.541 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 0.3 OUTLIER -136.0 125.73 25.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 112.777 -2.011 . . . . 0.0 113.172 -176.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.96 43.11 30.42 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.616 ' HA2' ' NH1' ' A' ' 15' ' ' ARG . . . 74.85 6.65 78.95 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.168 -1.015 . . . . 0.0 115.109 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.88 161.54 35.34 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.992 1.396 . . . . 0.0 112.396 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.953 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 97.3 m95 -94.32 115.25 27.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.651 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.562 ' C ' ' HD1' ' A' ' 13' ' ' TYR . 22.0 t -107.21 136.84 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 121.904 0.859 . . . . 0.0 108.791 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.662 HD23 ' OE1' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -53.92 122.64 10.47 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.321 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.59 HD22 ' CB ' ' B' ' 26' ' ' PHE . 4.9 tp -57.26 -36.06 70.52 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.683 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.442 ' HB2' HD11 ' A' ' 22' ' ' LEU . 25.9 m -61.47 -17.76 55.92 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.243 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 25' ' ' THR . 27.3 m -72.23 -18.39 61.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.615 ' CD1' HG11 ' A' ' 14' ' ' VAL . 88.9 m-85 -99.34 -10.54 22.18 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.332 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' B' ' 26' ' ' PHE . 9.3 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.689 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 119.733 -0.482 . . . . 0.0 111.972 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.626 ' CD2' ' HB2' ' A' ' 2' ' ' TYR . 3.6 m-85 -134.57 138.51 44.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.748 0.774 . . . . 0.0 110.809 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.574 HG21 ' CB ' ' A' ' 5' ' ' GLU . 0.8 OUTLIER -88.2 158.49 49.42 Favored Pre-proline 0 N--CA 1.47 0.528 0 CA-C-O 121.4 0.619 . . . . 0.0 112.621 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 87.8 Cg_endo -92.17 156.3 3.2 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 123.056 2.504 . . . . 0.0 111.232 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.847 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 0.7 OUTLIER -57.85 141.99 47.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -177.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.6 ' CB ' ' CD1' ' B' ' 20' ' ' TRP . . . -88.15 158.68 49.33 Favored Pre-proline 0 C--N 1.334 -0.103 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.361 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.476 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 10.1 Cg_endo -51.39 152.76 11.22 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.428 2.085 . . . . 0.0 111.68 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -114.85 67.95 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.471 0.653 . . . . 0.0 111.6 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -109.55 16.0 22.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.639 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.16 31.89 63.51 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.387 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . 0.634 ' O ' ' HA ' ' C' ' 16' ' ' LYS . 19.8 mm-40 -123.47 149.42 45.13 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.567 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.61 135.92 33.67 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.855 0.836 . . . . 0.0 111.66 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.538 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 80.7 m-85 -122.24 152.67 39.78 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 123.382 1.563 . . . . 0.0 112.654 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.49 HG23 ' O ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -106.99 156.69 7.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 111.266 -2.697 . . . . 0.0 105.93 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.931 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.19 105.55 15.64 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 118.76 -1.176 . . . . 0.0 108.13 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.803 ' HB2' ' O ' ' A' ' 11' ' ' GLN . 4.4 pttt -138.78 132.61 30.93 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 113.224 -1.807 . . . . 0.0 111.661 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.538 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 58.17 42.99 21.25 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 176.061 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.484 ' HA3' ' NH1' ' A' ' 8' ' ' ARG . . . 60.05 14.81 33.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.216 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -134.96 165.41 25.39 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 117.437 0.618 . . . . 0.0 111.842 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' TRP . . . . . 0.931 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 94.7 m95 -98.11 112.14 24.21 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.742 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.639 HG22 ' HG2' ' B' ' 16' ' ' LYS . 17.0 t -106.12 141.44 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 CA-C-O 121.848 0.833 . . . . 0.0 109.65 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.515 HD23 ' OE1' ' B' ' 11' ' ' GLN . 2.6 mt -57.27 127.72 33.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.999 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.575 HD22 ' CB ' ' C' ' 26' ' ' PHE . 5.7 tp -61.67 -40.04 93.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.579 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -19.77 66.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.176 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -68.32 -18.02 64.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.59 ' CB ' HD22 ' A' ' 23' ' ' LEU . 91.3 m-85 -99.29 -4.93 30.7 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.577 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.568 HD13 ' O ' ' C' ' 26' ' ' PHE . 4.5 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.227 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.714 -0.154 . . . . 0.0 112.714 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' TYR . . . . . 0.603 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.5 m-85 -120.3 146.57 45.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.932 0.396 . . . . 0.0 111.656 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . 0.689 ' O ' ' HB3' ' A' ' 2' ' ' TYR . 1.0 OUTLIER -92.11 158.65 39.03 Favored Pre-proline 0 CA--C 1.501 -0.926 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.592 178.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.684 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 75.7 Cg_endo -86.73 146.86 8.21 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.83 1.687 . . . . 0.0 112.426 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.579 ' HA ' ' CG2' ' A' ' 3' ' ' ILE . 1.8 tt0 -57.41 143.41 40.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 113.803 -1.544 . . . . 0.0 113.464 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.491 ' CB ' ' CD1' ' C' ' 20' ' ' TRP . . . -85.3 153.36 59.17 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.411 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.85 153.69 5.75 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.142 2.561 . . . . 0.0 112.986 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' ARG . . . . . 0.42 ' NH2' ' OE1' ' C' ' 5' ' ' GLU . 8.8 mtt85 -112.79 57.28 0.66 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.914 0.388 . . . . 0.0 111.782 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' ASP . . . . . 0.478 ' OD1' ' HB2' ' C' ' 11' ' ' GLN . 2.5 p30 -105.63 18.71 21.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' A' ' 16' ' ' LYS . . . 80.0 10.51 85.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.604 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' GLN . . . . . 0.612 ' HA ' ' NE2' ' C' ' 11' ' ' GLN . 0.2 OUTLIER -103.85 154.09 20.0 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 117.669 0.734 . . . . 0.0 109.271 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -95.91 134.26 39.12 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.529 0.68 . . . . 0.0 111.82 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.69 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 51.4 m-85 -117.51 154.68 31.05 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.783 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' VAL . . . . . 0.621 ' HB ' HG21 ' C' ' 21' ' ' VAL . 1.7 t -118.36 156.7 20.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.867 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -104.99 108.25 19.67 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.941 -177.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . 0.634 ' HA ' ' O ' ' B' ' 11' ' ' GLN . 0.0 OUTLIER -136.38 121.18 18.58 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.621 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.55 45.93 18.6 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.029 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.559 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 62.31 14.6 48.7 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.629 0.612 . . . . 0.0 114.629 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -130.19 162.2 29.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.3 1.05 . . . . 0.0 111.737 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . 0.867 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 68.0 m95 -96.27 114.71 26.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.715 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.621 HG21 ' HB ' ' C' ' 14' ' ' VAL . 2.3 m -111.35 130.66 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.117 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' LEU . . . . . 0.484 HD23 ' HG3' ' C' ' 11' ' ' GLN . 1.2 mt -53.46 125.02 16.48 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.101 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . 0.789 HD23 ' O ' ' C' ' 23' ' ' LEU . 0.2 OUTLIER -60.38 -36.62 78.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.737 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.08 -19.5 64.47 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.203 -0.311 . . . . 0.0 110.829 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' THR . . . . . 0.425 HG23 ' O ' ' C' ' 25' ' ' THR . 51.7 m -69.04 -18.4 64.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' PHE . . . . . 0.575 ' CB ' HD22 ' B' ' 23' ' ' LEU . 59.1 m-85 -100.06 -8.94 23.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.317 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.584 HD13 ' O ' ' A' ' 26' ' ' PHE . 5.5 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.176 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' C' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.372 0 CA-C-O 119.638 -0.535 . . . . 0.0 112.162 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.788 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 19.6 m-85 -134.88 166.8 22.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.603 0.701 . . . . 0.0 111.2 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.744 HG22 ' CZ ' ' A' ' 15' ' ' ARG . 1.1 pt -92.12 158.01 40.01 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.193 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 10.3 Cg_endo -82.49 147.7 14.15 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 121.764 1.643 . . . . 0.0 110.605 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.59 ' HA ' ' CG2' ' B' ' 3' ' ' ILE . 0.6 OUTLIER -58.36 142.9 46.82 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -176.666 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.51 ' HA ' ' CD1' ' A' ' 20' ' ' TRP . . . -87.14 160.74 48.33 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.317 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.475 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 51.9 Cg_exo -55.06 153.63 25.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.332 2.688 . . . . 0.0 113.621 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 71.3 mtm-85 -112.03 83.15 1.74 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.45 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -128.42 13.5 6.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.66 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.669 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 78.79 13.36 83.21 Favored Glycine 0 CA--C 1.51 -0.253 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.819 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.656 ' O ' ' HB2' ' B' ' 16' ' ' LYS . 11.5 mt-30 -115.55 148.75 39.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.848 0.356 . . . . 0.0 110.112 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' B' ' 14' ' ' VAL . . . -90.88 138.52 31.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 122.131 0.967 . . . . 0.0 112.562 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.538 ' HB3' ' HB3' ' A' ' 20' ' ' TRP . 61.9 m-85 -118.57 152.77 35.38 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.395 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.866 HG11 ' O ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -114.46 157.22 15.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.785 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.91 104.26 13.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.798 0.809 . . . . 0.0 111.524 -176.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 1.1 tttt -135.39 128.38 31.49 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.204 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.486 ' HA ' ' CG ' ' C' ' 8' ' ' ARG . 0.2 OUTLIER 55.33 44.97 26.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 63.14 15.92 57.06 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 114.993 0.757 . . . . 0.0 114.993 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -132.33 158.57 41.57 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.575 1.188 . . . . 0.0 111.777 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.785 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 92.7 m95 -94.92 115.67 27.75 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.182 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.866 ' O ' HG11 ' A' ' 14' ' ' VAL . 14.2 t -111.21 141.24 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-O 121.693 0.759 . . . . 0.0 110.185 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.504 HD23 ' HB3' ' A' ' 11' ' ' GLN . 2.4 mt -57.29 125.37 22.47 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.596 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.797 HD21 ' CG ' ' B' ' 26' ' ' PHE . 7.4 tp -57.49 -35.48 70.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.45 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -63.97 -20.06 65.61 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.36 -0.213 . . . . 0.0 111.146 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 m -68.81 -18.09 64.12 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.35 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 1.228 ' O ' HD11 ' C' ' 27' ' ' LEU . 80.7 m-85 -95.9 -21.36 18.11 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.662 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.686 HD11 ' O ' ' B' ' 26' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.168 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 120.209 -0.217 . . . . 0.0 113.166 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 3.4 m-85 -120.97 143.58 48.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.983 0.391 . . . . 0.0 110.93 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.746 HG22 ' NE ' ' B' ' 15' ' ' ARG . 5.0 pt -86.97 158.19 53.42 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 120.953 0.406 . . . . 0.0 112.031 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 84.0 Cg_endo -91.59 153.21 3.52 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.49 2.127 . . . . 0.0 111.671 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.651 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 0.6 OUTLIER -58.26 143.48 44.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.701 -177.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.477 ' HB3' ' CG ' ' B' ' 20' ' ' TRP . . . -86.99 171.39 10.07 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.795 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.468 ' HD2' ' CD2' ' B' ' 13' ' ' TYR . 18.8 Cg_exo -64.46 151.89 83.75 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.443 2.762 . . . . 0.0 113.028 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.425 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.3 OUTLIER -111.91 49.61 0.89 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -99.93 14.92 28.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.471 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.599 ' O ' ' HD2' ' C' ' 16' ' ' LYS . . . 79.64 15.04 80.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.169 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . 0.482 HE21 ' HA ' ' B' ' 11' ' ' GLN . 1.8 mm-40 -103.52 146.82 27.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.676 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -94.28 133.76 37.48 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.954 0.883 . . . . 0.0 112.339 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.659 ' HA ' ' O ' ' B' ' 21' ' ' VAL . 74.8 m-85 -121.31 152.9 38.41 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 123.148 1.451 . . . . 0.0 112.354 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.7 HG23 ' O ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -113.22 158.01 13.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 111.766 -2.47 . . . . 0.0 106.264 178.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.746 ' NE ' HG22 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -104.29 107.4 18.29 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 118.845 -1.142 . . . . 0.0 108.779 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.669 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -136.81 125.23 23.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.432 -178.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 55.04 44.94 27.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 176.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.466 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 62.19 16.14 52.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 115.222 0.849 . . . . 0.0 115.222 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' B' ' 16' ' ' LYS . 0.0 OUTLIER -134.81 161.3 35.58 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 118.624 1.212 . . . . 0.0 111.575 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' TRP . . . . . 0.592 ' HB3' ' CG ' ' B' ' 13' ' ' TYR . 90.0 m95 -97.02 112.82 24.4 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.515 0.674 . . . . 0.0 110.495 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.7 ' O ' HG23 ' B' ' 14' ' ' VAL . 0.5 OUTLIER -110.59 153.3 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.572 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.968 179.036 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.482 ' CD2' ' O ' ' B' ' 12' ' ' ALA . 3.9 mt -67.98 126.76 30.49 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 113.503 -1.68 . . . . 0.0 114.89 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.538 HD11 ' O ' ' B' ' 23' ' ' LEU . 3.5 tp -60.72 -43.77 97.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.887 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 14.3 m -63.59 -16.85 62.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.421 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.411 ' O ' HG22 ' B' ' 25' ' ' THR . 13.2 m -69.66 -17.51 63.5 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.797 ' CG ' HD21 ' A' ' 23' ' ' LEU . 24.8 m-85 -100.61 -5.6 26.47 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.358 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.85 HD12 ' O ' ' C' ' 26' ' ' PHE . 15.3 mt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.251 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 CA-C-O 120.275 -0.18 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.6 m-85 -128.53 141.0 51.51 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.88 0.34 . . . . 0.0 111.015 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . 0.751 ' CG2' ' HE ' ' C' ' 15' ' ' ARG . 2.3 pt -88.54 157.58 49.56 Favored Pre-proline 0 CA--C 1.496 -1.113 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.236 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.788 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 20.8 Cg_endo -86.35 147.45 8.78 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.821 1.681 . . . . 0.0 111.856 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.631 ' OE2' ' NH2' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -57.8 143.16 43.19 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.944 -177.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' C' ' 5' ' ' GLU . . . -85.59 152.38 57.21 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.856 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' PRO . . . . . 0.425 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 72.0 Cg_exo -49.73 156.02 3.46 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.519 2.813 . . . . 0.0 113.88 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' ARG . . . . . 0.486 ' CG ' ' HA ' ' A' ' 17' ' ' ASP . 2.6 mtp85 -111.9 57.25 0.64 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.994 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -102.09 17.9 22.12 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.784 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.34 11.0 75.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.795 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' GLN . . . . . 0.489 ' HB3' HD22 ' C' ' 22' ' ' LEU . 86.8 mt-30 -106.49 151.86 24.41 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.62 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -92.41 137.17 32.59 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.999 0.904 . . . . 0.0 112.627 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.528 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 79.8 m-85 -120.99 158.22 28.23 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.807 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' VAL . . . . . 0.56 HG22 ' O ' ' B' ' 13' ' ' TYR . 0.1 OUTLIER -125.45 159.46 32.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 113.357 -1.747 . . . . 0.0 106.495 177.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.984 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -103.67 107.71 18.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 122.436 1.113 . . . . 0.0 110.743 -175.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . 0.676 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 0.2 OUTLIER -136.57 133.23 36.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.995 -1.911 . . . . 0.0 110.365 178.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . 0.596 ' OD1' ' O ' ' C' ' 16' ' ' LYS . 0.1 OUTLIER 48.31 46.17 20.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 177.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.493 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.48 16.21 49.22 Favored Glycine 0 N--CA 1.453 -0.194 0 N-CA-C 114.373 0.509 . . . . 0.0 114.373 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -131.57 159.1 39.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 117.756 0.778 . . . . 0.0 111.666 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . 0.984 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 87.9 m95 -93.67 109.35 21.0 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.418 0.627 . . . . 0.0 110.33 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' C' ' 13' ' ' TYR . 5.9 t -103.81 135.82 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.913 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' LEU . . . . . 0.489 HD22 ' HB3' ' C' ' 11' ' ' GLN . 7.2 mt -50.37 122.44 6.99 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.797 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . 0.497 HD11 ' O ' ' C' ' 23' ' ' LEU . 1.3 tp -58.02 -39.91 79.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.546 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 35.4 t -64.2 -17.46 63.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.476 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' C' ' 22' ' ' LEU . 5.2 m -70.11 -18.76 63.26 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' PHE . . . . . 0.85 ' O ' HD12 ' B' ' 27' ' ' LEU . 89.7 m-85 -98.09 0.86 46.89 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.6 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 1.228 HD11 ' O ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.257 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.771 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 15.4 m-85 -97.63 176.62 5.77 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.608 0.704 . . . . 0.0 112.382 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.593 HG21 ' HE ' ' A' ' 15' ' ' ARG . 1.1 pt -104.7 159.71 28.43 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.33 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.603 ' HA ' ' CD1' ' B' ' 2' ' ' TYR . 13.9 Cg_endo -81.4 144.94 14.68 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.047 1.831 . . . . 0.0 111.716 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.49 ' HG3' HG21 ' B' ' 3' ' ' ILE . 22.5 tt0 -57.04 142.02 43.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 113.995 -1.457 . . . . 0.0 114.094 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.78 157.24 52.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.388 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 51.0 Cg_exo -54.54 151.14 32.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.977 2.451 . . . . 0.0 112.436 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 24.4 mtm180 -112.51 57.76 0.65 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.971 0.415 . . . . 0.0 112.051 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.05 18.66 19.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.792 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.779 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 80.17 14.95 79.71 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.906 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.683 ' C ' ' HB2' ' B' ' 16' ' ' LYS . 8.4 mt-30 -106.6 141.12 38.4 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.538 ' HA ' ' CB ' ' B' ' 16' ' ' LYS . . . -91.47 135.53 33.77 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 122.004 0.907 . . . . 0.0 112.102 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.759 ' CE1' HD22 ' A' ' 22' ' ' LEU . 56.4 m-85 -119.57 153.21 35.78 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.794 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -118.32 147.58 21.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.726 ' NH2' ' HA2' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -93.64 107.68 19.51 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.678 -1.209 . . . . 0.0 110.405 -177.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.673 ' HB2' ' C ' ' C' ' 11' ' ' GLN . 0.0 OUTLIER -138.21 124.97 21.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.519 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.776 ' HA ' ' CB ' ' C' ' 8' ' ' ARG . 0.8 OUTLIER 60.97 45.84 9.03 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 176.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.726 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 61.37 14.75 42.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.643 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -137.15 164.25 28.9 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 117.983 0.892 . . . . 0.0 112.198 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.697 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 81.4 m95 -93.11 116.2 28.81 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.188 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.793 ' O ' HG22 ' A' ' 14' ' ' VAL . 1.4 m -107.04 128.25 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.717 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.759 HD22 ' CE1' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -52.21 121.86 7.6 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.985 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.922 HD22 ' CG ' ' B' ' 26' ' ' PHE . 15.8 tp -58.44 -44.97 89.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.508 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 m -48.08 -26.32 1.79 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.324 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -67.02 -18.84 65.55 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.489 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 1.029 ' O ' HD21 ' C' ' 27' ' ' LEU . 61.5 m-85 -98.75 -5.03 32.11 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.143 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.836 ' CD1' ' O ' ' B' ' 26' ' ' PHE . 1.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.091 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.603 ' CD1' ' HA ' ' A' ' 4' ' ' PRO . 2.7 m-85 -129.03 135.61 49.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.796 0.298 . . . . 0.0 111.345 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.49 HG21 ' HG3' ' A' ' 5' ' ' GLU . 11.8 pt -86.97 155.84 55.25 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-O 120.993 0.425 . . . . 0.0 111.926 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.779 ' HD2' HH21 ' B' ' 15' ' ' ARG . 90.3 Cg_endo -86.93 154.25 8.53 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.427 2.752 . . . . 0.0 111.965 178.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.576 ' HA ' ' CG2' ' C' ' 3' ' ' ILE . 3.2 tt0 -58.48 143.46 45.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.472 ' HB1' ' CG ' ' B' ' 20' ' ' TRP . . . -86.9 158.16 53.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.12 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.415 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 19.0 Cg_endo -58.23 158.1 23.44 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.526 2.817 . . . . 0.0 113.106 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' C' ' 17' ' ' ASP . 1.3 mpp_? -112.22 74.6 0.87 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.294 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.41 8.24 10.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.698 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.713 ' O ' ' HE3' ' C' ' 16' ' ' LYS . . . 78.72 22.84 65.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.287 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . 0.713 ' OE1' HD21 ' B' ' 22' ' ' LEU . 56.2 mt-30 -116.32 145.4 43.21 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.548 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -91.83 134.82 34.41 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.065 0.936 . . . . 0.0 111.503 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.655 ' CE1' HD22 ' B' ' 22' ' ' LEU . 52.2 m-85 -120.27 153.01 36.97 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.132 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.783 HG21 ' O ' ' B' ' 21' ' ' VAL . 0.2 OUTLIER -113.23 154.14 14.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 112.727 -2.033 . . . . 0.0 105.716 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.817 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -106.22 100.63 10.15 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.257 1.027 . . . . 0.0 111.136 -176.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.779 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -134.66 126.71 29.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 113.347 -1.752 . . . . 0.0 110.847 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 38.4 t70 60.12 43.42 14.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.85 12.77 29.99 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.565 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.445 ' C ' ' NH1' ' B' ' 15' ' ' ARG . 28.0 mt-10 -128.56 160.03 33.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.09 0.945 . . . . 0.0 111.45 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' TRP . . . . . 0.817 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 81.9 m95 -95.14 116.19 28.41 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.301 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.783 ' O ' HG21 ' B' ' 14' ' ' VAL . 9.8 t -112.0 134.98 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.211 0 CA-C-O 121.746 0.784 . . . . 0.0 109.735 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.713 HD21 ' OE1' ' B' ' 11' ' ' GLN . 0.1 OUTLIER -52.71 124.94 15.15 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.821 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.649 HD21 ' CD2' ' C' ' 26' ' ' PHE . 18.2 tp -57.68 -38.35 75.01 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.256 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 25.6 t -62.66 -18.5 62.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.742 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 1.5 m -68.95 -17.88 64.01 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.922 ' CG ' HD22 ' A' ' 23' ' ' LEU . 81.4 m-85 -101.88 -12.69 18.06 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.673 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.611 HD12 ' O ' ' C' ' 26' ' ' PHE . 13.5 mt . . . . . 0 C--O 1.25 1.087 0 O-C-N 121.103 -0.998 . . . . 0.0 111.367 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.071 0 N-CA-C 112.815 -0.114 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.7 m-85 -121.91 145.98 47.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.732 0.266 . . . . 0.0 111.344 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . 0.667 HG22 ' CZ ' ' C' ' 15' ' ' ARG . 3.8 pt -85.46 150.11 53.4 Favored Pre-proline 0 CA--C 1.514 -0.415 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 10.9 Cg_endo -81.89 150.41 16.2 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.817 1.678 . . . . 0.0 111.203 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.492 ' HG2' HH21 ' C' ' 8' ' ' ARG . 6.2 tt0 -58.04 142.39 46.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.503 -1.226 . . . . 0.0 113.102 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ALA . . . . . 0.569 ' HB2' ' NH1' ' A' ' 15' ' ' ARG . . . -88.57 165.06 29.79 Favored Pre-proline 0 C--O 1.231 0.127 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.873 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' PRO . . . . . 0.45 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 24.7 Cg_exo -59.06 146.22 95.03 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.525 2.15 . . . . 0.0 110.679 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' ARG . . . . . 0.776 ' CB ' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -113.85 58.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.109 0.48 . . . . 0.0 111.5 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' C' ' 11' ' ' GLN . 6.8 p-10 -104.27 21.84 15.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.387 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . 0.615 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 78.88 12.7 83.89 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.226 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' GLN . . . . . 0.673 ' C ' ' HB2' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -113.02 143.05 44.97 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.685 ' HB1' ' CZ ' ' A' ' 26' ' ' PHE . . . -90.6 138.26 31.7 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.948 0.88 . . . . 0.0 111.852 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.58 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 60.4 m-85 -118.33 150.35 39.64 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.572 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' VAL . . . . . 0.632 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.3 OUTLIER -110.71 154.2 12.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.707 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.73 108.13 19.49 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.651 -1.22 . . . . 0.0 109.944 -177.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . 0.713 ' HE3' ' O ' ' B' ' 10' ' ' GLY . 0.0 OUTLIER -136.89 121.63 18.61 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.942 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' B' ' 8' ' ' ARG . 8.8 t70 58.56 45.75 15.8 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.55 ' HA2' ' NH2' ' C' ' 15' ' ' ARG . . . 63.97 15.71 58.6 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 115.064 0.786 . . . . 0.0 115.064 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -132.42 161.66 33.09 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.703 1.251 . . . . 0.0 112.118 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . 0.707 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 89.4 m95 -96.95 115.15 26.93 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.143 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.632 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.4 m -114.67 131.83 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.139 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' LEU . . . . . 0.571 HD21 ' CG ' ' C' ' 11' ' ' GLN . 2.1 mt -51.48 127.31 19.71 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.235 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' A' ' 26' ' ' PHE . 3.5 tp -59.87 -44.01 94.42 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.677 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -65.63 -22.26 66.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.934 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 16.6 m -69.29 -18.41 63.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' PHE . . . . . 0.649 ' CD2' HD21 ' B' ' 23' ' ' LEU . 42.9 m-85 -97.19 -0.31 47.07 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.555 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 1.029 HD21 ' O ' ' A' ' 26' ' ' PHE . 1.7 tp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.007 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.617 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 5.5 m-30 . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 111.925 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 1.017 HG23 ' HA ' ' C' ' 5' ' ' GLU . 4.5 pt -91.4 153.63 44.34 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.644 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 11.2 Cg_endo -86.25 153.42 9.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.723 2.282 . . . . 0.0 111.308 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.887 ' HA ' HG23 ' B' ' 3' ' ' ILE . 1.1 tp10 -58.21 142.34 47.85 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.785 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.21 160.77 48.05 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.166 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.553 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 43.9 Cg_exo -54.65 152.06 29.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.102 2.535 . . . . 0.0 112.958 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.583 ' HG3' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -111.63 57.76 0.63 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.165 0.507 . . . . 0.0 111.135 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -105.48 16.15 25.96 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.699 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' O ' ' HD2' ' B' ' 16' ' ' LYS . . . 79.98 14.08 81.22 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.81 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.643 ' HB3' HD21 ' A' ' 22' ' ' LEU . 3.0 mt-30 -107.11 157.73 17.62 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 117.156 0.478 . . . . 0.0 110.47 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.966 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -98.86 136.21 39.19 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.485 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.815 ' O ' HG23 ' B' ' 14' ' ' VAL . 66.2 m-85 -120.43 149.1 42.91 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.391 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -111.25 157.14 12.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.78 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -106.19 107.3 18.24 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 118.134 -1.426 . . . . 0.0 110.645 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.715 ' HG2' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -137.3 140.58 41.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.592 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.715 ' CG ' ' HG2' ' A' ' 16' ' ' LYS . 0.4 OUTLIER 45.21 45.65 9.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 177.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.433 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 61.82 16.81 52.98 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.383 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -133.71 162.34 32.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 118.124 0.962 . . . . 0.0 111.574 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.829 ' CZ2' HD12 ' A' ' 3' ' ' ILE . 73.4 m95 -93.94 114.1 26.24 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.471 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.887 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.4 m -107.19 132.66 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.295 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.643 HD21 ' HB3' ' A' ' 11' ' ' GLN . 4.4 mt -53.11 121.83 8.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.766 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.596 HD23 ' CD1' ' B' ' 26' ' ' PHE . 1.8 tp -60.09 -45.73 91.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.904 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.4 p -50.54 -26.28 5.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.962 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.2 m -67.5 -19.08 65.28 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.725 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 1.271 ' O ' HD21 ' C' ' 27' ' ' LEU . 12.7 m-85 -98.2 2.66 48.61 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.168 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.26 HD21 ' O ' ' B' ' 26' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.309 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.581 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 4.6 m-85 -130.89 141.64 50.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.985 0.422 . . . . 0.0 111.165 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 5' ' ' GLU . 6.4 pt -88.69 158.59 47.81 Favored Pre-proline 0 CA--C 1.515 -0.372 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.665 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 96.9 Cg_endo -88.48 150.21 6.41 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.984 2.456 . . . . 0.0 110.463 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 1.045 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.4 OUTLIER -57.54 149.19 21.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.935 -176.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.604 ' N ' ' HG3' ' B' ' 5' ' ' GLU . . . -91.0 152.55 44.39 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.195 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.71 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 6.2 Cg_exo -48.14 153.18 2.99 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.337 2.692 . . . . 0.0 113.251 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.541 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.9 OUTLIER -111.56 66.62 0.63 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.934 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -110.65 11.25 22.8 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.265 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.48 8.06 88.03 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.148 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.939 ' HB3' HD21 ' B' ' 22' ' ' LEU . 2.6 mm-40 -102.03 151.76 21.76 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.855 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -93.13 134.79 34.93 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.527 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.71 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 55.5 m-85 -119.85 151.54 38.7 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.021 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.966 HG21 ' HB1' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -113.72 159.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-N 113.61 -1.632 . . . . 0.0 106.832 175.647 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.966 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -103.7 107.9 18.96 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.489 1.137 . . . . 0.0 109.323 -176.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.821 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -135.82 131.81 35.87 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.036 -1.893 . . . . 0.0 111.432 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.601 ' OD1' ' O ' ' B' ' 16' ' ' LYS . 0.1 OUTLIER 47.8 46.86 18.52 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 177.027 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.497 ' H ' ' NH1' ' B' ' 15' ' ' ARG . . . 62.39 16.44 54.47 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 114.172 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -133.46 161.44 34.56 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 117.967 0.884 . . . . 0.0 111.702 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' TRP . . . . . 0.966 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 84.8 m95 -94.09 117.15 29.69 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.512 ' O ' HG12 ' B' ' 14' ' ' VAL . 5.4 t -114.63 136.6 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.196 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.071 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.939 HD21 ' HB3' ' B' ' 11' ' ' GLN . 2.8 mt -54.02 125.34 18.47 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.016 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.632 HD22 HG11 ' C' ' 14' ' ' VAL . 1.8 tp -56.75 -35.5 68.7 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.082 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' SER . . . . . 0.518 ' HA ' ' HB2' ' B' ' 27' ' ' LEU . 2.0 p -63.62 -19.59 64.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.021 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 23.6 m -70.51 -20.45 62.83 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 1.26 ' O ' HD21 ' A' ' 27' ' ' LEU . 96.2 m-85 -101.12 18.77 18.95 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-O 122.218 1.009 . . . . 0.0 108.328 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 1.056 HD21 ' O ' ' C' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.363 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.279 -0.329 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 2' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.3 m-30 -102.23 159.6 15.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 111.682 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 1.045 HG23 ' HA ' ' B' ' 5' ' ' GLU . 3.3 pt -86.97 154.73 55.4 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.806 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 9.9 Cg_endo -83.22 148.13 13.06 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.437 2.091 . . . . 0.0 110.856 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 1.017 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -58.09 143.53 43.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.057 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 6' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' C' ' 5' ' ' GLU . . . -83.77 167.46 28.1 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.268 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 7' ' ' PRO . . . . . 0.535 ' HD2' ' HB1' ' C' ' 6' ' ' ALA . 28.7 Cg_exo -59.04 151.5 65.68 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.042 2.495 . . . . 0.0 112.547 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 8' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -112.03 48.82 0.95 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.046 0.45 . . . . 0.0 111.581 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 9' ' ' ASP . . . . . 0.491 ' CG ' ' HG3' ' C' ' 11' ' ' GLN . 19.0 p-10 -104.94 19.35 20.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.088 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.482 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.65 14.27 81.36 Favored Glycine 0 C--O 1.229 -0.158 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.34 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 11' ' ' GLN . . . . . 0.914 ' HB3' HD21 ' C' ' 22' ' ' LEU . 7.1 mt-30 -105.1 141.15 37.17 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 12' ' ' ALA . . . . . 0.757 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -90.91 135.33 33.81 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.268 0.556 . . . . 0.0 110.981 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.511 ' CD2' ' HD2' ' C' ' 7' ' ' PRO . 70.9 m-85 -119.3 152.79 36.12 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.615 1.198 . . . . 0.0 112.637 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 14' ' ' VAL . . . . . 0.94 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.6 OUTLIER -113.37 145.82 18.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 112.624 -2.08 . . . . 0.0 106.35 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.761 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -95.01 115.47 27.46 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.906 -178.284 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.855 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 1.9 tttt -151.05 125.46 9.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.989 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 17' ' ' ASP . . . . . 0.541 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 0.3 OUTLIER 58.64 44.44 17.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.984 0.421 . . . . 0.0 111.462 177.677 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.505 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.8 16.42 51.56 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.996 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -133.73 161.94 33.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.032 0.916 . . . . 0.0 111.679 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' TRP . . . . . 0.799 ' CZ2' HD12 ' C' ' 3' ' ' ILE . 92.1 m95 -97.58 115.18 27.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.485 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.94 ' O ' HG23 ' C' ' 14' ' ' VAL . 6.4 t -110.06 137.59 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-O 121.596 0.712 . . . . 0.0 110.296 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 22' ' ' LEU . . . . . 0.914 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.3 mt -56.59 127.3 30.65 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.66 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.681 HD22 HG11 ' A' ' 14' ' ' VAL . 7.7 tp -59.16 -35.61 73.83 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.139 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 80.6 p -64.01 -19.88 65.5 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 122.12 -0.362 . . . . 0.0 110.977 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 73.3 m -67.63 -18.36 64.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' PHE . . . . . 1.056 ' O ' HD21 ' B' ' 27' ' ' LEU . 76.6 m-85 -101.88 9.37 40.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.426 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 1.271 HD21 ' O ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.478 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.895 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 22.9 m-85 . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 120.936 0.398 . . . . 0.0 111.667 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.896 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.0 OUTLIER -97.32 160.05 29.8 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.833 177.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 21.1 Cg_endo -82.47 145.77 13.41 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.034 1.823 . . . . 0.0 111.401 176.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.753 ' HA ' HG23 ' B' ' 3' ' ' ILE . 3.4 tt0 -57.61 142.6 44.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.006 -1.452 . . . . 0.0 113.76 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 20' ' ' TRP . . . -85.03 163.92 43.8 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.557 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.467 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 37.8 Cg_exo -57.31 151.13 54.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.979 2.453 . . . . 0.0 112.853 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 45.4 mtm-85 -112.32 58.26 0.64 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.44 15.55 21.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.737 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.763 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 78.79 14.58 81.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.695 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 1.01 ' HB3' HD21 ' A' ' 22' ' ' LEU . 7.7 mm-40 -102.83 141.32 35.84 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.924 ' HB1' HG11 ' B' ' 14' ' ' VAL . . . -91.52 133.39 35.55 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.784 0.802 . . . . 0.0 112.54 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.611 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 70.2 m-85 -118.66 151.42 37.98 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.961 1.363 . . . . 0.0 113.048 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.03 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -111.04 155.34 12.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 178.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.902 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.49 108.52 20.08 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.364 -177.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.677 ' HE3' ' O ' ' C' ' 10' ' ' GLY . 0.0 OUTLIER -136.73 120.72 17.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.65 -1.613 . . . . 0.0 111.977 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 0.4 OUTLIER 59.2 45.88 13.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 177.119 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.62 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 63.6 14.15 53.62 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.991 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -131.38 159.95 36.47 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 118.329 1.064 . . . . 0.0 111.429 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.902 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 93.0 m95 -97.53 114.77 26.72 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.882 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.03 ' O ' HG23 ' A' ' 14' ' ' VAL . 10.5 t -111.37 139.73 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-O 121.718 0.771 . . . . 0.0 110.032 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.01 HD21 ' HB3' ' A' ' 11' ' ' GLN . 3.7 mt -56.72 128.02 34.4 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.618 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.682 HD23 ' CG ' ' B' ' 26' ' ' PHE . 3.0 tp -61.5 -42.99 99.64 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.897 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -63.54 -18.59 64.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.738 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.0 m -69.69 -19.11 63.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 1.326 ' O ' HD21 ' C' ' 27' ' ' LEU . 96.3 m-85 -97.77 3.6 50.01 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.756 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.262 HD21 ' O ' ' B' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 4.8 m-85 -133.65 129.58 37.05 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.634 0.254 . . . . 0.0 110.595 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.753 HG23 ' HA ' ' A' ' 5' ' ' GLU . 3.5 pt -85.45 155.63 59.6 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.946 ' HD2' HH21 ' B' ' 15' ' ' ARG . 83.4 Cg_endo -83.39 160.22 14.94 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.638 2.226 . . . . 0.0 112.648 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.937 ' HA ' HG23 ' C' ' 3' ' ' ILE . 19.2 tt0 -60.74 143.08 55.15 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.507 ' HB1' ' CD ' ' B' ' 7' ' ' PRO . . . -84.72 169.61 16.05 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.568 -1.197 . . . . 0.0 112.053 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.507 ' CD ' ' HB1' ' B' ' 6' ' ' ALA . 12.2 Cg_exo -71.04 153.89 62.83 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.826 3.017 . . . . 0.0 113.064 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' C' ' 17' ' ' ASP . 1.7 mpp_? -112.0 84.56 1.98 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.297 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.32 6.57 4.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.338 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.862 ' O ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.15 14.74 81.43 Favored Glycine 0 CA--C 1.509 -0.29 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.512 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.927 ' HB3' HD21 ' B' ' 22' ' ' LEU . 0.4 OUTLIER -103.9 144.08 31.99 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.81 ' HB1' ' CG1' ' C' ' 14' ' ' VAL . . . -90.57 135.88 33.42 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.541 0.686 . . . . 0.0 110.404 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.624 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 43.5 m-85 -118.92 152.15 36.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.491 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.924 HG11 ' HB1' ' A' ' 12' ' ' ALA . 0.5 OUTLIER -105.55 158.79 5.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 175.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.946 HH21 ' HD2' ' B' ' 4' ' ' PRO . 0.0 OUTLIER -107.66 105.82 15.87 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 118.581 -1.248 . . . . 0.0 107.688 176.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.763 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -138.06 124.68 20.89 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.164 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 2.8 t0 58.92 43.79 17.49 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.322 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.19 12.69 38.96 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 119.243 -0.754 . . . . 0.0 114.529 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.495 ' C ' ' NH1' ' B' ' 15' ' ' ARG . 0.1 OUTLIER -127.43 154.72 44.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.113 1.456 . . . . 0.0 111.382 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 20' ' ' TRP . . . . . 0.886 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 76.2 m95 -93.74 113.41 25.46 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.752 HG22 HG12 ' B' ' 14' ' ' VAL . 1.4 m -108.61 132.85 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 CA-C-O 121.626 0.727 . . . . 0.0 111.282 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.927 HD21 ' HB3' ' B' ' 11' ' ' GLN . 1.8 mt -53.75 122.06 9.16 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.216 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.75 HD21 ' HB3' ' C' ' 26' ' ' PHE . 1.1 tp -57.61 -34.99 69.86 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.6 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 16.7 m -61.65 -16.58 49.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.434 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 31.7 m -69.78 -18.15 63.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 1.262 ' O ' HD21 ' A' ' 27' ' ' LEU . 8.8 m-85 -99.71 -11.4 20.9 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.449 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.804 HD13 ' O ' ' C' ' 26' ' ' PHE . 9.4 mt . . . . . 0 C--O 1.249 1.043 0 O-C-N 120.751 -1.218 . . . . 0.0 110.896 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 CA-C-O 119.861 -0.411 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 2' ' ' TYR . . . . . 0.663 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.6 m-30 -116.85 150.39 38.47 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.614 0.707 . . . . 0.0 111.241 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 0.937 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.4 pt -87.31 156.85 53.92 Favored Pre-proline 0 CA--C 1.506 -0.748 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.895 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 20.7 Cg_endo -87.8 152.96 7.35 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 122.153 1.902 . . . . 0.0 112.335 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.896 ' HA ' HG23 ' A' ' 3' ' ' ILE . 4.2 tt0 -57.38 141.45 47.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.086 -1.415 . . . . 0.0 113.321 -177.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 6' ' ' ALA . . . . . 0.614 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . . . -84.97 160.51 55.14 Favored Pre-proline 0 N--CA 1.455 -0.211 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.306 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 7' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.99 151.52 49.25 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.921 2.414 . . . . 0.0 112.22 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 20.7 mtm105 -111.57 70.37 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.407 0.623 . . . . 0.0 111.08 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -113.34 17.23 18.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.038 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.677 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 74.0 15.37 79.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.616 -1.278 . . . . 0.0 112.264 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 11' ' ' GLN . . . . . 0.694 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.1 OUTLIER -113.91 152.47 30.75 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.011 0.434 . . . . 0.0 110.977 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 12' ' ' ALA . . . . . 0.622 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -92.75 136.19 33.45 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.583 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.496 ' HD1' ' C ' ' C' ' 21' ' ' VAL . 70.4 m-85 -119.85 156.76 30.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.949 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 14' ' ' VAL . . . . . 0.81 ' CG1' ' HB1' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -108.64 155.62 9.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 176.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.726 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.96 107.67 18.79 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 118.34 -1.344 . . . . 0.0 107.789 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.862 ' HE2' ' O ' ' B' ' 10' ' ' GLY . 0.0 OUTLIER -136.57 124.49 22.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.978 -1.465 . . . . 0.0 111.381 -179.181 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 17' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' B' ' 8' ' ' ARG . 0.2 OUTLIER 58.71 45.34 15.92 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 176.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.43 ' C ' ' CZ ' ' C' ' 15' ' ' ARG . . . 63.02 16.42 57.46 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.907 -0.663 . . . . 0.0 114.475 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 19' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -134.65 161.08 36.12 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.289 1.044 . . . . 0.0 111.227 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 20' ' ' TRP . . . . . 0.726 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 91.2 m95 -97.28 115.04 26.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.527 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.615 HG21 ' HD3' ' C' ' 16' ' ' LYS . 21.5 t -107.92 141.2 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 121.767 0.794 . . . . 0.0 110.028 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 22' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.6 mt -57.78 124.2 18.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.302 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.906 HD22 HG11 ' A' ' 14' ' ' VAL . 25.8 tp -58.82 -52.15 66.97 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.33 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 41.8 t -43.64 -26.79 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.434 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -68.19 -18.65 64.65 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.585 0.707 . . . . 0.0 109.623 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' PHE . . . . . 0.804 ' O ' HD13 ' B' ' 27' ' ' LEU . 81.0 m-85 -99.65 -3.7 32.52 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.81 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 1.326 HD21 ' O ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.241 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 4.1 m-30 . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 120.634 0.254 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.832 HD12 ' CZ2' ' A' ' 20' ' ' TRP . 4.2 pt -91.75 161.53 33.65 Favored Pre-proline 0 CA--C 1.509 -0.603 0 CA-C-O 121.024 0.44 . . . . 0.0 111.582 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 33.2 Cg_endo -89.06 151.65 5.73 Favored 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 122.274 1.983 . . . . 0.0 110.686 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.942 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.5 OUTLIER -57.44 142.72 42.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.873 -177.036 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.6 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -84.39 165.07 40.29 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.524 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.474 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 28.5 Cg_exo -61.16 154.01 60.7 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 123.512 2.808 . . . . 0.0 113.202 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.446 ' CG ' ' HA ' ' B' ' 17' ' ' ASP . 2.0 mtp85 -112.04 69.98 0.7 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.262 0.553 . . . . 0.0 111.155 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -113.84 14.83 18.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.051 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.555 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 79.36 15.12 80.6 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.851 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.896 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -115.28 150.91 35.47 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.296 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.764 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -91.54 136.49 33.09 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.771 0.796 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.634 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 51.8 m-85 -117.43 151.65 36.62 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.344 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -112.87 152.9 14.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.74 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.04 107.32 18.23 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 118.962 -1.095 . . . . 0.0 108.503 -177.359 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.736 ' HE3' ' O ' ' C' ' 10' ' ' GLY . 0.6 OUTLIER -137.01 125.04 22.82 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 113.382 -1.736 . . . . 0.0 111.132 -178.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.563 ' HA ' ' HG3' ' C' ' 8' ' ' ARG . 0.2 OUTLIER 57.87 45.36 18.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.278 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.496 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 62.35 14.07 46.55 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 114.352 0.501 . . . . 0.0 114.352 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -131.0 161.93 30.89 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 117.889 0.845 . . . . 0.0 111.897 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.832 ' CZ2' HD12 ' A' ' 3' ' ' ILE . 82.5 m95 -96.42 113.91 25.53 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.952 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.867 ' O ' HG23 ' A' ' 14' ' ' VAL . 11.7 t -111.91 139.18 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 121.726 0.775 . . . . 0.0 110.034 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.896 HD21 ' HB3' ' A' ' 11' ' ' GLN . 2.1 mt -55.52 126.76 26.61 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.078 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.668 HD23 ' CG ' ' B' ' 26' ' ' PHE . 2.9 tp -59.91 -42.78 94.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.307 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.413 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 2.3 m -62.97 -19.15 64.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.7 m -69.7 -18.31 63.53 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.777 ' CB ' HD21 ' C' ' 23' ' ' LEU . 84.1 m-85 -97.54 2.05 49.66 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.574 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.953 ' CD1' ' O ' ' B' ' 26' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.072 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.616 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 3.7 m-85 -129.51 143.32 50.78 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.738 0.304 . . . . 0.0 110.988 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.942 HG23 ' HA ' ' A' ' 5' ' ' GLU . 2.6 pt -89.44 158.34 46.04 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-O 120.999 0.428 . . . . 0.0 112.139 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.77 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 92.2 Cg_endo -87.22 151.58 8.06 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.72 2.28 . . . . 0.0 111.075 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.914 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.8 OUTLIER -57.69 142.41 45.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.253 -177.443 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.63 ' HB3' ' NH1' ' C' ' 15' ' ' ARG . . . -83.72 166.67 32.84 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.462 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' B' ' 6' ' ' ALA . 22.2 Cg_exo -62.76 151.12 85.67 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.448 2.765 . . . . 0.0 112.588 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.627 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -112.79 60.52 0.64 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.985 0.421 . . . . 0.0 111.891 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' B' ' 11' ' ' GLN . 3.9 p30 -106.01 15.24 26.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.239 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.551 ' C ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.48 14.48 81.3 Favored Glycine 0 CA--C 1.506 -0.487 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.81 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.739 ' OE1' HD11 ' B' ' 22' ' ' LEU . 0.0 OUTLIER -113.19 152.83 29.24 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.484 0.659 . . . . 0.0 109.744 178.334 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 1.019 ' HB1' HG21 ' C' ' 14' ' ' VAL . . . -92.83 136.26 33.4 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.89 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.782 ' O ' HG23 ' C' ' 14' ' ' VAL . 58.4 m-85 -119.2 152.59 36.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.457 1.123 . . . . 0.0 112.265 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.937 HG23 ' O ' ' B' ' 21' ' ' VAL . 0.7 OUTLIER -112.49 155.84 13.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 113.122 -1.854 . . . . 0.0 106.214 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.982 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.14 107.1 17.9 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.884 -1.127 . . . . 0.0 108.92 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.764 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -136.79 124.02 21.81 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.505 -1.679 . . . . 0.0 111.792 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.446 ' HA ' ' CG ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 57.11 45.99 19.85 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.306 176.353 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.555 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 61.92 14.41 45.08 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.381 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.73 161.72 31.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.524 1.162 . . . . 0.0 111.803 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' TRP . . . . . 0.982 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 81.2 m95 -96.84 114.41 26.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.441 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.937 ' O ' HG23 ' B' ' 14' ' ' VAL . 10.6 t -111.16 142.4 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 121.768 0.794 . . . . 0.0 110.613 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.739 HD11 ' OE1' ' B' ' 11' ' ' GLN . 1.4 mt -56.82 122.68 12.75 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.399 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.673 HD23 ' CD2' ' C' ' 26' ' ' PHE . 2.8 tp -57.57 -43.18 84.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.87 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -19.28 65.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.944 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 4.1 m -67.72 -18.76 65.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.953 ' O ' ' CD1' ' A' ' 27' ' ' LEU . 87.4 m-85 -95.92 -16.11 21.96 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.325 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.984 HD13 ' O ' ' C' ' 26' ' ' PHE . 1.8 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.275 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.052 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 2' ' ' TYR . . . . . 0.77 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.5 m-30 -100.62 160.97 13.92 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.775 0.321 . . . . 0.0 111.798 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 0.914 HG23 ' HA ' ' B' ' 5' ' ' GLU . 7.4 pt -87.75 160.75 46.49 Favored Pre-proline 0 CA--C 1.516 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.624 ' O ' ' NE1' ' C' ' 20' ' ' TRP . 69.8 Cg_endo -92.38 144.09 2.6 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 122.614 2.209 . . . . 0.0 111.432 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.786 ' OE2' HG22 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -58.05 142.84 45.52 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -176.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 6' ' ' ALA . . . . . 0.878 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -87.37 156.69 53.81 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.814 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 7' ' ' PRO . . . . . 0.459 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 52.0 Cg_exo -49.61 153.69 5.18 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.111 2.541 . . . . 0.0 113.238 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 8' ' ' ARG . . . . . 0.563 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -111.64 64.73 0.62 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.368 0.604 . . . . 0.0 111.03 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -112.05 14.18 20.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.526 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.736 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.29 13.95 82.18 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.363 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 11' ' ' GLN . . . . . 0.87 ' HB3' HD21 ' C' ' 22' ' ' LEU . 1.3 mm-40 -106.25 155.01 19.92 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 12' ' ' ALA . . . . . 0.72 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -96.63 134.43 39.87 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.402 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.562 ' CD2' ' HB1' ' C' ' 6' ' ' ALA . 50.2 m-85 -118.79 155.21 31.54 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.071 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 14' ' ' VAL . . . . . 1.019 HG21 ' HB1' ' B' ' 12' ' ' ALA . 0.4 OUTLIER -118.87 160.79 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.88 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.23 107.71 18.84 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.482 1.134 . . . . 0.0 110.766 -176.266 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' B' ' 11' ' ' GLN . 0.0 OUTLIER -137.05 127.25 26.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.474 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 17' ' ' ASP . . . . . 0.627 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 1.1 m-20 55.79 45.97 23.29 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.633 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 60.54 15.37 39.51 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 19' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' C' ' 16' ' ' LYS . 0.0 OUTLIER -133.61 162.0 33.11 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.277 1.038 . . . . 0.0 111.043 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 20' ' ' TRP . . . . . 0.88 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 91.9 m95 -98.49 122.84 42.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.299 0.571 . . . . 0.0 110.732 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.415 ' O ' HG12 ' C' ' 14' ' ' VAL . 12.8 t -117.5 138.44 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.673 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 22' ' ' LEU . . . . . 0.87 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.5 mt -55.61 125.61 21.8 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.874 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.777 HD21 ' CB ' ' A' ' 26' ' ' PHE . 7.8 tp -57.15 -35.18 69.22 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.921 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -15.1 59.6 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.502 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 4.0 m -72.8 -18.93 61.42 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' PHE . . . . . 0.984 ' O ' HD13 ' B' ' 27' ' ' LEU . 92.0 m-85 -99.1 -6.95 27.42 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.607 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.685 HD23 HD22 ' B' ' 27' ' ' LEU . 58.4 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.899 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.727 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 8.4 m-30 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' C' ' 5' ' ' GLU . 5.6 pt -100.96 159.11 30.43 Favored Pre-proline 0 CA--C 1.508 -0.648 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.097 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 39.2 Cg_endo -86.58 152.92 8.95 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 121.623 1.549 . . . . 0.0 112.043 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.873 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.4 OUTLIER -57.25 143.24 40.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.753 -177.645 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.667 ' HA ' ' CD1' ' A' ' 20' ' ' TRP . . . -85.72 165.7 33.72 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.92 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 24.8 Cg_exo -58.85 151.07 67.36 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.957 2.438 . . . . 0.0 112.355 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.33 63.84 0.61 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.192 0.52 . . . . 0.0 111.25 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -110.27 13.34 23.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.592 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.19 8.94 87.15 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.394 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.927 ' HG3' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -102.4 151.14 22.62 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.227 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.642 ' HB1' ' CG1' ' B' ' 14' ' ' VAL . . . -92.1 136.26 33.32 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.606 0.717 . . . . 0.0 110.189 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.564 ' CE1' HD23 ' A' ' 22' ' ' LEU . 52.9 m-85 -119.09 154.28 33.44 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.711 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 21' ' ' VAL . 1.8 t -115.41 156.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.925 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -106.06 107.85 19.07 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.407 1.099 . . . . 0.0 110.46 -176.535 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.662 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 0.0 OUTLIER -138.2 126.75 23.44 Favored 'General case' 0 C--O 1.23 0.044 0 CA-C-N 113.062 -1.881 . . . . 0.0 112.052 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.586 ' HA ' ' HG3' ' C' ' 8' ' ' ARG . 0.4 OUTLIER 55.46 45.3 25.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 176.274 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.596 ' H ' ' NH2' ' A' ' 15' ' ' ARG . . . 62.1 15.59 50.69 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.568 -0.573 . . . . 0.0 114.528 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -134.33 162.97 30.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.498 1.149 . . . . 0.0 111.37 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.925 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 89.1 m95 -94.58 120.12 34.31 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.397 0.617 . . . . 0.0 110.792 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.797 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.6 m -115.69 131.35 68.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.949 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.927 HD21 ' HG3' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -51.09 123.87 10.29 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.786 -178.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.691 HD22 HG11 ' B' ' 14' ' ' VAL . 4.7 tp -57.43 -36.19 71.05 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.517 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.68 -21.18 66.52 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.949 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.0 m -70.1 -22.61 63.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.759 0.79 . . . . 0.0 108.97 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 1.051 ' O ' HD13 ' C' ' 27' ' ' LEU . 32.8 m-85 -97.87 -6.14 33.07 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.777 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.958 HD21 ' O ' ' B' ' 26' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.193 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.684 -0.166 . . . . 0.0 112.684 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.542 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 3.0 m-85 -130.48 138.61 50.35 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.861 0.362 . . . . 0.0 111.354 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.9 HG21 ' HE ' ' B' ' 15' ' ' ARG . 4.2 pt -88.89 159.65 45.32 Favored Pre-proline 0 N--CA 1.468 0.474 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 80.9 Cg_endo -91.05 152.59 3.86 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.875 2.383 . . . . 0.0 111.76 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 1.003 ' HA ' HG23 ' C' ' 3' ' ' ILE . 2.9 tt0 -58.39 142.8 47.27 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.737 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -88.33 146.23 37.44 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.597 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.472 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 11.4 Cg_exo -40.73 154.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.569 2.846 . . . . 0.0 113.678 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.41 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -111.94 65.0 0.62 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.818 179.401 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -110.77 18.54 19.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.304 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.464 ' HA2' ' OD2' ' C' ' 17' ' ' ASP . . . 75.6 7.83 83.54 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.564 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.542 ' HB3' HD21 ' B' ' 22' ' ' LEU . 0.9 OUTLIER -105.5 151.16 24.62 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.289 0.566 . . . . 0.0 110.071 178.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.556 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.81 137.32 32.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.635 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.567 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 60.2 m-85 -120.44 154.34 35.33 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.665 1.221 . . . . 0.0 111.476 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.925 HG23 ' O ' ' B' ' 21' ' ' VAL . 0.2 OUTLIER -111.89 156.15 13.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 112.58 -2.1 . . . . 0.0 106.625 179.111 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.971 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.74 103.91 13.51 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.118 0.961 . . . . 0.0 109.178 -178.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.799 ' HD3' HG21 ' B' ' 21' ' ' VAL . 0.0 OUTLIER -135.24 125.87 27.03 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.366 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.05 46.11 19.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.693 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 61.5 15.76 47.62 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 114.277 0.471 . . . . 0.0 114.277 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -133.36 161.91 33.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 117.904 0.852 . . . . 0.0 112.172 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' TRP . . . . . 0.971 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 83.9 m95 -95.86 114.73 26.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.215 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.925 ' O ' HG23 ' B' ' 14' ' ' VAL . 10.9 t -107.03 139.97 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.628 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.542 HD21 ' HB3' ' B' ' 11' ' ' GLN . 4.7 mt -58.04 124.33 18.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.326 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 1.003 HD22 HG11 ' C' ' 14' ' ' VAL . 35.6 tp -58.87 -39.98 82.99 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.523 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.2 m -62.77 -18.46 62.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.914 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 1.3 m -68.25 -17.6 64.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.958 ' O ' HD21 ' A' ' 27' ' ' LEU . 90.0 m-85 -102.69 -15.82 16.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.261 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.894 HD13 ' O ' ' C' ' 26' ' ' PHE . 5.5 mt . . . . . 0 C--O 1.249 1.07 0 O-C-N 121.137 -0.977 . . . . 0.0 111.024 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 2' ' ' TYR . . . . . 0.631 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.8 m-30 -96.09 161.72 13.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.333 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 1.003 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.9 pt -87.62 157.99 51.77 Favored Pre-proline 0 CA--C 1.512 -0.49 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.583 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.727 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 37.3 Cg_endo -89.65 146.09 4.84 Favored 'Trans proline' 0 N--CA 1.437 -1.853 0 C-N-CA 122.664 2.242 . . . . 0.0 111.336 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.926 ' HA ' HG23 ' A' ' 3' ' ' ILE . 1.1 tp10 -57.6 141.68 47.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 6' ' ' ALA . . . . . 0.895 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -83.83 157.55 63.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.535 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 7' ' ' PRO . . . . . 0.414 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 51.8 Cg_exo -50.93 153.34 8.79 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.642 2.228 . . . . 0.0 112.769 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 8' ' ' ARG . . . . . 0.586 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 1.6 mpt_? -111.21 63.18 0.61 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.302 0.572 . . . . 0.0 110.645 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -107.96 13.97 25.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.252 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.422 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.62 10.23 86.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.397 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 11' ' ' GLN . . . . . 0.63 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.6 OUTLIER -106.7 152.27 24.01 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 12' ' ' ALA . . . . . 0.69 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -93.36 137.94 32.18 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.274 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.648 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 61.8 m-85 -119.11 152.65 36.13 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.326 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 14' ' ' VAL . . . . . 1.029 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.1 OUTLIER -111.38 153.97 13.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 178.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.771 ' NH2' ' OE2' ' B' ' 5' ' ' GLU . 0.0 OUTLIER -104.9 106.28 16.7 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.984 -177.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.693 ' HE2' ' OD2' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -137.53 133.13 34.17 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 113.08 -1.873 . . . . 0.0 111.764 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 17' ' ' ASP . . . . . 0.693 ' OD2' ' HE2' ' C' ' 16' ' ' LYS . 0.4 OUTLIER 46.68 46.45 14.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.533 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.613 ' HA2' HH22 ' C' ' 15' ' ' ARG . . . 69.98 10.68 65.4 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.97 160.45 38.26 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.835 1.317 . . . . 0.0 112.349 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' TRP . . . . . 0.895 ' CG ' ' HB2' ' C' ' 6' ' ' ALA . 85.2 m95 -94.49 112.63 24.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.008 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 1.029 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.0 m -109.79 135.38 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.083 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 22' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.3 mt -53.21 124.32 14.21 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.145 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.765 HD11 HD21 ' C' ' 27' ' ' LEU . 2.6 tp -58.23 -42.36 86.13 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.761 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -22.61 66.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.055 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 48.2 m -69.46 -18.95 63.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' PHE . . . . . 0.894 ' O ' HD13 ' B' ' 27' ' ' LEU . 40.9 m-85 -100.34 -6.42 25.83 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.859 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 1.051 HD13 ' O ' ' A' ' 26' ' ' PHE . 2.6 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.661 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.793 ' CE2' ' HB2' ' C' ' 2' ' ' TYR . 0.4 OUTLIER . . . . . 0 CA--C 1.543 0.693 0 CA-C-O 119.912 -0.09 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.942 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.4 pt -104.74 158.96 30.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 37.2 Cg_endo -87.33 137.43 4.31 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.814 2.343 . . . . 0.0 111.802 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.873 ' HA ' HG23 ' B' ' 3' ' ' ILE . 2.9 tt0 -51.93 143.63 13.19 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.858 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.06 154.23 54.84 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.88 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 75.3 Cg_exo -51.73 157.34 5.57 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 123.613 2.875 . . . . 0.0 113.944 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -112.11 59.26 0.63 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.353 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -105.62 13.53 29.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.001 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.443 ' O ' ' HD2' ' B' ' 16' ' ' LYS . . . 79.66 13.57 82.27 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.777 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.623 ' HB3' HD21 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -106.21 156.76 18.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 117.156 0.478 . . . . 0.0 109.734 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.045 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -98.2 134.29 41.46 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.591 0.71 . . . . 0.0 112.021 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.875 ' O ' HG23 ' B' ' 14' ' ' VAL . 68.6 m-85 -120.1 151.76 38.58 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.649 1.214 . . . . 0.0 111.888 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.796 HG11 HD22 ' C' ' 23' ' ' LEU . 0.2 OUTLIER -112.98 157.76 13.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 113.105 -1.862 . . . . 0.0 106.566 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.999 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.56 106.05 16.39 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 118.579 -1.248 . . . . 0.0 109.437 -177.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.903 ' HG3' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -137.86 128.02 25.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.163 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.903 ' CG ' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 57.14 45.53 20.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 176.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.675 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 60.81 15.65 42.69 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.669 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -133.64 162.82 30.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.702 0.751 . . . . 0.0 111.767 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.999 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 84.0 m95 -97.21 110.83 23.3 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.948 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.793 ' O ' HG23 ' A' ' 14' ' ' VAL . 17.5 t -105.68 142.35 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.051 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.623 HD21 ' HB3' ' A' ' 11' ' ' GLN . 6.2 mt -56.41 124.56 18.53 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.057 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.664 HD23 ' CD2' ' B' ' 26' ' ' PHE . 2.7 tp -58.73 -39.98 82.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.24 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.4 p -63.8 -18.89 64.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.205 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.7 m -69.13 -18.48 63.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.882 ' O ' HD13 ' C' ' 27' ' ' LEU . 86.5 m-85 -97.33 -3.32 40.69 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.612 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.913 HD13 ' O ' ' B' ' 26' ' ' PHE . 7.7 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.462 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.486 2.023 0 CA-C-O 120.315 -0.158 . . . . 0.0 112.826 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.659 ' HD2' ' HB3' ' A' ' 2' ' ' TYR . 3.1 m-30 -105.23 151.78 23.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.758 0.313 . . . . 0.0 111.549 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.873 HG23 ' HA ' ' A' ' 5' ' ' GLU . 5.8 pt -88.91 159.47 45.66 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.883 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 70.1 Cg_endo -87.21 151.79 8.09 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 122.29 1.993 . . . . 0.0 111.403 177.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.999 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.4 OUTLIER -57.32 143.34 40.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.144 -177.441 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' B' ' 5' ' ' GLU . . . -83.48 162.15 54.38 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.544 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.34 152.94 43.29 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.231 2.62 . . . . 0.0 112.98 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.51 ' N ' ' HD3' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -112.24 60.23 0.63 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.165 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -105.27 15.33 27.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.574 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.59 ' O ' ' HE3' ' C' ' 16' ' ' LYS . . . 79.56 14.85 80.73 Favored Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 120.203 -0.998 . . . . 0.0 112.824 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.863 ' HB3' HD21 ' B' ' 22' ' ' LEU . 1.9 mm-40 -115.64 154.23 29.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.189 0.518 . . . . 0.0 110.585 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.695 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -93.43 134.18 35.94 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.391 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.537 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 74.6 m-85 -120.44 154.06 35.72 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.119 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 1.045 HG21 ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -113.89 159.58 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 CA-C-N 113.368 -1.742 . . . . 0.0 106.634 176.454 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.88 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -103.2 107.31 18.07 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.74 -176.304 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.853 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -137.05 131.54 32.94 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 112.942 -1.936 . . . . 0.0 113.114 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.588 ' OD1' ' O ' ' B' ' 16' ' ' LYS . 0.5 OUTLIER 46.75 45.08 14.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.552 ' HA2' HH22 ' B' ' 15' ' ' ARG . . . 76.72 -3.38 55.96 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.395 -0.907 . . . . 0.0 114.748 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.24 161.36 27.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.863 0.831 . . . . 0.0 111.911 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' TRP . . . . . 0.88 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 91.5 m95 -93.7 114.66 27.0 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.285 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.428 ' O ' HG12 ' B' ' 14' ' ' VAL . 11.2 t -108.31 138.11 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 CA-C-O 121.898 0.856 . . . . 0.0 110.376 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.863 HD21 ' HB3' ' B' ' 11' ' ' GLN . 1.9 mt -53.77 124.05 14.11 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.223 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.86 ' CD2' HD21 ' B' ' 27' ' ' LEU . 0.2 OUTLIER -57.93 -44.19 86.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 18.0 t -48.42 -26.27 2.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.23 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 10.8 m -68.64 -19.1 64.4 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.245 0.545 . . . . 0.0 110.452 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.913 ' O ' HD13 ' A' ' 27' ' ' LEU . 81.6 m-85 -98.23 -4.47 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.64 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.946 HD13 ' O ' ' C' ' 26' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.103 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 2' ' ' TYR . . . . . 0.883 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.4 m-30 -100.49 167.59 10.27 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.789 0.328 . . . . 0.0 111.213 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 0.999 HG23 ' HA ' ' B' ' 5' ' ' GLU . 1.1 pt -102.55 157.95 32.71 Favored Pre-proline 0 CA--C 1.504 -0.819 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.276 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 9.7 Cg_endo -82.81 145.06 12.58 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 121.696 1.597 . . . . 0.0 111.577 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.942 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -57.55 143.01 42.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.309 -177.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 6' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' C' ' 7' ' ' PRO . . . -84.09 170.37 14.14 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.306 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 7' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' C' ' 6' ' ' ALA . 21.8 Cg_exo -61.8 149.06 91.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.772 2.315 . . . . 0.0 111.822 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -112.14 64.68 0.63 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.146 0.498 . . . . 0.0 110.882 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 9' ' ' ASP . . . . . 0.462 ' CG ' ' HG3' ' C' ' 11' ' ' GLN . 13.6 p-10 -121.28 23.02 10.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.505 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.62 ' C ' ' HE2' ' A' ' 16' ' ' LYS . . . 79.75 15.26 79.75 Favored Glycine 0 CA--C 1.508 -0.38 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.844 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 11' ' ' GLN . . . . . 0.931 ' HB3' HD21 ' C' ' 22' ' ' LEU . 6.2 mt-30 -111.28 140.21 46.04 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 117.32 0.56 . . . . 0.0 110.837 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 12' ' ' ALA . . . . . 0.74 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -92.47 136.39 33.26 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.75 0.786 . . . . 0.0 110.785 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.553 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 69.1 m-85 -121.12 152.15 39.06 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.847 1.308 . . . . 0.0 112.32 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' VAL . . . . . 0.956 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.0 OUTLIER -107.06 154.58 7.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 177.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.728 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.67 107.45 18.45 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.208 -178.521 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.866 ' HG2' ' CG ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -137.1 134.45 36.46 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.106 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 17' ' ' ASP . . . . . 0.866 ' CG ' ' HG2' ' C' ' 16' ' ' LYS . 0.0 OUTLIER 48.45 45.6 20.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 176.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.428 ' O ' ' NH2' ' C' ' 15' ' ' ARG . . . 65.53 8.99 41.97 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -129.78 161.31 31.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.198 0.999 . . . . 0.0 111.358 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' TRP . . . . . 0.728 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 87.9 m95 -93.84 120.39 34.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.987 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.956 ' O ' HG23 ' C' ' 14' ' ' VAL . 11.1 t -113.0 137.79 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.549 0.69 . . . . 0.0 110.309 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' LEU . . . . . 0.931 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.2 mt -57.6 127.64 33.05 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.981 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.819 ' CD1' HD11 ' B' ' 23' ' ' LEU . 6.6 tp -58.79 -35.04 72.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.448 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -19.87 65.99 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 122.245 -0.285 . . . . 0.0 111.338 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -68.64 -18.25 64.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' PHE . . . . . 0.946 ' O ' HD13 ' B' ' 27' ' ' LEU . 93.3 m-85 -99.13 -7.78 26.14 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.011 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.882 HD13 ' O ' ' A' ' 26' ' ' PHE . 5.7 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.064 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.662 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 3.6 m-85 . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 120.539 0.209 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 1.03 HG23 ' HA ' ' C' ' 5' ' ' GLU . 4.3 pt -94.39 157.72 36.89 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-O 120.974 0.416 . . . . 0.0 111.975 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 21.4 Cg_endo -88.19 147.07 6.52 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 122.596 2.198 . . . . 0.0 111.102 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 1.058 ' OE2' HG22 ' B' ' 3' ' ' ILE . 1.3 tt0 -58.14 143.02 45.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.644 -176.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.886 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -86.42 163.8 40.6 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.976 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.624 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 31.3 Cg_exo -56.74 152.93 39.19 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.832 2.355 . . . . 0.0 112.824 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.634 ' CZ ' ' H ' ' B' ' 18' ' ' GLY . 0.0 OUTLIER -112.07 63.86 0.62 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.48 0.657 . . . . 0.0 111.594 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -110.78 14.67 22.19 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.478 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.857 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 79.12 15.93 79.55 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.898 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -109.81 148.17 31.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.137 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -91.68 135.2 34.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.293 0.568 . . . . 0.0 112.178 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.789 ' O ' HG23 ' B' ' 14' ' ' VAL . 65.6 m-85 -117.59 148.34 42.01 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 123.026 1.393 . . . . 0.0 111.905 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -107.01 154.26 7.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 112.1 -2.318 . . . . 0.0 104.813 177.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.744 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.77 106.98 17.7 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 118.057 -1.457 . . . . 0.0 108.274 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.723 ' HD3' HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -137.63 124.39 21.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.681 -178.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.89 46.84 16.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.464 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 65.97 6.29 30.63 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.741 -0.743 . . . . 0.0 114.554 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -129.74 161.95 29.52 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 117.894 0.847 . . . . 0.0 111.819 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.886 ' CG ' ' HB2' ' A' ' 6' ' ' ALA . 87.9 m95 -95.89 119.76 34.97 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.363 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.958 ' O ' HG23 ' A' ' 14' ' ' VAL . 15.9 t -114.5 141.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 CA-C-O 121.702 0.763 . . . . 0.0 109.933 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.898 HD21 ' HB3' ' A' ' 11' ' ' GLN . 1.7 mt -57.61 126.94 29.56 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.81 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.773 HD23 ' CD2' ' B' ' 26' ' ' PHE . 1.3 tp -60.36 -45.16 94.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.983 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.484 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 52.8 p -63.43 -19.05 64.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.752 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 6.8 m -69.38 -19.28 63.83 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 1.205 ' O ' HD21 ' C' ' 27' ' ' LEU . 87.9 m-85 -97.26 -2.47 42.59 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.789 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.077 HD13 ' O ' ' B' ' 26' ' ' PHE . 1.5 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.414 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.533 ' HA ' ' H ' ' A' ' 5' ' ' GLU . 5.5 m-85 -134.98 131.62 37.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.495 0.188 . . . . 0.0 110.988 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 1.058 HG22 ' OE2' ' A' ' 5' ' ' GLU . 21.3 pt -85.16 156.46 60.16 Favored Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 120.695 0.283 . . . . 0.0 110.8 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.67 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 71.8 Cg_endo -87.25 155.99 8.17 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.47 2.113 . . . . 0.0 111.524 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 1.151 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.6 OUTLIER -57.68 143.53 41.26 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.201 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' B' ' 20' ' ' TRP . . . -86.67 153.7 55.58 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.653 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.746 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 3.1 Cg_exo -50.48 153.81 7.06 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.48 2.787 . . . . 0.0 113.401 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.605 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -111.73 73.66 0.83 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.571 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -114.72 11.04 16.75 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.705 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' C' ' 16' ' ' LYS . . . 78.99 14.99 81.37 Favored Glycine 0 CA--C 1.512 -0.144 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.583 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' C' ' 16' ' ' LYS . 0.0 OUTLIER -118.73 158.52 25.39 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.096 0.474 . . . . 0.0 110.536 179.497 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.645 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.54 135.83 33.73 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.392 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.746 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 51.3 m-85 -120.64 153.53 36.73 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-N 114.42 -1.264 . . . . 0.0 112.088 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 1.137 HG21 ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -116.15 159.13 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 113.802 -1.544 . . . . 0.0 107.956 176.285 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.833 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.09 107.24 18.12 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 122.104 0.954 . . . . 0.0 110.23 -176.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.857 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -137.63 125.63 22.8 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.612 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.571 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 56.81 41.81 27.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.634 ' H ' ' CZ ' ' A' ' 8' ' ' ARG . . . 69.59 10.54 63.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.46 159.55 36.73 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 118.233 1.017 . . . . 0.0 111.881 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' TRP . . . . . 0.833 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 90.5 m95 -93.42 113.15 25.24 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.07 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.518 ' O ' HG12 ' B' ' 14' ' ' VAL . 18.7 t -109.55 136.94 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.161 0 CA-C-O 121.815 0.817 . . . . 0.0 110.43 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' B' ' 11' ' ' GLN . 4.9 mt -51.56 123.11 9.2 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.031 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.748 HD22 HG21 ' C' ' 14' ' ' VAL . 7.3 tp -57.01 -36.03 69.93 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.545 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -63.04 -17.3 62.09 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.601 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 3.4 m -71.48 -19.59 62.19 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 1.077 ' O ' HD13 ' A' ' 27' ' ' LEU . 90.4 m-85 -99.34 -3.62 33.55 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.159 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 1.237 HD21 ' O ' ' C' ' 26' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.196 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 1' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' B' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.106 0 N-CA-C 112.688 -0.165 . . . . 0.0 112.688 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 2' ' ' TYR . . . . . 0.67 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.0 m-85 -127.14 147.14 50.19 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.923 0.362 . . . . 0.0 111.653 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 1.151 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.3 pt -87.04 157.89 53.57 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 121.004 0.431 . . . . 0.0 111.589 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 19.2 Cg_endo -87.86 148.54 7.07 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 122.33 2.02 . . . . 0.0 110.873 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 1.03 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -57.59 143.38 41.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.584 -177.058 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 6' ' ' ALA . . . . . 0.687 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -85.29 162.24 49.33 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.449 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 7' ' ' PRO . . . . . 0.481 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 32.3 Cg_exo -56.78 155.08 28.68 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.004 2.469 . . . . 0.0 113.171 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.78 79.02 1.21 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.458 0.647 . . . . 0.0 111.601 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -125.15 11.62 8.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.355 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.67 10.66 85.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.07 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' GLN . . . . . 0.688 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.6 OUTLIER -102.02 151.1 22.54 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 12' ' ' ALA . . . . . 0.668 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -92.83 136.57 33.13 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.273 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.637 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 49.1 m-85 -117.99 155.42 30.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.554 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 14' ' ' VAL . . . . . 0.748 HG21 HD22 ' B' ' 23' ' ' LEU . 4.4 t -123.93 134.9 65.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.798 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -80.59 109.14 14.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.998 0.904 . . . . 0.0 111.204 -175.106 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.645 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -136.1 123.0 21.32 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 113.832 -1.531 . . . . 0.0 112.128 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 17' ' ' ASP . . . . . 0.605 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER 55.11 45.98 24.97 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 176.021 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.465 ' HA2' ' NH2' ' C' ' 15' ' ' ARG . . . 65.53 13.52 58.69 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 119.474 -0.626 . . . . 0.0 114.543 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 19' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' C' ' 16' ' ' LYS . 0.1 OUTLIER -133.05 161.41 34.44 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.488 1.144 . . . . 0.0 111.346 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 20' ' ' TRP . . . . . 0.798 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 82.3 m95 -93.35 116.19 28.75 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.087 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.551 HG22 ' HB ' ' C' ' 14' ' ' VAL . 1.7 m -108.29 129.57 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 CA-C-O 122.032 0.92 . . . . 0.0 111.25 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 22' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' C' ' 11' ' ' GLN . 2.1 mt -51.42 123.45 9.78 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.62 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.682 HD21 ' CB ' ' A' ' 26' ' ' PHE . 11.8 tp -60.37 -42.75 96.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.014 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -20.5 64.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.55 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 30.1 m -68.31 -18.59 64.55 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' PHE . . . . . 1.237 ' O ' HD21 ' B' ' 27' ' ' LEU . 52.8 m-85 -100.93 -8.77 22.17 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.073 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 1.205 HD21 ' O ' ' A' ' 26' ' ' PHE . 2.6 tp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.11 -0.947 . . . . 0.0 111.105 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.819 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 8.4 m-30 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 121.195 0.521 . . . . 0.0 111.86 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.743 HD13 ' HG3' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -92.74 159.59 35.92 Favored Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.501 178.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 43.1 Cg_endo -88.13 144.15 5.94 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.418 2.079 . . . . 0.0 111.487 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.917 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.6 OUTLIER -50.27 142.77 9.53 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.244 -178.195 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.691 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.13 166.24 27.2 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.563 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.505 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 34.5 Cg_exo -57.03 148.7 67.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.336 2.024 . . . . 0.0 111.627 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' B' ' 18' ' ' GLY . 85.7 mtt180 -112.58 62.68 0.63 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.078 0.466 . . . . 0.0 111.928 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -114.78 18.07 16.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.135 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.901 ' O ' ' HE2' ' B' ' 16' ' ' LYS . . . 79.02 14.6 81.77 Favored Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.864 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.87 ' HB3' HD21 ' A' ' 22' ' ' LEU . 15.8 mm100 -103.88 141.64 35.78 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.886 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -91.88 134.87 34.38 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.534 0.683 . . . . 0.0 110.914 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.864 ' O ' HG23 ' B' ' 14' ' ' VAL . 53.7 m-85 -120.04 149.75 41.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.409 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.843 HG21 ' CE2' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -104.61 156.64 5.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 176.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 1.065 ' HG3' HH11 ' A' ' 15' ' ' ARG . 0.0 OUTLIER -105.86 115.76 30.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.644 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' C' ' 11' ' ' GLN . 1.0 OUTLIER -151.69 129.17 11.38 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.825 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.666 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 0.1 OUTLIER 54.89 42.24 31.26 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.718 177.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.538 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 62.44 16.45 54.73 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 119.358 -0.69 . . . . 0.0 114.742 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.666 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -131.87 161.62 32.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.801 1.301 . . . . 0.0 111.613 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 1.015 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 91.5 m95 -99.47 112.32 24.53 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.892 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 14' ' ' VAL . 17.9 t -108.6 139.74 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.453 0.644 . . . . 0.0 109.652 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.87 HD21 ' HB3' ' A' ' 11' ' ' GLN . 1.3 mt -55.79 126.71 26.78 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.935 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.62 HD23 ' CD1' ' B' ' 26' ' ' PHE . 3.3 tp -58.46 -39.49 80.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.164 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.434 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -63.52 -19.14 64.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.046 -178.399 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.3 m -70.12 -18.58 63.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.093 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.843 ' CE2' HG21 ' A' ' 14' ' ' VAL . 80.7 m-85 -97.25 -1.82 44.02 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.847 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.011 ' CD1' ' O ' ' B' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.048 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.174 0 CA-C-O 120.19 -0.228 . . . . 0.0 112.755 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.53 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 4.4 m-85 -132.33 135.69 46.36 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 110.896 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.968 HG21 ' HE ' ' B' ' 15' ' ' ARG . 6.1 pt -87.19 159.31 51.14 Favored Pre-proline 0 CA--C 1.513 -0.462 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.716 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 92.0 Cg_endo -91.04 148.56 3.77 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 122.949 2.433 . . . . 0.0 111.376 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.793 ' OE2' ' HA2' ' C' ' 18' ' ' GLY . 0.9 OUTLIER -58.22 142.85 46.34 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.758 0.79 . . . . 0.0 112.959 -177.725 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.865 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -83.17 155.25 67.05 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.99 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.703 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 5.0 Cg_exo -45.75 152.7 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.743 2.962 . . . . 0.0 113.678 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' C' ' 17' ' ' ASP . 3.6 mtp180 -111.93 62.27 0.62 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.586 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -109.03 15.37 23.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.643 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.588 ' C ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.23 14.73 81.34 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.852 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.915 ' HB3' HD21 ' B' ' 22' ' ' LEU . 38.5 mm-40 -109.01 147.18 32.71 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 120.966 0.412 . . . . 0.0 110.508 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.637 ' HB1' ' CG1' ' C' ' 14' ' ' VAL . . . -92.57 136.16 33.46 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.638 0.732 . . . . 0.0 109.469 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 50.7 m-85 -122.09 155.46 35.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.264 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.886 HG21 ' HB1' ' A' ' 12' ' ' ALA . 1.5 p -114.93 159.81 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.477 175.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 1.012 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -102.95 114.42 28.7 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.133 0.968 . . . . 0.0 110.124 -176.225 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.901 ' HE2' ' O ' ' A' ' 10' ' ' GLY . 2.0 tttm -149.01 127.93 12.64 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.788 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 0.2 OUTLIER 56.29 45.25 23.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.458 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 62.13 14.13 45.22 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 119.484 -0.62 . . . . 0.0 114.196 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' B' ' 17' ' ' ASP . 0.1 OUTLIER -133.1 163.22 29.73 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.525 1.162 . . . . 0.0 112.011 -178.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 20' ' ' TRP . . . . . 1.012 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 92.5 m95 -97.65 113.02 24.68 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.204 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.493 ' C ' ' HD1' ' B' ' 13' ' ' TYR . 6.2 t -108.24 139.27 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 121.925 0.869 . . . . 0.0 110.333 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.915 HD21 ' HB3' ' B' ' 11' ' ' GLN . 3.8 mt -55.21 125.11 19.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.061 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.593 HD22 HG11 ' C' ' 14' ' ' VAL . 3.8 tp -57.77 -39.4 77.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.521 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 29.8 t -63.23 -17.34 62.34 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.708 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 18.3 m -70.37 -20.27 62.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 1.011 ' O ' ' CD1' ' A' ' 27' ' ' LEU . 88.1 m-85 -96.89 -15.54 21.15 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.575 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.68 HD21 ' HB3' ' C' ' 26' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.99 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 2' ' ' TYR . . . . . 0.716 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.1 m-30 -98.01 161.15 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.352 . . . . 0.0 111.524 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 0.79 HG23 ' HA ' ' B' ' 5' ' ' GLU . 1.5 pt -90.09 158.4 44.2 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.765 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.819 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 43.7 Cg_endo -90.23 153.99 4.64 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 122.432 2.088 . . . . 0.0 112.285 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.538 ' OE2' ' HA2' ' A' ' 18' ' ' GLY . 1.1 tp10 -57.56 142.4 44.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.917 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 6' ' ' ALA . . . . . 0.904 ' H ' HH12 ' A' ' 15' ' ' ARG . . . -89.08 162.89 36.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 113.699 -1.592 . . . . 0.0 110.864 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 7' ' ' PRO . . . . . 0.467 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 31.8 Cg_exo -57.27 152.39 46.17 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.075 2.517 . . . . 0.0 113.52 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 8' ' ' ARG . . . . . 0.575 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -111.77 67.75 0.65 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.128 0.489 . . . . 0.0 111.095 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 9' ' ' ASP . . . . . 0.539 ' OD1' ' HB2' ' C' ' 11' ' ' GLN . 6.1 p30 -116.72 12.98 15.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.107 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.495 ' O ' ' HE2' ' A' ' 16' ' ' LYS . . . 84.08 14.68 71.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.203 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 11' ' ' GLN . . . . . 0.64 ' HB3' HD21 ' C' ' 22' ' ' LEU . 19.1 mt-30 -110.79 150.56 28.94 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.492 0.663 . . . . 0.0 110.892 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 12' ' ' ALA . . . . . 0.592 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -92.52 136.87 32.85 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.477 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.606 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 59.3 m-85 -118.99 156.12 30.17 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.035 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 14' ' ' VAL . . . . . 0.882 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.2 OUTLIER -115.25 157.04 16.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.952 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.63 115.31 30.03 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 122.045 0.926 . . . . 0.0 110.903 -176.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' B' ' 11' ' ' GLN . 0.5 OUTLIER -153.47 132.96 12.89 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.339 -178.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 17' ' ' ASP . . . . . 0.459 ' HA ' ' HG2' ' B' ' 8' ' ' ARG . 0.2 OUTLIER 55.17 45.04 26.77 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 176.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.793 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.21 16.84 50.5 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-O 119.382 -0.677 . . . . 0.0 114.167 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -137.33 164.63 28.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.661 1.231 . . . . 0.0 112.255 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' TRP . . . . . 0.952 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 90.3 m95 -96.49 115.11 26.89 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.162 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.882 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.7 m -105.81 134.81 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.153 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' C' ' 11' ' ' GLN . 3.5 mt -55.44 122.03 10.31 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.72 HD21 ' HB3' ' A' ' 26' ' ' PHE . 4.5 tp -59.12 -38.24 79.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.498 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 28.7 t -62.44 -18.94 62.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.89 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 29.6 m -69.23 -18.03 63.84 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' PHE . . . . . 0.68 ' HB3' HD21 ' B' ' 27' ' ' LEU . 70.9 m-85 -101.04 -10.62 20.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.466 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 26' ' ' PHE . 25.4 mt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.873 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.75 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 5.9 m-85 . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 121.287 0.565 . . . . 0.0 112.23 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 1.064 HG23 ' HA ' ' C' ' 5' ' ' GLU . 3.5 pt -91.68 159.52 38.31 Favored Pre-proline 0 CA--C 1.51 -0.578 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.186 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 55.5 Cg_endo -84.58 139.71 7.91 Favored 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 121.17 1.247 . . . . 0.0 111.201 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.902 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.5 OUTLIER -47.97 143.03 4.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.59 -1.187 . . . . 0.0 113.87 -177.532 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.76 ' HB2' ' CD2' ' A' ' 20' ' ' TRP . . . -84.05 177.65 2.86 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.66 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.946 ' HB2' ' OD2' ' A' ' 9' ' ' ASP . 2.7 Cg_exo -75.5 155.23 40.64 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.576 2.851 . . . . 0.0 114.037 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.587 ' HG3' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -105.01 79.67 1.53 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 178.252 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.946 ' OD2' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -124.84 3.03 8.13 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.198 -178.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.49 0.36 83.61 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 119.571 -1.299 . . . . 0.0 111.188 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.843 ' O ' ' HB2' ' B' ' 16' ' ' LYS . 0.1 OUTLIER -101.69 151.76 21.64 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.853 ' HB1' ' CG1' ' B' ' 14' ' ' VAL . . . -91.48 137.94 31.97 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.439 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.629 ' CD2' ' HD2' ' A' ' 7' ' ' PRO . 47.5 m-85 -118.5 155.69 30.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.081 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.972 HG13 ' O ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -105.1 150.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.975 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.55 99.41 9.09 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.584 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 0.3 OUTLIER -136.0 125.73 25.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 112.777 -2.011 . . . . 0.0 113.172 -176.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.96 43.11 30.42 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.641 ' HA2' ' NH1' ' A' ' 15' ' ' ARG . . . 74.85 6.65 78.95 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.168 -1.015 . . . . 0.0 115.109 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.88 161.54 35.34 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.992 1.396 . . . . 0.0 112.396 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.975 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 97.3 m95 -94.32 115.25 27.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.651 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.972 ' O ' HG13 ' A' ' 14' ' ' VAL . 22.0 t -107.21 136.84 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 121.904 0.859 . . . . 0.0 108.791 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.721 HD21 ' OE1' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -53.92 122.64 10.47 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.321 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.979 HD12 HD11 ' C' ' 23' ' ' LEU . 4.9 tp -57.26 -36.06 70.52 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.683 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.661 ' HB2' HD12 ' A' ' 22' ' ' LEU . 25.9 m -61.47 -17.76 55.92 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.243 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -72.23 -18.39 61.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.973 ' O ' HD13 ' C' ' 27' ' ' LEU . 88.9 m-85 -99.34 -10.54 22.18 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.332 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.788 HD13 ' O ' ' B' ' 26' ' ' PHE . 9.3 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.689 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 119.733 -0.482 . . . . 0.0 111.972 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.662 ' CD2' ' HB2' ' A' ' 2' ' ' TYR . 3.6 m-85 -134.57 138.51 44.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.748 0.774 . . . . 0.0 110.809 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.902 HG23 ' HA ' ' A' ' 5' ' ' GLU . 0.8 OUTLIER -88.2 158.49 49.42 Favored Pre-proline 0 N--CA 1.47 0.528 0 CA-C-O 121.4 0.619 . . . . 0.0 112.621 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 87.8 Cg_endo -92.17 156.3 3.2 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 123.056 2.504 . . . . 0.0 111.232 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.847 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 0.7 OUTLIER -57.85 141.99 47.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -177.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.825 ' HB2' ' CD1' ' B' ' 20' ' ' TRP . . . -88.15 158.68 49.33 Favored Pre-proline 0 C--N 1.334 -0.103 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.361 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.485 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 10.1 Cg_endo -51.39 152.76 11.22 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.428 2.085 . . . . 0.0 111.68 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -114.85 67.95 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.471 0.653 . . . . 0.0 111.6 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -109.55 16.0 22.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.639 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.16 31.89 63.51 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.387 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.895 ' HB3' HD21 ' B' ' 22' ' ' LEU . 19.8 mm-40 -123.47 149.42 45.13 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.615 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.61 135.92 33.67 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.855 0.836 . . . . 0.0 111.66 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.573 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 80.7 m-85 -122.24 152.67 39.78 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 123.382 1.563 . . . . 0.0 112.654 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.853 ' CG1' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -106.99 156.69 7.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 111.266 -2.697 . . . . 0.0 105.93 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.954 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.19 105.55 15.64 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 118.76 -1.176 . . . . 0.0 108.13 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.843 ' HB2' ' O ' ' A' ' 11' ' ' GLN . 4.4 pttt -138.78 132.61 30.93 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 113.224 -1.807 . . . . 0.0 111.661 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.587 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 58.17 42.99 21.25 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 176.061 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.493 ' HA3' ' NH1' ' A' ' 8' ' ' ARG . . . 60.05 14.81 33.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.216 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -134.96 165.41 25.39 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 117.437 0.618 . . . . 0.0 111.842 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' TRP . . . . . 0.954 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 94.7 m95 -98.11 112.14 24.21 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.742 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.834 ' O ' HG23 ' B' ' 14' ' ' VAL . 17.0 t -106.12 141.44 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 CA-C-O 121.848 0.833 . . . . 0.0 109.65 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.895 HD21 ' HB3' ' B' ' 11' ' ' GLN . 2.6 mt -57.27 127.72 33.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.999 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.733 HD22 HG11 ' C' ' 14' ' ' VAL . 5.7 tp -61.67 -40.04 93.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.579 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -19.77 66.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.176 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -68.32 -18.02 64.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.788 ' O ' HD13 ' A' ' 27' ' ' LEU . 91.3 m-85 -99.29 -4.93 30.7 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.577 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.997 HD13 ' O ' ' C' ' 26' ' ' PHE . 4.5 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.227 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.714 -0.154 . . . . 0.0 112.714 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 2' ' ' TYR . . . . . 0.662 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.5 m-85 -120.3 146.57 45.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.932 0.396 . . . . 0.0 111.656 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 0.841 HG23 ' HA ' ' B' ' 5' ' ' GLU . 1.0 OUTLIER -92.11 158.65 39.03 Favored Pre-proline 0 CA--C 1.501 -0.926 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.592 178.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 75.7 Cg_endo -86.73 146.86 8.21 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.83 1.687 . . . . 0.0 112.426 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 1.064 ' HA ' HG23 ' A' ' 3' ' ' ILE . 1.8 tt0 -57.41 143.41 40.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 113.803 -1.544 . . . . 0.0 113.464 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 6' ' ' ALA . . . . . 0.769 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -85.3 153.36 59.17 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.411 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.85 153.69 5.75 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.142 2.561 . . . . 0.0 112.986 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' ARG . . . . . 0.42 ' NH2' ' OE1' ' C' ' 5' ' ' GLU . 8.8 mtt85 -112.79 57.28 0.66 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.914 0.388 . . . . 0.0 111.782 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 9' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' C' ' 11' ' ' GLN . 2.5 p30 -105.63 18.71 21.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.449 ' O ' ' HD2' ' A' ' 16' ' ' LYS . . . 80.0 10.51 85.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.604 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 11' ' ' GLN . . . . . 0.92 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.0 OUTLIER -103.85 154.09 20.0 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 117.669 0.734 . . . . 0.0 109.271 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 12' ' ' ALA . . . . . 0.71 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -95.91 134.26 39.12 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.529 0.68 . . . . 0.0 111.82 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.716 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 51.4 m-85 -117.51 154.68 31.05 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.783 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 14' ' ' VAL . . . . . 0.872 HG23 ' O ' ' C' ' 21' ' ' VAL . 1.7 t -118.36 156.7 20.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.882 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -104.99 108.25 19.67 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.941 -177.04 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' B' ' 11' ' ' GLN . 0.0 OUTLIER -136.38 121.18 18.58 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.621 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.55 45.93 18.6 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.029 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.582 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 62.31 14.6 48.7 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.629 0.612 . . . . 0.0 114.629 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -130.19 162.2 29.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.3 1.05 . . . . 0.0 111.737 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' TRP . . . . . 0.882 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 68.0 m95 -96.27 114.71 26.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.715 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.872 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.3 m -111.35 130.66 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.117 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' LEU . . . . . 0.92 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.2 mt -53.46 125.02 16.48 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.101 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.979 HD11 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -60.38 -36.62 78.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.737 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.08 -19.5 64.47 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.203 -0.311 . . . . 0.0 110.829 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 51.7 m -69.04 -18.4 64.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' PHE . . . . . 0.997 ' O ' HD13 ' B' ' 27' ' ' LEU . 59.1 m-85 -100.06 -8.94 23.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.317 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.973 HD13 ' O ' ' A' ' 26' ' ' PHE . 5.5 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.176 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.841 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 19.6 m-85 . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.792 0.329 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 1.024 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.1 pt -92.12 158.01 40.01 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.193 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 10.3 Cg_endo -82.49 147.7 14.15 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 121.764 1.643 . . . . 0.0 110.605 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 1.069 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.6 OUTLIER -58.36 142.9 46.82 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -176.666 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.752 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.14 160.74 48.33 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.317 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 51.9 Cg_exo -55.06 153.63 25.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.332 2.688 . . . . 0.0 113.621 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 71.3 mtm-85 -112.03 83.15 1.74 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.45 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -128.42 13.5 6.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.66 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.691 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 78.79 13.36 83.21 Favored Glycine 0 CA--C 1.51 -0.253 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.819 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.664 ' O ' ' HB2' ' B' ' 16' ' ' LYS . 11.5 mt-30 -115.55 148.75 39.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.848 0.356 . . . . 0.0 110.112 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -90.88 138.52 31.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 122.131 0.967 . . . . 0.0 112.562 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.525 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 61.9 m-85 -118.57 152.77 35.38 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.395 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.07 HG21 ' HB1' ' C' ' 12' ' ' ALA . 0.2 OUTLIER -114.46 157.22 15.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.343 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.78 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.91 104.26 13.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.798 0.809 . . . . 0.0 111.524 -176.507 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.668 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 1.1 tttt -135.39 128.38 31.49 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.204 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.521 ' HA ' ' CG ' ' C' ' 8' ' ' ARG . 0.2 OUTLIER 55.33 44.97 26.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.588 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.494 ' HA2' HH21 ' A' ' 15' ' ' ARG . . . 63.14 15.92 57.06 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 114.993 0.757 . . . . 0.0 114.993 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -132.33 158.57 41.57 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.575 1.188 . . . . 0.0 111.777 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.78 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 92.7 m95 -94.92 115.67 27.75 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.182 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 14.2 t -111.21 141.24 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-O 121.693 0.759 . . . . 0.0 110.185 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 12' ' ' ALA . 2.4 mt -57.29 125.37 22.47 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.596 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.874 HD22 HG11 ' B' ' 14' ' ' VAL . 7.4 tp -57.49 -35.48 70.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.45 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -63.97 -20.06 65.61 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.36 -0.213 . . . . 0.0 111.146 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 m -68.81 -18.09 64.12 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.35 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 1.062 ' O ' ' CD1' ' C' ' 27' ' ' LEU . 80.7 m-85 -95.9 -21.36 18.11 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.662 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.005 HD22 HD23 ' B' ' 27' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.168 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 120.209 -0.217 . . . . 0.0 113.166 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 3.4 m-85 -120.97 143.58 48.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.983 0.391 . . . . 0.0 110.93 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 1.069 HG23 ' HA ' ' A' ' 5' ' ' GLU . 5.0 pt -86.97 158.19 53.42 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 120.953 0.406 . . . . 0.0 112.031 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 84.0 Cg_endo -91.59 153.21 3.52 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.49 2.127 . . . . 0.0 111.671 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.889 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.6 OUTLIER -58.26 143.48 44.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.701 -177.463 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.69 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -86.99 171.39 10.07 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.795 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.537 ' HD2' ' HB1' ' B' ' 6' ' ' ALA . 18.8 Cg_exo -64.46 151.89 83.75 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.443 2.762 . . . . 0.0 113.028 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.45 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.3 OUTLIER -111.91 49.61 0.89 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -99.93 14.92 28.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.471 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.606 ' O ' ' HD2' ' C' ' 16' ' ' LYS . . . 79.64 15.04 80.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.169 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.929 ' HB3' HD21 ' B' ' 22' ' ' LEU . 12.6 mm100 -103.52 146.82 27.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.857 ' O ' HD23 ' B' ' 22' ' ' LEU . . . -94.28 133.76 37.48 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.954 0.883 . . . . 0.0 112.339 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.683 ' O ' HG23 ' C' ' 14' ' ' VAL . 74.8 m-85 -121.31 152.9 38.41 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 123.148 1.451 . . . . 0.0 112.354 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.874 HG11 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -113.22 158.01 13.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 111.766 -2.47 . . . . 0.0 106.264 178.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.548 ' NH2' ' OE2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -104.29 107.4 18.29 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 118.845 -1.142 . . . . 0.0 108.779 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.691 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -136.81 125.23 23.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.432 -178.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 55.04 44.94 27.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 176.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.487 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 62.19 16.14 52.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 115.222 0.849 . . . . 0.0 115.222 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' B' ' 16' ' ' LYS . 0.0 OUTLIER -134.81 161.3 35.58 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 118.624 1.212 . . . . 0.0 111.575 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 20' ' ' TRP . . . . . 0.69 ' CG ' ' HB2' ' B' ' 6' ' ' ALA . 90.0 m95 -97.02 112.82 24.4 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.515 0.674 . . . . 0.0 110.495 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' B' ' 13' ' ' TYR . 0.5 OUTLIER -110.59 153.3 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.572 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.968 179.036 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.929 HD21 ' HB3' ' B' ' 11' ' ' GLN . 3.9 mt -67.98 126.76 30.49 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 113.503 -1.68 . . . . 0.0 114.89 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.55 ' O ' HD12 ' B' ' 23' ' ' LEU . 3.5 tp -60.72 -43.77 97.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.887 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' SER . . . . . 0.504 ' HA ' HD12 ' B' ' 27' ' ' LEU . 14.3 m -63.59 -16.85 62.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.421 -177.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 13.2 m -69.66 -17.51 63.5 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.817 ' O ' HD13 ' A' ' 27' ' ' LEU . 24.8 m-85 -100.61 -5.6 26.47 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.358 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 1.005 HD23 HD22 ' A' ' 27' ' ' LEU . 15.3 mt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.251 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 CA-C-O 120.275 -0.18 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 2' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.6 m-85 -128.53 141.0 51.51 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.88 0.34 . . . . 0.0 111.015 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.3 pt -88.54 157.58 49.56 Favored Pre-proline 0 CA--C 1.496 -1.113 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.236 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.841 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 20.8 Cg_endo -86.35 147.45 8.78 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.821 1.681 . . . . 0.0 111.856 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 1.024 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -57.8 143.16 43.19 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.944 -177.352 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 6' ' ' ALA . . . . . 0.697 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -85.59 152.38 57.21 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.856 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 7' ' ' PRO . . . . . 0.405 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 72.0 Cg_exo -49.73 156.02 3.46 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.519 2.813 . . . . 0.0 113.88 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 8' ' ' ARG . . . . . 0.521 ' CG ' ' HA ' ' A' ' 17' ' ' ASP . 2.6 mtp85 -111.9 57.25 0.64 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.994 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -102.09 17.9 22.12 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.784 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.34 11.0 75.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.795 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' GLN . . . . . 0.55 ' OE1' HD21 ' C' ' 22' ' ' LEU . 86.8 mt-30 -106.49 151.86 24.41 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 12' ' ' ALA . . . . . 1.07 ' HB1' HG21 ' A' ' 14' ' ' VAL . . . -92.41 137.17 32.59 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.999 0.904 . . . . 0.0 112.627 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.698 ' O ' HG23 ' A' ' 14' ' ' VAL . 79.8 m-85 -120.99 158.22 28.23 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.807 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 14' ' ' VAL . . . . . 0.83 HG21 ' HB1' ' B' ' 12' ' ' ALA . 0.1 OUTLIER -125.45 159.46 32.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 113.357 -1.747 . . . . 0.0 106.495 177.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 1.009 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -103.67 107.71 18.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 122.436 1.113 . . . . 0.0 110.743 -175.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.713 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 0.2 OUTLIER -136.57 133.23 36.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.995 -1.911 . . . . 0.0 110.365 178.546 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 17' ' ' ASP . . . . . 0.596 ' OD1' ' O ' ' C' ' 16' ' ' LYS . 0.1 OUTLIER 48.31 46.17 20.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 177.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.517 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.48 16.21 49.22 Favored Glycine 0 N--CA 1.453 -0.194 0 N-CA-C 114.373 0.509 . . . . 0.0 114.373 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -131.57 159.1 39.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 117.756 0.778 . . . . 0.0 111.666 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' TRP . . . . . 1.009 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 87.9 m95 -93.67 109.35 21.0 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.418 0.627 . . . . 0.0 110.33 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 5.9 t -103.81 135.82 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.913 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 22' ' ' LEU . . . . . 0.55 HD21 ' OE1' ' C' ' 11' ' ' GLN . 7.2 mt -50.37 122.44 6.99 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.797 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.542 HD23 ' CD1' ' A' ' 26' ' ' PHE . 1.3 tp -58.02 -39.91 79.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.546 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 35.4 t -64.2 -17.46 63.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.476 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' C' ' 22' ' ' LEU . 5.2 m -70.11 -18.76 63.26 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 26' ' ' PHE . . . . . 0.791 ' HB3' HD11 ' B' ' 27' ' ' LEU . 89.7 m-85 -98.09 0.86 46.89 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.6 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 1.062 ' CD1' ' O ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.257 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.81 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 15.4 m-85 . . . . . 0 CA--C 1.531 0.218 0 CA-C-O 121.577 0.703 . . . . 0.0 112.382 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.866 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.1 pt -104.7 159.71 28.43 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.33 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.604 ' HA ' ' CD1' ' B' ' 2' ' ' TYR . 13.9 Cg_endo -81.4 144.94 14.68 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.047 1.831 . . . . 0.0 111.716 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.887 ' HA ' HG23 ' B' ' 3' ' ' ILE . 22.5 tt0 -57.04 142.02 43.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 113.995 -1.457 . . . . 0.0 114.094 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.707 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.78 157.24 52.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.388 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.429 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 51.0 Cg_exo -54.54 151.14 32.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.977 2.451 . . . . 0.0 112.436 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 24.4 mtm180 -112.51 57.76 0.65 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.971 0.415 . . . . 0.0 112.051 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.05 18.66 19.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.792 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.799 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 80.17 14.95 79.71 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.906 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.709 ' C ' ' HB2' ' B' ' 16' ' ' LYS . 8.4 mt-30 -106.6 141.12 38.4 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.551 ' HA ' ' CB ' ' B' ' 16' ' ' LYS . . . -91.47 135.53 33.77 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 122.004 0.907 . . . . 0.0 112.102 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.65 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 56.4 m-85 -119.57 153.21 35.78 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.794 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -118.32 147.58 21.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.743 ' NH2' ' HA2' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -93.64 107.68 19.51 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.678 -1.209 . . . . 0.0 110.405 -177.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.82 ' CD ' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -138.21 124.97 21.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.519 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.807 ' HA ' ' CB ' ' C' ' 8' ' ' ARG . 0.8 OUTLIER 60.97 45.84 9.03 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 176.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.743 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 61.37 14.75 42.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.643 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -137.15 164.25 28.9 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 117.983 0.892 . . . . 0.0 112.198 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.721 ' CZ2' HD12 ' A' ' 3' ' ' ILE . 81.4 m95 -93.11 116.2 28.81 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.188 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.924 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.4 m -107.04 128.25 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.717 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -52.21 121.86 7.6 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.985 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.978 HD22 HG11 ' B' ' 14' ' ' VAL . 15.8 tp -58.44 -44.97 89.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.508 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.406 ' HB2' HD12 ' A' ' 22' ' ' LEU . 4.9 m -48.08 -26.32 1.79 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.324 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -67.02 -18.84 65.55 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.489 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 1.249 ' O ' HD21 ' C' ' 27' ' ' LEU . 61.5 m-85 -98.75 -5.03 32.11 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.143 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.909 HD11 ' HB3' ' B' ' 26' ' ' PHE . 1.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.091 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' TYR . . . . . 0.604 ' CD1' ' HA ' ' A' ' 4' ' ' PRO . 2.7 m-85 -129.03 135.61 49.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.796 0.298 . . . . 0.0 111.345 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 5' ' ' GLU . 11.8 pt -86.97 155.84 55.25 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-O 120.993 0.425 . . . . 0.0 111.926 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.826 ' HD2' HH21 ' B' ' 15' ' ' ARG . 90.3 Cg_endo -86.93 154.25 8.53 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.427 2.752 . . . . 0.0 111.965 178.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 1.038 ' HA ' HG23 ' C' ' 3' ' ' ILE . 3.2 tt0 -58.48 143.46 45.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.592 ' HB2' ' CE2' ' B' ' 20' ' ' TRP . . . -86.9 158.16 53.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.12 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' B' ' 6' ' ' ALA . 19.0 Cg_endo -58.23 158.1 23.44 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.526 2.817 . . . . 0.0 113.106 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' C' ' 17' ' ' ASP . 1.3 mpp_? -112.22 74.6 0.87 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.294 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.41 8.24 10.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.698 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.735 ' O ' ' HE3' ' C' ' 16' ' ' LYS . . . 78.72 22.84 65.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.287 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.786 ' HB3' HD21 ' B' ' 22' ' ' LEU . 56.2 mt-30 -116.32 145.4 43.21 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' C' ' 14' ' ' VAL . . . -91.83 134.82 34.41 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.065 0.936 . . . . 0.0 111.503 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.695 ' CE1' HD23 ' B' ' 22' ' ' LEU . 52.2 m-85 -120.27 153.01 36.97 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.132 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.978 HG11 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -113.23 154.14 14.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 112.727 -2.033 . . . . 0.0 105.716 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.826 HH21 ' HD2' ' B' ' 4' ' ' PRO . 0.0 OUTLIER -106.22 100.63 10.15 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.257 1.027 . . . . 0.0 111.136 -176.472 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.799 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -134.66 126.71 29.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 113.347 -1.752 . . . . 0.0 110.847 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.774 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 38.4 t70 60.12 43.42 14.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.85 12.77 29.99 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.565 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.445 ' C ' ' NH1' ' B' ' 15' ' ' ARG . 28.0 mt-10 -128.56 160.03 33.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.09 0.945 . . . . 0.0 111.45 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' TRP . . . . . 0.82 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 81.9 m95 -95.14 116.19 28.41 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.301 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.968 ' O ' HG23 ' B' ' 14' ' ' VAL . 9.8 t -112.0 134.98 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.211 0 CA-C-O 121.746 0.784 . . . . 0.0 109.735 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.786 HD21 ' HB3' ' B' ' 11' ' ' GLN . 0.1 OUTLIER -52.71 124.94 15.15 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.821 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.791 HD21 ' CB ' ' C' ' 26' ' ' PHE . 18.2 tp -57.68 -38.35 75.01 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.256 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 25.6 t -62.66 -18.5 62.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.742 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 1.5 m -68.95 -17.88 64.01 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.909 ' HB3' HD11 ' A' ' 27' ' ' LEU . 81.4 m-85 -101.88 -12.69 18.06 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.673 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.781 HD13 ' O ' ' C' ' 26' ' ' PHE . 13.5 mt . . . . . 0 C--O 1.25 1.087 0 O-C-N 121.103 -0.998 . . . . 0.0 111.367 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.071 0 N-CA-C 112.815 -0.114 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 2' ' ' TYR . . . . . 0.582 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.7 m-85 -121.91 145.98 47.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.732 0.266 . . . . 0.0 111.344 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 1.038 HG23 ' HA ' ' B' ' 5' ' ' GLU . 3.8 pt -85.46 150.11 53.4 Favored Pre-proline 0 CA--C 1.514 -0.415 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.81 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 10.9 Cg_endo -81.89 150.41 16.2 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.817 1.678 . . . . 0.0 111.203 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.866 ' HA ' HG23 ' A' ' 3' ' ' ILE . 6.2 tt0 -58.04 142.39 46.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.503 -1.226 . . . . 0.0 113.102 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 6' ' ' ALA . . . . . 0.646 ' HB2' ' CD2' ' C' ' 20' ' ' TRP . . . -88.57 165.06 29.79 Favored Pre-proline 0 C--O 1.231 0.127 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.873 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 7' ' ' PRO . . . . . 0.488 ' HD2' ' HB1' ' C' ' 6' ' ' ALA . 24.7 Cg_exo -59.06 146.22 95.03 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.525 2.15 . . . . 0.0 110.679 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 8' ' ' ARG . . . . . 0.807 ' CB ' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -113.85 58.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.109 0.48 . . . . 0.0 111.5 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 9' ' ' ASP . . . . . 0.505 ' OD2' ' HB2' ' C' ' 11' ' ' GLN . 6.8 p-10 -104.27 21.84 15.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.387 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 10' ' ' GLY . . . . . 0.643 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 78.88 12.7 83.89 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.226 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 11' ' ' GLN . . . . . 0.931 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.9 OUTLIER -113.02 143.05 44.97 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.257 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 12' ' ' ALA . . . . . 0.687 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -90.6 138.26 31.7 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.948 0.88 . . . . 0.0 111.852 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.608 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 60.4 m-85 -118.33 150.35 39.64 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.572 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' VAL . . . . . 1.025 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.3 OUTLIER -110.71 154.2 12.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.728 ' NH2' HG22 ' C' ' 3' ' ' ILE . 0.0 OUTLIER -105.73 108.13 19.49 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.651 -1.22 . . . . 0.0 109.944 -177.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.735 ' HE3' ' O ' ' B' ' 10' ' ' GLY . 0.0 OUTLIER -136.89 121.63 18.61 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.942 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 17' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' B' ' 8' ' ' ARG . 8.8 t70 58.56 45.75 15.8 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.562 ' HA2' ' NH2' ' C' ' 15' ' ' ARG . . . 63.97 15.71 58.6 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 115.064 0.786 . . . . 0.0 115.064 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -132.42 161.66 33.09 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.703 1.251 . . . . 0.0 112.118 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' TRP . . . . . 0.711 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 89.4 m95 -96.95 115.15 26.93 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.143 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 1.025 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.4 m -114.67 131.83 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.139 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 22' ' ' LEU . . . . . 0.931 HD21 ' HB3' ' C' ' 11' ' ' GLN . 2.1 mt -51.48 127.31 19.71 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.235 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.681 HD22 HG11 ' A' ' 14' ' ' VAL . 3.5 tp -59.87 -44.01 94.42 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.677 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -65.63 -22.26 66.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.934 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 16.6 m -69.29 -18.41 63.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' PHE . . . . . 0.791 ' CB ' HD21 ' B' ' 23' ' ' LEU . 42.9 m-85 -97.19 -0.31 47.07 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.555 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 1.249 HD21 ' O ' ' A' ' 26' ' ' PHE . 1.7 tp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.007 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.617 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 5.5 m-30 -102.52 160.93 14.13 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 111.925 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 1.017 HG23 ' HA ' ' C' ' 5' ' ' GLU . 4.5 pt -91.4 153.63 44.34 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.644 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 11.2 Cg_endo -86.25 153.42 9.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.723 2.282 . . . . 0.0 111.308 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.887 ' HA ' HG23 ' B' ' 3' ' ' ILE . 1.1 tp10 -58.21 142.34 47.85 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.785 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.21 160.77 48.05 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.166 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.553 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 43.9 Cg_exo -54.65 152.06 29.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.102 2.535 . . . . 0.0 112.958 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.583 ' HG3' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -111.63 57.76 0.63 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.165 0.507 . . . . 0.0 111.135 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -105.48 16.15 25.96 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.699 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' O ' ' HD2' ' B' ' 16' ' ' LYS . . . 79.98 14.08 81.22 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.81 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.643 ' HB3' HD21 ' A' ' 22' ' ' LEU . 3.0 mt-30 -107.11 157.73 17.62 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 117.156 0.478 . . . . 0.0 110.47 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.966 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -98.86 136.21 39.19 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.485 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.815 ' O ' HG23 ' B' ' 14' ' ' VAL . 66.2 m-85 -120.43 149.1 42.91 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.391 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -111.25 157.14 12.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.78 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -106.19 107.3 18.24 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 118.134 -1.426 . . . . 0.0 110.645 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.715 ' HG2' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -137.3 140.58 41.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.592 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.715 ' CG ' ' HG2' ' A' ' 16' ' ' LYS . 0.4 OUTLIER 45.21 45.65 9.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 177.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.433 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 61.82 16.81 52.98 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.383 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -133.71 162.34 32.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 118.124 0.962 . . . . 0.0 111.574 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.829 ' CZ2' HD12 ' A' ' 3' ' ' ILE . 73.4 m95 -93.94 114.1 26.24 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.471 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.887 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.4 m -107.19 132.66 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.295 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.643 HD21 ' HB3' ' A' ' 11' ' ' GLN . 4.4 mt -53.11 121.83 8.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.766 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.596 HD23 ' CD1' ' B' ' 26' ' ' PHE . 1.8 tp -60.09 -45.73 91.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.904 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.4 p -50.54 -26.28 5.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.962 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.2 m -67.5 -19.08 65.28 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.725 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 1.271 ' O ' HD21 ' C' ' 27' ' ' LEU . 12.7 m-85 -98.2 2.66 48.61 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.168 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.26 HD21 ' O ' ' B' ' 26' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.309 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.581 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 4.6 m-85 -130.89 141.64 50.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.985 0.422 . . . . 0.0 111.165 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 5' ' ' GLU . 6.4 pt -88.69 158.59 47.81 Favored Pre-proline 0 CA--C 1.515 -0.372 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.665 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 96.9 Cg_endo -88.48 150.21 6.41 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.984 2.456 . . . . 0.0 110.463 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 1.045 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.4 OUTLIER -57.54 149.19 21.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.935 -176.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.604 ' N ' ' HG3' ' B' ' 5' ' ' GLU . . . -91.0 152.55 44.39 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.195 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.71 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 6.2 Cg_exo -48.14 153.18 2.99 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.337 2.692 . . . . 0.0 113.251 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.541 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.9 OUTLIER -111.56 66.62 0.63 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.934 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -110.65 11.25 22.8 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.265 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.48 8.06 88.03 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.148 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.939 ' HB3' HD21 ' B' ' 22' ' ' LEU . 2.6 mm-40 -102.03 151.76 21.76 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.855 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -93.13 134.79 34.93 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.527 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.71 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 55.5 m-85 -119.85 151.54 38.7 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.021 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.966 HG21 ' HB1' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -113.72 159.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-N 113.61 -1.632 . . . . 0.0 106.832 175.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.966 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -103.7 107.9 18.96 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.489 1.137 . . . . 0.0 109.323 -176.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.821 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -135.82 131.81 35.87 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.036 -1.893 . . . . 0.0 111.432 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.601 ' OD1' ' O ' ' B' ' 16' ' ' LYS . 0.1 OUTLIER 47.8 46.86 18.52 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 177.027 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.497 ' H ' ' NH1' ' B' ' 15' ' ' ARG . . . 62.39 16.44 54.47 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 114.172 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -133.46 161.44 34.56 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 117.967 0.884 . . . . 0.0 111.702 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' TRP . . . . . 0.966 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 84.8 m95 -94.09 117.15 29.69 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.512 ' O ' HG12 ' B' ' 14' ' ' VAL . 5.4 t -114.63 136.6 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.196 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.071 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.939 HD21 ' HB3' ' B' ' 11' ' ' GLN . 2.8 mt -54.02 125.34 18.47 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.016 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.632 HD22 HG11 ' C' ' 14' ' ' VAL . 1.8 tp -56.75 -35.5 68.7 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.082 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.518 ' HA ' ' HB2' ' B' ' 27' ' ' LEU . 2.0 p -63.62 -19.59 64.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.021 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 23.6 m -70.51 -20.45 62.83 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 1.26 ' O ' HD21 ' A' ' 27' ' ' LEU . 96.2 m-85 -101.12 18.77 18.95 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-O 122.218 1.009 . . . . 0.0 108.328 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 1.056 HD21 ' O ' ' C' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.363 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.279 -0.329 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.3 m-30 -102.23 159.6 15.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 111.682 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 1.045 HG23 ' HA ' ' B' ' 5' ' ' GLU . 3.3 pt -86.97 154.73 55.4 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.806 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 9.9 Cg_endo -83.22 148.13 13.06 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.437 2.091 . . . . 0.0 110.856 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 1.017 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -58.09 143.53 43.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' C' ' 5' ' ' GLU . . . -83.77 167.46 28.1 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.268 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 7' ' ' PRO . . . . . 0.535 ' HD2' ' HB1' ' C' ' 6' ' ' ALA . 28.7 Cg_exo -59.04 151.5 65.68 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.042 2.495 . . . . 0.0 112.547 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 8' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -112.03 48.82 0.95 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.046 0.45 . . . . 0.0 111.581 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 9' ' ' ASP . . . . . 0.491 ' CG ' ' HG3' ' C' ' 11' ' ' GLN . 19.0 p-10 -104.94 19.35 20.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.088 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.482 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.65 14.27 81.36 Favored Glycine 0 C--O 1.229 -0.158 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.34 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' GLN . . . . . 0.914 ' HB3' HD21 ' C' ' 22' ' ' LEU . 7.1 mt-30 -105.1 141.15 37.17 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 12' ' ' ALA . . . . . 0.757 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -90.91 135.33 33.81 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.268 0.556 . . . . 0.0 110.981 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.511 ' CD2' ' HD2' ' C' ' 7' ' ' PRO . 70.9 m-85 -119.3 152.79 36.12 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.615 1.198 . . . . 0.0 112.637 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' VAL . . . . . 0.94 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.6 OUTLIER -113.37 145.82 18.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 112.624 -2.08 . . . . 0.0 106.35 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.761 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -95.01 115.47 27.46 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.906 -178.284 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.855 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 1.9 tttt -151.05 125.46 9.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.989 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 17' ' ' ASP . . . . . 0.541 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 0.3 OUTLIER 58.64 44.44 17.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.984 0.421 . . . . 0.0 111.462 177.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.505 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.8 16.42 51.56 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.996 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -133.73 161.94 33.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.032 0.916 . . . . 0.0 111.679 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' TRP . . . . . 0.799 ' CZ2' HD12 ' C' ' 3' ' ' ILE . 92.1 m95 -97.58 115.18 27.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.485 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.94 ' O ' HG23 ' C' ' 14' ' ' VAL . 6.4 t -110.06 137.59 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-O 121.596 0.712 . . . . 0.0 110.296 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' LEU . . . . . 0.914 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.3 mt -56.59 127.3 30.65 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.66 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.681 HD22 HG11 ' A' ' 14' ' ' VAL . 7.7 tp -59.16 -35.61 73.83 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.139 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 80.6 p -64.01 -19.88 65.5 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 122.12 -0.362 . . . . 0.0 110.977 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 73.3 m -67.63 -18.36 64.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' PHE . . . . . 1.056 ' O ' HD21 ' B' ' 27' ' ' LEU . 76.6 m-85 -101.88 9.37 40.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.426 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 1.271 HD21 ' O ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.478 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' C' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 119.45 -0.639 . . . . 0.0 112.209 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.895 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 22.9 m-85 -135.3 165.13 26.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 117.933 0.867 . . . . 0.0 111.667 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.896 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.0 OUTLIER -97.32 160.05 29.8 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.833 177.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 21.1 Cg_endo -82.47 145.77 13.41 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.034 1.823 . . . . 0.0 111.401 176.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.753 ' HA ' HG23 ' B' ' 3' ' ' ILE . 3.4 tt0 -57.61 142.6 44.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.006 -1.452 . . . . 0.0 113.76 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 20' ' ' TRP . . . -85.03 163.92 43.8 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.557 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.467 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 37.8 Cg_exo -57.31 151.13 54.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.979 2.453 . . . . 0.0 112.853 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 45.4 mtm-85 -112.32 58.26 0.64 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.44 15.55 21.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.737 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.763 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 78.79 14.58 81.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.695 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 1.01 ' HB3' HD21 ' A' ' 22' ' ' LEU . 7.7 mm-40 -102.83 141.32 35.84 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.924 ' HB1' HG11 ' B' ' 14' ' ' VAL . . . -91.52 133.39 35.55 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.784 0.802 . . . . 0.0 112.54 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.611 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 70.2 m-85 -118.66 151.42 37.98 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.961 1.363 . . . . 0.0 113.048 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.03 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -111.04 155.34 12.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 178.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.902 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.49 108.52 20.08 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.364 -177.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.677 ' HE3' ' O ' ' C' ' 10' ' ' GLY . 0.0 OUTLIER -136.73 120.72 17.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.65 -1.613 . . . . 0.0 111.977 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 0.4 OUTLIER 59.2 45.88 13.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 177.119 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.62 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 63.6 14.15 53.62 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.991 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -131.38 159.95 36.47 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 118.329 1.064 . . . . 0.0 111.429 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.902 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 93.0 m95 -97.53 114.77 26.72 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.882 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.03 ' O ' HG23 ' A' ' 14' ' ' VAL . 10.5 t -111.37 139.73 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-O 121.718 0.771 . . . . 0.0 110.032 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.01 HD21 ' HB3' ' A' ' 11' ' ' GLN . 3.7 mt -56.72 128.02 34.4 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.618 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.682 HD23 ' CG ' ' B' ' 26' ' ' PHE . 3.0 tp -61.5 -42.99 99.64 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.897 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -63.54 -18.59 64.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.738 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.0 m -69.69 -19.11 63.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 1.326 ' O ' HD21 ' C' ' 27' ' ' LEU . 96.3 m-85 -97.77 3.6 50.01 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.756 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.262 HD21 ' O ' ' B' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 4.8 m-85 -133.65 129.58 37.05 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.634 0.254 . . . . 0.0 110.595 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.753 HG23 ' HA ' ' A' ' 5' ' ' GLU . 3.5 pt -85.45 155.63 59.6 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.946 ' HD2' HH21 ' B' ' 15' ' ' ARG . 83.4 Cg_endo -83.39 160.22 14.94 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.638 2.226 . . . . 0.0 112.648 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.937 ' HA ' HG23 ' C' ' 3' ' ' ILE . 19.2 tt0 -60.74 143.08 55.15 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.507 ' HB1' ' CD ' ' B' ' 7' ' ' PRO . . . -84.72 169.61 16.05 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.568 -1.197 . . . . 0.0 112.053 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.507 ' CD ' ' HB1' ' B' ' 6' ' ' ALA . 12.2 Cg_exo -71.04 153.89 62.83 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.826 3.017 . . . . 0.0 113.064 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' C' ' 17' ' ' ASP . 1.7 mpp_? -112.0 84.56 1.98 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.297 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.32 6.57 4.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.338 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.862 ' O ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.15 14.74 81.43 Favored Glycine 0 CA--C 1.509 -0.29 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.512 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.927 ' HB3' HD21 ' B' ' 22' ' ' LEU . 0.4 OUTLIER -103.9 144.08 31.99 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.81 ' HB1' ' CG1' ' C' ' 14' ' ' VAL . . . -90.57 135.88 33.42 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.541 0.686 . . . . 0.0 110.404 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.624 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 43.5 m-85 -118.92 152.15 36.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.491 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.924 HG11 ' HB1' ' A' ' 12' ' ' ALA . 0.5 OUTLIER -105.55 158.79 5.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 175.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.946 HH21 ' HD2' ' B' ' 4' ' ' PRO . 0.0 OUTLIER -107.66 105.82 15.87 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 118.581 -1.248 . . . . 0.0 107.688 176.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.763 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -138.06 124.68 20.89 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.164 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 2.8 t0 58.92 43.79 17.49 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.322 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.19 12.69 38.96 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 119.243 -0.754 . . . . 0.0 114.529 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.495 ' C ' ' NH1' ' B' ' 15' ' ' ARG . 0.1 OUTLIER -127.43 154.72 44.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.113 1.456 . . . . 0.0 111.382 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 20' ' ' TRP . . . . . 0.886 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 76.2 m95 -93.74 113.41 25.46 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.752 HG22 HG12 ' B' ' 14' ' ' VAL . 1.4 m -108.61 132.85 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 CA-C-O 121.626 0.727 . . . . 0.0 111.282 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.927 HD21 ' HB3' ' B' ' 11' ' ' GLN . 1.8 mt -53.75 122.06 9.16 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.216 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.75 HD21 ' HB3' ' C' ' 26' ' ' PHE . 1.1 tp -57.61 -34.99 69.86 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.6 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 16.7 m -61.65 -16.58 49.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.434 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 31.7 m -69.78 -18.15 63.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 1.262 ' O ' HD21 ' A' ' 27' ' ' LEU . 8.8 m-85 -99.71 -11.4 20.9 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.449 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.804 HD13 ' O ' ' C' ' 26' ' ' PHE . 9.4 mt . . . . . 0 C--O 1.249 1.043 0 O-C-N 120.751 -1.218 . . . . 0.0 110.896 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 CA-C-O 119.861 -0.411 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' TYR . . . . . 0.663 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.6 m-30 -116.85 150.39 38.47 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.614 0.707 . . . . 0.0 111.241 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 0.937 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.4 pt -87.31 156.85 53.92 Favored Pre-proline 0 CA--C 1.506 -0.748 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.895 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 20.7 Cg_endo -87.8 152.96 7.35 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 122.153 1.902 . . . . 0.0 112.335 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.896 ' HA ' HG23 ' A' ' 3' ' ' ILE . 4.2 tt0 -57.38 141.45 47.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.086 -1.415 . . . . 0.0 113.321 -177.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.614 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . . . -84.97 160.51 55.14 Favored Pre-proline 0 N--CA 1.455 -0.211 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.306 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 7' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.99 151.52 49.25 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.921 2.414 . . . . 0.0 112.22 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 20.7 mtm105 -111.57 70.37 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.407 0.623 . . . . 0.0 111.08 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -113.34 17.23 18.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.038 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.677 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 74.0 15.37 79.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.616 -1.278 . . . . 0.0 112.264 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 11' ' ' GLN . . . . . 0.694 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.1 OUTLIER -113.91 152.47 30.75 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.011 0.434 . . . . 0.0 110.977 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 12' ' ' ALA . . . . . 0.622 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -92.75 136.19 33.45 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.583 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.496 ' HD1' ' C ' ' C' ' 21' ' ' VAL . 70.4 m-85 -119.85 156.76 30.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.949 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' VAL . . . . . 0.81 ' CG1' ' HB1' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -108.64 155.62 9.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 176.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.726 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.96 107.67 18.79 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 118.34 -1.344 . . . . 0.0 107.789 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.862 ' HE2' ' O ' ' B' ' 10' ' ' GLY . 0.0 OUTLIER -136.57 124.49 22.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.978 -1.465 . . . . 0.0 111.381 -179.181 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 17' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' B' ' 8' ' ' ARG . 0.2 OUTLIER 58.71 45.34 15.92 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 176.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.43 ' C ' ' CZ ' ' C' ' 15' ' ' ARG . . . 63.02 16.42 57.46 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.907 -0.663 . . . . 0.0 114.475 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 19' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -134.65 161.08 36.12 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.289 1.044 . . . . 0.0 111.227 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 20' ' ' TRP . . . . . 0.726 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 91.2 m95 -97.28 115.04 26.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.527 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.615 HG21 ' HD3' ' C' ' 16' ' ' LYS . 21.5 t -107.92 141.2 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 121.767 0.794 . . . . 0.0 110.028 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 22' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.6 mt -57.78 124.2 18.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.302 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.906 HD22 HG11 ' A' ' 14' ' ' VAL . 25.8 tp -58.82 -52.15 66.97 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.33 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 41.8 t -43.64 -26.79 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.434 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -68.19 -18.65 64.65 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.585 0.707 . . . . 0.0 109.623 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' PHE . . . . . 0.804 ' O ' HD13 ' B' ' 27' ' ' LEU . 81.0 m-85 -99.65 -3.7 32.52 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.81 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 1.326 HD21 ' O ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.241 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' C' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 4.1 m-30 -110.83 153.38 25.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.634 0.254 . . . . 0.0 111.409 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.832 HD12 ' CZ2' ' A' ' 20' ' ' TRP . 4.2 pt -91.75 161.53 33.65 Favored Pre-proline 0 CA--C 1.509 -0.603 0 CA-C-O 121.024 0.44 . . . . 0.0 111.582 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 33.2 Cg_endo -89.06 151.65 5.73 Favored 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 122.274 1.983 . . . . 0.0 110.686 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.942 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.5 OUTLIER -57.44 142.72 42.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.873 -177.036 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.6 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -84.39 165.07 40.29 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.524 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.474 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 28.5 Cg_exo -61.16 154.01 60.7 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 123.512 2.808 . . . . 0.0 113.202 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.446 ' CG ' ' HA ' ' B' ' 17' ' ' ASP . 2.0 mtp85 -112.04 69.98 0.7 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.262 0.553 . . . . 0.0 111.155 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -113.84 14.83 18.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.051 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.555 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 79.36 15.12 80.6 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.851 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.896 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -115.28 150.91 35.47 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.296 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.764 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -91.54 136.49 33.09 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.771 0.796 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.634 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 51.8 m-85 -117.43 151.65 36.62 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.344 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -112.87 152.9 14.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.74 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.04 107.32 18.23 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 118.962 -1.095 . . . . 0.0 108.503 -177.359 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.736 ' HE3' ' O ' ' C' ' 10' ' ' GLY . 0.6 OUTLIER -137.01 125.04 22.82 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 113.382 -1.736 . . . . 0.0 111.132 -178.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.563 ' HA ' ' HG3' ' C' ' 8' ' ' ARG . 0.2 OUTLIER 57.87 45.36 18.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.278 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.496 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 62.35 14.07 46.55 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 114.352 0.501 . . . . 0.0 114.352 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -131.0 161.93 30.89 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 117.889 0.845 . . . . 0.0 111.897 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.832 ' CZ2' HD12 ' A' ' 3' ' ' ILE . 82.5 m95 -96.42 113.91 25.53 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.952 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.867 ' O ' HG23 ' A' ' 14' ' ' VAL . 11.7 t -111.91 139.18 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 121.726 0.775 . . . . 0.0 110.034 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.896 HD21 ' HB3' ' A' ' 11' ' ' GLN . 2.1 mt -55.52 126.76 26.61 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.078 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.668 HD23 ' CG ' ' B' ' 26' ' ' PHE . 2.9 tp -59.91 -42.78 94.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.307 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.413 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 2.3 m -62.97 -19.15 64.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.7 m -69.7 -18.31 63.53 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.777 ' CB ' HD21 ' C' ' 23' ' ' LEU . 84.1 m-85 -97.54 2.05 49.66 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.574 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.953 ' CD1' ' O ' ' B' ' 26' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.072 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.616 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 3.7 m-85 -129.51 143.32 50.78 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.738 0.304 . . . . 0.0 110.988 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.942 HG23 ' HA ' ' A' ' 5' ' ' GLU . 2.6 pt -89.44 158.34 46.04 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-O 120.999 0.428 . . . . 0.0 112.139 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.77 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 92.2 Cg_endo -87.22 151.58 8.06 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.72 2.28 . . . . 0.0 111.075 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.914 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.8 OUTLIER -57.69 142.41 45.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.253 -177.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.63 ' HB3' ' NH1' ' C' ' 15' ' ' ARG . . . -83.72 166.67 32.84 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.462 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' B' ' 6' ' ' ALA . 22.2 Cg_exo -62.76 151.12 85.67 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.448 2.765 . . . . 0.0 112.588 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.627 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -112.79 60.52 0.64 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.985 0.421 . . . . 0.0 111.891 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' B' ' 11' ' ' GLN . 3.9 p30 -106.01 15.24 26.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.239 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.551 ' C ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.48 14.48 81.3 Favored Glycine 0 CA--C 1.506 -0.487 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.81 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.739 ' OE1' HD11 ' B' ' 22' ' ' LEU . 0.0 OUTLIER -113.19 152.83 29.24 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.484 0.659 . . . . 0.0 109.744 178.334 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 1.019 ' HB1' HG21 ' C' ' 14' ' ' VAL . . . -92.83 136.26 33.4 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.89 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.782 ' O ' HG23 ' C' ' 14' ' ' VAL . 58.4 m-85 -119.2 152.59 36.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.457 1.123 . . . . 0.0 112.265 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.937 HG23 ' O ' ' B' ' 21' ' ' VAL . 0.7 OUTLIER -112.49 155.84 13.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 113.122 -1.854 . . . . 0.0 106.214 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.982 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.14 107.1 17.9 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.884 -1.127 . . . . 0.0 108.92 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.764 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -136.79 124.02 21.81 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.505 -1.679 . . . . 0.0 111.792 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.446 ' HA ' ' CG ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 57.11 45.99 19.85 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.306 176.353 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.555 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 61.92 14.41 45.08 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.381 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.73 161.72 31.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.524 1.162 . . . . 0.0 111.803 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' TRP . . . . . 0.982 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 81.2 m95 -96.84 114.41 26.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.441 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.937 ' O ' HG23 ' B' ' 14' ' ' VAL . 10.6 t -111.16 142.4 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 121.768 0.794 . . . . 0.0 110.613 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.739 HD11 ' OE1' ' B' ' 11' ' ' GLN . 1.4 mt -56.82 122.68 12.75 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.399 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.673 HD23 ' CD2' ' C' ' 26' ' ' PHE . 2.8 tp -57.57 -43.18 84.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.87 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -19.28 65.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.944 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 4.1 m -67.72 -18.76 65.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.953 ' O ' ' CD1' ' A' ' 27' ' ' LEU . 87.4 m-85 -95.92 -16.11 21.96 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.325 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.984 HD13 ' O ' ' C' ' 26' ' ' PHE . 1.8 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.275 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.052 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' TYR . . . . . 0.77 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.5 m-30 -100.62 160.97 13.92 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.775 0.321 . . . . 0.0 111.798 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 0.914 HG23 ' HA ' ' B' ' 5' ' ' GLU . 7.4 pt -87.75 160.75 46.49 Favored Pre-proline 0 CA--C 1.516 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.624 ' O ' ' NE1' ' C' ' 20' ' ' TRP . 69.8 Cg_endo -92.38 144.09 2.6 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 122.614 2.209 . . . . 0.0 111.432 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.786 ' OE2' HG22 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -58.05 142.84 45.52 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -176.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.878 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -87.37 156.69 53.81 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.814 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 7' ' ' PRO . . . . . 0.459 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 52.0 Cg_exo -49.61 153.69 5.18 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.111 2.541 . . . . 0.0 113.238 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 8' ' ' ARG . . . . . 0.563 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -111.64 64.73 0.62 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.368 0.604 . . . . 0.0 111.03 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -112.05 14.18 20.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.526 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.736 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.29 13.95 82.18 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.363 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 11' ' ' GLN . . . . . 0.87 ' HB3' HD21 ' C' ' 22' ' ' LEU . 1.3 mm-40 -106.25 155.01 19.92 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 12' ' ' ALA . . . . . 0.72 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -96.63 134.43 39.87 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.402 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.562 ' CD2' ' HB1' ' C' ' 6' ' ' ALA . 50.2 m-85 -118.79 155.21 31.54 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.071 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 14' ' ' VAL . . . . . 1.019 HG21 ' HB1' ' B' ' 12' ' ' ALA . 0.4 OUTLIER -118.87 160.79 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.88 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.23 107.71 18.84 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.482 1.134 . . . . 0.0 110.766 -176.266 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' B' ' 11' ' ' GLN . 0.0 OUTLIER -137.05 127.25 26.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.474 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 17' ' ' ASP . . . . . 0.627 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 1.1 m-20 55.79 45.97 23.29 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.633 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 60.54 15.37 39.51 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 19' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' C' ' 16' ' ' LYS . 0.0 OUTLIER -133.61 162.0 33.11 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.277 1.038 . . . . 0.0 111.043 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 20' ' ' TRP . . . . . 0.88 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 91.9 m95 -98.49 122.84 42.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.299 0.571 . . . . 0.0 110.732 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.415 ' O ' HG12 ' C' ' 14' ' ' VAL . 12.8 t -117.5 138.44 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.673 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 22' ' ' LEU . . . . . 0.87 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.5 mt -55.61 125.61 21.8 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.874 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.777 HD21 ' CB ' ' A' ' 26' ' ' PHE . 7.8 tp -57.15 -35.18 69.22 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.921 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -15.1 59.6 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.502 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 4.0 m -72.8 -18.93 61.42 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' PHE . . . . . 0.984 ' O ' HD13 ' B' ' 27' ' ' LEU . 92.0 m-85 -99.1 -6.95 27.42 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.607 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.685 HD23 HD22 ' B' ' 27' ' ' LEU . 58.4 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.899 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' C' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.727 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 8.4 m-30 -103.29 167.02 10.08 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' C' ' 5' ' ' GLU . 5.6 pt -100.96 159.11 30.43 Favored Pre-proline 0 CA--C 1.508 -0.648 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.097 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 39.2 Cg_endo -86.58 152.92 8.95 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 121.623 1.549 . . . . 0.0 112.043 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.873 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.4 OUTLIER -57.25 143.24 40.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.753 -177.645 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.667 ' HA ' ' CD1' ' A' ' 20' ' ' TRP . . . -85.72 165.7 33.72 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.92 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 24.8 Cg_exo -58.85 151.07 67.36 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.957 2.438 . . . . 0.0 112.355 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.33 63.84 0.61 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.192 0.52 . . . . 0.0 111.25 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -110.27 13.34 23.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.592 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.19 8.94 87.15 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.394 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.927 ' HG3' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -102.4 151.14 22.62 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.227 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.642 ' HB1' ' CG1' ' B' ' 14' ' ' VAL . . . -92.1 136.26 33.32 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.606 0.717 . . . . 0.0 110.189 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.564 ' CE1' HD23 ' A' ' 22' ' ' LEU . 52.9 m-85 -119.09 154.28 33.44 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.711 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 21' ' ' VAL . 1.8 t -115.41 156.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.925 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -106.06 107.85 19.07 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.407 1.099 . . . . 0.0 110.46 -176.535 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.662 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 0.0 OUTLIER -138.2 126.75 23.44 Favored 'General case' 0 C--O 1.23 0.044 0 CA-C-N 113.062 -1.881 . . . . 0.0 112.052 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.586 ' HA ' ' HG3' ' C' ' 8' ' ' ARG . 0.4 OUTLIER 55.46 45.3 25.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 176.274 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.596 ' H ' ' NH2' ' A' ' 15' ' ' ARG . . . 62.1 15.59 50.69 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.568 -0.573 . . . . 0.0 114.528 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -134.33 162.97 30.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.498 1.149 . . . . 0.0 111.37 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.925 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 89.1 m95 -94.58 120.12 34.31 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.397 0.617 . . . . 0.0 110.792 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.797 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.6 m -115.69 131.35 68.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.949 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.927 HD21 ' HG3' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -51.09 123.87 10.29 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.786 -178.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.691 HD22 HG11 ' B' ' 14' ' ' VAL . 4.7 tp -57.43 -36.19 71.05 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.517 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.68 -21.18 66.52 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.949 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.0 m -70.1 -22.61 63.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.759 0.79 . . . . 0.0 108.97 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 1.051 ' O ' HD13 ' C' ' 27' ' ' LEU . 32.8 m-85 -97.87 -6.14 33.07 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.777 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.958 HD21 ' O ' ' B' ' 26' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.193 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.684 -0.166 . . . . 0.0 112.684 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.542 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 3.0 m-85 -130.48 138.61 50.35 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.861 0.362 . . . . 0.0 111.354 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.9 HG21 ' HE ' ' B' ' 15' ' ' ARG . 4.2 pt -88.89 159.65 45.32 Favored Pre-proline 0 N--CA 1.468 0.474 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 80.9 Cg_endo -91.05 152.59 3.86 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.875 2.383 . . . . 0.0 111.76 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 1.003 ' HA ' HG23 ' C' ' 3' ' ' ILE . 2.9 tt0 -58.39 142.8 47.27 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.737 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -88.33 146.23 37.44 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.597 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.472 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 11.4 Cg_exo -40.73 154.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.569 2.846 . . . . 0.0 113.678 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.41 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -111.94 65.0 0.62 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.818 179.401 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -110.77 18.54 19.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.304 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.464 ' HA2' ' OD2' ' C' ' 17' ' ' ASP . . . 75.6 7.83 83.54 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.564 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.542 ' HB3' HD21 ' B' ' 22' ' ' LEU . 0.9 OUTLIER -105.5 151.16 24.62 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.289 0.566 . . . . 0.0 110.071 178.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.556 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.81 137.32 32.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.635 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.567 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 60.2 m-85 -120.44 154.34 35.33 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.665 1.221 . . . . 0.0 111.476 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.925 HG23 ' O ' ' B' ' 21' ' ' VAL . 0.2 OUTLIER -111.89 156.15 13.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 112.58 -2.1 . . . . 0.0 106.625 179.111 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.971 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.74 103.91 13.51 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.118 0.961 . . . . 0.0 109.178 -178.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.799 ' HD3' HG21 ' B' ' 21' ' ' VAL . 0.0 OUTLIER -135.24 125.87 27.03 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.366 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.05 46.11 19.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.693 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 61.5 15.76 47.62 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 114.277 0.471 . . . . 0.0 114.277 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -133.36 161.91 33.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 117.904 0.852 . . . . 0.0 112.172 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' TRP . . . . . 0.971 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 83.9 m95 -95.86 114.73 26.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.215 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.925 ' O ' HG23 ' B' ' 14' ' ' VAL . 10.9 t -107.03 139.97 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.628 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.542 HD21 ' HB3' ' B' ' 11' ' ' GLN . 4.7 mt -58.04 124.33 18.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.326 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 1.003 HD22 HG11 ' C' ' 14' ' ' VAL . 35.6 tp -58.87 -39.98 82.99 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.523 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.2 m -62.77 -18.46 62.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.914 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 1.3 m -68.25 -17.6 64.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.958 ' O ' HD21 ' A' ' 27' ' ' LEU . 90.0 m-85 -102.69 -15.82 16.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.261 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.894 HD13 ' O ' ' C' ' 26' ' ' PHE . 5.5 mt . . . . . 0 C--O 1.249 1.07 0 O-C-N 121.137 -0.977 . . . . 0.0 111.024 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' TYR . . . . . 0.631 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.8 m-30 -96.09 161.72 13.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.333 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 1.003 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.9 pt -87.62 157.99 51.77 Favored Pre-proline 0 CA--C 1.512 -0.49 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.583 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.727 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 37.3 Cg_endo -89.65 146.09 4.84 Favored 'Trans proline' 0 N--CA 1.437 -1.853 0 C-N-CA 122.664 2.242 . . . . 0.0 111.336 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.926 ' HA ' HG23 ' A' ' 3' ' ' ILE . 1.1 tp10 -57.6 141.68 47.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.895 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -83.83 157.55 63.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.535 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 7' ' ' PRO . . . . . 0.414 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 51.8 Cg_exo -50.93 153.34 8.79 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.642 2.228 . . . . 0.0 112.769 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 8' ' ' ARG . . . . . 0.586 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 1.6 mpt_? -111.21 63.18 0.61 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.302 0.572 . . . . 0.0 110.645 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -107.96 13.97 25.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.252 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.422 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.62 10.23 86.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.397 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 11' ' ' GLN . . . . . 0.63 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.6 OUTLIER -106.7 152.27 24.01 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 12' ' ' ALA . . . . . 0.69 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -93.36 137.94 32.18 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.274 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.648 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 61.8 m-85 -119.11 152.65 36.13 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.326 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 14' ' ' VAL . . . . . 1.029 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.1 OUTLIER -111.38 153.97 13.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 178.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.771 ' NH2' ' OE2' ' B' ' 5' ' ' GLU . 0.0 OUTLIER -104.9 106.28 16.7 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.984 -177.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.693 ' HE2' ' OD2' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -137.53 133.13 34.17 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 113.08 -1.873 . . . . 0.0 111.764 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 17' ' ' ASP . . . . . 0.693 ' OD2' ' HE2' ' C' ' 16' ' ' LYS . 0.4 OUTLIER 46.68 46.45 14.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.533 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.613 ' HA2' HH22 ' C' ' 15' ' ' ARG . . . 69.98 10.68 65.4 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.97 160.45 38.26 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.835 1.317 . . . . 0.0 112.349 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' TRP . . . . . 0.895 ' CG ' ' HB2' ' C' ' 6' ' ' ALA . 85.2 m95 -94.49 112.63 24.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.008 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 1.029 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.0 m -109.79 135.38 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.083 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 22' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.3 mt -53.21 124.32 14.21 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.145 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.765 HD11 HD21 ' C' ' 27' ' ' LEU . 2.6 tp -58.23 -42.36 86.13 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.761 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -22.61 66.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.055 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 48.2 m -69.46 -18.95 63.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' PHE . . . . . 0.894 ' O ' HD13 ' B' ' 27' ' ' LEU . 40.9 m-85 -100.34 -6.42 25.83 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.859 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 1.051 HD13 ' O ' ' A' ' 26' ' ' PHE . 2.6 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.661 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.99 ' O ' ' HA ' ' C' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.123 0 CA-C-O 120.02 -0.322 . . . . 0.0 112.676 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.793 ' CE2' ' HB2' ' C' ' 2' ' ' TYR . 0.4 OUTLIER -138.67 146.24 41.37 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.112 0.565 . . . . 0.0 110.921 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.942 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.4 pt -104.74 158.96 30.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 37.2 Cg_endo -87.33 137.43 4.31 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.814 2.343 . . . . 0.0 111.802 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.873 ' HA ' HG23 ' B' ' 3' ' ' ILE . 2.9 tt0 -51.93 143.63 13.19 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.858 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.06 154.23 54.84 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.88 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 75.3 Cg_exo -51.73 157.34 5.57 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 123.613 2.875 . . . . 0.0 113.944 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -112.11 59.26 0.63 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.353 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -105.62 13.53 29.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.001 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.443 ' O ' ' HD2' ' B' ' 16' ' ' LYS . . . 79.66 13.57 82.27 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.777 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.623 ' HB3' HD21 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -106.21 156.76 18.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 117.156 0.478 . . . . 0.0 109.734 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.045 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -98.2 134.29 41.46 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.591 0.71 . . . . 0.0 112.021 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.875 ' O ' HG23 ' B' ' 14' ' ' VAL . 68.6 m-85 -120.1 151.76 38.58 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.649 1.214 . . . . 0.0 111.888 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.796 HG11 HD22 ' C' ' 23' ' ' LEU . 0.2 OUTLIER -112.98 157.76 13.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 113.105 -1.862 . . . . 0.0 106.566 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.999 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.56 106.05 16.39 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 118.579 -1.248 . . . . 0.0 109.437 -177.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.903 ' HG3' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -137.86 128.02 25.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.163 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.903 ' CG ' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 57.14 45.53 20.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 176.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.675 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 60.81 15.65 42.69 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.669 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -133.64 162.82 30.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.702 0.751 . . . . 0.0 111.767 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.999 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 84.0 m95 -97.21 110.83 23.3 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.948 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.793 ' O ' HG23 ' A' ' 14' ' ' VAL . 17.5 t -105.68 142.35 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.051 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.623 HD21 ' HB3' ' A' ' 11' ' ' GLN . 6.2 mt -56.41 124.56 18.53 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.057 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.664 HD23 ' CD2' ' B' ' 26' ' ' PHE . 2.7 tp -58.73 -39.98 82.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.24 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.4 p -63.8 -18.89 64.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.205 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.7 m -69.13 -18.48 63.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.882 ' O ' HD13 ' C' ' 27' ' ' LEU . 86.5 m-85 -97.33 -3.32 40.69 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.612 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.913 HD13 ' O ' ' B' ' 26' ' ' PHE . 7.7 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.462 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.486 2.023 0 CA-C-O 120.315 -0.158 . . . . 0.0 112.826 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.659 ' HD2' ' HB3' ' A' ' 2' ' ' TYR . 3.1 m-30 -105.23 151.78 23.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.758 0.313 . . . . 0.0 111.549 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.873 HG23 ' HA ' ' A' ' 5' ' ' GLU . 5.8 pt -88.91 159.47 45.66 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.883 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 70.1 Cg_endo -87.21 151.79 8.09 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 122.29 1.993 . . . . 0.0 111.403 177.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.999 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.4 OUTLIER -57.32 143.34 40.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.144 -177.441 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' B' ' 5' ' ' GLU . . . -83.48 162.15 54.38 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.544 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.34 152.94 43.29 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.231 2.62 . . . . 0.0 112.98 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.51 ' N ' ' HD3' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -112.24 60.23 0.63 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.165 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -105.27 15.33 27.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.574 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.59 ' O ' ' HE3' ' C' ' 16' ' ' LYS . . . 79.56 14.85 80.73 Favored Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 120.203 -0.998 . . . . 0.0 112.824 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.863 ' HB3' HD21 ' B' ' 22' ' ' LEU . 1.9 mm-40 -115.64 154.23 29.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.189 0.518 . . . . 0.0 110.585 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.695 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -93.43 134.18 35.94 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.391 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.537 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 74.6 m-85 -120.44 154.06 35.72 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.119 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 1.045 HG21 ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -113.89 159.58 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 CA-C-N 113.368 -1.742 . . . . 0.0 106.634 176.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.88 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -103.2 107.31 18.07 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.74 -176.304 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.853 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -137.05 131.54 32.94 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 112.942 -1.936 . . . . 0.0 113.114 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.588 ' OD1' ' O ' ' B' ' 16' ' ' LYS . 0.5 OUTLIER 46.75 45.08 14.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.552 ' HA2' HH22 ' B' ' 15' ' ' ARG . . . 76.72 -3.38 55.96 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.395 -0.907 . . . . 0.0 114.748 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.24 161.36 27.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.863 0.831 . . . . 0.0 111.911 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' TRP . . . . . 0.88 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 91.5 m95 -93.7 114.66 27.0 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.285 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.428 ' O ' HG12 ' B' ' 14' ' ' VAL . 11.2 t -108.31 138.11 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 CA-C-O 121.898 0.856 . . . . 0.0 110.376 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.863 HD21 ' HB3' ' B' ' 11' ' ' GLN . 1.9 mt -53.77 124.05 14.11 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.223 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.86 ' CD2' HD21 ' B' ' 27' ' ' LEU . 0.2 OUTLIER -57.93 -44.19 86.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 18.0 t -48.42 -26.27 2.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.23 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 10.8 m -68.64 -19.1 64.4 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.245 0.545 . . . . 0.0 110.452 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.913 ' O ' HD13 ' A' ' 27' ' ' LEU . 81.6 m-85 -98.23 -4.47 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.64 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.946 HD13 ' O ' ' C' ' 26' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.103 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' TYR . . . . . 0.883 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.4 m-30 -100.49 167.59 10.27 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.789 0.328 . . . . 0.0 111.213 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 0.999 HG23 ' HA ' ' B' ' 5' ' ' GLU . 1.1 pt -102.55 157.95 32.71 Favored Pre-proline 0 CA--C 1.504 -0.819 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.276 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.99 ' HA ' ' O ' ' A' ' 1' ' ' GLY . 9.7 Cg_endo -82.81 145.06 12.58 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 121.696 1.597 . . . . 0.0 111.577 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.942 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -57.55 143.01 42.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.309 -177.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' C' ' 7' ' ' PRO . . . -84.09 170.37 14.14 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.306 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 7' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' C' ' 6' ' ' ALA . 21.8 Cg_exo -61.8 149.06 91.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.772 2.315 . . . . 0.0 111.822 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -112.14 64.68 0.63 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.146 0.498 . . . . 0.0 110.882 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' ASP . . . . . 0.462 ' CG ' ' HG3' ' C' ' 11' ' ' GLN . 13.6 p-10 -121.28 23.02 10.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.505 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.62 ' C ' ' HE2' ' A' ' 16' ' ' LYS . . . 79.75 15.26 79.75 Favored Glycine 0 CA--C 1.508 -0.38 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.844 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 11' ' ' GLN . . . . . 0.931 ' HB3' HD21 ' C' ' 22' ' ' LEU . 6.2 mt-30 -111.28 140.21 46.04 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 117.32 0.56 . . . . 0.0 110.837 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 12' ' ' ALA . . . . . 0.74 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -92.47 136.39 33.26 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.75 0.786 . . . . 0.0 110.785 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.553 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 69.1 m-85 -121.12 152.15 39.06 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.847 1.308 . . . . 0.0 112.32 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' VAL . . . . . 0.956 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.0 OUTLIER -107.06 154.58 7.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 177.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.728 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.67 107.45 18.45 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.208 -178.521 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.866 ' HG2' ' CG ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -137.1 134.45 36.46 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.106 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 17' ' ' ASP . . . . . 0.866 ' CG ' ' HG2' ' C' ' 16' ' ' LYS . 0.0 OUTLIER 48.45 45.6 20.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 176.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.428 ' O ' ' NH2' ' C' ' 15' ' ' ARG . . . 65.53 8.99 41.97 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -129.78 161.31 31.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.198 0.999 . . . . 0.0 111.358 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' TRP . . . . . 0.728 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 87.9 m95 -93.84 120.39 34.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.987 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.956 ' O ' HG23 ' C' ' 14' ' ' VAL . 11.1 t -113.0 137.79 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.549 0.69 . . . . 0.0 110.309 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' LEU . . . . . 0.931 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.2 mt -57.6 127.64 33.05 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.981 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.819 ' CD1' HD11 ' B' ' 23' ' ' LEU . 6.6 tp -58.79 -35.04 72.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.448 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -19.87 65.99 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 122.245 -0.285 . . . . 0.0 111.338 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -68.64 -18.25 64.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' PHE . . . . . 0.946 ' O ' HD13 ' B' ' 27' ' ' LEU . 93.3 m-85 -99.13 -7.78 26.14 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.011 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.882 HD13 ' O ' ' A' ' 26' ' ' PHE . 5.7 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.064 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' C' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.487 2.098 0 N-CA-C 112.359 -0.297 . . . . 0.0 112.359 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.662 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 3.6 m-85 -121.79 150.96 41.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.971 0.385 . . . . 0.0 111.04 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 1.03 HG23 ' HA ' ' C' ' 5' ' ' GLU . 4.3 pt -94.39 157.72 36.89 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-O 120.974 0.416 . . . . 0.0 111.975 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 21.4 Cg_endo -88.19 147.07 6.52 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 122.596 2.198 . . . . 0.0 111.102 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 1.058 ' OE2' HG22 ' B' ' 3' ' ' ILE . 1.3 tt0 -58.14 143.02 45.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.644 -176.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.886 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -86.42 163.8 40.6 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.976 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.624 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 31.3 Cg_exo -56.74 152.93 39.19 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.832 2.355 . . . . 0.0 112.824 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.634 ' CZ ' ' H ' ' B' ' 18' ' ' GLY . 0.0 OUTLIER -112.07 63.86 0.62 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.48 0.657 . . . . 0.0 111.594 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -110.78 14.67 22.19 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.478 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.857 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 79.12 15.93 79.55 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.898 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -109.81 148.17 31.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.137 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -91.68 135.2 34.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.293 0.568 . . . . 0.0 112.178 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.789 ' O ' HG23 ' B' ' 14' ' ' VAL . 65.6 m-85 -117.59 148.34 42.01 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 123.026 1.393 . . . . 0.0 111.905 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -107.01 154.26 7.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 112.1 -2.318 . . . . 0.0 104.813 177.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.744 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.77 106.98 17.7 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 118.057 -1.457 . . . . 0.0 108.274 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.723 ' HD3' HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -137.63 124.39 21.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.681 -178.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.89 46.84 16.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.464 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 65.97 6.29 30.63 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.741 -0.743 . . . . 0.0 114.554 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -129.74 161.95 29.52 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 117.894 0.847 . . . . 0.0 111.819 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.886 ' CG ' ' HB2' ' A' ' 6' ' ' ALA . 87.9 m95 -95.89 119.76 34.97 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.363 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.958 ' O ' HG23 ' A' ' 14' ' ' VAL . 15.9 t -114.5 141.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 CA-C-O 121.702 0.763 . . . . 0.0 109.933 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.898 HD21 ' HB3' ' A' ' 11' ' ' GLN . 1.7 mt -57.61 126.94 29.56 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.81 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.773 HD23 ' CD2' ' B' ' 26' ' ' PHE . 1.3 tp -60.36 -45.16 94.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.983 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.484 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 52.8 p -63.43 -19.05 64.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.752 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 6.8 m -69.38 -19.28 63.83 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 1.205 ' O ' HD21 ' C' ' 27' ' ' LEU . 87.9 m-85 -97.26 -2.47 42.59 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.789 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.077 HD13 ' O ' ' B' ' 26' ' ' PHE . 1.5 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.414 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.533 ' HA ' ' H ' ' A' ' 5' ' ' GLU . 5.5 m-85 -134.98 131.62 37.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.495 0.188 . . . . 0.0 110.988 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 1.058 HG22 ' OE2' ' A' ' 5' ' ' GLU . 21.3 pt -85.16 156.46 60.16 Favored Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 120.695 0.283 . . . . 0.0 110.8 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.67 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 71.8 Cg_endo -87.25 155.99 8.17 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.47 2.113 . . . . 0.0 111.524 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 1.151 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.6 OUTLIER -57.68 143.53 41.26 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.201 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' B' ' 20' ' ' TRP . . . -86.67 153.7 55.58 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.653 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.746 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 3.1 Cg_exo -50.48 153.81 7.06 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.48 2.787 . . . . 0.0 113.401 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.605 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -111.73 73.66 0.83 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.571 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -114.72 11.04 16.75 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.705 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' C' ' 16' ' ' LYS . . . 78.99 14.99 81.37 Favored Glycine 0 CA--C 1.512 -0.144 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.583 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' C' ' 16' ' ' LYS . 0.0 OUTLIER -118.73 158.52 25.39 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.096 0.474 . . . . 0.0 110.536 179.497 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.645 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.54 135.83 33.73 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.392 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.746 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 51.3 m-85 -120.64 153.53 36.73 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-N 114.42 -1.264 . . . . 0.0 112.088 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 1.137 HG21 ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -116.15 159.13 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 113.802 -1.544 . . . . 0.0 107.956 176.285 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.833 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.09 107.24 18.12 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 122.104 0.954 . . . . 0.0 110.23 -176.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.857 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -137.63 125.63 22.8 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.612 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.571 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 56.81 41.81 27.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.634 ' H ' ' CZ ' ' A' ' 8' ' ' ARG . . . 69.59 10.54 63.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.46 159.55 36.73 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 118.233 1.017 . . . . 0.0 111.881 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' TRP . . . . . 0.833 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 90.5 m95 -93.42 113.15 25.24 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.07 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.518 ' O ' HG12 ' B' ' 14' ' ' VAL . 18.7 t -109.55 136.94 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.161 0 CA-C-O 121.815 0.817 . . . . 0.0 110.43 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' B' ' 11' ' ' GLN . 4.9 mt -51.56 123.11 9.2 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.031 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.748 HD22 HG21 ' C' ' 14' ' ' VAL . 7.3 tp -57.01 -36.03 69.93 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.545 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -63.04 -17.3 62.09 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.601 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 3.4 m -71.48 -19.59 62.19 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 1.077 ' O ' HD13 ' A' ' 27' ' ' LEU . 90.4 m-85 -99.34 -3.62 33.55 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.159 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 1.237 HD21 ' O ' ' C' ' 26' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.196 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 1' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' B' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.106 0 N-CA-C 112.688 -0.165 . . . . 0.0 112.688 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 2' ' ' TYR . . . . . 0.67 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.0 m-85 -127.14 147.14 50.19 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.923 0.362 . . . . 0.0 111.653 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 1.151 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.3 pt -87.04 157.89 53.57 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 121.004 0.431 . . . . 0.0 111.589 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 19.2 Cg_endo -87.86 148.54 7.07 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 122.33 2.02 . . . . 0.0 110.873 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 1.03 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -57.59 143.38 41.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.584 -177.058 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.687 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -85.29 162.24 49.33 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.449 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 7' ' ' PRO . . . . . 0.481 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 32.3 Cg_exo -56.78 155.08 28.68 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.004 2.469 . . . . 0.0 113.171 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.78 79.02 1.21 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.458 0.647 . . . . 0.0 111.601 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -125.15 11.62 8.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.355 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.67 10.66 85.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.07 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' GLN . . . . . 0.688 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.6 OUTLIER -102.02 151.1 22.54 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 12' ' ' ALA . . . . . 0.668 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -92.83 136.57 33.13 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.273 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.637 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 49.1 m-85 -117.99 155.42 30.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.554 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 14' ' ' VAL . . . . . 0.748 HG21 HD22 ' B' ' 23' ' ' LEU . 4.4 t -123.93 134.9 65.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.798 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -80.59 109.14 14.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.998 0.904 . . . . 0.0 111.204 -175.106 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.645 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -136.1 123.0 21.32 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 113.832 -1.531 . . . . 0.0 112.128 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 17' ' ' ASP . . . . . 0.605 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER 55.11 45.98 24.97 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 176.021 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.465 ' HA2' ' NH2' ' C' ' 15' ' ' ARG . . . 65.53 13.52 58.69 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 119.474 -0.626 . . . . 0.0 114.543 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 19' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' C' ' 16' ' ' LYS . 0.1 OUTLIER -133.05 161.41 34.44 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.488 1.144 . . . . 0.0 111.346 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 20' ' ' TRP . . . . . 0.798 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 82.3 m95 -93.35 116.19 28.75 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.087 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.551 HG22 ' HB ' ' C' ' 14' ' ' VAL . 1.7 m -108.29 129.57 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 CA-C-O 122.032 0.92 . . . . 0.0 111.25 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 22' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' C' ' 11' ' ' GLN . 2.1 mt -51.42 123.45 9.78 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.62 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.682 HD21 ' CB ' ' A' ' 26' ' ' PHE . 11.8 tp -60.37 -42.75 96.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.014 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -20.5 64.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.55 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 30.1 m -68.31 -18.59 64.55 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' PHE . . . . . 1.237 ' O ' HD21 ' B' ' 27' ' ' LEU . 52.8 m-85 -100.93 -8.77 22.17 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.073 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 1.205 HD21 ' O ' ' A' ' 26' ' ' PHE . 2.6 tp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.11 -0.947 . . . . 0.0 111.105 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 119.814 -0.437 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.819 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 8.4 m-30 -108.92 162.37 14.27 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.839 0.819 . . . . 0.0 111.86 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.743 HD13 ' HG3' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -92.74 159.59 35.92 Favored Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.501 178.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 43.1 Cg_endo -88.13 144.15 5.94 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.418 2.079 . . . . 0.0 111.487 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.917 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.6 OUTLIER -50.27 142.77 9.53 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.244 -178.195 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.691 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.13 166.24 27.2 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.563 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.505 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 34.5 Cg_exo -57.03 148.7 67.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.336 2.024 . . . . 0.0 111.627 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' B' ' 18' ' ' GLY . 85.7 mtt180 -112.58 62.68 0.63 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.078 0.466 . . . . 0.0 111.928 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -114.78 18.07 16.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.135 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.901 ' O ' ' HE2' ' B' ' 16' ' ' LYS . . . 79.02 14.6 81.77 Favored Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.864 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.87 ' HB3' HD21 ' A' ' 22' ' ' LEU . 15.8 mm100 -103.88 141.64 35.78 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.886 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -91.88 134.87 34.38 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.534 0.683 . . . . 0.0 110.914 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.864 ' O ' HG23 ' B' ' 14' ' ' VAL . 53.7 m-85 -120.04 149.75 41.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.409 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.843 HG21 ' CE2' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -104.61 156.64 5.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 176.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 1.065 ' HG3' HH11 ' A' ' 15' ' ' ARG . 0.0 OUTLIER -105.86 115.76 30.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.644 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' C' ' 11' ' ' GLN . 1.0 OUTLIER -151.69 129.17 11.38 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.825 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.666 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 0.1 OUTLIER 54.89 42.24 31.26 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.718 177.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.538 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 62.44 16.45 54.73 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 119.358 -0.69 . . . . 0.0 114.742 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.666 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -131.87 161.62 32.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.801 1.301 . . . . 0.0 111.613 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 1.015 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 91.5 m95 -99.47 112.32 24.53 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.892 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 14' ' ' VAL . 17.9 t -108.6 139.74 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.453 0.644 . . . . 0.0 109.652 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.87 HD21 ' HB3' ' A' ' 11' ' ' GLN . 1.3 mt -55.79 126.71 26.78 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.935 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.62 HD23 ' CD1' ' B' ' 26' ' ' PHE . 3.3 tp -58.46 -39.49 80.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.164 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.434 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -63.52 -19.14 64.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.046 -178.399 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.3 m -70.12 -18.58 63.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.093 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.843 ' CE2' HG21 ' A' ' 14' ' ' VAL . 80.7 m-85 -97.25 -1.82 44.02 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.847 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.011 ' CD1' ' O ' ' B' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.048 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.174 0 CA-C-O 120.19 -0.228 . . . . 0.0 112.755 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.53 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 4.4 m-85 -132.33 135.69 46.36 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 110.896 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.968 HG21 ' HE ' ' B' ' 15' ' ' ARG . 6.1 pt -87.19 159.31 51.14 Favored Pre-proline 0 CA--C 1.513 -0.462 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.716 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 92.0 Cg_endo -91.04 148.56 3.77 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 122.949 2.433 . . . . 0.0 111.376 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.793 ' OE2' ' HA2' ' C' ' 18' ' ' GLY . 0.9 OUTLIER -58.22 142.85 46.34 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.758 0.79 . . . . 0.0 112.959 -177.725 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.865 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -83.17 155.25 67.05 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.99 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.703 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 5.0 Cg_exo -45.75 152.7 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.743 2.962 . . . . 0.0 113.678 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' C' ' 17' ' ' ASP . 3.6 mtp180 -111.93 62.27 0.62 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.586 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -109.03 15.37 23.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.643 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.588 ' C ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.23 14.73 81.34 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.852 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.915 ' HB3' HD21 ' B' ' 22' ' ' LEU . 38.5 mm-40 -109.01 147.18 32.71 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 120.966 0.412 . . . . 0.0 110.508 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.637 ' HB1' ' CG1' ' C' ' 14' ' ' VAL . . . -92.57 136.16 33.46 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.638 0.732 . . . . 0.0 109.469 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 50.7 m-85 -122.09 155.46 35.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.264 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.886 HG21 ' HB1' ' A' ' 12' ' ' ALA . 1.5 p -114.93 159.81 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.477 175.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 1.012 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -102.95 114.42 28.7 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.133 0.968 . . . . 0.0 110.124 -176.225 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.901 ' HE2' ' O ' ' A' ' 10' ' ' GLY . 2.0 tttm -149.01 127.93 12.64 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.788 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 0.2 OUTLIER 56.29 45.25 23.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.458 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 62.13 14.13 45.22 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 119.484 -0.62 . . . . 0.0 114.196 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' B' ' 17' ' ' ASP . 0.1 OUTLIER -133.1 163.22 29.73 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.525 1.162 . . . . 0.0 112.011 -178.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 20' ' ' TRP . . . . . 1.012 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 92.5 m95 -97.65 113.02 24.68 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.204 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.493 ' C ' ' HD1' ' B' ' 13' ' ' TYR . 6.2 t -108.24 139.27 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 121.925 0.869 . . . . 0.0 110.333 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.915 HD21 ' HB3' ' B' ' 11' ' ' GLN . 3.8 mt -55.21 125.11 19.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.061 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.593 HD22 HG11 ' C' ' 14' ' ' VAL . 3.8 tp -57.77 -39.4 77.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.521 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 29.8 t -63.23 -17.34 62.34 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.708 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 18.3 m -70.37 -20.27 62.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 1.011 ' O ' ' CD1' ' A' ' 27' ' ' LEU . 88.1 m-85 -96.89 -15.54 21.15 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.575 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.68 HD21 ' HB3' ' C' ' 26' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.99 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' TYR . . . . . 0.716 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.1 m-30 -98.01 161.15 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.352 . . . . 0.0 111.524 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 0.79 HG23 ' HA ' ' B' ' 5' ' ' GLU . 1.5 pt -90.09 158.4 44.2 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.765 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.819 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 43.7 Cg_endo -90.23 153.99 4.64 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 122.432 2.088 . . . . 0.0 112.285 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.538 ' OE2' ' HA2' ' A' ' 18' ' ' GLY . 1.1 tp10 -57.56 142.4 44.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.917 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.904 ' H ' HH12 ' A' ' 15' ' ' ARG . . . -89.08 162.89 36.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 113.699 -1.592 . . . . 0.0 110.864 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 7' ' ' PRO . . . . . 0.467 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 31.8 Cg_exo -57.27 152.39 46.17 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.075 2.517 . . . . 0.0 113.52 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 8' ' ' ARG . . . . . 0.575 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -111.77 67.75 0.65 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.128 0.489 . . . . 0.0 111.095 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 9' ' ' ASP . . . . . 0.539 ' OD1' ' HB2' ' C' ' 11' ' ' GLN . 6.1 p30 -116.72 12.98 15.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.107 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.495 ' O ' ' HE2' ' A' ' 16' ' ' LYS . . . 84.08 14.68 71.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.203 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 11' ' ' GLN . . . . . 0.64 ' HB3' HD21 ' C' ' 22' ' ' LEU . 19.1 mt-30 -110.79 150.56 28.94 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.492 0.663 . . . . 0.0 110.892 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 12' ' ' ALA . . . . . 0.592 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -92.52 136.87 32.85 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.477 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.606 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 59.3 m-85 -118.99 156.12 30.17 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.035 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 14' ' ' VAL . . . . . 0.882 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.2 OUTLIER -115.25 157.04 16.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.952 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.63 115.31 30.03 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 122.045 0.926 . . . . 0.0 110.903 -176.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' B' ' 11' ' ' GLN . 0.5 OUTLIER -153.47 132.96 12.89 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.339 -178.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 17' ' ' ASP . . . . . 0.459 ' HA ' ' HG2' ' B' ' 8' ' ' ARG . 0.2 OUTLIER 55.17 45.04 26.77 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 176.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.793 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.21 16.84 50.5 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-O 119.382 -0.677 . . . . 0.0 114.167 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -137.33 164.63 28.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.661 1.231 . . . . 0.0 112.255 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' TRP . . . . . 0.952 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 90.3 m95 -96.49 115.11 26.89 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.162 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.882 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.7 m -105.81 134.81 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.153 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' C' ' 11' ' ' GLN . 3.5 mt -55.44 122.03 10.31 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.72 HD21 ' HB3' ' A' ' 26' ' ' PHE . 4.5 tp -59.12 -38.24 79.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.498 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 28.7 t -62.44 -18.94 62.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.89 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 29.6 m -69.23 -18.03 63.84 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' PHE . . . . . 0.68 ' HB3' HD21 ' B' ' 27' ' ' LEU . 70.9 m-85 -101.04 -10.62 20.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.466 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 26' ' ' PHE . 25.4 mt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.873 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 112.58 -0.208 . . . . 0.0 112.58 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.75 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 5.9 m-85 -99.02 167.21 10.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 112.23 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 1.064 HG23 ' HA ' ' C' ' 5' ' ' GLU . 3.5 pt -91.68 159.52 38.31 Favored Pre-proline 0 CA--C 1.51 -0.578 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.186 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 55.5 Cg_endo -84.58 139.71 7.91 Favored 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 121.17 1.247 . . . . 0.0 111.201 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.902 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.5 OUTLIER -47.97 143.03 4.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.59 -1.187 . . . . 0.0 113.87 -177.532 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.76 ' HB2' ' CD2' ' A' ' 20' ' ' TRP . . . -84.05 177.65 2.86 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.66 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.946 ' HB2' ' OD2' ' A' ' 9' ' ' ASP . 2.7 Cg_exo -75.5 155.23 40.64 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.576 2.851 . . . . 0.0 114.037 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.587 ' HG3' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -105.01 79.67 1.53 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 178.252 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.946 ' OD2' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -124.84 3.03 8.13 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.198 -178.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.49 0.36 83.61 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 119.571 -1.299 . . . . 0.0 111.188 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.843 ' O ' ' HB2' ' B' ' 16' ' ' LYS . 0.1 OUTLIER -101.69 151.76 21.64 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.853 ' HB1' ' CG1' ' B' ' 14' ' ' VAL . . . -91.48 137.94 31.97 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.439 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.629 ' CD2' ' HD2' ' A' ' 7' ' ' PRO . 47.5 m-85 -118.5 155.69 30.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.081 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.972 HG13 ' O ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -105.1 150.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.975 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.55 99.41 9.09 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.584 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 0.3 OUTLIER -136.0 125.73 25.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 112.777 -2.011 . . . . 0.0 113.172 -176.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.96 43.11 30.42 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.641 ' HA2' ' NH1' ' A' ' 15' ' ' ARG . . . 74.85 6.65 78.95 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.168 -1.015 . . . . 0.0 115.109 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.88 161.54 35.34 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.992 1.396 . . . . 0.0 112.396 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.975 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 97.3 m95 -94.32 115.25 27.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.651 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.972 ' O ' HG13 ' A' ' 14' ' ' VAL . 22.0 t -107.21 136.84 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 121.904 0.859 . . . . 0.0 108.791 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.721 HD21 ' OE1' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -53.92 122.64 10.47 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.321 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.979 HD12 HD11 ' C' ' 23' ' ' LEU . 4.9 tp -57.26 -36.06 70.52 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.683 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.661 ' HB2' HD12 ' A' ' 22' ' ' LEU . 25.9 m -61.47 -17.76 55.92 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.243 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -72.23 -18.39 61.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.973 ' O ' HD13 ' C' ' 27' ' ' LEU . 88.9 m-85 -99.34 -10.54 22.18 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.332 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.788 HD13 ' O ' ' B' ' 26' ' ' PHE . 9.3 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.689 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 119.733 -0.482 . . . . 0.0 111.972 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.662 ' CD2' ' HB2' ' A' ' 2' ' ' TYR . 3.6 m-85 -134.57 138.51 44.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.748 0.774 . . . . 0.0 110.809 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.902 HG23 ' HA ' ' A' ' 5' ' ' GLU . 0.8 OUTLIER -88.2 158.49 49.42 Favored Pre-proline 0 N--CA 1.47 0.528 0 CA-C-O 121.4 0.619 . . . . 0.0 112.621 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 87.8 Cg_endo -92.17 156.3 3.2 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 123.056 2.504 . . . . 0.0 111.232 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.847 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 0.7 OUTLIER -57.85 141.99 47.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -177.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.825 ' HB2' ' CD1' ' B' ' 20' ' ' TRP . . . -88.15 158.68 49.33 Favored Pre-proline 0 C--N 1.334 -0.103 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.361 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.485 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 10.1 Cg_endo -51.39 152.76 11.22 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.428 2.085 . . . . 0.0 111.68 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -114.85 67.95 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.471 0.653 . . . . 0.0 111.6 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -109.55 16.0 22.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.639 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.16 31.89 63.51 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.387 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.895 ' HB3' HD21 ' B' ' 22' ' ' LEU . 19.8 mm-40 -123.47 149.42 45.13 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.615 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.61 135.92 33.67 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.855 0.836 . . . . 0.0 111.66 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.573 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 80.7 m-85 -122.24 152.67 39.78 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 123.382 1.563 . . . . 0.0 112.654 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.853 ' CG1' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -106.99 156.69 7.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 111.266 -2.697 . . . . 0.0 105.93 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.954 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.19 105.55 15.64 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 118.76 -1.176 . . . . 0.0 108.13 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.843 ' HB2' ' O ' ' A' ' 11' ' ' GLN . 4.4 pttt -138.78 132.61 30.93 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 113.224 -1.807 . . . . 0.0 111.661 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.587 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 58.17 42.99 21.25 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 176.061 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.493 ' HA3' ' NH1' ' A' ' 8' ' ' ARG . . . 60.05 14.81 33.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.216 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -134.96 165.41 25.39 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 117.437 0.618 . . . . 0.0 111.842 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' TRP . . . . . 0.954 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 94.7 m95 -98.11 112.14 24.21 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.742 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.834 ' O ' HG23 ' B' ' 14' ' ' VAL . 17.0 t -106.12 141.44 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 CA-C-O 121.848 0.833 . . . . 0.0 109.65 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.895 HD21 ' HB3' ' B' ' 11' ' ' GLN . 2.6 mt -57.27 127.72 33.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.999 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.733 HD22 HG11 ' C' ' 14' ' ' VAL . 5.7 tp -61.67 -40.04 93.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.579 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -19.77 66.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.176 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -68.32 -18.02 64.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.788 ' O ' HD13 ' A' ' 27' ' ' LEU . 91.3 m-85 -99.29 -4.93 30.7 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.577 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.997 HD13 ' O ' ' C' ' 26' ' ' PHE . 4.5 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.227 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.714 -0.154 . . . . 0.0 112.714 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' TYR . . . . . 0.662 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.5 m-85 -120.3 146.57 45.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.932 0.396 . . . . 0.0 111.656 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 0.841 HG23 ' HA ' ' B' ' 5' ' ' GLU . 1.0 OUTLIER -92.11 158.65 39.03 Favored Pre-proline 0 CA--C 1.501 -0.926 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.592 178.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 75.7 Cg_endo -86.73 146.86 8.21 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.83 1.687 . . . . 0.0 112.426 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 1.064 ' HA ' HG23 ' A' ' 3' ' ' ILE . 1.8 tt0 -57.41 143.41 40.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 113.803 -1.544 . . . . 0.0 113.464 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.769 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -85.3 153.36 59.17 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.411 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.85 153.69 5.75 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.142 2.561 . . . . 0.0 112.986 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' ARG . . . . . 0.42 ' NH2' ' OE1' ' C' ' 5' ' ' GLU . 8.8 mtt85 -112.79 57.28 0.66 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.914 0.388 . . . . 0.0 111.782 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' C' ' 11' ' ' GLN . 2.5 p30 -105.63 18.71 21.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.449 ' O ' ' HD2' ' A' ' 16' ' ' LYS . . . 80.0 10.51 85.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.604 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 11' ' ' GLN . . . . . 0.92 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.0 OUTLIER -103.85 154.09 20.0 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 117.669 0.734 . . . . 0.0 109.271 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 12' ' ' ALA . . . . . 0.71 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -95.91 134.26 39.12 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.529 0.68 . . . . 0.0 111.82 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.716 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 51.4 m-85 -117.51 154.68 31.05 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.783 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 14' ' ' VAL . . . . . 0.872 HG23 ' O ' ' C' ' 21' ' ' VAL . 1.7 t -118.36 156.7 20.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.882 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -104.99 108.25 19.67 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.941 -177.04 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' B' ' 11' ' ' GLN . 0.0 OUTLIER -136.38 121.18 18.58 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.621 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.55 45.93 18.6 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.029 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.582 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 62.31 14.6 48.7 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.629 0.612 . . . . 0.0 114.629 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -130.19 162.2 29.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.3 1.05 . . . . 0.0 111.737 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' TRP . . . . . 0.882 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 68.0 m95 -96.27 114.71 26.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.715 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.872 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.3 m -111.35 130.66 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.117 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' LEU . . . . . 0.92 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.2 mt -53.46 125.02 16.48 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.101 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.979 HD11 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -60.38 -36.62 78.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.737 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.08 -19.5 64.47 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.203 -0.311 . . . . 0.0 110.829 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 51.7 m -69.04 -18.4 64.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' PHE . . . . . 0.997 ' O ' HD13 ' B' ' 27' ' ' LEU . 59.1 m-85 -100.06 -8.94 23.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.317 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.973 HD13 ' O ' ' A' ' 26' ' ' PHE . 5.5 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.176 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' C' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.372 0 CA-C-O 119.638 -0.535 . . . . 0.0 112.162 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.841 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 19.6 m-85 -134.88 166.8 22.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.603 0.701 . . . . 0.0 111.2 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 1.024 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.1 pt -92.12 158.01 40.01 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.193 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 10.3 Cg_endo -82.49 147.7 14.15 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 121.764 1.643 . . . . 0.0 110.605 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 1.069 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.6 OUTLIER -58.36 142.9 46.82 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -176.666 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.752 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.14 160.74 48.33 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.317 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 51.9 Cg_exo -55.06 153.63 25.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.332 2.688 . . . . 0.0 113.621 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 71.3 mtm-85 -112.03 83.15 1.74 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.45 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -128.42 13.5 6.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.66 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.691 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 78.79 13.36 83.21 Favored Glycine 0 CA--C 1.51 -0.253 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.819 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.664 ' O ' ' HB2' ' B' ' 16' ' ' LYS . 11.5 mt-30 -115.55 148.75 39.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.848 0.356 . . . . 0.0 110.112 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -90.88 138.52 31.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 122.131 0.967 . . . . 0.0 112.562 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.525 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 61.9 m-85 -118.57 152.77 35.38 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.395 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.07 HG21 ' HB1' ' C' ' 12' ' ' ALA . 0.2 OUTLIER -114.46 157.22 15.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.343 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.78 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.91 104.26 13.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.798 0.809 . . . . 0.0 111.524 -176.507 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.668 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 1.1 tttt -135.39 128.38 31.49 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.204 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.521 ' HA ' ' CG ' ' C' ' 8' ' ' ARG . 0.2 OUTLIER 55.33 44.97 26.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.588 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.494 ' HA2' HH21 ' A' ' 15' ' ' ARG . . . 63.14 15.92 57.06 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 114.993 0.757 . . . . 0.0 114.993 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -132.33 158.57 41.57 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.575 1.188 . . . . 0.0 111.777 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.78 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 92.7 m95 -94.92 115.67 27.75 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.182 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 14.2 t -111.21 141.24 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-O 121.693 0.759 . . . . 0.0 110.185 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 12' ' ' ALA . 2.4 mt -57.29 125.37 22.47 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.596 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.874 HD22 HG11 ' B' ' 14' ' ' VAL . 7.4 tp -57.49 -35.48 70.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.45 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -63.97 -20.06 65.61 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.36 -0.213 . . . . 0.0 111.146 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 m -68.81 -18.09 64.12 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.35 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 1.062 ' O ' ' CD1' ' C' ' 27' ' ' LEU . 80.7 m-85 -95.9 -21.36 18.11 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.662 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.005 HD22 HD23 ' B' ' 27' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.168 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 120.209 -0.217 . . . . 0.0 113.166 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 3.4 m-85 -120.97 143.58 48.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.983 0.391 . . . . 0.0 110.93 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 1.069 HG23 ' HA ' ' A' ' 5' ' ' GLU . 5.0 pt -86.97 158.19 53.42 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 120.953 0.406 . . . . 0.0 112.031 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 84.0 Cg_endo -91.59 153.21 3.52 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.49 2.127 . . . . 0.0 111.671 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.889 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.6 OUTLIER -58.26 143.48 44.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.701 -177.463 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.69 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -86.99 171.39 10.07 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.795 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.537 ' HD2' ' HB1' ' B' ' 6' ' ' ALA . 18.8 Cg_exo -64.46 151.89 83.75 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.443 2.762 . . . . 0.0 113.028 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.45 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.3 OUTLIER -111.91 49.61 0.89 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -99.93 14.92 28.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.471 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.606 ' O ' ' HD2' ' C' ' 16' ' ' LYS . . . 79.64 15.04 80.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.169 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.929 ' HB3' HD21 ' B' ' 22' ' ' LEU . 12.6 mm100 -103.52 146.82 27.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.857 ' O ' HD23 ' B' ' 22' ' ' LEU . . . -94.28 133.76 37.48 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.954 0.883 . . . . 0.0 112.339 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.683 ' O ' HG23 ' C' ' 14' ' ' VAL . 74.8 m-85 -121.31 152.9 38.41 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 123.148 1.451 . . . . 0.0 112.354 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.874 HG11 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -113.22 158.01 13.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 111.766 -2.47 . . . . 0.0 106.264 178.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.548 ' NH2' ' OE2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -104.29 107.4 18.29 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 118.845 -1.142 . . . . 0.0 108.779 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.691 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -136.81 125.23 23.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.432 -178.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 55.04 44.94 27.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 176.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.487 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 62.19 16.14 52.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 115.222 0.849 . . . . 0.0 115.222 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' B' ' 16' ' ' LYS . 0.0 OUTLIER -134.81 161.3 35.58 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 118.624 1.212 . . . . 0.0 111.575 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 20' ' ' TRP . . . . . 0.69 ' CG ' ' HB2' ' B' ' 6' ' ' ALA . 90.0 m95 -97.02 112.82 24.4 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.515 0.674 . . . . 0.0 110.495 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' B' ' 13' ' ' TYR . 0.5 OUTLIER -110.59 153.3 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.572 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.968 179.036 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.929 HD21 ' HB3' ' B' ' 11' ' ' GLN . 3.9 mt -67.98 126.76 30.49 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 113.503 -1.68 . . . . 0.0 114.89 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.55 ' O ' HD12 ' B' ' 23' ' ' LEU . 3.5 tp -60.72 -43.77 97.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.887 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.504 ' HA ' HD12 ' B' ' 27' ' ' LEU . 14.3 m -63.59 -16.85 62.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.421 -177.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 13.2 m -69.66 -17.51 63.5 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.817 ' O ' HD13 ' A' ' 27' ' ' LEU . 24.8 m-85 -100.61 -5.6 26.47 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.358 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 1.005 HD23 HD22 ' A' ' 27' ' ' LEU . 15.3 mt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.251 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 CA-C-O 120.275 -0.18 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.6 m-85 -128.53 141.0 51.51 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.88 0.34 . . . . 0.0 111.015 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.3 pt -88.54 157.58 49.56 Favored Pre-proline 0 CA--C 1.496 -1.113 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.236 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.841 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 20.8 Cg_endo -86.35 147.45 8.78 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.821 1.681 . . . . 0.0 111.856 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 1.024 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -57.8 143.16 43.19 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.944 -177.352 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.697 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -85.59 152.38 57.21 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.856 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 7' ' ' PRO . . . . . 0.405 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 72.0 Cg_exo -49.73 156.02 3.46 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.519 2.813 . . . . 0.0 113.88 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 8' ' ' ARG . . . . . 0.521 ' CG ' ' HA ' ' A' ' 17' ' ' ASP . 2.6 mtp85 -111.9 57.25 0.64 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.994 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -102.09 17.9 22.12 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.784 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.34 11.0 75.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.795 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' GLN . . . . . 0.55 ' OE1' HD21 ' C' ' 22' ' ' LEU . 86.8 mt-30 -106.49 151.86 24.41 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' ALA . . . . . 1.07 ' HB1' HG21 ' A' ' 14' ' ' VAL . . . -92.41 137.17 32.59 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.999 0.904 . . . . 0.0 112.627 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.698 ' O ' HG23 ' A' ' 14' ' ' VAL . 79.8 m-85 -120.99 158.22 28.23 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.807 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' VAL . . . . . 0.83 HG21 ' HB1' ' B' ' 12' ' ' ALA . 0.1 OUTLIER -125.45 159.46 32.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 113.357 -1.747 . . . . 0.0 106.495 177.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 1.009 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -103.67 107.71 18.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 122.436 1.113 . . . . 0.0 110.743 -175.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.713 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 0.2 OUTLIER -136.57 133.23 36.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.995 -1.911 . . . . 0.0 110.365 178.546 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 17' ' ' ASP . . . . . 0.596 ' OD1' ' O ' ' C' ' 16' ' ' LYS . 0.1 OUTLIER 48.31 46.17 20.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 177.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.517 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.48 16.21 49.22 Favored Glycine 0 N--CA 1.453 -0.194 0 N-CA-C 114.373 0.509 . . . . 0.0 114.373 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -131.57 159.1 39.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 117.756 0.778 . . . . 0.0 111.666 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' TRP . . . . . 1.009 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 87.9 m95 -93.67 109.35 21.0 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.418 0.627 . . . . 0.0 110.33 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 5.9 t -103.81 135.82 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.913 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 22' ' ' LEU . . . . . 0.55 HD21 ' OE1' ' C' ' 11' ' ' GLN . 7.2 mt -50.37 122.44 6.99 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.797 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.542 HD23 ' CD1' ' A' ' 26' ' ' PHE . 1.3 tp -58.02 -39.91 79.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.546 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 35.4 t -64.2 -17.46 63.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.476 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' C' ' 22' ' ' LEU . 5.2 m -70.11 -18.76 63.26 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 26' ' ' PHE . . . . . 0.791 ' HB3' HD11 ' B' ' 27' ' ' LEU . 89.7 m-85 -98.09 0.86 46.89 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.6 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 1.062 ' CD1' ' O ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.257 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.81 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 15.4 m-85 -97.63 176.62 5.77 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.608 0.704 . . . . 0.0 112.382 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.866 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.1 pt -104.7 159.71 28.43 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.33 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.604 ' HA ' ' CD1' ' B' ' 2' ' ' TYR . 13.9 Cg_endo -81.4 144.94 14.68 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.047 1.831 . . . . 0.0 111.716 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.887 ' HA ' HG23 ' B' ' 3' ' ' ILE . 22.5 tt0 -57.04 142.02 43.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 113.995 -1.457 . . . . 0.0 114.094 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.707 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.78 157.24 52.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.388 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.429 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 51.0 Cg_exo -54.54 151.14 32.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.977 2.451 . . . . 0.0 112.436 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 24.4 mtm180 -112.51 57.76 0.65 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.971 0.415 . . . . 0.0 112.051 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.05 18.66 19.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.792 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.799 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 80.17 14.95 79.71 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.906 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.709 ' C ' ' HB2' ' B' ' 16' ' ' LYS . 8.4 mt-30 -106.6 141.12 38.4 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.551 ' HA ' ' CB ' ' B' ' 16' ' ' LYS . . . -91.47 135.53 33.77 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 122.004 0.907 . . . . 0.0 112.102 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.65 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 56.4 m-85 -119.57 153.21 35.78 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.794 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -118.32 147.58 21.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.743 ' NH2' ' HA2' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -93.64 107.68 19.51 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.678 -1.209 . . . . 0.0 110.405 -177.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.82 ' CD ' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -138.21 124.97 21.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.519 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.807 ' HA ' ' CB ' ' C' ' 8' ' ' ARG . 0.8 OUTLIER 60.97 45.84 9.03 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 176.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.743 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 61.37 14.75 42.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.643 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -137.15 164.25 28.9 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 117.983 0.892 . . . . 0.0 112.198 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.721 ' CZ2' HD12 ' A' ' 3' ' ' ILE . 81.4 m95 -93.11 116.2 28.81 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.188 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.924 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.4 m -107.04 128.25 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.717 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -52.21 121.86 7.6 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.985 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.978 HD22 HG11 ' B' ' 14' ' ' VAL . 15.8 tp -58.44 -44.97 89.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.508 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.406 ' HB2' HD12 ' A' ' 22' ' ' LEU . 4.9 m -48.08 -26.32 1.79 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.324 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -67.02 -18.84 65.55 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.489 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 1.249 ' O ' HD21 ' C' ' 27' ' ' LEU . 61.5 m-85 -98.75 -5.03 32.11 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.143 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.909 HD11 ' HB3' ' B' ' 26' ' ' PHE . 1.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.091 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' TYR . . . . . 0.604 ' CD1' ' HA ' ' A' ' 4' ' ' PRO . 2.7 m-85 -129.03 135.61 49.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.796 0.298 . . . . 0.0 111.345 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 5' ' ' GLU . 11.8 pt -86.97 155.84 55.25 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-O 120.993 0.425 . . . . 0.0 111.926 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.826 ' HD2' HH21 ' B' ' 15' ' ' ARG . 90.3 Cg_endo -86.93 154.25 8.53 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.427 2.752 . . . . 0.0 111.965 178.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 1.038 ' HA ' HG23 ' C' ' 3' ' ' ILE . 3.2 tt0 -58.48 143.46 45.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.592 ' HB2' ' CE2' ' B' ' 20' ' ' TRP . . . -86.9 158.16 53.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.12 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' B' ' 6' ' ' ALA . 19.0 Cg_endo -58.23 158.1 23.44 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.526 2.817 . . . . 0.0 113.106 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' C' ' 17' ' ' ASP . 1.3 mpp_? -112.22 74.6 0.87 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.294 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.41 8.24 10.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.698 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.735 ' O ' ' HE3' ' C' ' 16' ' ' LYS . . . 78.72 22.84 65.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.287 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.786 ' HB3' HD21 ' B' ' 22' ' ' LEU . 56.2 mt-30 -116.32 145.4 43.21 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' C' ' 14' ' ' VAL . . . -91.83 134.82 34.41 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.065 0.936 . . . . 0.0 111.503 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.695 ' CE1' HD23 ' B' ' 22' ' ' LEU . 52.2 m-85 -120.27 153.01 36.97 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.132 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.978 HG11 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -113.23 154.14 14.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 112.727 -2.033 . . . . 0.0 105.716 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.826 HH21 ' HD2' ' B' ' 4' ' ' PRO . 0.0 OUTLIER -106.22 100.63 10.15 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.257 1.027 . . . . 0.0 111.136 -176.472 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.799 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -134.66 126.71 29.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 113.347 -1.752 . . . . 0.0 110.847 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.774 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 38.4 t70 60.12 43.42 14.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.85 12.77 29.99 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.565 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.445 ' C ' ' NH1' ' B' ' 15' ' ' ARG . 28.0 mt-10 -128.56 160.03 33.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.09 0.945 . . . . 0.0 111.45 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' TRP . . . . . 0.82 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 81.9 m95 -95.14 116.19 28.41 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.301 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.968 ' O ' HG23 ' B' ' 14' ' ' VAL . 9.8 t -112.0 134.98 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.211 0 CA-C-O 121.746 0.784 . . . . 0.0 109.735 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.786 HD21 ' HB3' ' B' ' 11' ' ' GLN . 0.1 OUTLIER -52.71 124.94 15.15 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.821 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.791 HD21 ' CB ' ' C' ' 26' ' ' PHE . 18.2 tp -57.68 -38.35 75.01 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.256 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 25.6 t -62.66 -18.5 62.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.742 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 1.5 m -68.95 -17.88 64.01 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.909 ' HB3' HD11 ' A' ' 27' ' ' LEU . 81.4 m-85 -101.88 -12.69 18.06 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.673 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.781 HD13 ' O ' ' C' ' 26' ' ' PHE . 13.5 mt . . . . . 0 C--O 1.25 1.087 0 O-C-N 121.103 -0.998 . . . . 0.0 111.367 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.071 0 N-CA-C 112.815 -0.114 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' TYR . . . . . 0.582 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.7 m-85 -121.91 145.98 47.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.732 0.266 . . . . 0.0 111.344 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 1.038 HG23 ' HA ' ' B' ' 5' ' ' GLU . 3.8 pt -85.46 150.11 53.4 Favored Pre-proline 0 CA--C 1.514 -0.415 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.81 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 10.9 Cg_endo -81.89 150.41 16.2 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.817 1.678 . . . . 0.0 111.203 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.866 ' HA ' HG23 ' A' ' 3' ' ' ILE . 6.2 tt0 -58.04 142.39 46.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.503 -1.226 . . . . 0.0 113.102 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ALA . . . . . 0.646 ' HB2' ' CD2' ' C' ' 20' ' ' TRP . . . -88.57 165.06 29.79 Favored Pre-proline 0 C--O 1.231 0.127 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.873 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 7' ' ' PRO . . . . . 0.488 ' HD2' ' HB1' ' C' ' 6' ' ' ALA . 24.7 Cg_exo -59.06 146.22 95.03 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.525 2.15 . . . . 0.0 110.679 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 8' ' ' ARG . . . . . 0.807 ' CB ' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -113.85 58.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.109 0.48 . . . . 0.0 111.5 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 9' ' ' ASP . . . . . 0.505 ' OD2' ' HB2' ' C' ' 11' ' ' GLN . 6.8 p-10 -104.27 21.84 15.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.387 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 10' ' ' GLY . . . . . 0.643 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 78.88 12.7 83.89 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.226 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 11' ' ' GLN . . . . . 0.931 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.9 OUTLIER -113.02 143.05 44.97 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.257 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 12' ' ' ALA . . . . . 0.687 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -90.6 138.26 31.7 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.948 0.88 . . . . 0.0 111.852 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.608 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 60.4 m-85 -118.33 150.35 39.64 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.572 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' VAL . . . . . 1.025 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.3 OUTLIER -110.71 154.2 12.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.728 ' NH2' HG22 ' C' ' 3' ' ' ILE . 0.0 OUTLIER -105.73 108.13 19.49 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.651 -1.22 . . . . 0.0 109.944 -177.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.735 ' HE3' ' O ' ' B' ' 10' ' ' GLY . 0.0 OUTLIER -136.89 121.63 18.61 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.942 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 17' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' B' ' 8' ' ' ARG . 8.8 t70 58.56 45.75 15.8 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.562 ' HA2' ' NH2' ' C' ' 15' ' ' ARG . . . 63.97 15.71 58.6 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 115.064 0.786 . . . . 0.0 115.064 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -132.42 161.66 33.09 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.703 1.251 . . . . 0.0 112.118 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' TRP . . . . . 0.711 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 89.4 m95 -96.95 115.15 26.93 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.143 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 1.025 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.4 m -114.67 131.83 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.139 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 22' ' ' LEU . . . . . 0.931 HD21 ' HB3' ' C' ' 11' ' ' GLN . 2.1 mt -51.48 127.31 19.71 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.235 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.681 HD22 HG11 ' A' ' 14' ' ' VAL . 3.5 tp -59.87 -44.01 94.42 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.677 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -65.63 -22.26 66.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.934 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 16.6 m -69.29 -18.41 63.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' PHE . . . . . 0.791 ' CB ' HD21 ' B' ' 23' ' ' LEU . 42.9 m-85 -97.19 -0.31 47.07 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.555 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 1.249 HD21 ' O ' ' A' ' 26' ' ' PHE . 1.7 tp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.007 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.617 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 5.5 m-30 . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 111.925 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 1.017 HG23 ' HA ' ' C' ' 5' ' ' GLU . 4.5 pt -91.4 153.63 44.34 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.644 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 11.2 Cg_endo -86.25 153.42 9.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.723 2.282 . . . . 0.0 111.308 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.887 ' HA ' HG23 ' B' ' 3' ' ' ILE . 1.1 tp10 -58.21 142.34 47.85 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.785 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.21 160.77 48.05 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.166 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.553 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 43.9 Cg_exo -54.65 152.06 29.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.102 2.535 . . . . 0.0 112.958 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.583 ' HG3' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -111.63 57.76 0.63 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.165 0.507 . . . . 0.0 111.135 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -105.48 16.15 25.96 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.699 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' O ' ' HD2' ' B' ' 16' ' ' LYS . . . 79.98 14.08 81.22 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.81 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.643 ' HB3' HD21 ' A' ' 22' ' ' LEU . 3.0 mt-30 -107.11 157.73 17.62 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 117.156 0.478 . . . . 0.0 110.47 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.966 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -98.86 136.21 39.19 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.485 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.815 ' O ' HG23 ' B' ' 14' ' ' VAL . 66.2 m-85 -120.43 149.1 42.91 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.391 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -111.25 157.14 12.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.78 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -106.19 107.3 18.24 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 118.134 -1.426 . . . . 0.0 110.645 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.715 ' HG2' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -137.3 140.58 41.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.592 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.715 ' CG ' ' HG2' ' A' ' 16' ' ' LYS . 0.4 OUTLIER 45.21 45.65 9.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 177.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.433 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 61.82 16.81 52.98 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.383 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -133.71 162.34 32.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 118.124 0.962 . . . . 0.0 111.574 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.829 ' CZ2' HD12 ' A' ' 3' ' ' ILE . 73.4 m95 -93.94 114.1 26.24 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.471 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.887 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.4 m -107.19 132.66 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.295 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.643 HD21 ' HB3' ' A' ' 11' ' ' GLN . 4.4 mt -53.11 121.83 8.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.766 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.596 HD23 ' CD1' ' B' ' 26' ' ' PHE . 1.8 tp -60.09 -45.73 91.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.904 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.4 p -50.54 -26.28 5.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.962 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.2 m -67.5 -19.08 65.28 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.725 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 1.271 ' O ' HD21 ' C' ' 27' ' ' LEU . 12.7 m-85 -98.2 2.66 48.61 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.168 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.26 HD21 ' O ' ' B' ' 26' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.309 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.581 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 4.6 m-85 -130.89 141.64 50.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.985 0.422 . . . . 0.0 111.165 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 5' ' ' GLU . 6.4 pt -88.69 158.59 47.81 Favored Pre-proline 0 CA--C 1.515 -0.372 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.665 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 96.9 Cg_endo -88.48 150.21 6.41 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.984 2.456 . . . . 0.0 110.463 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 1.045 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.4 OUTLIER -57.54 149.19 21.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.935 -176.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.604 ' N ' ' HG3' ' B' ' 5' ' ' GLU . . . -91.0 152.55 44.39 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.195 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.71 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 6.2 Cg_exo -48.14 153.18 2.99 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.337 2.692 . . . . 0.0 113.251 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.541 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.9 OUTLIER -111.56 66.62 0.63 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.934 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -110.65 11.25 22.8 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.265 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.48 8.06 88.03 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.148 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.939 ' HB3' HD21 ' B' ' 22' ' ' LEU . 2.6 mm-40 -102.03 151.76 21.76 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.855 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -93.13 134.79 34.93 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.527 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.71 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 55.5 m-85 -119.85 151.54 38.7 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.021 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.966 HG21 ' HB1' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -113.72 159.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-N 113.61 -1.632 . . . . 0.0 106.832 175.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.966 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -103.7 107.9 18.96 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.489 1.137 . . . . 0.0 109.323 -176.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.821 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -135.82 131.81 35.87 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.036 -1.893 . . . . 0.0 111.432 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.601 ' OD1' ' O ' ' B' ' 16' ' ' LYS . 0.1 OUTLIER 47.8 46.86 18.52 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 177.027 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.497 ' H ' ' NH1' ' B' ' 15' ' ' ARG . . . 62.39 16.44 54.47 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 114.172 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -133.46 161.44 34.56 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 117.967 0.884 . . . . 0.0 111.702 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' TRP . . . . . 0.966 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 84.8 m95 -94.09 117.15 29.69 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.512 ' O ' HG12 ' B' ' 14' ' ' VAL . 5.4 t -114.63 136.6 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.196 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.071 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.939 HD21 ' HB3' ' B' ' 11' ' ' GLN . 2.8 mt -54.02 125.34 18.47 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.016 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.632 HD22 HG11 ' C' ' 14' ' ' VAL . 1.8 tp -56.75 -35.5 68.7 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.082 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . 0.518 ' HA ' ' HB2' ' B' ' 27' ' ' LEU . 2.0 p -63.62 -19.59 64.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.021 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 23.6 m -70.51 -20.45 62.83 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 1.26 ' O ' HD21 ' A' ' 27' ' ' LEU . 96.2 m-85 -101.12 18.77 18.95 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-O 122.218 1.009 . . . . 0.0 108.328 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 1.056 HD21 ' O ' ' C' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.363 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.279 -0.329 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 2' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.3 m-30 -102.23 159.6 15.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 111.682 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 1.045 HG23 ' HA ' ' B' ' 5' ' ' GLU . 3.3 pt -86.97 154.73 55.4 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.806 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 9.9 Cg_endo -83.22 148.13 13.06 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.437 2.091 . . . . 0.0 110.856 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 1.017 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -58.09 143.53 43.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' C' ' 5' ' ' GLU . . . -83.77 167.46 28.1 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.268 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' PRO . . . . . 0.535 ' HD2' ' HB1' ' C' ' 6' ' ' ALA . 28.7 Cg_exo -59.04 151.5 65.68 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.042 2.495 . . . . 0.0 112.547 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -112.03 48.82 0.95 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.046 0.45 . . . . 0.0 111.581 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' ASP . . . . . 0.491 ' CG ' ' HG3' ' C' ' 11' ' ' GLN . 19.0 p-10 -104.94 19.35 20.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.088 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.482 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.65 14.27 81.36 Favored Glycine 0 C--O 1.229 -0.158 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.34 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' GLN . . . . . 0.914 ' HB3' HD21 ' C' ' 22' ' ' LEU . 7.1 mt-30 -105.1 141.15 37.17 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . 0.757 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -90.91 135.33 33.81 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.268 0.556 . . . . 0.0 110.981 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.511 ' CD2' ' HD2' ' C' ' 7' ' ' PRO . 70.9 m-85 -119.3 152.79 36.12 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.615 1.198 . . . . 0.0 112.637 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' VAL . . . . . 0.94 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.6 OUTLIER -113.37 145.82 18.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 112.624 -2.08 . . . . 0.0 106.35 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.761 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -95.01 115.47 27.46 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.906 -178.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.855 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 1.9 tttt -151.05 125.46 9.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.989 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . 0.541 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 0.3 OUTLIER 58.64 44.44 17.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.984 0.421 . . . . 0.0 111.462 177.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.505 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.8 16.42 51.56 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.996 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -133.73 161.94 33.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.032 0.916 . . . . 0.0 111.679 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' TRP . . . . . 0.799 ' CZ2' HD12 ' C' ' 3' ' ' ILE . 92.1 m95 -97.58 115.18 27.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.485 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.94 ' O ' HG23 ' C' ' 14' ' ' VAL . 6.4 t -110.06 137.59 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-O 121.596 0.712 . . . . 0.0 110.296 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' LEU . . . . . 0.914 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.3 mt -56.59 127.3 30.65 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.66 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.681 HD22 HG11 ' A' ' 14' ' ' VAL . 7.7 tp -59.16 -35.61 73.83 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.139 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 80.6 p -64.01 -19.88 65.5 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 122.12 -0.362 . . . . 0.0 110.977 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 73.3 m -67.63 -18.36 64.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' PHE . . . . . 1.056 ' O ' HD21 ' B' ' 27' ' ' LEU . 76.6 m-85 -101.88 9.37 40.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.426 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 1.271 HD21 ' O ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.478 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.895 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 22.9 m-85 . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 120.936 0.398 . . . . 0.0 111.667 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.896 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.0 OUTLIER -97.32 160.05 29.8 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.833 177.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 21.1 Cg_endo -82.47 145.77 13.41 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.034 1.823 . . . . 0.0 111.401 176.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.753 ' HA ' HG23 ' B' ' 3' ' ' ILE . 3.4 tt0 -57.61 142.6 44.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.006 -1.452 . . . . 0.0 113.76 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 20' ' ' TRP . . . -85.03 163.92 43.8 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.557 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.467 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 37.8 Cg_exo -57.31 151.13 54.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.979 2.453 . . . . 0.0 112.853 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 45.4 mtm-85 -112.32 58.26 0.64 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.44 15.55 21.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.737 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.763 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 78.79 14.58 81.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.695 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 1.01 ' HB3' HD21 ' A' ' 22' ' ' LEU . 7.7 mm-40 -102.83 141.32 35.84 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.924 ' HB1' HG11 ' B' ' 14' ' ' VAL . . . -91.52 133.39 35.55 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.784 0.802 . . . . 0.0 112.54 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.611 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 70.2 m-85 -118.66 151.42 37.98 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.961 1.363 . . . . 0.0 113.048 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.03 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -111.04 155.34 12.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 178.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.902 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.49 108.52 20.08 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.364 -177.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.677 ' HE3' ' O ' ' C' ' 10' ' ' GLY . 0.0 OUTLIER -136.73 120.72 17.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.65 -1.613 . . . . 0.0 111.977 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 0.4 OUTLIER 59.2 45.88 13.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 177.119 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.62 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 63.6 14.15 53.62 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.991 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -131.38 159.95 36.47 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 118.329 1.064 . . . . 0.0 111.429 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.902 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 93.0 m95 -97.53 114.77 26.72 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.882 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.03 ' O ' HG23 ' A' ' 14' ' ' VAL . 10.5 t -111.37 139.73 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-O 121.718 0.771 . . . . 0.0 110.032 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.01 HD21 ' HB3' ' A' ' 11' ' ' GLN . 3.7 mt -56.72 128.02 34.4 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.618 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.682 HD23 ' CG ' ' B' ' 26' ' ' PHE . 3.0 tp -61.5 -42.99 99.64 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.897 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -63.54 -18.59 64.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.738 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.0 m -69.69 -19.11 63.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 1.326 ' O ' HD21 ' C' ' 27' ' ' LEU . 96.3 m-85 -97.77 3.6 50.01 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.756 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.262 HD21 ' O ' ' B' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 4.8 m-85 -133.65 129.58 37.05 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.634 0.254 . . . . 0.0 110.595 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.753 HG23 ' HA ' ' A' ' 5' ' ' GLU . 3.5 pt -85.45 155.63 59.6 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.946 ' HD2' HH21 ' B' ' 15' ' ' ARG . 83.4 Cg_endo -83.39 160.22 14.94 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.638 2.226 . . . . 0.0 112.648 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.937 ' HA ' HG23 ' C' ' 3' ' ' ILE . 19.2 tt0 -60.74 143.08 55.15 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.507 ' HB1' ' CD ' ' B' ' 7' ' ' PRO . . . -84.72 169.61 16.05 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.568 -1.197 . . . . 0.0 112.053 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.507 ' CD ' ' HB1' ' B' ' 6' ' ' ALA . 12.2 Cg_exo -71.04 153.89 62.83 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.826 3.017 . . . . 0.0 113.064 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' C' ' 17' ' ' ASP . 1.7 mpp_? -112.0 84.56 1.98 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.297 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.32 6.57 4.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.338 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.862 ' O ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.15 14.74 81.43 Favored Glycine 0 CA--C 1.509 -0.29 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.512 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.927 ' HB3' HD21 ' B' ' 22' ' ' LEU . 0.4 OUTLIER -103.9 144.08 31.99 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.81 ' HB1' ' CG1' ' C' ' 14' ' ' VAL . . . -90.57 135.88 33.42 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.541 0.686 . . . . 0.0 110.404 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.624 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 43.5 m-85 -118.92 152.15 36.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.491 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.924 HG11 ' HB1' ' A' ' 12' ' ' ALA . 0.5 OUTLIER -105.55 158.79 5.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 175.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.946 HH21 ' HD2' ' B' ' 4' ' ' PRO . 0.0 OUTLIER -107.66 105.82 15.87 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 118.581 -1.248 . . . . 0.0 107.688 176.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.763 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -138.06 124.68 20.89 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.164 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 2.8 t0 58.92 43.79 17.49 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.322 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.19 12.69 38.96 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 119.243 -0.754 . . . . 0.0 114.529 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.495 ' C ' ' NH1' ' B' ' 15' ' ' ARG . 0.1 OUTLIER -127.43 154.72 44.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.113 1.456 . . . . 0.0 111.382 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' TRP . . . . . 0.886 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 76.2 m95 -93.74 113.41 25.46 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.752 HG22 HG12 ' B' ' 14' ' ' VAL . 1.4 m -108.61 132.85 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 CA-C-O 121.626 0.727 . . . . 0.0 111.282 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.927 HD21 ' HB3' ' B' ' 11' ' ' GLN . 1.8 mt -53.75 122.06 9.16 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.216 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.75 HD21 ' HB3' ' C' ' 26' ' ' PHE . 1.1 tp -57.61 -34.99 69.86 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.6 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 16.7 m -61.65 -16.58 49.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.434 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 31.7 m -69.78 -18.15 63.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 1.262 ' O ' HD21 ' A' ' 27' ' ' LEU . 8.8 m-85 -99.71 -11.4 20.9 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.449 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.804 HD13 ' O ' ' C' ' 26' ' ' PHE . 9.4 mt . . . . . 0 C--O 1.249 1.043 0 O-C-N 120.751 -1.218 . . . . 0.0 110.896 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 CA-C-O 119.861 -0.411 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 2' ' ' TYR . . . . . 0.663 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.6 m-30 -116.85 150.39 38.47 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.614 0.707 . . . . 0.0 111.241 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 0.937 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.4 pt -87.31 156.85 53.92 Favored Pre-proline 0 CA--C 1.506 -0.748 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.895 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 20.7 Cg_endo -87.8 152.96 7.35 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 122.153 1.902 . . . . 0.0 112.335 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.896 ' HA ' HG23 ' A' ' 3' ' ' ILE . 4.2 tt0 -57.38 141.45 47.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.086 -1.415 . . . . 0.0 113.321 -177.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' ALA . . . . . 0.614 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . . . -84.97 160.51 55.14 Favored Pre-proline 0 N--CA 1.455 -0.211 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.306 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.99 151.52 49.25 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.921 2.414 . . . . 0.0 112.22 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 20.7 mtm105 -111.57 70.37 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.407 0.623 . . . . 0.0 111.08 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -113.34 17.23 18.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.038 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.677 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 74.0 15.37 79.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.616 -1.278 . . . . 0.0 112.264 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' GLN . . . . . 0.694 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.1 OUTLIER -113.91 152.47 30.75 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.011 0.434 . . . . 0.0 110.977 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . 0.622 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -92.75 136.19 33.45 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.583 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.496 ' HD1' ' C ' ' C' ' 21' ' ' VAL . 70.4 m-85 -119.85 156.76 30.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.949 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' VAL . . . . . 0.81 ' CG1' ' HB1' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -108.64 155.62 9.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 176.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.726 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.96 107.67 18.79 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 118.34 -1.344 . . . . 0.0 107.789 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.862 ' HE2' ' O ' ' B' ' 10' ' ' GLY . 0.0 OUTLIER -136.57 124.49 22.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.978 -1.465 . . . . 0.0 111.381 -179.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' B' ' 8' ' ' ARG . 0.2 OUTLIER 58.71 45.34 15.92 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 176.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.43 ' C ' ' CZ ' ' C' ' 15' ' ' ARG . . . 63.02 16.42 57.46 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.907 -0.663 . . . . 0.0 114.475 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -134.65 161.08 36.12 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.289 1.044 . . . . 0.0 111.227 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' TRP . . . . . 0.726 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 91.2 m95 -97.28 115.04 26.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.527 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.615 HG21 ' HD3' ' C' ' 16' ' ' LYS . 21.5 t -107.92 141.2 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 121.767 0.794 . . . . 0.0 110.028 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.6 mt -57.78 124.2 18.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.302 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.906 HD22 HG11 ' A' ' 14' ' ' VAL . 25.8 tp -58.82 -52.15 66.97 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.33 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 41.8 t -43.64 -26.79 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.434 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -68.19 -18.65 64.65 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.585 0.707 . . . . 0.0 109.623 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' PHE . . . . . 0.804 ' O ' HD13 ' B' ' 27' ' ' LEU . 81.0 m-85 -99.65 -3.7 32.52 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.81 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 1.326 HD21 ' O ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.241 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 4.1 m-30 . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 120.634 0.254 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.832 HD12 ' CZ2' ' A' ' 20' ' ' TRP . 4.2 pt -91.75 161.53 33.65 Favored Pre-proline 0 CA--C 1.509 -0.603 0 CA-C-O 121.024 0.44 . . . . 0.0 111.582 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 33.2 Cg_endo -89.06 151.65 5.73 Favored 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 122.274 1.983 . . . . 0.0 110.686 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.942 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.5 OUTLIER -57.44 142.72 42.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.873 -177.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.6 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -84.39 165.07 40.29 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.524 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.474 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 28.5 Cg_exo -61.16 154.01 60.7 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 123.512 2.808 . . . . 0.0 113.202 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.446 ' CG ' ' HA ' ' B' ' 17' ' ' ASP . 2.0 mtp85 -112.04 69.98 0.7 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.262 0.553 . . . . 0.0 111.155 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -113.84 14.83 18.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.051 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.555 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 79.36 15.12 80.6 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.851 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.896 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -115.28 150.91 35.47 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.764 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -91.54 136.49 33.09 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.771 0.796 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.634 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 51.8 m-85 -117.43 151.65 36.62 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.344 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -112.87 152.9 14.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.74 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.04 107.32 18.23 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 118.962 -1.095 . . . . 0.0 108.503 -177.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.736 ' HE3' ' O ' ' C' ' 10' ' ' GLY . 0.6 OUTLIER -137.01 125.04 22.82 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 113.382 -1.736 . . . . 0.0 111.132 -178.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.563 ' HA ' ' HG3' ' C' ' 8' ' ' ARG . 0.2 OUTLIER 57.87 45.36 18.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.496 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 62.35 14.07 46.55 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 114.352 0.501 . . . . 0.0 114.352 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -131.0 161.93 30.89 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 117.889 0.845 . . . . 0.0 111.897 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.832 ' CZ2' HD12 ' A' ' 3' ' ' ILE . 82.5 m95 -96.42 113.91 25.53 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.952 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.867 ' O ' HG23 ' A' ' 14' ' ' VAL . 11.7 t -111.91 139.18 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 121.726 0.775 . . . . 0.0 110.034 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.896 HD21 ' HB3' ' A' ' 11' ' ' GLN . 2.1 mt -55.52 126.76 26.61 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.078 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.668 HD23 ' CG ' ' B' ' 26' ' ' PHE . 2.9 tp -59.91 -42.78 94.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.307 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.413 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 2.3 m -62.97 -19.15 64.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.7 m -69.7 -18.31 63.53 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.777 ' CB ' HD21 ' C' ' 23' ' ' LEU . 84.1 m-85 -97.54 2.05 49.66 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.574 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.953 ' CD1' ' O ' ' B' ' 26' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.072 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.616 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 3.7 m-85 -129.51 143.32 50.78 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.738 0.304 . . . . 0.0 110.988 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.942 HG23 ' HA ' ' A' ' 5' ' ' GLU . 2.6 pt -89.44 158.34 46.04 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-O 120.999 0.428 . . . . 0.0 112.139 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.77 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 92.2 Cg_endo -87.22 151.58 8.06 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.72 2.28 . . . . 0.0 111.075 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.914 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.8 OUTLIER -57.69 142.41 45.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.253 -177.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.63 ' HB3' ' NH1' ' C' ' 15' ' ' ARG . . . -83.72 166.67 32.84 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.462 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' B' ' 6' ' ' ALA . 22.2 Cg_exo -62.76 151.12 85.67 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.448 2.765 . . . . 0.0 112.588 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.627 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -112.79 60.52 0.64 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.985 0.421 . . . . 0.0 111.891 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' B' ' 11' ' ' GLN . 3.9 p30 -106.01 15.24 26.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.239 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.551 ' C ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.48 14.48 81.3 Favored Glycine 0 CA--C 1.506 -0.487 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.81 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.739 ' OE1' HD11 ' B' ' 22' ' ' LEU . 0.0 OUTLIER -113.19 152.83 29.24 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.484 0.659 . . . . 0.0 109.744 178.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 1.019 ' HB1' HG21 ' C' ' 14' ' ' VAL . . . -92.83 136.26 33.4 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.89 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.782 ' O ' HG23 ' C' ' 14' ' ' VAL . 58.4 m-85 -119.2 152.59 36.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.457 1.123 . . . . 0.0 112.265 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.937 HG23 ' O ' ' B' ' 21' ' ' VAL . 0.7 OUTLIER -112.49 155.84 13.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 113.122 -1.854 . . . . 0.0 106.214 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.982 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.14 107.1 17.9 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.884 -1.127 . . . . 0.0 108.92 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.764 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -136.79 124.02 21.81 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.505 -1.679 . . . . 0.0 111.792 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.446 ' HA ' ' CG ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 57.11 45.99 19.85 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.306 176.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.555 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 61.92 14.41 45.08 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.381 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.73 161.72 31.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.524 1.162 . . . . 0.0 111.803 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' TRP . . . . . 0.982 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 81.2 m95 -96.84 114.41 26.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.441 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.937 ' O ' HG23 ' B' ' 14' ' ' VAL . 10.6 t -111.16 142.4 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 121.768 0.794 . . . . 0.0 110.613 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.739 HD11 ' OE1' ' B' ' 11' ' ' GLN . 1.4 mt -56.82 122.68 12.75 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.399 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.673 HD23 ' CD2' ' C' ' 26' ' ' PHE . 2.8 tp -57.57 -43.18 84.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.87 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -19.28 65.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.944 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 4.1 m -67.72 -18.76 65.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.953 ' O ' ' CD1' ' A' ' 27' ' ' LEU . 87.4 m-85 -95.92 -16.11 21.96 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.325 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.984 HD13 ' O ' ' C' ' 26' ' ' PHE . 1.8 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.275 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.052 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 2' ' ' TYR . . . . . 0.77 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.5 m-30 -100.62 160.97 13.92 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.775 0.321 . . . . 0.0 111.798 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 0.914 HG23 ' HA ' ' B' ' 5' ' ' GLU . 7.4 pt -87.75 160.75 46.49 Favored Pre-proline 0 CA--C 1.516 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.624 ' O ' ' NE1' ' C' ' 20' ' ' TRP . 69.8 Cg_endo -92.38 144.09 2.6 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 122.614 2.209 . . . . 0.0 111.432 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.786 ' OE2' HG22 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -58.05 142.84 45.52 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -176.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' ALA . . . . . 0.878 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -87.37 156.69 53.81 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.814 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' PRO . . . . . 0.459 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 52.0 Cg_exo -49.61 153.69 5.18 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.111 2.541 . . . . 0.0 113.238 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' ARG . . . . . 0.563 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -111.64 64.73 0.62 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.368 0.604 . . . . 0.0 111.03 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -112.05 14.18 20.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.526 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.736 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.29 13.95 82.18 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.363 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' GLN . . . . . 0.87 ' HB3' HD21 ' C' ' 22' ' ' LEU . 1.3 mm-40 -106.25 155.01 19.92 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . 0.72 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -96.63 134.43 39.87 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.402 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.562 ' CD2' ' HB1' ' C' ' 6' ' ' ALA . 50.2 m-85 -118.79 155.21 31.54 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.071 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' VAL . . . . . 1.019 HG21 ' HB1' ' B' ' 12' ' ' ALA . 0.4 OUTLIER -118.87 160.79 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.88 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.23 107.71 18.84 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.482 1.134 . . . . 0.0 110.766 -176.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' B' ' 11' ' ' GLN . 0.0 OUTLIER -137.05 127.25 26.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.474 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . 0.627 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 1.1 m-20 55.79 45.97 23.29 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.633 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 60.54 15.37 39.51 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' C' ' 16' ' ' LYS . 0.0 OUTLIER -133.61 162.0 33.11 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.277 1.038 . . . . 0.0 111.043 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' TRP . . . . . 0.88 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 91.9 m95 -98.49 122.84 42.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.299 0.571 . . . . 0.0 110.732 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.415 ' O ' HG12 ' C' ' 14' ' ' VAL . 12.8 t -117.5 138.44 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.673 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' LEU . . . . . 0.87 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.5 mt -55.61 125.61 21.8 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.874 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.777 HD21 ' CB ' ' A' ' 26' ' ' PHE . 7.8 tp -57.15 -35.18 69.22 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.921 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -15.1 59.6 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.502 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 4.0 m -72.8 -18.93 61.42 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' PHE . . . . . 0.984 ' O ' HD13 ' B' ' 27' ' ' LEU . 92.0 m-85 -99.1 -6.95 27.42 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.607 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.685 HD23 HD22 ' B' ' 27' ' ' LEU . 58.4 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.899 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.727 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 8.4 m-30 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' C' ' 5' ' ' GLU . 5.6 pt -100.96 159.11 30.43 Favored Pre-proline 0 CA--C 1.508 -0.648 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.097 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 39.2 Cg_endo -86.58 152.92 8.95 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 121.623 1.549 . . . . 0.0 112.043 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.873 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.4 OUTLIER -57.25 143.24 40.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.753 -177.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.667 ' HA ' ' CD1' ' A' ' 20' ' ' TRP . . . -85.72 165.7 33.72 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.92 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 24.8 Cg_exo -58.85 151.07 67.36 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.957 2.438 . . . . 0.0 112.355 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.33 63.84 0.61 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.192 0.52 . . . . 0.0 111.25 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -110.27 13.34 23.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.592 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.19 8.94 87.15 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.394 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.927 ' HG3' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -102.4 151.14 22.62 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.227 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.642 ' HB1' ' CG1' ' B' ' 14' ' ' VAL . . . -92.1 136.26 33.32 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.606 0.717 . . . . 0.0 110.189 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.564 ' CE1' HD23 ' A' ' 22' ' ' LEU . 52.9 m-85 -119.09 154.28 33.44 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.711 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 21' ' ' VAL . 1.8 t -115.41 156.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.925 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -106.06 107.85 19.07 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.407 1.099 . . . . 0.0 110.46 -176.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.662 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 0.0 OUTLIER -138.2 126.75 23.44 Favored 'General case' 0 C--O 1.23 0.044 0 CA-C-N 113.062 -1.881 . . . . 0.0 112.052 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.586 ' HA ' ' HG3' ' C' ' 8' ' ' ARG . 0.4 OUTLIER 55.46 45.3 25.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 176.274 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.596 ' H ' ' NH2' ' A' ' 15' ' ' ARG . . . 62.1 15.59 50.69 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.568 -0.573 . . . . 0.0 114.528 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -134.33 162.97 30.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.498 1.149 . . . . 0.0 111.37 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.925 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 89.1 m95 -94.58 120.12 34.31 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.397 0.617 . . . . 0.0 110.792 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.797 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.6 m -115.69 131.35 68.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.949 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.927 HD21 ' HG3' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -51.09 123.87 10.29 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.786 -178.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.691 HD22 HG11 ' B' ' 14' ' ' VAL . 4.7 tp -57.43 -36.19 71.05 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.517 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.68 -21.18 66.52 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.949 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.0 m -70.1 -22.61 63.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.759 0.79 . . . . 0.0 108.97 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 1.051 ' O ' HD13 ' C' ' 27' ' ' LEU . 32.8 m-85 -97.87 -6.14 33.07 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.777 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.958 HD21 ' O ' ' B' ' 26' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.193 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.684 -0.166 . . . . 0.0 112.684 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.542 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 3.0 m-85 -130.48 138.61 50.35 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.861 0.362 . . . . 0.0 111.354 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.9 HG21 ' HE ' ' B' ' 15' ' ' ARG . 4.2 pt -88.89 159.65 45.32 Favored Pre-proline 0 N--CA 1.468 0.474 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 80.9 Cg_endo -91.05 152.59 3.86 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.875 2.383 . . . . 0.0 111.76 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 1.003 ' HA ' HG23 ' C' ' 3' ' ' ILE . 2.9 tt0 -58.39 142.8 47.27 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.737 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -88.33 146.23 37.44 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.597 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.472 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 11.4 Cg_exo -40.73 154.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.569 2.846 . . . . 0.0 113.678 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.41 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -111.94 65.0 0.62 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.818 179.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -110.77 18.54 19.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.304 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.464 ' HA2' ' OD2' ' C' ' 17' ' ' ASP . . . 75.6 7.83 83.54 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.564 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.542 ' HB3' HD21 ' B' ' 22' ' ' LEU . 0.1 OUTLIER -105.5 151.16 24.62 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.289 0.566 . . . . 0.0 110.071 178.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.556 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.81 137.32 32.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.635 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.567 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 60.2 m-85 -120.44 154.34 35.33 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.665 1.221 . . . . 0.0 111.476 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.925 HG23 ' O ' ' B' ' 21' ' ' VAL . 0.2 OUTLIER -111.89 156.15 13.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 112.58 -2.1 . . . . 0.0 106.625 179.111 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.971 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.74 103.91 13.51 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.118 0.961 . . . . 0.0 109.178 -178.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.799 ' HD3' HG21 ' B' ' 21' ' ' VAL . 0.0 OUTLIER -135.24 125.87 27.03 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.366 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.05 46.11 19.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.693 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 61.5 15.76 47.62 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 114.277 0.471 . . . . 0.0 114.277 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -133.36 161.91 33.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 117.904 0.852 . . . . 0.0 112.172 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' TRP . . . . . 0.971 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 83.9 m95 -95.86 114.73 26.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.215 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.925 ' O ' HG23 ' B' ' 14' ' ' VAL . 10.9 t -107.03 139.97 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.628 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.542 HD21 ' HB3' ' B' ' 11' ' ' GLN . 4.7 mt -58.04 124.33 18.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.326 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 1.003 HD22 HG11 ' C' ' 14' ' ' VAL . 35.6 tp -58.87 -39.98 82.99 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.523 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.2 m -62.77 -18.46 62.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.914 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 1.3 m -68.25 -17.6 64.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.958 ' O ' HD21 ' A' ' 27' ' ' LEU . 90.0 m-85 -102.69 -15.82 16.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.261 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.894 HD13 ' O ' ' C' ' 26' ' ' PHE . 5.5 mt . . . . . 0 C--O 1.249 1.07 0 O-C-N 121.137 -0.977 . . . . 0.0 111.024 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 2' ' ' TYR . . . . . 0.631 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.8 m-30 -96.09 161.72 13.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.333 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 1.003 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.9 pt -87.62 157.99 51.77 Favored Pre-proline 0 CA--C 1.512 -0.49 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.583 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.727 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 37.3 Cg_endo -89.65 146.09 4.84 Favored 'Trans proline' 0 N--CA 1.437 -1.853 0 C-N-CA 122.664 2.242 . . . . 0.0 111.336 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.926 ' HA ' HG23 ' A' ' 3' ' ' ILE . 1.1 tp10 -57.6 141.68 47.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' ALA . . . . . 0.895 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -83.83 157.55 63.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.535 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' PRO . . . . . 0.414 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 51.8 Cg_exo -50.93 153.34 8.79 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.642 2.228 . . . . 0.0 112.769 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' ARG . . . . . 0.586 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 1.6 mpt_? -111.21 63.18 0.61 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.302 0.572 . . . . 0.0 110.645 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -107.96 13.97 25.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.252 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.422 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.62 10.23 86.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.397 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' GLN . . . . . 0.63 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.6 OUTLIER -106.7 152.27 24.01 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . 0.69 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -93.36 137.94 32.18 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.274 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.648 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 61.8 m-85 -119.11 152.65 36.13 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.326 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' VAL . . . . . 1.029 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.1 OUTLIER -111.38 153.97 13.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 178.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.771 ' NH2' ' OE2' ' B' ' 5' ' ' GLU . 0.0 OUTLIER -104.9 106.28 16.7 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.984 -177.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.693 ' HE2' ' OD2' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -137.53 133.13 34.17 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 113.08 -1.873 . . . . 0.0 111.764 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . 0.693 ' OD2' ' HE2' ' C' ' 16' ' ' LYS . 0.4 OUTLIER 46.68 46.45 14.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.613 ' HA2' HH22 ' C' ' 15' ' ' ARG . . . 69.98 10.68 65.4 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.97 160.45 38.26 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.835 1.317 . . . . 0.0 112.349 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' TRP . . . . . 0.895 ' CG ' ' HB2' ' C' ' 6' ' ' ALA . 85.2 m95 -94.49 112.63 24.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.008 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 1.029 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.0 m -109.79 135.38 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.083 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.3 mt -53.21 124.32 14.21 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.145 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.765 HD11 HD21 ' C' ' 27' ' ' LEU . 2.6 tp -58.23 -42.36 86.13 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.761 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -22.61 66.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.055 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 48.2 m -69.46 -18.95 63.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' PHE . . . . . 0.894 ' O ' HD13 ' B' ' 27' ' ' LEU . 40.9 m-85 -100.34 -6.42 25.83 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.859 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 1.051 HD13 ' O ' ' A' ' 26' ' ' PHE . 2.6 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.661 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.793 ' CE2' ' HB2' ' C' ' 2' ' ' TYR . 0.4 OUTLIER . . . . . 0 CA--C 1.543 0.693 0 CA-C-O 119.912 -0.09 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.942 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.4 pt -104.74 158.96 30.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 37.2 Cg_endo -87.33 137.43 4.31 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.814 2.343 . . . . 0.0 111.802 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.873 ' HA ' HG23 ' B' ' 3' ' ' ILE . 2.9 tt0 -51.93 143.63 13.19 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.858 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.06 154.23 54.84 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.88 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 75.3 Cg_exo -51.73 157.34 5.57 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 123.613 2.875 . . . . 0.0 113.944 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -112.11 59.26 0.63 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.353 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -105.62 13.53 29.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.001 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.443 ' O ' ' HD2' ' B' ' 16' ' ' LYS . . . 79.66 13.57 82.27 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.777 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.623 ' HB3' HD21 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -106.21 156.76 18.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 117.156 0.478 . . . . 0.0 109.734 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.045 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -98.2 134.29 41.46 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.591 0.71 . . . . 0.0 112.021 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.875 ' O ' HG23 ' B' ' 14' ' ' VAL . 68.6 m-85 -120.1 151.76 38.58 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.649 1.214 . . . . 0.0 111.888 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.796 HG11 HD22 ' C' ' 23' ' ' LEU . 0.2 OUTLIER -112.98 157.76 13.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 113.105 -1.862 . . . . 0.0 106.566 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.999 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.56 106.05 16.39 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 118.579 -1.248 . . . . 0.0 109.437 -177.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.903 ' HG3' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -137.86 128.02 25.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.163 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.903 ' CG ' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 57.14 45.53 20.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 176.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.675 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 60.81 15.65 42.69 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.669 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -133.64 162.82 30.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.702 0.751 . . . . 0.0 111.767 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.999 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 84.0 m95 -97.21 110.83 23.3 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.948 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.793 ' O ' HG23 ' A' ' 14' ' ' VAL . 17.5 t -105.68 142.35 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.051 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.623 HD21 ' HB3' ' A' ' 11' ' ' GLN . 6.2 mt -56.41 124.56 18.53 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.057 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.664 HD23 ' CD2' ' B' ' 26' ' ' PHE . 2.7 tp -58.73 -39.98 82.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.24 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.4 p -63.8 -18.89 64.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.205 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.7 m -69.13 -18.48 63.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.882 ' O ' HD13 ' C' ' 27' ' ' LEU . 86.5 m-85 -97.33 -3.32 40.69 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.612 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.913 HD13 ' O ' ' B' ' 26' ' ' PHE . 7.7 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.462 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.486 2.023 0 CA-C-O 120.315 -0.158 . . . . 0.0 112.826 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.659 ' HD2' ' HB3' ' A' ' 2' ' ' TYR . 3.1 m-30 -105.23 151.78 23.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.758 0.313 . . . . 0.0 111.549 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.873 HG23 ' HA ' ' A' ' 5' ' ' GLU . 5.8 pt -88.91 159.47 45.66 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.883 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 70.1 Cg_endo -87.21 151.79 8.09 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 122.29 1.993 . . . . 0.0 111.403 177.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.999 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.4 OUTLIER -57.32 143.34 40.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.144 -177.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' B' ' 5' ' ' GLU . . . -83.48 162.15 54.38 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.544 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.34 152.94 43.29 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.231 2.62 . . . . 0.0 112.98 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.51 ' N ' ' HD3' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -112.24 60.23 0.63 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.165 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -105.27 15.33 27.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.574 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.59 ' O ' ' HE3' ' C' ' 16' ' ' LYS . . . 79.56 14.85 80.73 Favored Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 120.203 -0.998 . . . . 0.0 112.824 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.863 ' HB3' HD21 ' B' ' 22' ' ' LEU . 1.9 mm-40 -115.64 154.23 29.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.189 0.518 . . . . 0.0 110.585 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.695 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -93.43 134.18 35.94 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.391 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.537 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 74.6 m-85 -120.44 154.06 35.72 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.119 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 1.045 HG21 ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -113.89 159.58 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 CA-C-N 113.368 -1.742 . . . . 0.0 106.634 176.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.88 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -103.2 107.31 18.07 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.74 -176.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.853 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -137.05 131.54 32.94 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 112.942 -1.936 . . . . 0.0 113.114 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.588 ' OD1' ' O ' ' B' ' 16' ' ' LYS . 0.5 OUTLIER 46.75 45.08 14.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.552 ' HA2' HH22 ' B' ' 15' ' ' ARG . . . 76.72 -3.38 55.96 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.395 -0.907 . . . . 0.0 114.748 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.24 161.36 27.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.863 0.831 . . . . 0.0 111.911 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' TRP . . . . . 0.88 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 91.5 m95 -93.7 114.66 27.0 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.285 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.428 ' O ' HG12 ' B' ' 14' ' ' VAL . 11.2 t -108.31 138.11 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 CA-C-O 121.898 0.856 . . . . 0.0 110.376 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.863 HD21 ' HB3' ' B' ' 11' ' ' GLN . 1.9 mt -53.77 124.05 14.11 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.223 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.86 ' CD2' HD21 ' B' ' 27' ' ' LEU . 0.2 OUTLIER -57.93 -44.19 86.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 18.0 t -48.42 -26.27 2.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.23 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 10.8 m -68.64 -19.1 64.4 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.245 0.545 . . . . 0.0 110.452 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.913 ' O ' HD13 ' A' ' 27' ' ' LEU . 81.6 m-85 -98.23 -4.47 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.64 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.946 HD13 ' O ' ' C' ' 26' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.103 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 2' ' ' TYR . . . . . 0.883 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.4 m-30 -100.49 167.59 10.27 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.789 0.328 . . . . 0.0 111.213 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 0.999 HG23 ' HA ' ' B' ' 5' ' ' GLU . 1.1 pt -102.55 157.95 32.71 Favored Pre-proline 0 CA--C 1.504 -0.819 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.276 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 9.7 Cg_endo -82.81 145.06 12.58 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 121.696 1.597 . . . . 0.0 111.577 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.942 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -57.55 143.01 42.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.309 -177.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' C' ' 7' ' ' PRO . . . -84.09 170.37 14.14 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.306 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' C' ' 6' ' ' ALA . 21.8 Cg_exo -61.8 149.06 91.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.772 2.315 . . . . 0.0 111.822 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -112.14 64.68 0.63 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.146 0.498 . . . . 0.0 110.882 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' ASP . . . . . 0.462 ' CG ' ' HG3' ' C' ' 11' ' ' GLN . 13.6 p-10 -121.28 23.02 10.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.505 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.62 ' C ' ' HE2' ' A' ' 16' ' ' LYS . . . 79.75 15.26 79.75 Favored Glycine 0 CA--C 1.508 -0.38 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.844 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' GLN . . . . . 0.931 ' HB3' HD21 ' C' ' 22' ' ' LEU . 6.2 mt-30 -111.28 140.21 46.04 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 117.32 0.56 . . . . 0.0 110.837 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . 0.74 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -92.47 136.39 33.26 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.75 0.786 . . . . 0.0 110.785 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.553 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 69.1 m-85 -121.12 152.15 39.06 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.847 1.308 . . . . 0.0 112.32 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' VAL . . . . . 0.956 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.0 OUTLIER -107.06 154.58 7.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 177.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.728 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.67 107.45 18.45 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.208 -178.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.866 ' HG2' ' CG ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -137.1 134.45 36.46 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.106 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . 0.866 ' CG ' ' HG2' ' C' ' 16' ' ' LYS . 0.0 OUTLIER 48.45 45.6 20.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 176.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.428 ' O ' ' NH2' ' C' ' 15' ' ' ARG . . . 65.53 8.99 41.97 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -129.78 161.31 31.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.198 0.999 . . . . 0.0 111.358 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' TRP . . . . . 0.728 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 87.9 m95 -93.84 120.39 34.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.987 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.956 ' O ' HG23 ' C' ' 14' ' ' VAL . 11.1 t -113.0 137.79 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.549 0.69 . . . . 0.0 110.309 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' LEU . . . . . 0.931 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.2 mt -57.6 127.64 33.05 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.981 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.819 ' CD1' HD11 ' B' ' 23' ' ' LEU . 6.6 tp -58.79 -35.04 72.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.448 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -19.87 65.99 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 122.245 -0.285 . . . . 0.0 111.338 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -68.64 -18.25 64.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' PHE . . . . . 0.946 ' O ' HD13 ' B' ' 27' ' ' LEU . 93.3 m-85 -99.13 -7.78 26.14 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.011 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.882 HD13 ' O ' ' A' ' 26' ' ' PHE . 5.7 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.064 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.662 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 3.6 m-85 . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 120.539 0.209 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 1.03 HG23 ' HA ' ' C' ' 5' ' ' GLU . 4.3 pt -94.39 157.72 36.89 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-O 120.974 0.416 . . . . 0.0 111.975 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 21.4 Cg_endo -88.19 147.07 6.52 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 122.596 2.198 . . . . 0.0 111.102 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 1.058 ' OE2' HG22 ' B' ' 3' ' ' ILE . 1.3 tt0 -58.14 143.02 45.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.644 -176.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.886 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -86.42 163.8 40.6 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.976 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.624 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 31.3 Cg_exo -56.74 152.93 39.19 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.832 2.355 . . . . 0.0 112.824 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.634 ' CZ ' ' H ' ' B' ' 18' ' ' GLY . 0.0 OUTLIER -112.07 63.86 0.62 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.48 0.657 . . . . 0.0 111.594 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -110.78 14.67 22.19 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.478 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.857 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 79.12 15.93 79.55 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.898 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -109.81 148.17 31.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.137 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -91.68 135.2 34.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.293 0.568 . . . . 0.0 112.178 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.789 ' O ' HG23 ' B' ' 14' ' ' VAL . 65.6 m-85 -117.59 148.34 42.01 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 123.026 1.393 . . . . 0.0 111.905 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -107.01 154.26 7.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 112.1 -2.318 . . . . 0.0 104.813 177.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.744 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.77 106.98 17.7 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 118.057 -1.457 . . . . 0.0 108.274 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.723 ' HD3' HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -137.63 124.39 21.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.681 -178.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.89 46.84 16.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.464 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 65.97 6.29 30.63 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.741 -0.743 . . . . 0.0 114.554 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -129.74 161.95 29.52 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 117.894 0.847 . . . . 0.0 111.819 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.886 ' CG ' ' HB2' ' A' ' 6' ' ' ALA . 87.9 m95 -95.89 119.76 34.97 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.363 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.958 ' O ' HG23 ' A' ' 14' ' ' VAL . 15.9 t -114.5 141.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 CA-C-O 121.702 0.763 . . . . 0.0 109.933 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.898 HD21 ' HB3' ' A' ' 11' ' ' GLN . 1.7 mt -57.61 126.94 29.56 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.81 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.773 HD23 ' CD2' ' B' ' 26' ' ' PHE . 1.3 tp -60.36 -45.16 94.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.983 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.484 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 52.8 p -63.43 -19.05 64.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.752 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 6.8 m -69.38 -19.28 63.83 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 1.205 ' O ' HD21 ' C' ' 27' ' ' LEU . 87.9 m-85 -97.26 -2.47 42.59 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.789 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.077 HD13 ' O ' ' B' ' 26' ' ' PHE . 1.5 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.414 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.533 ' HA ' ' H ' ' A' ' 5' ' ' GLU . 5.5 m-85 -134.98 131.62 37.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.495 0.188 . . . . 0.0 110.988 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 1.058 HG22 ' OE2' ' A' ' 5' ' ' GLU . 21.3 pt -85.16 156.46 60.16 Favored Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 120.695 0.283 . . . . 0.0 110.8 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.67 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 71.8 Cg_endo -87.25 155.99 8.17 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.47 2.113 . . . . 0.0 111.524 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 1.151 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.6 OUTLIER -57.68 143.53 41.26 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.201 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' B' ' 20' ' ' TRP . . . -86.67 153.7 55.58 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.653 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.746 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 3.1 Cg_exo -50.48 153.81 7.06 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.48 2.787 . . . . 0.0 113.401 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.605 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -111.73 73.66 0.83 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.571 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -114.72 11.04 16.75 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.705 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' C' ' 16' ' ' LYS . . . 78.99 14.99 81.37 Favored Glycine 0 CA--C 1.512 -0.144 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.583 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' C' ' 16' ' ' LYS . 0.0 OUTLIER -118.73 158.52 25.39 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.096 0.474 . . . . 0.0 110.536 179.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.645 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.54 135.83 33.73 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.392 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.746 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 51.3 m-85 -120.64 153.53 36.73 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-N 114.42 -1.264 . . . . 0.0 112.088 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 1.137 HG21 ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -116.15 159.13 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 113.802 -1.544 . . . . 0.0 107.956 176.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.833 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.09 107.24 18.12 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 122.104 0.954 . . . . 0.0 110.23 -176.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.857 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -137.63 125.63 22.8 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.612 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.571 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 56.81 41.81 27.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.634 ' H ' ' CZ ' ' A' ' 8' ' ' ARG . . . 69.59 10.54 63.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.46 159.55 36.73 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 118.233 1.017 . . . . 0.0 111.881 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' TRP . . . . . 0.833 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 90.5 m95 -93.42 113.15 25.24 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.07 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.518 ' O ' HG12 ' B' ' 14' ' ' VAL . 18.7 t -109.55 136.94 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.161 0 CA-C-O 121.815 0.817 . . . . 0.0 110.43 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' B' ' 11' ' ' GLN . 4.9 mt -51.56 123.11 9.2 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.031 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.748 HD22 HG21 ' C' ' 14' ' ' VAL . 7.3 tp -57.01 -36.03 69.93 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.545 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -63.04 -17.3 62.09 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.601 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 3.4 m -71.48 -19.59 62.19 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 1.077 ' O ' HD13 ' A' ' 27' ' ' LEU . 90.4 m-85 -99.34 -3.62 33.55 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.159 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 1.237 HD21 ' O ' ' C' ' 26' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.196 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' B' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.106 0 N-CA-C 112.688 -0.165 . . . . 0.0 112.688 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 2' ' ' TYR . . . . . 0.67 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.0 m-85 -127.14 147.14 50.19 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.923 0.362 . . . . 0.0 111.653 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 1.151 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.3 pt -87.04 157.89 53.57 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 121.004 0.431 . . . . 0.0 111.589 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 19.2 Cg_endo -87.86 148.54 7.07 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 122.33 2.02 . . . . 0.0 110.873 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 1.03 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -57.59 143.38 41.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.584 -177.058 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' ALA . . . . . 0.687 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -85.29 162.24 49.33 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.449 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' PRO . . . . . 0.481 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 32.3 Cg_exo -56.78 155.08 28.68 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.004 2.469 . . . . 0.0 113.171 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.78 79.02 1.21 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.458 0.647 . . . . 0.0 111.601 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -125.15 11.62 8.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.355 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.67 10.66 85.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.07 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' GLN . . . . . 0.688 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.6 OUTLIER -102.02 151.1 22.54 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . 0.668 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -92.83 136.57 33.13 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.273 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.637 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 49.1 m-85 -117.99 155.42 30.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.554 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' VAL . . . . . 0.748 HG21 HD22 ' B' ' 23' ' ' LEU . 4.4 t -123.93 134.9 65.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.798 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -80.59 109.14 14.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.998 0.904 . . . . 0.0 111.204 -175.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.645 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -136.1 123.0 21.32 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 113.832 -1.531 . . . . 0.0 112.128 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . 0.605 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER 55.11 45.98 24.97 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 176.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.465 ' HA2' ' NH2' ' C' ' 15' ' ' ARG . . . 65.53 13.52 58.69 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 119.474 -0.626 . . . . 0.0 114.543 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' C' ' 16' ' ' LYS . 0.1 OUTLIER -133.05 161.41 34.44 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.488 1.144 . . . . 0.0 111.346 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' TRP . . . . . 0.798 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 82.3 m95 -93.35 116.19 28.75 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.087 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.551 HG22 ' HB ' ' C' ' 14' ' ' VAL . 1.7 m -108.29 129.57 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 CA-C-O 122.032 0.92 . . . . 0.0 111.25 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' C' ' 11' ' ' GLN . 2.1 mt -51.42 123.45 9.78 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.62 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.682 HD21 ' CB ' ' A' ' 26' ' ' PHE . 11.8 tp -60.37 -42.75 96.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.014 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -20.5 64.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.55 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 30.1 m -68.31 -18.59 64.55 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' PHE . . . . . 1.237 ' O ' HD21 ' B' ' 27' ' ' LEU . 52.8 m-85 -100.93 -8.77 22.17 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.073 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 1.205 HD21 ' O ' ' A' ' 26' ' ' PHE . 2.6 tp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.11 -0.947 . . . . 0.0 111.105 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.819 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 8.4 m-30 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 121.195 0.521 . . . . 0.0 111.86 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.743 HD13 ' HG3' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -92.74 159.59 35.92 Favored Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.501 178.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 43.1 Cg_endo -88.13 144.15 5.94 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.418 2.079 . . . . 0.0 111.487 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.917 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.6 OUTLIER -50.27 142.77 9.53 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.244 -178.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.691 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.13 166.24 27.2 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.563 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.505 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 34.5 Cg_exo -57.03 148.7 67.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.336 2.024 . . . . 0.0 111.627 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' B' ' 18' ' ' GLY . 85.7 mtt180 -112.58 62.68 0.63 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.078 0.466 . . . . 0.0 111.928 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -114.78 18.07 16.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.135 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.901 ' O ' ' HE2' ' B' ' 16' ' ' LYS . . . 79.02 14.6 81.77 Favored Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.864 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.87 ' HB3' HD21 ' A' ' 22' ' ' LEU . 3.7 mm-40 -103.88 141.64 35.78 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.886 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -91.88 134.87 34.38 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.534 0.683 . . . . 0.0 110.914 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.864 ' O ' HG23 ' B' ' 14' ' ' VAL . 53.7 m-85 -120.04 149.75 41.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.409 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.843 HG21 ' CE2' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -104.61 156.64 5.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 176.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 1.065 ' HG3' HH11 ' A' ' 15' ' ' ARG . 0.0 OUTLIER -105.86 115.76 30.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.644 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' C' ' 11' ' ' GLN . 1.0 OUTLIER -151.69 129.17 11.38 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.825 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.666 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 0.1 OUTLIER 54.89 42.24 31.26 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.718 177.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.538 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 62.44 16.45 54.73 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 119.358 -0.69 . . . . 0.0 114.742 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.666 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -131.87 161.62 32.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.801 1.301 . . . . 0.0 111.613 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 1.015 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 91.5 m95 -99.47 112.32 24.53 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.892 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 14' ' ' VAL . 17.9 t -108.6 139.74 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.453 0.644 . . . . 0.0 109.652 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.87 HD21 ' HB3' ' A' ' 11' ' ' GLN . 1.3 mt -55.79 126.71 26.78 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.935 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.62 HD23 ' CD1' ' B' ' 26' ' ' PHE . 3.3 tp -58.46 -39.49 80.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.164 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.434 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -63.52 -19.14 64.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.046 -178.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.3 m -70.12 -18.58 63.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.093 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.843 ' CE2' HG21 ' A' ' 14' ' ' VAL . 80.7 m-85 -97.25 -1.82 44.02 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.847 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.011 ' CD1' ' O ' ' B' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.048 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.174 0 CA-C-O 120.19 -0.228 . . . . 0.0 112.755 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.53 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 4.4 m-85 -132.33 135.69 46.36 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 110.896 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.968 HG21 ' HE ' ' B' ' 15' ' ' ARG . 6.1 pt -87.19 159.31 51.14 Favored Pre-proline 0 CA--C 1.513 -0.462 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.716 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 92.0 Cg_endo -91.04 148.56 3.77 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 122.949 2.433 . . . . 0.0 111.376 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.793 ' OE2' ' HA2' ' C' ' 18' ' ' GLY . 0.9 OUTLIER -58.22 142.85 46.34 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.758 0.79 . . . . 0.0 112.959 -177.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.865 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -83.17 155.25 67.05 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.99 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.703 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 5.0 Cg_exo -45.75 152.7 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.743 2.962 . . . . 0.0 113.678 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' C' ' 17' ' ' ASP . 3.6 mtp180 -111.93 62.27 0.62 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.586 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -109.03 15.37 23.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.643 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.588 ' C ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.23 14.73 81.34 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.852 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.915 ' HB3' HD21 ' B' ' 22' ' ' LEU . 38.5 mm-40 -109.01 147.18 32.71 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 120.966 0.412 . . . . 0.0 110.508 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.637 ' HB1' ' CG1' ' C' ' 14' ' ' VAL . . . -92.57 136.16 33.46 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.638 0.732 . . . . 0.0 109.469 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 50.7 m-85 -122.09 155.46 35.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.264 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.886 HG21 ' HB1' ' A' ' 12' ' ' ALA . 1.5 p -114.93 159.81 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.477 175.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 1.012 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -102.95 114.42 28.7 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.133 0.968 . . . . 0.0 110.124 -176.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.901 ' HE2' ' O ' ' A' ' 10' ' ' GLY . 2.0 tttm -149.01 127.93 12.64 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.788 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 0.2 OUTLIER 56.29 45.25 23.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.458 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 62.13 14.13 45.22 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 119.484 -0.62 . . . . 0.0 114.196 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' B' ' 17' ' ' ASP . 0.1 OUTLIER -133.1 163.22 29.73 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.525 1.162 . . . . 0.0 112.011 -178.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' TRP . . . . . 1.012 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 92.5 m95 -97.65 113.02 24.68 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.204 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.493 ' C ' ' HD1' ' B' ' 13' ' ' TYR . 6.2 t -108.24 139.27 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 121.925 0.869 . . . . 0.0 110.333 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.915 HD21 ' HB3' ' B' ' 11' ' ' GLN . 3.8 mt -55.21 125.11 19.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.061 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.593 HD22 HG11 ' C' ' 14' ' ' VAL . 3.8 tp -57.77 -39.4 77.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.521 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 29.8 t -63.23 -17.34 62.34 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.708 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 18.3 m -70.37 -20.27 62.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 1.011 ' O ' ' CD1' ' A' ' 27' ' ' LEU . 88.1 m-85 -96.89 -15.54 21.15 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.575 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.68 HD21 ' HB3' ' C' ' 26' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.99 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 2' ' ' TYR . . . . . 0.716 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.1 m-30 -98.01 161.15 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.352 . . . . 0.0 111.524 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 0.79 HG23 ' HA ' ' B' ' 5' ' ' GLU . 1.5 pt -90.09 158.4 44.2 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.765 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.819 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 43.7 Cg_endo -90.23 153.99 4.64 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 122.432 2.088 . . . . 0.0 112.285 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.538 ' OE2' ' HA2' ' A' ' 18' ' ' GLY . 1.1 tp10 -57.56 142.4 44.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.917 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' ALA . . . . . 0.904 ' H ' HH12 ' A' ' 15' ' ' ARG . . . -89.08 162.89 36.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 113.699 -1.592 . . . . 0.0 110.864 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' PRO . . . . . 0.467 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 31.8 Cg_exo -57.27 152.39 46.17 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.075 2.517 . . . . 0.0 113.52 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' ARG . . . . . 0.575 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -111.77 67.75 0.65 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.128 0.489 . . . . 0.0 111.095 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' ASP . . . . . 0.539 ' OD1' ' HB2' ' C' ' 11' ' ' GLN . 6.1 p30 -116.72 12.98 15.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.107 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.495 ' O ' ' HE2' ' A' ' 16' ' ' LYS . . . 84.08 14.68 71.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.203 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' GLN . . . . . 0.64 ' HB3' HD21 ' C' ' 22' ' ' LEU . 19.1 mt-30 -110.79 150.56 28.94 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.492 0.663 . . . . 0.0 110.892 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . 0.592 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -92.52 136.87 32.85 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.477 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.606 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 59.3 m-85 -118.99 156.12 30.17 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.035 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' VAL . . . . . 0.882 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.2 OUTLIER -115.25 157.04 16.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.952 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.63 115.31 30.03 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 122.045 0.926 . . . . 0.0 110.903 -176.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' B' ' 11' ' ' GLN . 0.5 OUTLIER -153.47 132.96 12.89 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.339 -178.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . 0.459 ' HA ' ' HG2' ' B' ' 8' ' ' ARG . 0.2 OUTLIER 55.17 45.04 26.77 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 176.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.793 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.21 16.84 50.5 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-O 119.382 -0.677 . . . . 0.0 114.167 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -137.33 164.63 28.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.661 1.231 . . . . 0.0 112.255 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' TRP . . . . . 0.952 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 90.3 m95 -96.49 115.11 26.89 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.162 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.882 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.7 m -105.81 134.81 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.153 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' C' ' 11' ' ' GLN . 3.5 mt -55.44 122.03 10.31 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.72 HD21 ' HB3' ' A' ' 26' ' ' PHE . 4.5 tp -59.12 -38.24 79.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.498 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 28.7 t -62.44 -18.94 62.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.89 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 29.6 m -69.23 -18.03 63.84 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' PHE . . . . . 0.68 ' HB3' HD21 ' B' ' 27' ' ' LEU . 70.9 m-85 -101.04 -10.62 20.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.466 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 26' ' ' PHE . 25.4 mt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.873 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.75 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 5.9 m-85 . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 121.287 0.565 . . . . 0.0 112.23 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 1.064 HG23 ' HA ' ' C' ' 5' ' ' GLU . 3.5 pt -91.68 159.52 38.31 Favored Pre-proline 0 CA--C 1.51 -0.578 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.186 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 55.5 Cg_endo -84.58 139.71 7.91 Favored 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 121.17 1.247 . . . . 0.0 111.201 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.902 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.5 OUTLIER -47.97 143.03 4.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.59 -1.187 . . . . 0.0 113.87 -177.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.76 ' HB2' ' CD2' ' A' ' 20' ' ' TRP . . . -84.05 177.65 2.86 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.66 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.946 ' HB2' ' OD2' ' A' ' 9' ' ' ASP . 2.7 Cg_exo -75.5 155.23 40.64 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.576 2.851 . . . . 0.0 114.037 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.587 ' HG3' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -105.01 79.67 1.53 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 178.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.946 ' OD2' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -124.84 3.03 8.13 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.198 -178.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.49 0.36 83.61 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 119.571 -1.299 . . . . 0.0 111.188 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.843 ' O ' ' HB2' ' B' ' 16' ' ' LYS . 0.1 OUTLIER -101.69 151.76 21.64 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.853 ' HB1' ' CG1' ' B' ' 14' ' ' VAL . . . -91.48 137.94 31.97 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.439 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.629 ' CD2' ' HD2' ' A' ' 7' ' ' PRO . 47.5 m-85 -118.5 155.69 30.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.081 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.972 HG13 ' O ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -105.1 150.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.975 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.55 99.41 9.09 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.584 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 0.3 OUTLIER -136.0 125.73 25.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 112.777 -2.011 . . . . 0.0 113.172 -176.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.96 43.11 30.42 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.641 ' HA2' ' NH1' ' A' ' 15' ' ' ARG . . . 74.85 6.65 78.95 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.168 -1.015 . . . . 0.0 115.109 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.88 161.54 35.34 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.992 1.396 . . . . 0.0 112.396 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.975 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 97.3 m95 -94.32 115.25 27.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.651 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.972 ' O ' HG13 ' A' ' 14' ' ' VAL . 22.0 t -107.21 136.84 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 121.904 0.859 . . . . 0.0 108.791 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.721 HD21 ' OE1' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -53.92 122.64 10.47 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.321 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.979 HD12 HD11 ' C' ' 23' ' ' LEU . 4.9 tp -57.26 -36.06 70.52 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.683 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.661 ' HB2' HD12 ' A' ' 22' ' ' LEU . 25.9 m -61.47 -17.76 55.92 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.243 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -72.23 -18.39 61.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.973 ' O ' HD13 ' C' ' 27' ' ' LEU . 88.9 m-85 -99.34 -10.54 22.18 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.332 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.788 HD13 ' O ' ' B' ' 26' ' ' PHE . 9.3 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.689 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 119.733 -0.482 . . . . 0.0 111.972 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.662 ' CD2' ' HB2' ' A' ' 2' ' ' TYR . 3.6 m-85 -134.57 138.51 44.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.748 0.774 . . . . 0.0 110.809 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.902 HG23 ' HA ' ' A' ' 5' ' ' GLU . 0.8 OUTLIER -88.2 158.49 49.42 Favored Pre-proline 0 N--CA 1.47 0.528 0 CA-C-O 121.4 0.619 . . . . 0.0 112.621 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 87.8 Cg_endo -92.17 156.3 3.2 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 123.056 2.504 . . . . 0.0 111.232 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.847 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 0.7 OUTLIER -57.85 141.99 47.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -177.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.825 ' HB2' ' CD1' ' B' ' 20' ' ' TRP . . . -88.15 158.68 49.33 Favored Pre-proline 0 C--N 1.334 -0.103 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.361 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.485 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 10.1 Cg_endo -51.39 152.76 11.22 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.428 2.085 . . . . 0.0 111.68 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -114.85 67.95 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.471 0.653 . . . . 0.0 111.6 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -109.55 16.0 22.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.639 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.16 31.89 63.51 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.387 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.895 ' HB3' HD21 ' B' ' 22' ' ' LEU . 19.8 mm-40 -123.47 149.42 45.13 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.615 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.61 135.92 33.67 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.855 0.836 . . . . 0.0 111.66 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.573 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 80.7 m-85 -122.24 152.67 39.78 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 123.382 1.563 . . . . 0.0 112.654 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.853 ' CG1' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -106.99 156.69 7.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 111.266 -2.697 . . . . 0.0 105.93 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.954 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.19 105.55 15.64 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 118.76 -1.176 . . . . 0.0 108.13 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.843 ' HB2' ' O ' ' A' ' 11' ' ' GLN . 4.4 pttt -138.78 132.61 30.93 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 113.224 -1.807 . . . . 0.0 111.661 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.587 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 58.17 42.99 21.25 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 176.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.493 ' HA3' ' NH1' ' A' ' 8' ' ' ARG . . . 60.05 14.81 33.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.216 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -134.96 165.41 25.39 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 117.437 0.618 . . . . 0.0 111.842 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' TRP . . . . . 0.954 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 94.7 m95 -98.11 112.14 24.21 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.742 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.834 ' O ' HG23 ' B' ' 14' ' ' VAL . 17.0 t -106.12 141.44 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 CA-C-O 121.848 0.833 . . . . 0.0 109.65 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.895 HD21 ' HB3' ' B' ' 11' ' ' GLN . 2.6 mt -57.27 127.72 33.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.999 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.733 HD22 HG11 ' C' ' 14' ' ' VAL . 5.7 tp -61.67 -40.04 93.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.579 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -19.77 66.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.176 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -68.32 -18.02 64.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.788 ' O ' HD13 ' A' ' 27' ' ' LEU . 91.3 m-85 -99.29 -4.93 30.7 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.577 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.997 HD13 ' O ' ' C' ' 26' ' ' PHE . 4.5 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.227 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.714 -0.154 . . . . 0.0 112.714 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 2' ' ' TYR . . . . . 0.662 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.5 m-85 -120.3 146.57 45.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.932 0.396 . . . . 0.0 111.656 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 0.841 HG23 ' HA ' ' B' ' 5' ' ' GLU . 1.0 OUTLIER -92.11 158.65 39.03 Favored Pre-proline 0 CA--C 1.501 -0.926 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.592 178.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 75.7 Cg_endo -86.73 146.86 8.21 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.83 1.687 . . . . 0.0 112.426 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 1.064 ' HA ' HG23 ' A' ' 3' ' ' ILE . 1.8 tt0 -57.41 143.41 40.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 113.803 -1.544 . . . . 0.0 113.464 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' ALA . . . . . 0.769 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -85.3 153.36 59.17 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.411 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.85 153.69 5.75 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.142 2.561 . . . . 0.0 112.986 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' ARG . . . . . 0.42 ' NH2' ' OE1' ' C' ' 5' ' ' GLU . 8.8 mtt85 -112.79 57.28 0.66 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.914 0.388 . . . . 0.0 111.782 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' C' ' 11' ' ' GLN . 2.5 p30 -105.63 18.71 21.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.449 ' O ' ' HD2' ' A' ' 16' ' ' LYS . . . 80.0 10.51 85.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.604 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' GLN . . . . . 0.92 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.2 OUTLIER -103.85 154.09 20.0 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 117.669 0.734 . . . . 0.0 109.271 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . 0.71 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -95.91 134.26 39.12 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.529 0.68 . . . . 0.0 111.82 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.716 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 51.4 m-85 -117.51 154.68 31.05 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.783 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' VAL . . . . . 0.872 HG23 ' O ' ' C' ' 21' ' ' VAL . 1.7 t -118.36 156.7 20.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.882 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -104.99 108.25 19.67 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.941 -177.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' B' ' 11' ' ' GLN . 0.0 OUTLIER -136.38 121.18 18.58 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.621 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.55 45.93 18.6 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.029 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.582 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 62.31 14.6 48.7 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.629 0.612 . . . . 0.0 114.629 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -130.19 162.2 29.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.3 1.05 . . . . 0.0 111.737 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' TRP . . . . . 0.882 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 68.0 m95 -96.27 114.71 26.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.715 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.872 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.3 m -111.35 130.66 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.117 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' LEU . . . . . 0.92 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.2 mt -53.46 125.02 16.48 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.101 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.979 HD11 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -60.38 -36.62 78.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.737 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.08 -19.5 64.47 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.203 -0.311 . . . . 0.0 110.829 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 51.7 m -69.04 -18.4 64.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' PHE . . . . . 0.997 ' O ' HD13 ' B' ' 27' ' ' LEU . 59.1 m-85 -100.06 -8.94 23.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.317 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.973 HD13 ' O ' ' A' ' 26' ' ' PHE . 5.5 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.176 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.841 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 19.6 m-85 . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.792 0.329 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 1.024 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.1 pt -92.12 158.01 40.01 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.193 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 10.3 Cg_endo -82.49 147.7 14.15 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 121.764 1.643 . . . . 0.0 110.605 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 1.069 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.6 OUTLIER -58.36 142.9 46.82 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -176.666 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.752 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.14 160.74 48.33 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.317 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 51.9 Cg_exo -55.06 153.63 25.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.332 2.688 . . . . 0.0 113.621 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 71.3 mtm-85 -112.03 83.15 1.74 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.45 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -128.42 13.5 6.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.66 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.691 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 78.79 13.36 83.21 Favored Glycine 0 CA--C 1.51 -0.253 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.819 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.664 ' O ' ' HB2' ' B' ' 16' ' ' LYS . 11.5 mt-30 -115.55 148.75 39.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.848 0.356 . . . . 0.0 110.112 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -90.88 138.52 31.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 122.131 0.967 . . . . 0.0 112.562 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.525 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 61.9 m-85 -118.57 152.77 35.38 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.395 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.07 HG21 ' HB1' ' C' ' 12' ' ' ALA . 0.2 OUTLIER -114.46 157.22 15.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.78 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.91 104.26 13.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.798 0.809 . . . . 0.0 111.524 -176.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.668 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 1.1 tttt -135.39 128.38 31.49 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.204 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.521 ' HA ' ' CG ' ' C' ' 8' ' ' ARG . 0.2 OUTLIER 55.33 44.97 26.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.494 ' HA2' HH21 ' A' ' 15' ' ' ARG . . . 63.14 15.92 57.06 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 114.993 0.757 . . . . 0.0 114.993 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -132.33 158.57 41.57 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.575 1.188 . . . . 0.0 111.777 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.78 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 92.7 m95 -94.92 115.67 27.75 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.182 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 14.2 t -111.21 141.24 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-O 121.693 0.759 . . . . 0.0 110.185 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 12' ' ' ALA . 2.4 mt -57.29 125.37 22.47 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.596 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.874 HD22 HG11 ' B' ' 14' ' ' VAL . 7.4 tp -57.49 -35.48 70.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.45 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -63.97 -20.06 65.61 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.36 -0.213 . . . . 0.0 111.146 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 m -68.81 -18.09 64.12 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.35 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 1.062 ' O ' ' CD1' ' C' ' 27' ' ' LEU . 80.7 m-85 -95.9 -21.36 18.11 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.662 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.005 HD22 HD23 ' B' ' 27' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.168 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 120.209 -0.217 . . . . 0.0 113.166 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 3.4 m-85 -120.97 143.58 48.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.983 0.391 . . . . 0.0 110.93 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 1.069 HG23 ' HA ' ' A' ' 5' ' ' GLU . 5.0 pt -86.97 158.19 53.42 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 120.953 0.406 . . . . 0.0 112.031 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 84.0 Cg_endo -91.59 153.21 3.52 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.49 2.127 . . . . 0.0 111.671 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.889 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.6 OUTLIER -58.26 143.48 44.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.701 -177.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.69 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -86.99 171.39 10.07 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.795 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.537 ' HD2' ' HB1' ' B' ' 6' ' ' ALA . 18.8 Cg_exo -64.46 151.89 83.75 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.443 2.762 . . . . 0.0 113.028 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.45 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.3 OUTLIER -111.91 49.61 0.89 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -99.93 14.92 28.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.471 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.606 ' O ' ' HD2' ' C' ' 16' ' ' LYS . . . 79.64 15.04 80.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.169 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.929 ' HB3' HD21 ' B' ' 22' ' ' LEU . 1.8 mm-40 -103.52 146.82 27.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.857 ' O ' HD23 ' B' ' 22' ' ' LEU . . . -94.28 133.76 37.48 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.954 0.883 . . . . 0.0 112.339 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.683 ' O ' HG23 ' C' ' 14' ' ' VAL . 74.8 m-85 -121.31 152.9 38.41 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 123.148 1.451 . . . . 0.0 112.354 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.874 HG11 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -113.22 158.01 13.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 111.766 -2.47 . . . . 0.0 106.264 178.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.548 ' NH2' ' OE2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -104.29 107.4 18.29 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 118.845 -1.142 . . . . 0.0 108.779 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.691 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -136.81 125.23 23.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.432 -178.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 55.04 44.94 27.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 176.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.487 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 62.19 16.14 52.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 115.222 0.849 . . . . 0.0 115.222 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' B' ' 16' ' ' LYS . 0.0 OUTLIER -134.81 161.3 35.58 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 118.624 1.212 . . . . 0.0 111.575 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' TRP . . . . . 0.69 ' CG ' ' HB2' ' B' ' 6' ' ' ALA . 90.0 m95 -97.02 112.82 24.4 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.515 0.674 . . . . 0.0 110.495 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' B' ' 13' ' ' TYR . 0.5 OUTLIER -110.59 153.3 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.572 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.968 179.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.929 HD21 ' HB3' ' B' ' 11' ' ' GLN . 3.9 mt -67.98 126.76 30.49 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 113.503 -1.68 . . . . 0.0 114.89 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.55 ' O ' HD12 ' B' ' 23' ' ' LEU . 3.5 tp -60.72 -43.77 97.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.887 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . 0.504 ' HA ' HD12 ' B' ' 27' ' ' LEU . 14.3 m -63.59 -16.85 62.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.421 -177.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 13.2 m -69.66 -17.51 63.5 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.817 ' O ' HD13 ' A' ' 27' ' ' LEU . 24.8 m-85 -100.61 -5.6 26.47 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.358 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 1.005 HD23 HD22 ' A' ' 27' ' ' LEU . 15.3 mt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.251 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 CA-C-O 120.275 -0.18 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 2' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.6 m-85 -128.53 141.0 51.51 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.88 0.34 . . . . 0.0 111.015 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.3 pt -88.54 157.58 49.56 Favored Pre-proline 0 CA--C 1.496 -1.113 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.236 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.841 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 20.8 Cg_endo -86.35 147.45 8.78 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.821 1.681 . . . . 0.0 111.856 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 1.024 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -57.8 143.16 43.19 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.944 -177.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' ALA . . . . . 0.697 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -85.59 152.38 57.21 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.856 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' PRO . . . . . 0.405 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 72.0 Cg_exo -49.73 156.02 3.46 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.519 2.813 . . . . 0.0 113.88 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' ARG . . . . . 0.521 ' CG ' ' HA ' ' A' ' 17' ' ' ASP . 2.6 mtp85 -111.9 57.25 0.64 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.994 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -102.09 17.9 22.12 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.784 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.34 11.0 75.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.795 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' GLN . . . . . 0.55 ' OE1' HD21 ' C' ' 22' ' ' LEU . 86.8 mt-30 -106.49 151.86 24.41 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . 1.07 ' HB1' HG21 ' A' ' 14' ' ' VAL . . . -92.41 137.17 32.59 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.999 0.904 . . . . 0.0 112.627 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.698 ' O ' HG23 ' A' ' 14' ' ' VAL . 79.8 m-85 -120.99 158.22 28.23 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.807 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' VAL . . . . . 0.83 HG21 ' HB1' ' B' ' 12' ' ' ALA . 0.1 OUTLIER -125.45 159.46 32.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 113.357 -1.747 . . . . 0.0 106.495 177.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 1.009 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -103.67 107.71 18.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 122.436 1.113 . . . . 0.0 110.743 -175.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.713 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 0.2 OUTLIER -136.57 133.23 36.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.995 -1.911 . . . . 0.0 110.365 178.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . 0.596 ' OD1' ' O ' ' C' ' 16' ' ' LYS . 0.1 OUTLIER 48.31 46.17 20.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 177.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.517 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.48 16.21 49.22 Favored Glycine 0 N--CA 1.453 -0.194 0 N-CA-C 114.373 0.509 . . . . 0.0 114.373 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -131.57 159.1 39.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 117.756 0.778 . . . . 0.0 111.666 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' TRP . . . . . 1.009 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 87.9 m95 -93.67 109.35 21.0 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.418 0.627 . . . . 0.0 110.33 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 5.9 t -103.81 135.82 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.913 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' LEU . . . . . 0.55 HD21 ' OE1' ' C' ' 11' ' ' GLN . 7.2 mt -50.37 122.44 6.99 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.797 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.542 HD23 ' CD1' ' A' ' 26' ' ' PHE . 1.3 tp -58.02 -39.91 79.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.546 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 35.4 t -64.2 -17.46 63.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.476 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' C' ' 22' ' ' LEU . 5.2 m -70.11 -18.76 63.26 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' PHE . . . . . 0.791 ' HB3' HD11 ' B' ' 27' ' ' LEU . 89.7 m-85 -98.09 0.86 46.89 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.6 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 1.062 ' CD1' ' O ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.257 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.81 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 15.4 m-85 . . . . . 0 CA--C 1.531 0.218 0 CA-C-O 121.577 0.703 . . . . 0.0 112.382 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.866 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.1 pt -104.7 159.71 28.43 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.33 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.604 ' HA ' ' CD1' ' B' ' 2' ' ' TYR . 13.9 Cg_endo -81.4 144.94 14.68 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.047 1.831 . . . . 0.0 111.716 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.887 ' HA ' HG23 ' B' ' 3' ' ' ILE . 22.5 tt0 -57.04 142.02 43.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 113.995 -1.457 . . . . 0.0 114.094 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.707 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.78 157.24 52.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.388 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.429 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 51.0 Cg_exo -54.54 151.14 32.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.977 2.451 . . . . 0.0 112.436 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 24.4 mtm180 -112.51 57.76 0.65 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.971 0.415 . . . . 0.0 112.051 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.05 18.66 19.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.792 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.799 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 80.17 14.95 79.71 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.906 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.709 ' C ' ' HB2' ' B' ' 16' ' ' LYS . 8.4 mt-30 -106.6 141.12 38.4 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.551 ' HA ' ' CB ' ' B' ' 16' ' ' LYS . . . -91.47 135.53 33.77 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 122.004 0.907 . . . . 0.0 112.102 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.65 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 56.4 m-85 -119.57 153.21 35.78 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.794 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -118.32 147.58 21.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.743 ' NH2' ' HA2' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -93.64 107.68 19.51 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.678 -1.209 . . . . 0.0 110.405 -177.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.82 ' CD ' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -138.21 124.97 21.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.519 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.807 ' HA ' ' CB ' ' C' ' 8' ' ' ARG . 0.8 OUTLIER 60.97 45.84 9.03 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 176.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.743 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 61.37 14.75 42.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.643 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -137.15 164.25 28.9 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 117.983 0.892 . . . . 0.0 112.198 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.721 ' CZ2' HD12 ' A' ' 3' ' ' ILE . 81.4 m95 -93.11 116.2 28.81 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.188 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.924 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.4 m -107.04 128.25 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.717 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -52.21 121.86 7.6 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.985 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.978 HD22 HG11 ' B' ' 14' ' ' VAL . 15.8 tp -58.44 -44.97 89.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.508 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.406 ' HB2' HD12 ' A' ' 22' ' ' LEU . 4.9 m -48.08 -26.32 1.79 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.324 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -67.02 -18.84 65.55 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.489 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 1.249 ' O ' HD21 ' C' ' 27' ' ' LEU . 61.5 m-85 -98.75 -5.03 32.11 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.143 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.909 HD11 ' HB3' ' B' ' 26' ' ' PHE . 1.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.091 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' TYR . . . . . 0.604 ' CD1' ' HA ' ' A' ' 4' ' ' PRO . 2.7 m-85 -129.03 135.61 49.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.796 0.298 . . . . 0.0 111.345 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 5' ' ' GLU . 11.8 pt -86.97 155.84 55.25 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-O 120.993 0.425 . . . . 0.0 111.926 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.826 ' HD2' HH21 ' B' ' 15' ' ' ARG . 90.3 Cg_endo -86.93 154.25 8.53 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.427 2.752 . . . . 0.0 111.965 178.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 1.038 ' HA ' HG23 ' C' ' 3' ' ' ILE . 3.2 tt0 -58.48 143.46 45.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.592 ' HB2' ' CE2' ' B' ' 20' ' ' TRP . . . -86.9 158.16 53.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.12 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' B' ' 6' ' ' ALA . 19.0 Cg_endo -58.23 158.1 23.44 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.526 2.817 . . . . 0.0 113.106 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' C' ' 17' ' ' ASP . 1.3 mpp_? -112.22 74.6 0.87 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.294 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.41 8.24 10.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.698 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.735 ' O ' ' HE3' ' C' ' 16' ' ' LYS . . . 78.72 22.84 65.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.287 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.786 ' HB3' HD21 ' B' ' 22' ' ' LEU . 56.2 mt-30 -116.32 145.4 43.21 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' C' ' 14' ' ' VAL . . . -91.83 134.82 34.41 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.065 0.936 . . . . 0.0 111.503 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.695 ' CE1' HD23 ' B' ' 22' ' ' LEU . 52.2 m-85 -120.27 153.01 36.97 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.132 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.978 HG11 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -113.23 154.14 14.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 112.727 -2.033 . . . . 0.0 105.716 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.826 HH21 ' HD2' ' B' ' 4' ' ' PRO . 0.0 OUTLIER -106.22 100.63 10.15 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.257 1.027 . . . . 0.0 111.136 -176.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.799 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -134.66 126.71 29.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 113.347 -1.752 . . . . 0.0 110.847 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.774 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 38.4 t70 60.12 43.42 14.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.85 12.77 29.99 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.565 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.445 ' C ' ' NH1' ' B' ' 15' ' ' ARG . 28.0 mt-10 -128.56 160.03 33.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.09 0.945 . . . . 0.0 111.45 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' TRP . . . . . 0.82 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 81.9 m95 -95.14 116.19 28.41 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.301 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.968 ' O ' HG23 ' B' ' 14' ' ' VAL . 9.8 t -112.0 134.98 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.211 0 CA-C-O 121.746 0.784 . . . . 0.0 109.735 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.786 HD21 ' HB3' ' B' ' 11' ' ' GLN . 0.1 OUTLIER -52.71 124.94 15.15 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.821 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.791 HD21 ' CB ' ' C' ' 26' ' ' PHE . 18.2 tp -57.68 -38.35 75.01 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.256 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 25.6 t -62.66 -18.5 62.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.742 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 1.5 m -68.95 -17.88 64.01 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.909 ' HB3' HD11 ' A' ' 27' ' ' LEU . 81.4 m-85 -101.88 -12.69 18.06 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.673 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.781 HD13 ' O ' ' C' ' 26' ' ' PHE . 13.5 mt . . . . . 0 C--O 1.25 1.087 0 O-C-N 121.103 -0.998 . . . . 0.0 111.367 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.071 0 N-CA-C 112.815 -0.114 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 2' ' ' TYR . . . . . 0.582 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.7 m-85 -121.91 145.98 47.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.732 0.266 . . . . 0.0 111.344 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 1.038 HG23 ' HA ' ' B' ' 5' ' ' GLU . 3.8 pt -85.46 150.11 53.4 Favored Pre-proline 0 CA--C 1.514 -0.415 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.81 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 10.9 Cg_endo -81.89 150.41 16.2 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.817 1.678 . . . . 0.0 111.203 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.866 ' HA ' HG23 ' A' ' 3' ' ' ILE . 6.2 tt0 -58.04 142.39 46.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.503 -1.226 . . . . 0.0 113.102 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' ALA . . . . . 0.646 ' HB2' ' CD2' ' C' ' 20' ' ' TRP . . . -88.57 165.06 29.79 Favored Pre-proline 0 C--O 1.231 0.127 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.873 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' PRO . . . . . 0.488 ' HD2' ' HB1' ' C' ' 6' ' ' ALA . 24.7 Cg_exo -59.06 146.22 95.03 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.525 2.15 . . . . 0.0 110.679 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' ARG . . . . . 0.807 ' CB ' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -113.85 58.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.109 0.48 . . . . 0.0 111.5 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' ASP . . . . . 0.505 ' OD2' ' HB2' ' C' ' 11' ' ' GLN . 6.8 p-10 -104.27 21.84 15.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.387 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' GLY . . . . . 0.643 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 78.88 12.7 83.89 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.226 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' GLN . . . . . 0.931 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.9 OUTLIER -113.02 143.05 44.97 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . 0.687 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -90.6 138.26 31.7 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.948 0.88 . . . . 0.0 111.852 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.608 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 60.4 m-85 -118.33 150.35 39.64 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.572 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' VAL . . . . . 1.025 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.3 OUTLIER -110.71 154.2 12.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.728 ' NH2' HG22 ' C' ' 3' ' ' ILE . 0.0 OUTLIER -105.73 108.13 19.49 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.651 -1.22 . . . . 0.0 109.944 -177.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.735 ' HE3' ' O ' ' B' ' 10' ' ' GLY . 0.0 OUTLIER -136.89 121.63 18.61 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.942 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' B' ' 8' ' ' ARG . 8.8 t70 58.56 45.75 15.8 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.562 ' HA2' ' NH2' ' C' ' 15' ' ' ARG . . . 63.97 15.71 58.6 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 115.064 0.786 . . . . 0.0 115.064 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -132.42 161.66 33.09 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.703 1.251 . . . . 0.0 112.118 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' TRP . . . . . 0.711 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 89.4 m95 -96.95 115.15 26.93 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.143 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 1.025 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.4 m -114.67 131.83 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.139 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' LEU . . . . . 0.931 HD21 ' HB3' ' C' ' 11' ' ' GLN . 2.1 mt -51.48 127.31 19.71 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.235 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.681 HD22 HG11 ' A' ' 14' ' ' VAL . 3.5 tp -59.87 -44.01 94.42 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.677 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -65.63 -22.26 66.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.934 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 16.6 m -69.29 -18.41 63.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' PHE . . . . . 0.791 ' CB ' HD21 ' B' ' 23' ' ' LEU . 42.9 m-85 -97.19 -0.31 47.07 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.555 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 1.249 HD21 ' O ' ' A' ' 26' ' ' PHE . 1.7 tp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.007 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.617 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 5.5 m-30 -102.52 160.93 14.13 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 111.925 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 1.017 HG23 ' HA ' ' C' ' 5' ' ' GLU . 4.5 pt -91.4 153.63 44.34 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.644 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 11.2 Cg_endo -86.25 153.42 9.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.723 2.282 . . . . 0.0 111.308 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.887 ' HA ' HG23 ' B' ' 3' ' ' ILE . 1.1 tp10 -58.21 142.34 47.85 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.785 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.21 160.77 48.05 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.166 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.553 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 43.9 Cg_exo -54.65 152.06 29.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.102 2.535 . . . . 0.0 112.958 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.583 ' HG3' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -111.63 57.76 0.63 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.165 0.507 . . . . 0.0 111.135 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -105.48 16.15 25.96 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.699 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' O ' ' HD2' ' B' ' 16' ' ' LYS . . . 79.98 14.08 81.22 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.81 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.643 ' HB3' HD21 ' A' ' 22' ' ' LEU . 3.0 mt-30 -107.11 157.73 17.62 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 117.156 0.478 . . . . 0.0 110.47 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.966 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -98.86 136.21 39.19 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.485 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.815 ' O ' HG23 ' B' ' 14' ' ' VAL . 66.2 m-85 -120.43 149.1 42.91 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.391 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -111.25 157.14 12.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.78 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -106.19 107.3 18.24 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 118.134 -1.426 . . . . 0.0 110.645 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.715 ' HG2' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -137.3 140.58 41.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.592 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.715 ' CG ' ' HG2' ' A' ' 16' ' ' LYS . 0.4 OUTLIER 45.21 45.65 9.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 177.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.433 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 61.82 16.81 52.98 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.383 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -133.71 162.34 32.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 118.124 0.962 . . . . 0.0 111.574 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.829 ' CZ2' HD12 ' A' ' 3' ' ' ILE . 73.4 m95 -93.94 114.1 26.24 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.471 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.887 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.4 m -107.19 132.66 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.295 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.643 HD21 ' HB3' ' A' ' 11' ' ' GLN . 4.4 mt -53.11 121.83 8.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.766 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.596 HD23 ' CD1' ' B' ' 26' ' ' PHE . 1.8 tp -60.09 -45.73 91.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.904 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.4 p -50.54 -26.28 5.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.962 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.2 m -67.5 -19.08 65.28 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.725 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 1.271 ' O ' HD21 ' C' ' 27' ' ' LEU . 12.7 m-85 -98.2 2.66 48.61 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.168 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.26 HD21 ' O ' ' B' ' 26' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.309 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.581 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 4.6 m-85 -130.89 141.64 50.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.985 0.422 . . . . 0.0 111.165 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 5' ' ' GLU . 6.4 pt -88.69 158.59 47.81 Favored Pre-proline 0 CA--C 1.515 -0.372 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.665 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 96.9 Cg_endo -88.48 150.21 6.41 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.984 2.456 . . . . 0.0 110.463 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 1.045 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.4 OUTLIER -57.54 149.19 21.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.935 -176.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.604 ' N ' ' HG3' ' B' ' 5' ' ' GLU . . . -91.0 152.55 44.39 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.195 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.71 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 6.2 Cg_exo -48.14 153.18 2.99 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.337 2.692 . . . . 0.0 113.251 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.541 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.9 OUTLIER -111.56 66.62 0.63 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.934 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -110.65 11.25 22.8 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.265 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.48 8.06 88.03 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.148 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.939 ' HB3' HD21 ' B' ' 22' ' ' LEU . 2.6 mm-40 -102.03 151.76 21.76 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.855 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -93.13 134.79 34.93 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.527 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.71 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 55.5 m-85 -119.85 151.54 38.7 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.021 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.966 HG21 ' HB1' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -113.72 159.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-N 113.61 -1.632 . . . . 0.0 106.832 175.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.966 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -103.7 107.9 18.96 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.489 1.137 . . . . 0.0 109.323 -176.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.821 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -135.82 131.81 35.87 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.036 -1.893 . . . . 0.0 111.432 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.601 ' OD1' ' O ' ' B' ' 16' ' ' LYS . 0.1 OUTLIER 47.8 46.86 18.52 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 177.027 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.497 ' H ' ' NH1' ' B' ' 15' ' ' ARG . . . 62.39 16.44 54.47 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 114.172 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -133.46 161.44 34.56 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 117.967 0.884 . . . . 0.0 111.702 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' TRP . . . . . 0.966 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 84.8 m95 -94.09 117.15 29.69 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.512 ' O ' HG12 ' B' ' 14' ' ' VAL . 5.4 t -114.63 136.6 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.196 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.071 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.939 HD21 ' HB3' ' B' ' 11' ' ' GLN . 2.8 mt -54.02 125.34 18.47 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.016 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.632 HD22 HG11 ' C' ' 14' ' ' VAL . 1.8 tp -56.75 -35.5 68.7 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.082 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.518 ' HA ' ' HB2' ' B' ' 27' ' ' LEU . 2.0 p -63.62 -19.59 64.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.021 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 23.6 m -70.51 -20.45 62.83 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 1.26 ' O ' HD21 ' A' ' 27' ' ' LEU . 96.2 m-85 -101.12 18.77 18.95 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-O 122.218 1.009 . . . . 0.0 108.328 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 1.056 HD21 ' O ' ' C' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.363 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.279 -0.329 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.3 m-30 -102.23 159.6 15.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 111.682 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 1.045 HG23 ' HA ' ' B' ' 5' ' ' GLU . 3.3 pt -86.97 154.73 55.4 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.806 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 9.9 Cg_endo -83.22 148.13 13.06 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.437 2.091 . . . . 0.0 110.856 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 1.017 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -58.09 143.53 43.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' C' ' 5' ' ' GLU . . . -83.77 167.46 28.1 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.268 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' PRO . . . . . 0.535 ' HD2' ' HB1' ' C' ' 6' ' ' ALA . 28.7 Cg_exo -59.04 151.5 65.68 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.042 2.495 . . . . 0.0 112.547 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -112.03 48.82 0.95 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.046 0.45 . . . . 0.0 111.581 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' ASP . . . . . 0.491 ' CG ' ' HG3' ' C' ' 11' ' ' GLN . 19.0 p-10 -104.94 19.35 20.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.088 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.482 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.65 14.27 81.36 Favored Glycine 0 C--O 1.229 -0.158 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.34 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' GLN . . . . . 0.914 ' HB3' HD21 ' C' ' 22' ' ' LEU . 7.1 mt-30 -105.1 141.15 37.17 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . 0.757 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -90.91 135.33 33.81 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.268 0.556 . . . . 0.0 110.981 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.511 ' CD2' ' HD2' ' C' ' 7' ' ' PRO . 70.9 m-85 -119.3 152.79 36.12 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.615 1.198 . . . . 0.0 112.637 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' VAL . . . . . 0.94 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.6 OUTLIER -113.37 145.82 18.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 112.624 -2.08 . . . . 0.0 106.35 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.761 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -95.01 115.47 27.46 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.906 -178.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.855 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 1.9 tttt -151.05 125.46 9.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.989 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . 0.541 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 0.3 OUTLIER 58.64 44.44 17.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.984 0.421 . . . . 0.0 111.462 177.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.505 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.8 16.42 51.56 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.996 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -133.73 161.94 33.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.032 0.916 . . . . 0.0 111.679 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . 0.799 ' CZ2' HD12 ' C' ' 3' ' ' ILE . 92.1 m95 -97.58 115.18 27.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.485 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.94 ' O ' HG23 ' C' ' 14' ' ' VAL . 6.4 t -110.06 137.59 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-O 121.596 0.712 . . . . 0.0 110.296 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' LEU . . . . . 0.914 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.3 mt -56.59 127.3 30.65 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.66 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.681 HD22 HG11 ' A' ' 14' ' ' VAL . 7.7 tp -59.16 -35.61 73.83 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.139 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 80.6 p -64.01 -19.88 65.5 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 122.12 -0.362 . . . . 0.0 110.977 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 73.3 m -67.63 -18.36 64.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' PHE . . . . . 1.056 ' O ' HD21 ' B' ' 27' ' ' LEU . 76.6 m-85 -101.88 9.37 40.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.426 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 1.271 HD21 ' O ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.478 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' C' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 119.45 -0.639 . . . . 0.0 112.209 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.895 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 22.9 m-85 -135.3 165.13 26.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 117.933 0.867 . . . . 0.0 111.667 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.896 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.0 OUTLIER -97.32 160.05 29.8 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.833 177.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 21.1 Cg_endo -82.47 145.77 13.41 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.034 1.823 . . . . 0.0 111.401 176.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.753 ' HA ' HG23 ' B' ' 3' ' ' ILE . 3.4 tt0 -57.61 142.6 44.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.006 -1.452 . . . . 0.0 113.76 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 20' ' ' TRP . . . -85.03 163.92 43.8 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.557 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.467 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 37.8 Cg_exo -57.31 151.13 54.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.979 2.453 . . . . 0.0 112.853 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 45.4 mtm-85 -112.32 58.26 0.64 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.44 15.55 21.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.737 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.763 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 78.79 14.58 81.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.695 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 1.01 ' HB3' HD21 ' A' ' 22' ' ' LEU . 7.7 mm-40 -102.83 141.32 35.84 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.924 ' HB1' HG11 ' B' ' 14' ' ' VAL . . . -91.52 133.39 35.55 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.784 0.802 . . . . 0.0 112.54 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.611 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 70.2 m-85 -118.66 151.42 37.98 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.961 1.363 . . . . 0.0 113.048 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.03 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -111.04 155.34 12.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 178.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.902 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.49 108.52 20.08 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.364 -177.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.677 ' HE3' ' O ' ' C' ' 10' ' ' GLY . 0.0 OUTLIER -136.73 120.72 17.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.65 -1.613 . . . . 0.0 111.977 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 0.4 OUTLIER 59.2 45.88 13.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 177.119 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.62 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 63.6 14.15 53.62 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.991 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -131.38 159.95 36.47 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 118.329 1.064 . . . . 0.0 111.429 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.902 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 93.0 m95 -97.53 114.77 26.72 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.882 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.03 ' O ' HG23 ' A' ' 14' ' ' VAL . 10.5 t -111.37 139.73 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-O 121.718 0.771 . . . . 0.0 110.032 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.01 HD21 ' HB3' ' A' ' 11' ' ' GLN . 3.7 mt -56.72 128.02 34.4 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.618 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.682 HD23 ' CG ' ' B' ' 26' ' ' PHE . 3.0 tp -61.5 -42.99 99.64 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.897 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -63.54 -18.59 64.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.738 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.0 m -69.69 -19.11 63.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 1.326 ' O ' HD21 ' C' ' 27' ' ' LEU . 96.3 m-85 -97.77 3.6 50.01 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.756 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.262 HD21 ' O ' ' B' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 4.8 m-85 -133.65 129.58 37.05 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.634 0.254 . . . . 0.0 110.595 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.753 HG23 ' HA ' ' A' ' 5' ' ' GLU . 3.5 pt -85.45 155.63 59.6 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.946 ' HD2' HH21 ' B' ' 15' ' ' ARG . 83.4 Cg_endo -83.39 160.22 14.94 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.638 2.226 . . . . 0.0 112.648 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.937 ' HA ' HG23 ' C' ' 3' ' ' ILE . 19.2 tt0 -60.74 143.08 55.15 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.507 ' HB1' ' CD ' ' B' ' 7' ' ' PRO . . . -84.72 169.61 16.05 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.568 -1.197 . . . . 0.0 112.053 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.507 ' CD ' ' HB1' ' B' ' 6' ' ' ALA . 12.2 Cg_exo -71.04 153.89 62.83 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.826 3.017 . . . . 0.0 113.064 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' C' ' 17' ' ' ASP . 1.7 mpp_? -112.0 84.56 1.98 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.297 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.32 6.57 4.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.338 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.862 ' O ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.15 14.74 81.43 Favored Glycine 0 CA--C 1.509 -0.29 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.512 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.927 ' HB3' HD21 ' B' ' 22' ' ' LEU . 0.4 OUTLIER -103.9 144.08 31.99 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.81 ' HB1' ' CG1' ' C' ' 14' ' ' VAL . . . -90.57 135.88 33.42 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.541 0.686 . . . . 0.0 110.404 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.624 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 43.5 m-85 -118.92 152.15 36.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.491 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.924 HG11 ' HB1' ' A' ' 12' ' ' ALA . 0.5 OUTLIER -105.55 158.79 5.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 175.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.946 HH21 ' HD2' ' B' ' 4' ' ' PRO . 0.0 OUTLIER -107.66 105.82 15.87 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 118.581 -1.248 . . . . 0.0 107.688 176.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.763 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -138.06 124.68 20.89 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.164 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 2.8 t0 58.92 43.79 17.49 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.322 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.19 12.69 38.96 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 119.243 -0.754 . . . . 0.0 114.529 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.495 ' C ' ' NH1' ' B' ' 15' ' ' ARG . 0.1 OUTLIER -127.43 154.72 44.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.113 1.456 . . . . 0.0 111.382 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' TRP . . . . . 0.886 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 76.2 m95 -93.74 113.41 25.46 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.752 HG22 HG12 ' B' ' 14' ' ' VAL . 1.4 m -108.61 132.85 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 CA-C-O 121.626 0.727 . . . . 0.0 111.282 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.927 HD21 ' HB3' ' B' ' 11' ' ' GLN . 1.8 mt -53.75 122.06 9.16 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.216 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.75 HD21 ' HB3' ' C' ' 26' ' ' PHE . 1.1 tp -57.61 -34.99 69.86 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.6 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 16.7 m -61.65 -16.58 49.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.434 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 31.7 m -69.78 -18.15 63.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 1.262 ' O ' HD21 ' A' ' 27' ' ' LEU . 8.8 m-85 -99.71 -11.4 20.9 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.449 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.804 HD13 ' O ' ' C' ' 26' ' ' PHE . 9.4 mt . . . . . 0 C--O 1.249 1.043 0 O-C-N 120.751 -1.218 . . . . 0.0 110.896 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 CA-C-O 119.861 -0.411 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' TYR . . . . . 0.663 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.6 m-30 -116.85 150.39 38.47 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.614 0.707 . . . . 0.0 111.241 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 0.937 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.4 pt -87.31 156.85 53.92 Favored Pre-proline 0 CA--C 1.506 -0.748 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.895 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 20.7 Cg_endo -87.8 152.96 7.35 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 122.153 1.902 . . . . 0.0 112.335 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.896 ' HA ' HG23 ' A' ' 3' ' ' ILE . 4.2 tt0 -57.38 141.45 47.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.086 -1.415 . . . . 0.0 113.321 -177.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.614 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . . . -84.97 160.51 55.14 Favored Pre-proline 0 N--CA 1.455 -0.211 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.306 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.99 151.52 49.25 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.921 2.414 . . . . 0.0 112.22 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 20.7 mtm105 -111.57 70.37 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.407 0.623 . . . . 0.0 111.08 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -113.34 17.23 18.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.038 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.677 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 74.0 15.37 79.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.616 -1.278 . . . . 0.0 112.264 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' GLN . . . . . 0.694 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.1 OUTLIER -113.91 152.47 30.75 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.011 0.434 . . . . 0.0 110.977 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . 0.622 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . . . -92.75 136.19 33.45 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.583 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.496 ' HD1' ' C ' ' C' ' 21' ' ' VAL . 70.4 m-85 -119.85 156.76 30.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.949 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' VAL . . . . . 0.81 ' CG1' ' HB1' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -108.64 155.62 9.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 176.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.726 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.96 107.67 18.79 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 118.34 -1.344 . . . . 0.0 107.789 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.862 ' HE2' ' O ' ' B' ' 10' ' ' GLY . 0.0 OUTLIER -136.57 124.49 22.72 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.978 -1.465 . . . . 0.0 111.381 -179.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' B' ' 8' ' ' ARG . 0.2 OUTLIER 58.71 45.34 15.92 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 176.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.43 ' C ' ' CZ ' ' C' ' 15' ' ' ARG . . . 63.02 16.42 57.46 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.907 -0.663 . . . . 0.0 114.475 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -134.65 161.08 36.12 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.289 1.044 . . . . 0.0 111.227 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . 0.726 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 91.2 m95 -97.28 115.04 26.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.527 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.615 HG21 ' HD3' ' C' ' 16' ' ' LYS . 21.5 t -107.92 141.2 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 121.767 0.794 . . . . 0.0 110.028 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.6 mt -57.78 124.2 18.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.302 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.906 HD22 HG11 ' A' ' 14' ' ' VAL . 25.8 tp -58.82 -52.15 66.97 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.33 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 41.8 t -43.64 -26.79 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.434 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -68.19 -18.65 64.65 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.585 0.707 . . . . 0.0 109.623 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' PHE . . . . . 0.804 ' O ' HD13 ' B' ' 27' ' ' LEU . 81.0 m-85 -99.65 -3.7 32.52 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.81 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 1.326 HD21 ' O ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.241 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' C' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 4.1 m-30 -110.83 153.38 25.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.634 0.254 . . . . 0.0 111.409 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.832 HD12 ' CZ2' ' A' ' 20' ' ' TRP . 4.2 pt -91.75 161.53 33.65 Favored Pre-proline 0 CA--C 1.509 -0.603 0 CA-C-O 121.024 0.44 . . . . 0.0 111.582 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 33.2 Cg_endo -89.06 151.65 5.73 Favored 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 122.274 1.983 . . . . 0.0 110.686 176.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.942 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.5 OUTLIER -57.44 142.72 42.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.873 -177.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.6 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -84.39 165.07 40.29 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.524 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.474 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 28.5 Cg_exo -61.16 154.01 60.7 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 123.512 2.808 . . . . 0.0 113.202 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.446 ' CG ' ' HA ' ' B' ' 17' ' ' ASP . 2.0 mtp85 -112.04 69.98 0.7 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.262 0.553 . . . . 0.0 111.155 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -113.84 14.83 18.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.051 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.555 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 79.36 15.12 80.6 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.851 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.896 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -115.28 150.91 35.47 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.764 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -91.54 136.49 33.09 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.771 0.796 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.634 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 51.8 m-85 -117.43 151.65 36.62 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.344 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -112.87 152.9 14.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.74 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.04 107.32 18.23 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 118.962 -1.095 . . . . 0.0 108.503 -177.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.736 ' HE3' ' O ' ' C' ' 10' ' ' GLY . 0.6 OUTLIER -137.01 125.04 22.82 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 113.382 -1.736 . . . . 0.0 111.132 -178.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.563 ' HA ' ' HG3' ' C' ' 8' ' ' ARG . 0.2 OUTLIER 57.87 45.36 18.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.496 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 62.35 14.07 46.55 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 114.352 0.501 . . . . 0.0 114.352 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -131.0 161.93 30.89 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 117.889 0.845 . . . . 0.0 111.897 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.832 ' CZ2' HD12 ' A' ' 3' ' ' ILE . 82.5 m95 -96.42 113.91 25.53 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.952 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.867 ' O ' HG23 ' A' ' 14' ' ' VAL . 11.7 t -111.91 139.18 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 121.726 0.775 . . . . 0.0 110.034 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.896 HD21 ' HB3' ' A' ' 11' ' ' GLN . 2.1 mt -55.52 126.76 26.61 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.078 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.668 HD23 ' CG ' ' B' ' 26' ' ' PHE . 2.9 tp -59.91 -42.78 94.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.307 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.413 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 2.3 m -62.97 -19.15 64.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.7 m -69.7 -18.31 63.53 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.777 ' CB ' HD21 ' C' ' 23' ' ' LEU . 84.1 m-85 -97.54 2.05 49.66 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.574 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.953 ' CD1' ' O ' ' B' ' 26' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.072 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.616 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 3.7 m-85 -129.51 143.32 50.78 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.738 0.304 . . . . 0.0 110.988 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.942 HG23 ' HA ' ' A' ' 5' ' ' GLU . 2.6 pt -89.44 158.34 46.04 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-O 120.999 0.428 . . . . 0.0 112.139 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.77 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 92.2 Cg_endo -87.22 151.58 8.06 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.72 2.28 . . . . 0.0 111.075 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.914 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.8 OUTLIER -57.69 142.41 45.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.253 -177.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.63 ' HB3' ' NH1' ' C' ' 15' ' ' ARG . . . -83.72 166.67 32.84 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.462 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' B' ' 6' ' ' ALA . 22.2 Cg_exo -62.76 151.12 85.67 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.448 2.765 . . . . 0.0 112.588 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.627 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -112.79 60.52 0.64 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.985 0.421 . . . . 0.0 111.891 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' B' ' 11' ' ' GLN . 3.9 p30 -106.01 15.24 26.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.239 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.551 ' C ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.48 14.48 81.3 Favored Glycine 0 CA--C 1.506 -0.487 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.81 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.739 ' OE1' HD11 ' B' ' 22' ' ' LEU . 0.0 OUTLIER -113.19 152.83 29.24 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.484 0.659 . . . . 0.0 109.744 178.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 1.019 ' HB1' HG21 ' C' ' 14' ' ' VAL . . . -92.83 136.26 33.4 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.89 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.782 ' O ' HG23 ' C' ' 14' ' ' VAL . 58.4 m-85 -119.2 152.59 36.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.457 1.123 . . . . 0.0 112.265 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.937 HG23 ' O ' ' B' ' 21' ' ' VAL . 0.7 OUTLIER -112.49 155.84 13.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 113.122 -1.854 . . . . 0.0 106.214 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.982 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.14 107.1 17.9 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.884 -1.127 . . . . 0.0 108.92 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.764 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -136.79 124.02 21.81 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.505 -1.679 . . . . 0.0 111.792 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.446 ' HA ' ' CG ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 57.11 45.99 19.85 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.306 176.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.555 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 61.92 14.41 45.08 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.381 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.73 161.72 31.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.524 1.162 . . . . 0.0 111.803 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' TRP . . . . . 0.982 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 81.2 m95 -96.84 114.41 26.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.441 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.937 ' O ' HG23 ' B' ' 14' ' ' VAL . 10.6 t -111.16 142.4 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 121.768 0.794 . . . . 0.0 110.613 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.739 HD11 ' OE1' ' B' ' 11' ' ' GLN . 1.4 mt -56.82 122.68 12.75 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.399 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.673 HD23 ' CD2' ' C' ' 26' ' ' PHE . 2.8 tp -57.57 -43.18 84.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.87 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -19.28 65.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.944 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 4.1 m -67.72 -18.76 65.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.953 ' O ' ' CD1' ' A' ' 27' ' ' LEU . 87.4 m-85 -95.92 -16.11 21.96 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.325 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.984 HD13 ' O ' ' C' ' 26' ' ' PHE . 1.8 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.275 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.052 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' TYR . . . . . 0.77 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.5 m-30 -100.62 160.97 13.92 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.775 0.321 . . . . 0.0 111.798 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 0.914 HG23 ' HA ' ' B' ' 5' ' ' GLU . 7.4 pt -87.75 160.75 46.49 Favored Pre-proline 0 CA--C 1.516 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.624 ' O ' ' NE1' ' C' ' 20' ' ' TRP . 69.8 Cg_endo -92.38 144.09 2.6 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 122.614 2.209 . . . . 0.0 111.432 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.786 ' OE2' HG22 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -58.05 142.84 45.52 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -176.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.878 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -87.37 156.69 53.81 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.814 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' PRO . . . . . 0.459 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 52.0 Cg_exo -49.61 153.69 5.18 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.111 2.541 . . . . 0.0 113.238 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' ARG . . . . . 0.563 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -111.64 64.73 0.62 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.368 0.604 . . . . 0.0 111.03 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -112.05 14.18 20.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.526 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.736 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.29 13.95 82.18 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.363 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' GLN . . . . . 0.87 ' HB3' HD21 ' C' ' 22' ' ' LEU . 1.3 mm-40 -106.25 155.01 19.92 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . 0.72 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -96.63 134.43 39.87 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.402 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.562 ' CD2' ' HB1' ' C' ' 6' ' ' ALA . 50.2 m-85 -118.79 155.21 31.54 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.071 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' VAL . . . . . 1.019 HG21 ' HB1' ' B' ' 12' ' ' ALA . 0.4 OUTLIER -118.87 160.79 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.88 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.23 107.71 18.84 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.482 1.134 . . . . 0.0 110.766 -176.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' B' ' 11' ' ' GLN . 0.0 OUTLIER -137.05 127.25 26.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.474 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . 0.627 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 1.1 m-20 55.79 45.97 23.29 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.633 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 60.54 15.37 39.51 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' C' ' 16' ' ' LYS . 0.0 OUTLIER -133.61 162.0 33.11 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.277 1.038 . . . . 0.0 111.043 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . 0.88 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 91.9 m95 -98.49 122.84 42.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.299 0.571 . . . . 0.0 110.732 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.415 ' O ' HG12 ' C' ' 14' ' ' VAL . 12.8 t -117.5 138.44 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.673 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' LEU . . . . . 0.87 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.5 mt -55.61 125.61 21.8 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.874 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.777 HD21 ' CB ' ' A' ' 26' ' ' PHE . 7.8 tp -57.15 -35.18 69.22 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.921 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -15.1 59.6 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.502 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 4.0 m -72.8 -18.93 61.42 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' PHE . . . . . 0.984 ' O ' HD13 ' B' ' 27' ' ' LEU . 92.0 m-85 -99.1 -6.95 27.42 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.607 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.685 HD23 HD22 ' B' ' 27' ' ' LEU . 58.4 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.899 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' C' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.727 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 8.4 m-30 -103.29 167.02 10.08 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' C' ' 5' ' ' GLU . 5.6 pt -100.96 159.11 30.43 Favored Pre-proline 0 CA--C 1.508 -0.648 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.097 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 39.2 Cg_endo -86.58 152.92 8.95 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 121.623 1.549 . . . . 0.0 112.043 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.873 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.4 OUTLIER -57.25 143.24 40.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.753 -177.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.667 ' HA ' ' CD1' ' A' ' 20' ' ' TRP . . . -85.72 165.7 33.72 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.92 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 24.8 Cg_exo -58.85 151.07 67.36 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.957 2.438 . . . . 0.0 112.355 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.33 63.84 0.61 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.192 0.52 . . . . 0.0 111.25 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -110.27 13.34 23.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.592 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.19 8.94 87.15 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.394 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.927 ' HG3' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -102.4 151.14 22.62 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.227 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.642 ' HB1' ' CG1' ' B' ' 14' ' ' VAL . . . -92.1 136.26 33.32 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.606 0.717 . . . . 0.0 110.189 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.564 ' CE1' HD23 ' A' ' 22' ' ' LEU . 52.9 m-85 -119.09 154.28 33.44 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.711 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 21' ' ' VAL . 1.8 t -115.41 156.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.925 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -106.06 107.85 19.07 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.407 1.099 . . . . 0.0 110.46 -176.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.662 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 0.0 OUTLIER -138.2 126.75 23.44 Favored 'General case' 0 C--O 1.23 0.044 0 CA-C-N 113.062 -1.881 . . . . 0.0 112.052 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.586 ' HA ' ' HG3' ' C' ' 8' ' ' ARG . 0.4 OUTLIER 55.46 45.3 25.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 176.274 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.596 ' H ' ' NH2' ' A' ' 15' ' ' ARG . . . 62.1 15.59 50.69 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.568 -0.573 . . . . 0.0 114.528 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -134.33 162.97 30.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.498 1.149 . . . . 0.0 111.37 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.925 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 89.1 m95 -94.58 120.12 34.31 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.397 0.617 . . . . 0.0 110.792 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.797 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.6 m -115.69 131.35 68.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.949 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.927 HD21 ' HG3' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -51.09 123.87 10.29 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.786 -178.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.691 HD22 HG11 ' B' ' 14' ' ' VAL . 4.7 tp -57.43 -36.19 71.05 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.517 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.68 -21.18 66.52 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.949 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.0 m -70.1 -22.61 63.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.759 0.79 . . . . 0.0 108.97 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 1.051 ' O ' HD13 ' C' ' 27' ' ' LEU . 32.8 m-85 -97.87 -6.14 33.07 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.777 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.958 HD21 ' O ' ' B' ' 26' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.193 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.684 -0.166 . . . . 0.0 112.684 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.542 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 3.0 m-85 -130.48 138.61 50.35 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.861 0.362 . . . . 0.0 111.354 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.9 HG21 ' HE ' ' B' ' 15' ' ' ARG . 4.2 pt -88.89 159.65 45.32 Favored Pre-proline 0 N--CA 1.468 0.474 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 80.9 Cg_endo -91.05 152.59 3.86 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.875 2.383 . . . . 0.0 111.76 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 1.003 ' HA ' HG23 ' C' ' 3' ' ' ILE . 2.9 tt0 -58.39 142.8 47.27 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.737 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -88.33 146.23 37.44 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.597 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.472 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 11.4 Cg_exo -40.73 154.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.569 2.846 . . . . 0.0 113.678 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.41 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -111.94 65.0 0.62 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.818 179.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -110.77 18.54 19.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.304 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.464 ' HA2' ' OD2' ' C' ' 17' ' ' ASP . . . 75.6 7.83 83.54 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.564 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.542 ' HB3' HD21 ' B' ' 22' ' ' LEU . 0.1 OUTLIER -105.5 151.16 24.62 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.289 0.566 . . . . 0.0 110.071 178.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.556 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.81 137.32 32.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.635 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.567 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 60.2 m-85 -120.44 154.34 35.33 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.665 1.221 . . . . 0.0 111.476 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.925 HG23 ' O ' ' B' ' 21' ' ' VAL . 0.2 OUTLIER -111.89 156.15 13.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 112.58 -2.1 . . . . 0.0 106.625 179.111 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.971 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.74 103.91 13.51 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.118 0.961 . . . . 0.0 109.178 -178.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.799 ' HD3' HG21 ' B' ' 21' ' ' VAL . 0.0 OUTLIER -135.24 125.87 27.03 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.366 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.05 46.11 19.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.693 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 61.5 15.76 47.62 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 114.277 0.471 . . . . 0.0 114.277 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -133.36 161.91 33.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 117.904 0.852 . . . . 0.0 112.172 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' TRP . . . . . 0.971 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 83.9 m95 -95.86 114.73 26.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.215 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.925 ' O ' HG23 ' B' ' 14' ' ' VAL . 10.9 t -107.03 139.97 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.628 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.542 HD21 ' HB3' ' B' ' 11' ' ' GLN . 4.7 mt -58.04 124.33 18.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.326 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 1.003 HD22 HG11 ' C' ' 14' ' ' VAL . 35.6 tp -58.87 -39.98 82.99 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.523 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.2 m -62.77 -18.46 62.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.914 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 1.3 m -68.25 -17.6 64.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.958 ' O ' HD21 ' A' ' 27' ' ' LEU . 90.0 m-85 -102.69 -15.82 16.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.261 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.894 HD13 ' O ' ' C' ' 26' ' ' PHE . 5.5 mt . . . . . 0 C--O 1.249 1.07 0 O-C-N 121.137 -0.977 . . . . 0.0 111.024 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' TYR . . . . . 0.631 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.8 m-30 -96.09 161.72 13.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.333 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 1.003 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.9 pt -87.62 157.99 51.77 Favored Pre-proline 0 CA--C 1.512 -0.49 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.583 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.727 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 37.3 Cg_endo -89.65 146.09 4.84 Favored 'Trans proline' 0 N--CA 1.437 -1.853 0 C-N-CA 122.664 2.242 . . . . 0.0 111.336 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.926 ' HA ' HG23 ' A' ' 3' ' ' ILE . 1.1 tp10 -57.6 141.68 47.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.895 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -83.83 157.55 63.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.535 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' PRO . . . . . 0.414 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 51.8 Cg_exo -50.93 153.34 8.79 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.642 2.228 . . . . 0.0 112.769 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' ARG . . . . . 0.586 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 1.6 mpt_? -111.21 63.18 0.61 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.302 0.572 . . . . 0.0 110.645 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -107.96 13.97 25.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.252 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.422 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 79.62 10.23 86.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.397 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' GLN . . . . . 0.63 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.6 OUTLIER -106.7 152.27 24.01 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . 0.69 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -93.36 137.94 32.18 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.274 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.648 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 61.8 m-85 -119.11 152.65 36.13 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.326 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' VAL . . . . . 1.029 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.1 OUTLIER -111.38 153.97 13.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 178.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.771 ' NH2' ' OE2' ' B' ' 5' ' ' GLU . 0.0 OUTLIER -104.9 106.28 16.7 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.984 -177.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.693 ' HE2' ' OD2' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -137.53 133.13 34.17 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 113.08 -1.873 . . . . 0.0 111.764 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . 0.693 ' OD2' ' HE2' ' C' ' 16' ' ' LYS . 0.4 OUTLIER 46.68 46.45 14.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.613 ' HA2' HH22 ' C' ' 15' ' ' ARG . . . 69.98 10.68 65.4 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.97 160.45 38.26 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.835 1.317 . . . . 0.0 112.349 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . 0.895 ' CG ' ' HB2' ' C' ' 6' ' ' ALA . 85.2 m95 -94.49 112.63 24.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.008 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 1.029 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.0 m -109.79 135.38 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.083 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.3 mt -53.21 124.32 14.21 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.145 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.765 HD11 HD21 ' C' ' 27' ' ' LEU . 2.6 tp -58.23 -42.36 86.13 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.761 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -22.61 66.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.055 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 48.2 m -69.46 -18.95 63.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' PHE . . . . . 0.894 ' O ' HD13 ' B' ' 27' ' ' LEU . 40.9 m-85 -100.34 -6.42 25.83 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.859 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 1.051 HD13 ' O ' ' A' ' 26' ' ' PHE . 2.6 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.661 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.99 ' O ' ' HA ' ' C' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.123 0 CA-C-O 120.02 -0.322 . . . . 0.0 112.676 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.793 ' CE2' ' HB2' ' C' ' 2' ' ' TYR . 0.4 OUTLIER -138.67 146.24 41.37 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.112 0.565 . . . . 0.0 110.921 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.942 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.4 pt -104.74 158.96 30.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 37.2 Cg_endo -87.33 137.43 4.31 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.814 2.343 . . . . 0.0 111.802 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.873 ' HA ' HG23 ' B' ' 3' ' ' ILE . 2.9 tt0 -51.93 143.63 13.19 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.858 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.06 154.23 54.84 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.88 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 75.3 Cg_exo -51.73 157.34 5.57 Favored 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 123.613 2.875 . . . . 0.0 113.944 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -112.11 59.26 0.63 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.353 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -105.62 13.53 29.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.001 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.443 ' O ' ' HD2' ' B' ' 16' ' ' LYS . . . 79.66 13.57 82.27 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.777 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.623 ' HB3' HD21 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -106.21 156.76 18.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 117.156 0.478 . . . . 0.0 109.734 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.045 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -98.2 134.29 41.46 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.591 0.71 . . . . 0.0 112.021 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.875 ' O ' HG23 ' B' ' 14' ' ' VAL . 68.6 m-85 -120.1 151.76 38.58 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.649 1.214 . . . . 0.0 111.888 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.796 HG11 HD22 ' C' ' 23' ' ' LEU . 0.2 OUTLIER -112.98 157.76 13.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 113.105 -1.862 . . . . 0.0 106.566 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.999 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.56 106.05 16.39 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 118.579 -1.248 . . . . 0.0 109.437 -177.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.903 ' HG3' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -137.86 128.02 25.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.163 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.903 ' CG ' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 57.14 45.53 20.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 176.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.675 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 60.81 15.65 42.69 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.669 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -133.64 162.82 30.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.702 0.751 . . . . 0.0 111.767 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.999 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 84.0 m95 -97.21 110.83 23.3 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.948 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.793 ' O ' HG23 ' A' ' 14' ' ' VAL . 17.5 t -105.68 142.35 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.051 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.623 HD21 ' HB3' ' A' ' 11' ' ' GLN . 6.2 mt -56.41 124.56 18.53 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.057 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.664 HD23 ' CD2' ' B' ' 26' ' ' PHE . 2.7 tp -58.73 -39.98 82.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.24 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.4 p -63.8 -18.89 64.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.205 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.7 m -69.13 -18.48 63.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.882 ' O ' HD13 ' C' ' 27' ' ' LEU . 86.5 m-85 -97.33 -3.32 40.69 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.612 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.913 HD13 ' O ' ' B' ' 26' ' ' PHE . 7.7 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.462 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.486 2.023 0 CA-C-O 120.315 -0.158 . . . . 0.0 112.826 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.659 ' HD2' ' HB3' ' A' ' 2' ' ' TYR . 3.1 m-30 -105.23 151.78 23.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.758 0.313 . . . . 0.0 111.549 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.873 HG23 ' HA ' ' A' ' 5' ' ' GLU . 5.8 pt -88.91 159.47 45.66 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.883 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 70.1 Cg_endo -87.21 151.79 8.09 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 122.29 1.993 . . . . 0.0 111.403 177.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.999 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.4 OUTLIER -57.32 143.34 40.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.144 -177.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' B' ' 5' ' ' GLU . . . -83.48 162.15 54.38 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.544 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.34 152.94 43.29 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.231 2.62 . . . . 0.0 112.98 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.51 ' N ' ' HD3' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -112.24 60.23 0.63 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.165 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -105.27 15.33 27.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.574 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.59 ' O ' ' HE3' ' C' ' 16' ' ' LYS . . . 79.56 14.85 80.73 Favored Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 120.203 -0.998 . . . . 0.0 112.824 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.863 ' HB3' HD21 ' B' ' 22' ' ' LEU . 1.9 mm-40 -115.64 154.23 29.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.189 0.518 . . . . 0.0 110.585 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.695 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -93.43 134.18 35.94 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.391 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.537 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 74.6 m-85 -120.44 154.06 35.72 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.119 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 1.045 HG21 ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -113.89 159.58 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 CA-C-N 113.368 -1.742 . . . . 0.0 106.634 176.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.88 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -103.2 107.31 18.07 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.74 -176.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.853 ' HB2' ' HA ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -137.05 131.54 32.94 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 112.942 -1.936 . . . . 0.0 113.114 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.588 ' OD1' ' O ' ' B' ' 16' ' ' LYS . 0.5 OUTLIER 46.75 45.08 14.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.552 ' HA2' HH22 ' B' ' 15' ' ' ARG . . . 76.72 -3.38 55.96 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.395 -0.907 . . . . 0.0 114.748 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.24 161.36 27.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.863 0.831 . . . . 0.0 111.911 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' TRP . . . . . 0.88 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 91.5 m95 -93.7 114.66 27.0 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.285 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.428 ' O ' HG12 ' B' ' 14' ' ' VAL . 11.2 t -108.31 138.11 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 CA-C-O 121.898 0.856 . . . . 0.0 110.376 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.863 HD21 ' HB3' ' B' ' 11' ' ' GLN . 1.9 mt -53.77 124.05 14.11 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.223 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.86 ' CD2' HD21 ' B' ' 27' ' ' LEU . 0.2 OUTLIER -57.93 -44.19 86.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 18.0 t -48.42 -26.27 2.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.23 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 10.8 m -68.64 -19.1 64.4 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.245 0.545 . . . . 0.0 110.452 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.913 ' O ' HD13 ' A' ' 27' ' ' LEU . 81.6 m-85 -98.23 -4.47 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.64 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.946 HD13 ' O ' ' C' ' 26' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.103 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' TYR . . . . . 0.883 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.4 m-30 -100.49 167.59 10.27 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.789 0.328 . . . . 0.0 111.213 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 0.999 HG23 ' HA ' ' B' ' 5' ' ' GLU . 1.1 pt -102.55 157.95 32.71 Favored Pre-proline 0 CA--C 1.504 -0.819 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.276 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.99 ' HA ' ' O ' ' A' ' 1' ' ' GLY . 9.7 Cg_endo -82.81 145.06 12.58 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 121.696 1.597 . . . . 0.0 111.577 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.942 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -57.55 143.01 42.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.309 -177.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' C' ' 7' ' ' PRO . . . -84.09 170.37 14.14 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.306 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' C' ' 6' ' ' ALA . 21.8 Cg_exo -61.8 149.06 91.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.772 2.315 . . . . 0.0 111.822 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -112.14 64.68 0.63 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.146 0.498 . . . . 0.0 110.882 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' ASP . . . . . 0.462 ' CG ' ' HG3' ' C' ' 11' ' ' GLN . 13.6 p-10 -121.28 23.02 10.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.505 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.62 ' C ' ' HE2' ' A' ' 16' ' ' LYS . . . 79.75 15.26 79.75 Favored Glycine 0 CA--C 1.508 -0.38 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.844 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' GLN . . . . . 0.931 ' HB3' HD21 ' C' ' 22' ' ' LEU . 6.2 mt-30 -111.28 140.21 46.04 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 117.32 0.56 . . . . 0.0 110.837 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . 0.74 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -92.47 136.39 33.26 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.75 0.786 . . . . 0.0 110.785 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.553 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 69.1 m-85 -121.12 152.15 39.06 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.847 1.308 . . . . 0.0 112.32 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' VAL . . . . . 0.956 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.0 OUTLIER -107.06 154.58 7.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 177.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.728 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.67 107.45 18.45 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.208 -178.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.866 ' HG2' ' CG ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -137.1 134.45 36.46 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.106 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . 0.866 ' CG ' ' HG2' ' C' ' 16' ' ' LYS . 0.0 OUTLIER 48.45 45.6 20.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 176.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.428 ' O ' ' NH2' ' C' ' 15' ' ' ARG . . . 65.53 8.99 41.97 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -129.78 161.31 31.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.198 0.999 . . . . 0.0 111.358 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . 0.728 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 87.9 m95 -93.84 120.39 34.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.987 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.956 ' O ' HG23 ' C' ' 14' ' ' VAL . 11.1 t -113.0 137.79 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.549 0.69 . . . . 0.0 110.309 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' LEU . . . . . 0.931 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.2 mt -57.6 127.64 33.05 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.981 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.819 ' CD1' HD11 ' B' ' 23' ' ' LEU . 6.6 tp -58.79 -35.04 72.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.448 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -19.87 65.99 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 122.245 -0.285 . . . . 0.0 111.338 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -68.64 -18.25 64.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' PHE . . . . . 0.946 ' O ' HD13 ' B' ' 27' ' ' LEU . 93.3 m-85 -99.13 -7.78 26.14 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.011 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.882 HD13 ' O ' ' A' ' 26' ' ' PHE . 5.7 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.064 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' C' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.487 2.098 0 N-CA-C 112.359 -0.297 . . . . 0.0 112.359 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.662 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 3.6 m-85 -121.79 150.96 41.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.971 0.385 . . . . 0.0 111.04 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 1.03 HG23 ' HA ' ' C' ' 5' ' ' GLU . 4.3 pt -94.39 157.72 36.89 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-O 120.974 0.416 . . . . 0.0 111.975 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 21.4 Cg_endo -88.19 147.07 6.52 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 122.596 2.198 . . . . 0.0 111.102 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 1.058 ' OE2' HG22 ' B' ' 3' ' ' ILE . 1.3 tt0 -58.14 143.02 45.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.644 -176.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.886 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -86.42 163.8 40.6 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.976 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.624 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 31.3 Cg_exo -56.74 152.93 39.19 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.832 2.355 . . . . 0.0 112.824 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.634 ' CZ ' ' H ' ' B' ' 18' ' ' GLY . 0.0 OUTLIER -112.07 63.86 0.62 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.48 0.657 . . . . 0.0 111.594 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -110.78 14.67 22.19 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.478 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.857 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 79.12 15.93 79.55 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.898 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -109.81 148.17 31.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.137 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -91.68 135.2 34.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.293 0.568 . . . . 0.0 112.178 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.789 ' O ' HG23 ' B' ' 14' ' ' VAL . 65.6 m-85 -117.59 148.34 42.01 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 123.026 1.393 . . . . 0.0 111.905 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -107.01 154.26 7.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 112.1 -2.318 . . . . 0.0 104.813 177.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.744 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.77 106.98 17.7 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 118.057 -1.457 . . . . 0.0 108.274 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.723 ' HD3' HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -137.63 124.39 21.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.681 -178.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.89 46.84 16.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.464 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 65.97 6.29 30.63 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.741 -0.743 . . . . 0.0 114.554 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -129.74 161.95 29.52 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 117.894 0.847 . . . . 0.0 111.819 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.886 ' CG ' ' HB2' ' A' ' 6' ' ' ALA . 87.9 m95 -95.89 119.76 34.97 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.363 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.958 ' O ' HG23 ' A' ' 14' ' ' VAL . 15.9 t -114.5 141.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 CA-C-O 121.702 0.763 . . . . 0.0 109.933 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.898 HD21 ' HB3' ' A' ' 11' ' ' GLN . 1.7 mt -57.61 126.94 29.56 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.81 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.773 HD23 ' CD2' ' B' ' 26' ' ' PHE . 1.3 tp -60.36 -45.16 94.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.983 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.484 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 52.8 p -63.43 -19.05 64.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.752 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 6.8 m -69.38 -19.28 63.83 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 1.205 ' O ' HD21 ' C' ' 27' ' ' LEU . 87.9 m-85 -97.26 -2.47 42.59 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.789 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.077 HD13 ' O ' ' B' ' 26' ' ' PHE . 1.5 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.414 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.533 ' HA ' ' H ' ' A' ' 5' ' ' GLU . 5.5 m-85 -134.98 131.62 37.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.495 0.188 . . . . 0.0 110.988 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 1.058 HG22 ' OE2' ' A' ' 5' ' ' GLU . 21.3 pt -85.16 156.46 60.16 Favored Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 120.695 0.283 . . . . 0.0 110.8 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.67 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 71.8 Cg_endo -87.25 155.99 8.17 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.47 2.113 . . . . 0.0 111.524 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 1.151 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.6 OUTLIER -57.68 143.53 41.26 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.201 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' B' ' 20' ' ' TRP . . . -86.67 153.7 55.58 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.653 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.746 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 3.1 Cg_exo -50.48 153.81 7.06 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.48 2.787 . . . . 0.0 113.401 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.605 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.0 OUTLIER -111.73 73.66 0.83 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.571 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -114.72 11.04 16.75 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.705 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' C' ' 16' ' ' LYS . . . 78.99 14.99 81.37 Favored Glycine 0 CA--C 1.512 -0.144 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.583 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' C' ' 16' ' ' LYS . 0.0 OUTLIER -118.73 158.52 25.39 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.096 0.474 . . . . 0.0 110.536 179.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.645 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.54 135.83 33.73 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.392 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.746 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 51.3 m-85 -120.64 153.53 36.73 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-N 114.42 -1.264 . . . . 0.0 112.088 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 1.137 HG21 ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -116.15 159.13 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 113.802 -1.544 . . . . 0.0 107.956 176.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.833 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.09 107.24 18.12 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 122.104 0.954 . . . . 0.0 110.23 -176.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.857 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -137.63 125.63 22.8 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.612 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.571 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 56.81 41.81 27.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.634 ' H ' ' CZ ' ' A' ' 8' ' ' ARG . . . 69.59 10.54 63.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.46 159.55 36.73 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 118.233 1.017 . . . . 0.0 111.881 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' TRP . . . . . 0.833 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 90.5 m95 -93.42 113.15 25.24 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.07 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.518 ' O ' HG12 ' B' ' 14' ' ' VAL . 18.7 t -109.55 136.94 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.161 0 CA-C-O 121.815 0.817 . . . . 0.0 110.43 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' B' ' 11' ' ' GLN . 4.9 mt -51.56 123.11 9.2 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.031 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.748 HD22 HG21 ' C' ' 14' ' ' VAL . 7.3 tp -57.01 -36.03 69.93 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.545 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -63.04 -17.3 62.09 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.601 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 3.4 m -71.48 -19.59 62.19 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 1.077 ' O ' HD13 ' A' ' 27' ' ' LEU . 90.4 m-85 -99.34 -3.62 33.55 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.159 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 1.237 HD21 ' O ' ' C' ' 26' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.196 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' B' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.106 0 N-CA-C 112.688 -0.165 . . . . 0.0 112.688 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' TYR . . . . . 0.67 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.0 m-85 -127.14 147.14 50.19 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.923 0.362 . . . . 0.0 111.653 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 1.151 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.3 pt -87.04 157.89 53.57 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 121.004 0.431 . . . . 0.0 111.589 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 19.2 Cg_endo -87.86 148.54 7.07 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 122.33 2.02 . . . . 0.0 110.873 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 1.03 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -57.59 143.38 41.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.584 -177.058 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.687 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -85.29 162.24 49.33 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.449 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' PRO . . . . . 0.481 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 32.3 Cg_exo -56.78 155.08 28.68 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.004 2.469 . . . . 0.0 113.171 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.78 79.02 1.21 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.458 0.647 . . . . 0.0 111.601 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -125.15 11.62 8.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.355 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.67 10.66 85.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.07 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' GLN . . . . . 0.688 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.6 OUTLIER -102.02 151.1 22.54 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . 0.668 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -92.83 136.57 33.13 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.273 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.637 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 49.1 m-85 -117.99 155.42 30.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.554 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' VAL . . . . . 0.748 HG21 HD22 ' B' ' 23' ' ' LEU . 4.4 t -123.93 134.9 65.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.798 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -80.59 109.14 14.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.998 0.904 . . . . 0.0 111.204 -175.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.645 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -136.1 123.0 21.32 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 113.832 -1.531 . . . . 0.0 112.128 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . 0.605 ' HA ' ' HG3' ' B' ' 8' ' ' ARG . 0.1 OUTLIER 55.11 45.98 24.97 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 176.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.465 ' HA2' ' NH2' ' C' ' 15' ' ' ARG . . . 65.53 13.52 58.69 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 119.474 -0.626 . . . . 0.0 114.543 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' C' ' 16' ' ' LYS . 0.1 OUTLIER -133.05 161.41 34.44 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.488 1.144 . . . . 0.0 111.346 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . 0.798 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 82.3 m95 -93.35 116.19 28.75 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.087 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.551 HG22 ' HB ' ' C' ' 14' ' ' VAL . 1.7 m -108.29 129.57 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 CA-C-O 122.032 0.92 . . . . 0.0 111.25 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' C' ' 11' ' ' GLN . 2.1 mt -51.42 123.45 9.78 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.62 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.682 HD21 ' CB ' ' A' ' 26' ' ' PHE . 11.8 tp -60.37 -42.75 96.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.014 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -20.5 64.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.55 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 30.1 m -68.31 -18.59 64.55 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' PHE . . . . . 1.237 ' O ' HD21 ' B' ' 27' ' ' LEU . 52.8 m-85 -100.93 -8.77 22.17 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.073 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 1.205 HD21 ' O ' ' A' ' 26' ' ' PHE . 2.6 tp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.11 -0.947 . . . . 0.0 111.105 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 119.814 -0.437 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.819 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 8.4 m-30 -108.92 162.37 14.27 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.839 0.819 . . . . 0.0 111.86 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.743 HD13 ' HG3' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -92.74 159.59 35.92 Favored Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.501 178.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 43.1 Cg_endo -88.13 144.15 5.94 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.418 2.079 . . . . 0.0 111.487 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.917 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.6 OUTLIER -50.27 142.77 9.53 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.244 -178.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.691 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.13 166.24 27.2 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.563 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.505 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 34.5 Cg_exo -57.03 148.7 67.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.336 2.024 . . . . 0.0 111.627 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' B' ' 18' ' ' GLY . 85.7 mtt180 -112.58 62.68 0.63 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.078 0.466 . . . . 0.0 111.928 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -114.78 18.07 16.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.135 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.901 ' O ' ' HE2' ' B' ' 16' ' ' LYS . . . 79.02 14.6 81.77 Favored Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.864 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.87 ' HB3' HD21 ' A' ' 22' ' ' LEU . 3.7 mm-40 -103.88 141.64 35.78 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.886 ' HB1' HG21 ' B' ' 14' ' ' VAL . . . -91.88 134.87 34.38 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.534 0.683 . . . . 0.0 110.914 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.864 ' O ' HG23 ' B' ' 14' ' ' VAL . 53.7 m-85 -120.04 149.75 41.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.409 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.843 HG21 ' CE2' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -104.61 156.64 5.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 176.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 1.065 ' HG3' HH11 ' A' ' 15' ' ' ARG . 0.0 OUTLIER -105.86 115.76 30.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.644 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' C' ' 11' ' ' GLN . 1.0 OUTLIER -151.69 129.17 11.38 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.825 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.666 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 0.1 OUTLIER 54.89 42.24 31.26 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.718 177.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.538 ' HA2' ' OE2' ' C' ' 5' ' ' GLU . . . 62.44 16.45 54.73 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 119.358 -0.69 . . . . 0.0 114.742 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.666 ' HG3' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -131.87 161.62 32.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.801 1.301 . . . . 0.0 111.613 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 1.015 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 91.5 m95 -99.47 112.32 24.53 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.892 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 14' ' ' VAL . 17.9 t -108.6 139.74 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.453 0.644 . . . . 0.0 109.652 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.87 HD21 ' HB3' ' A' ' 11' ' ' GLN . 1.3 mt -55.79 126.71 26.78 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.935 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.62 HD23 ' CD1' ' B' ' 26' ' ' PHE . 3.3 tp -58.46 -39.49 80.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.164 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.434 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -63.52 -19.14 64.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.046 -178.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.3 m -70.12 -18.58 63.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.093 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.843 ' CE2' HG21 ' A' ' 14' ' ' VAL . 80.7 m-85 -97.25 -1.82 44.02 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.847 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.011 ' CD1' ' O ' ' B' ' 26' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.048 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.174 0 CA-C-O 120.19 -0.228 . . . . 0.0 112.755 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.53 ' HB3' ' CD2' ' C' ' 2' ' ' TYR . 4.4 m-85 -132.33 135.69 46.36 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 110.896 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.968 HG21 ' HE ' ' B' ' 15' ' ' ARG . 6.1 pt -87.19 159.31 51.14 Favored Pre-proline 0 CA--C 1.513 -0.462 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.716 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 92.0 Cg_endo -91.04 148.56 3.77 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 122.949 2.433 . . . . 0.0 111.376 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.793 ' OE2' ' HA2' ' C' ' 18' ' ' GLY . 0.9 OUTLIER -58.22 142.85 46.34 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.758 0.79 . . . . 0.0 112.959 -177.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.865 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -83.17 155.25 67.05 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.99 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.703 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 5.0 Cg_exo -45.75 152.7 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.743 2.962 . . . . 0.0 113.678 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' C' ' 17' ' ' ASP . 3.6 mtp180 -111.93 62.27 0.62 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.586 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -109.03 15.37 23.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.643 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.588 ' C ' ' HE2' ' C' ' 16' ' ' LYS . . . 79.23 14.73 81.34 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.852 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.915 ' HB3' HD21 ' B' ' 22' ' ' LEU . 38.5 mm-40 -109.01 147.18 32.71 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 120.966 0.412 . . . . 0.0 110.508 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.637 ' HB1' ' CG1' ' C' ' 14' ' ' VAL . . . -92.57 136.16 33.46 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.638 0.732 . . . . 0.0 109.469 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' B' ' 7' ' ' PRO . 50.7 m-85 -122.09 155.46 35.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.264 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.886 HG21 ' HB1' ' A' ' 12' ' ' ALA . 1.5 p -114.93 159.81 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.477 175.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 1.012 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -102.95 114.42 28.7 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.133 0.968 . . . . 0.0 110.124 -176.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.901 ' HE2' ' O ' ' A' ' 10' ' ' GLY . 2.0 tttm -149.01 127.93 12.64 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.788 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' B' ' 19' ' ' GLU . 0.2 OUTLIER 56.29 45.25 23.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.458 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 62.13 14.13 45.22 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 119.484 -0.62 . . . . 0.0 114.196 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' B' ' 17' ' ' ASP . 0.1 OUTLIER -133.1 163.22 29.73 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.525 1.162 . . . . 0.0 112.011 -178.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' TRP . . . . . 1.012 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 92.5 m95 -97.65 113.02 24.68 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.204 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.493 ' C ' ' HD1' ' B' ' 13' ' ' TYR . 6.2 t -108.24 139.27 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 121.925 0.869 . . . . 0.0 110.333 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.915 HD21 ' HB3' ' B' ' 11' ' ' GLN . 3.8 mt -55.21 125.11 19.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.061 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.593 HD22 HG11 ' C' ' 14' ' ' VAL . 3.8 tp -57.77 -39.4 77.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.521 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 29.8 t -63.23 -17.34 62.34 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.708 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 18.3 m -70.37 -20.27 62.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 1.011 ' O ' ' CD1' ' A' ' 27' ' ' LEU . 88.1 m-85 -96.89 -15.54 21.15 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.575 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.68 HD21 ' HB3' ' C' ' 26' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.99 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' TYR . . . . . 0.716 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 5.1 m-30 -98.01 161.15 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.352 . . . . 0.0 111.524 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 0.79 HG23 ' HA ' ' B' ' 5' ' ' GLU . 1.5 pt -90.09 158.4 44.2 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.765 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.819 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 43.7 Cg_endo -90.23 153.99 4.64 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 122.432 2.088 . . . . 0.0 112.285 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.538 ' OE2' ' HA2' ' A' ' 18' ' ' GLY . 1.1 tp10 -57.56 142.4 44.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.917 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.904 ' H ' HH12 ' A' ' 15' ' ' ARG . . . -89.08 162.89 36.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 113.699 -1.592 . . . . 0.0 110.864 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' PRO . . . . . 0.467 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 31.8 Cg_exo -57.27 152.39 46.17 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.075 2.517 . . . . 0.0 113.52 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' ARG . . . . . 0.575 ' HG3' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -111.77 67.75 0.65 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.128 0.489 . . . . 0.0 111.095 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' ASP . . . . . 0.539 ' OD1' ' HB2' ' C' ' 11' ' ' GLN . 6.1 p30 -116.72 12.98 15.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.107 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.495 ' O ' ' HE2' ' A' ' 16' ' ' LYS . . . 84.08 14.68 71.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.203 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' GLN . . . . . 0.64 ' HB3' HD21 ' C' ' 22' ' ' LEU . 19.1 mt-30 -110.79 150.56 28.94 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.492 0.663 . . . . 0.0 110.892 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . 0.592 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -92.52 136.87 32.85 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.477 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.606 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 59.3 m-85 -118.99 156.12 30.17 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.035 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' VAL . . . . . 0.882 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.2 OUTLIER -115.25 157.04 16.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.952 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -105.63 115.31 30.03 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 122.045 0.926 . . . . 0.0 110.903 -176.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' B' ' 11' ' ' GLN . 0.5 OUTLIER -153.47 132.96 12.89 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.339 -178.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . 0.459 ' HA ' ' HG2' ' B' ' 8' ' ' ARG . 0.2 OUTLIER 55.17 45.04 26.77 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 176.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.793 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.21 16.84 50.5 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-O 119.382 -0.677 . . . . 0.0 114.167 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -137.33 164.63 28.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.661 1.231 . . . . 0.0 112.255 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . 0.952 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 90.3 m95 -96.49 115.11 26.89 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.162 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.882 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.7 m -105.81 134.81 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.153 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' C' ' 11' ' ' GLN . 3.5 mt -55.44 122.03 10.31 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.72 HD21 ' HB3' ' A' ' 26' ' ' PHE . 4.5 tp -59.12 -38.24 79.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.498 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 28.7 t -62.44 -18.94 62.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.89 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 29.6 m -69.23 -18.03 63.84 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' PHE . . . . . 0.68 ' HB3' HD21 ' B' ' 27' ' ' LEU . 70.9 m-85 -101.04 -10.62 20.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.466 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 26' ' ' PHE . 25.4 mt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.873 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 112.58 -0.208 . . . . 0.0 112.58 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.75 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 5.9 m-85 -99.02 167.21 10.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 112.23 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 1.064 HG23 ' HA ' ' C' ' 5' ' ' GLU . 3.5 pt -91.68 159.52 38.31 Favored Pre-proline 0 CA--C 1.51 -0.578 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.186 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 55.5 Cg_endo -84.58 139.71 7.91 Favored 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 121.17 1.247 . . . . 0.0 111.201 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.902 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.5 OUTLIER -47.97 143.03 4.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.59 -1.187 . . . . 0.0 113.87 -177.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.76 ' HB2' ' CD2' ' A' ' 20' ' ' TRP . . . -84.05 177.65 2.86 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.66 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.946 ' HB2' ' OD2' ' A' ' 9' ' ' ASP . 2.7 Cg_exo -75.5 155.23 40.64 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.576 2.851 . . . . 0.0 114.037 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.587 ' HG3' ' HA ' ' B' ' 17' ' ' ASP . 0.0 OUTLIER -105.01 79.67 1.53 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 178.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.946 ' OD2' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -124.84 3.03 8.13 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.198 -178.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.49 0.36 83.61 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 119.571 -1.299 . . . . 0.0 111.188 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.843 ' O ' ' HB2' ' B' ' 16' ' ' LYS . 0.1 OUTLIER -101.69 151.76 21.64 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.853 ' HB1' ' CG1' ' B' ' 14' ' ' VAL . . . -91.48 137.94 31.97 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.439 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.629 ' CD2' ' HD2' ' A' ' 7' ' ' PRO . 47.5 m-85 -118.5 155.69 30.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.081 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.972 HG13 ' O ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -105.1 150.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.975 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -104.55 99.41 9.09 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.584 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 0.3 OUTLIER -136.0 125.73 25.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 112.777 -2.011 . . . . 0.0 113.172 -176.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.96 43.11 30.42 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.641 ' HA2' ' NH1' ' A' ' 15' ' ' ARG . . . 74.85 6.65 78.95 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.168 -1.015 . . . . 0.0 115.109 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.88 161.54 35.34 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.992 1.396 . . . . 0.0 112.396 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.975 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 97.3 m95 -94.32 115.25 27.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.651 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.972 ' O ' HG13 ' A' ' 14' ' ' VAL . 22.0 t -107.21 136.84 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 121.904 0.859 . . . . 0.0 108.791 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.721 HD21 ' OE1' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -53.92 122.64 10.47 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.321 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.979 HD12 HD11 ' C' ' 23' ' ' LEU . 4.9 tp -57.26 -36.06 70.52 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.683 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.661 ' HB2' HD12 ' A' ' 22' ' ' LEU . 25.9 m -61.47 -17.76 55.92 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.243 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -72.23 -18.39 61.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.973 ' O ' HD13 ' C' ' 27' ' ' LEU . 88.9 m-85 -99.34 -10.54 22.18 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.332 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.788 HD13 ' O ' ' B' ' 26' ' ' PHE . 9.3 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.689 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 119.733 -0.482 . . . . 0.0 111.972 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.662 ' CD2' ' HB2' ' A' ' 2' ' ' TYR . 3.6 m-85 -134.57 138.51 44.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.748 0.774 . . . . 0.0 110.809 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.902 HG23 ' HA ' ' A' ' 5' ' ' GLU . 0.8 OUTLIER -88.2 158.49 49.42 Favored Pre-proline 0 N--CA 1.47 0.528 0 CA-C-O 121.4 0.619 . . . . 0.0 112.621 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 87.8 Cg_endo -92.17 156.3 3.2 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 123.056 2.504 . . . . 0.0 111.232 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.847 ' OE2' ' NH2' ' C' ' 15' ' ' ARG . 0.7 OUTLIER -57.85 141.99 47.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -177.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.825 ' HB2' ' CD1' ' B' ' 20' ' ' TRP . . . -88.15 158.68 49.33 Favored Pre-proline 0 C--N 1.334 -0.103 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.361 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.485 ' HG2' ' CE2' ' B' ' 13' ' ' TYR . 10.1 Cg_endo -51.39 152.76 11.22 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.428 2.085 . . . . 0.0 111.68 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -114.85 67.95 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.471 0.653 . . . . 0.0 111.6 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -109.55 16.0 22.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.639 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.16 31.89 63.51 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.387 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.895 ' HB3' HD21 ' B' ' 22' ' ' LEU . 19.8 mm-40 -123.47 149.42 45.13 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.615 ' HA ' ' HB2' ' C' ' 16' ' ' LYS . . . -92.61 135.92 33.67 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.855 0.836 . . . . 0.0 111.66 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.573 ' CG ' ' HB3' ' B' ' 20' ' ' TRP . 80.7 m-85 -122.24 152.67 39.78 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 123.382 1.563 . . . . 0.0 112.654 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.853 ' CG1' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -106.99 156.69 7.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 111.266 -2.697 . . . . 0.0 105.93 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.954 ' HG2' ' CH2' ' B' ' 20' ' ' TRP . 0.0 OUTLIER -105.19 105.55 15.64 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 118.76 -1.176 . . . . 0.0 108.13 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.843 ' HB2' ' O ' ' A' ' 11' ' ' GLN . 4.4 pttt -138.78 132.61 30.93 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 113.224 -1.807 . . . . 0.0 111.661 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.587 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 58.17 42.99 21.25 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 176.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.493 ' HA3' ' NH1' ' A' ' 8' ' ' ARG . . . 60.05 14.81 33.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.216 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -134.96 165.41 25.39 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 117.437 0.618 . . . . 0.0 111.842 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' TRP . . . . . 0.954 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 94.7 m95 -98.11 112.14 24.21 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.742 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.834 ' O ' HG23 ' B' ' 14' ' ' VAL . 17.0 t -106.12 141.44 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 CA-C-O 121.848 0.833 . . . . 0.0 109.65 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.895 HD21 ' HB3' ' B' ' 11' ' ' GLN . 2.6 mt -57.27 127.72 33.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.999 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.733 HD22 HG11 ' C' ' 14' ' ' VAL . 5.7 tp -61.67 -40.04 93.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.579 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -19.77 66.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.176 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -68.32 -18.02 64.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.788 ' O ' HD13 ' A' ' 27' ' ' LEU . 91.3 m-85 -99.29 -4.93 30.7 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.577 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.997 HD13 ' O ' ' C' ' 26' ' ' PHE . 4.5 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.227 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.714 -0.154 . . . . 0.0 112.714 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' TYR . . . . . 0.662 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.5 m-85 -120.3 146.57 45.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.932 0.396 . . . . 0.0 111.656 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 0.841 HG23 ' HA ' ' B' ' 5' ' ' GLU . 1.0 OUTLIER -92.11 158.65 39.03 Favored Pre-proline 0 CA--C 1.501 -0.926 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.592 178.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 75.7 Cg_endo -86.73 146.86 8.21 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.83 1.687 . . . . 0.0 112.426 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 1.064 ' HA ' HG23 ' A' ' 3' ' ' ILE . 1.8 tt0 -57.41 143.41 40.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 113.803 -1.544 . . . . 0.0 113.464 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.769 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -85.3 153.36 59.17 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.411 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.85 153.69 5.75 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.142 2.561 . . . . 0.0 112.986 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' ARG . . . . . 0.42 ' NH2' ' OE1' ' C' ' 5' ' ' GLU . 8.8 mtt85 -112.79 57.28 0.66 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.914 0.388 . . . . 0.0 111.782 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' C' ' 11' ' ' GLN . 2.5 p30 -105.63 18.71 21.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.449 ' O ' ' HD2' ' A' ' 16' ' ' LYS . . . 80.0 10.51 85.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.604 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' GLN . . . . . 0.92 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.2 OUTLIER -103.85 154.09 20.0 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 117.669 0.734 . . . . 0.0 109.271 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . 0.71 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -95.91 134.26 39.12 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.529 0.68 . . . . 0.0 111.82 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.716 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 51.4 m-85 -117.51 154.68 31.05 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.783 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' VAL . . . . . 0.872 HG23 ' O ' ' C' ' 21' ' ' VAL . 1.7 t -118.36 156.7 20.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.882 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -104.99 108.25 19.67 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.941 -177.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' B' ' 11' ' ' GLN . 0.0 OUTLIER -136.38 121.18 18.58 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.621 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.55 45.93 18.6 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.029 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.582 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 62.31 14.6 48.7 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.629 0.612 . . . . 0.0 114.629 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -130.19 162.2 29.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.3 1.05 . . . . 0.0 111.737 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . 0.882 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 68.0 m95 -96.27 114.71 26.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.715 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.872 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.3 m -111.35 130.66 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.117 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' LEU . . . . . 0.92 HD21 ' HB3' ' C' ' 11' ' ' GLN . 1.2 mt -53.46 125.02 16.48 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.101 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.979 HD11 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -60.38 -36.62 78.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.737 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.08 -19.5 64.47 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.203 -0.311 . . . . 0.0 110.829 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 51.7 m -69.04 -18.4 64.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' PHE . . . . . 0.997 ' O ' HD13 ' B' ' 27' ' ' LEU . 59.1 m-85 -100.06 -8.94 23.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.317 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.973 HD13 ' O ' ' A' ' 26' ' ' PHE . 5.5 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.176 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' C' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.372 0 CA-C-O 119.638 -0.535 . . . . 0.0 112.162 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.841 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 19.6 m-85 -134.88 166.8 22.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.603 0.701 . . . . 0.0 111.2 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 1.024 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.1 pt -92.12 158.01 40.01 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.193 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' B' ' 2' ' ' TYR . 10.3 Cg_endo -82.49 147.7 14.15 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 121.764 1.643 . . . . 0.0 110.605 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 1.069 ' HA ' HG23 ' B' ' 3' ' ' ILE . 0.6 OUTLIER -58.36 142.9 46.82 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -176.666 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.752 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.14 160.74 48.33 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.317 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 51.9 Cg_exo -55.06 153.63 25.31 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.332 2.688 . . . . 0.0 113.621 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 71.3 mtm-85 -112.03 83.15 1.74 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.45 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -128.42 13.5 6.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.66 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.691 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 78.79 13.36 83.21 Favored Glycine 0 CA--C 1.51 -0.253 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.819 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.664 ' O ' ' HB2' ' B' ' 16' ' ' LYS . 11.5 mt-30 -115.55 148.75 39.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.848 0.356 . . . . 0.0 110.112 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' B' ' 16' ' ' LYS . . . -90.88 138.52 31.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 122.131 0.967 . . . . 0.0 112.562 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.525 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 61.9 m-85 -118.57 152.77 35.38 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.395 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.07 HG21 ' HB1' ' C' ' 12' ' ' ALA . 0.2 OUTLIER -114.46 157.22 15.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.78 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -105.91 104.26 13.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.798 0.809 . . . . 0.0 111.524 -176.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.668 ' HB2' ' HA ' ' C' ' 12' ' ' ALA . 1.1 tttt -135.39 128.38 31.49 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.204 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.521 ' HA ' ' CG ' ' C' ' 8' ' ' ARG . 0.2 OUTLIER 55.33 44.97 26.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.494 ' HA2' HH21 ' A' ' 15' ' ' ARG . . . 63.14 15.92 57.06 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 114.993 0.757 . . . . 0.0 114.993 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -132.33 158.57 41.57 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.575 1.188 . . . . 0.0 111.777 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.78 ' CH2' ' HG2' ' A' ' 15' ' ' ARG . 92.7 m95 -94.92 115.67 27.75 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.182 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 14.2 t -111.21 141.24 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-O 121.693 0.759 . . . . 0.0 110.185 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 12' ' ' ALA . 2.4 mt -57.29 125.37 22.47 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.596 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.874 HD22 HG11 ' B' ' 14' ' ' VAL . 7.4 tp -57.49 -35.48 70.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.45 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -63.97 -20.06 65.61 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.36 -0.213 . . . . 0.0 111.146 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 m -68.81 -18.09 64.12 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.35 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 1.062 ' O ' ' CD1' ' C' ' 27' ' ' LEU . 80.7 m-85 -95.9 -21.36 18.11 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.662 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.005 HD22 HD23 ' B' ' 27' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.168 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 120.209 -0.217 . . . . 0.0 113.166 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 3.4 m-85 -120.97 143.58 48.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.983 0.391 . . . . 0.0 110.93 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 1.069 HG23 ' HA ' ' A' ' 5' ' ' GLU . 5.0 pt -86.97 158.19 53.42 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 120.953 0.406 . . . . 0.0 112.031 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' C' ' 2' ' ' TYR . 84.0 Cg_endo -91.59 153.21 3.52 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.49 2.127 . . . . 0.0 111.671 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.889 ' HA ' HG23 ' C' ' 3' ' ' ILE . 0.6 OUTLIER -58.26 143.48 44.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.701 -177.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.69 ' HB2' ' CG ' ' B' ' 20' ' ' TRP . . . -86.99 171.39 10.07 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.795 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.537 ' HD2' ' HB1' ' B' ' 6' ' ' ALA . 18.8 Cg_exo -64.46 151.89 83.75 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.443 2.762 . . . . 0.0 113.028 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.45 ' HG3' ' HA ' ' C' ' 17' ' ' ASP . 0.3 OUTLIER -111.91 49.61 0.89 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -99.93 14.92 28.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.471 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.606 ' O ' ' HD2' ' C' ' 16' ' ' LYS . . . 79.64 15.04 80.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.169 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.929 ' HB3' HD21 ' B' ' 22' ' ' LEU . 1.8 mm-40 -103.52 146.82 27.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.857 ' O ' HD23 ' B' ' 22' ' ' LEU . . . -94.28 133.76 37.48 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.954 0.883 . . . . 0.0 112.339 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.683 ' O ' HG23 ' C' ' 14' ' ' VAL . 74.8 m-85 -121.31 152.9 38.41 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 123.148 1.451 . . . . 0.0 112.354 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.874 HG11 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -113.22 158.01 13.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 111.766 -2.47 . . . . 0.0 106.264 178.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.548 ' NH2' ' OE2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -104.29 107.4 18.29 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 118.845 -1.142 . . . . 0.0 108.779 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.691 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -136.81 125.23 23.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.432 -178.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER 55.04 44.94 27.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 176.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.487 ' HA2' ' OE2' ' A' ' 5' ' ' GLU . . . 62.19 16.14 52.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 115.222 0.849 . . . . 0.0 115.222 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' B' ' 16' ' ' LYS . 0.0 OUTLIER -134.81 161.3 35.58 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 118.624 1.212 . . . . 0.0 111.575 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' TRP . . . . . 0.69 ' CG ' ' HB2' ' B' ' 6' ' ' ALA . 90.0 m95 -97.02 112.82 24.4 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.515 0.674 . . . . 0.0 110.495 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' B' ' 13' ' ' TYR . 0.5 OUTLIER -110.59 153.3 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.572 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.968 179.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.929 HD21 ' HB3' ' B' ' 11' ' ' GLN . 3.9 mt -67.98 126.76 30.49 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 113.503 -1.68 . . . . 0.0 114.89 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.55 ' O ' HD12 ' B' ' 23' ' ' LEU . 3.5 tp -60.72 -43.77 97.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.887 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.504 ' HA ' HD12 ' B' ' 27' ' ' LEU . 14.3 m -63.59 -16.85 62.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.421 -177.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 13.2 m -69.66 -17.51 63.5 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.817 ' O ' HD13 ' A' ' 27' ' ' LEU . 24.8 m-85 -100.61 -5.6 26.47 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.358 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 1.005 HD23 HD22 ' A' ' 27' ' ' LEU . 15.3 mt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.251 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 CA-C-O 120.275 -0.18 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.6 m-85 -128.53 141.0 51.51 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.88 0.34 . . . . 0.0 111.015 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' B' ' 5' ' ' GLU . 2.3 pt -88.54 157.58 49.56 Favored Pre-proline 0 CA--C 1.496 -1.113 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.236 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.841 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 20.8 Cg_endo -86.35 147.45 8.78 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.821 1.681 . . . . 0.0 111.856 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 1.024 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -57.8 143.16 43.19 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.944 -177.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.697 ' HB2' ' CG ' ' C' ' 20' ' ' TRP . . . -85.59 152.38 57.21 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.856 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' PRO . . . . . 0.405 ' HD2' ' CE2' ' C' ' 13' ' ' TYR . 72.0 Cg_exo -49.73 156.02 3.46 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.519 2.813 . . . . 0.0 113.88 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' ARG . . . . . 0.521 ' CG ' ' HA ' ' A' ' 17' ' ' ASP . 2.6 mtp85 -111.9 57.25 0.64 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.994 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -102.09 17.9 22.12 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.784 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.34 11.0 75.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.795 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' GLN . . . . . 0.55 ' OE1' HD21 ' C' ' 22' ' ' LEU . 86.8 mt-30 -106.49 151.86 24.41 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . 1.07 ' HB1' HG21 ' A' ' 14' ' ' VAL . . . -92.41 137.17 32.59 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.999 0.904 . . . . 0.0 112.627 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.698 ' O ' HG23 ' A' ' 14' ' ' VAL . 79.8 m-85 -120.99 158.22 28.23 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.807 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' VAL . . . . . 0.83 HG21 ' HB1' ' B' ' 12' ' ' ALA . 0.1 OUTLIER -125.45 159.46 32.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 113.357 -1.747 . . . . 0.0 106.495 177.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 1.009 ' HG2' ' CH2' ' C' ' 20' ' ' TRP . 0.0 OUTLIER -103.67 107.71 18.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 122.436 1.113 . . . . 0.0 110.743 -175.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.713 ' HB2' ' HA ' ' B' ' 12' ' ' ALA . 0.2 OUTLIER -136.57 133.23 36.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.995 -1.911 . . . . 0.0 110.365 178.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . 0.596 ' OD1' ' O ' ' C' ' 16' ' ' LYS . 0.1 OUTLIER 48.31 46.17 20.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 177.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.517 ' HA2' ' OE2' ' B' ' 5' ' ' GLU . . . 61.48 16.21 49.22 Favored Glycine 0 N--CA 1.453 -0.194 0 N-CA-C 114.373 0.509 . . . . 0.0 114.373 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -131.57 159.1 39.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 117.756 0.778 . . . . 0.0 111.666 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . 1.009 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 87.9 m95 -93.67 109.35 21.0 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.418 0.627 . . . . 0.0 110.33 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 5.9 t -103.81 135.82 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.913 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' LEU . . . . . 0.55 HD21 ' OE1' ' C' ' 11' ' ' GLN . 7.2 mt -50.37 122.44 6.99 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.797 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.542 HD23 ' CD1' ' A' ' 26' ' ' PHE . 1.3 tp -58.02 -39.91 79.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.546 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 35.4 t -64.2 -17.46 63.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.476 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' C' ' 22' ' ' LEU . 5.2 m -70.11 -18.76 63.26 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' PHE . . . . . 0.791 ' HB3' HD11 ' B' ' 27' ' ' LEU . 89.7 m-85 -98.09 0.86 46.89 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.6 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 1.062 ' CD1' ' O ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.257 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.81 ' HA ' ' HA ' ' C' ' 4' ' ' PRO . 15.4 m-85 -97.63 176.62 5.77 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.608 0.704 . . . . 0.0 112.382 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.866 HG23 ' HA ' ' C' ' 5' ' ' GLU . 1.1 pt -104.7 159.71 28.43 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.33 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.604 ' HA ' ' CD1' ' B' ' 2' ' ' TYR . 13.9 Cg_endo -81.4 144.94 14.68 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.047 1.831 . . . . 0.0 111.716 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.887 ' HA ' HG23 ' B' ' 3' ' ' ILE . 22.5 tt0 -57.04 142.02 43.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 113.995 -1.457 . . . . 0.0 114.094 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.707 ' HB2' ' CG ' ' A' ' 20' ' ' TRP . . . -87.78 157.24 52.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.388 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.429 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 51.0 Cg_exo -54.54 151.14 32.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.977 2.451 . . . . 0.0 112.436 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' B' ' 17' ' ' ASP . 24.4 mtm180 -112.51 57.76 0.65 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.971 0.415 . . . . 0.0 112.051 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.05 18.66 19.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.792 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.799 ' O ' ' HE3' ' B' ' 16' ' ' LYS . . . 80.17 14.95 79.71 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.906 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.709 ' C ' ' HB2' ' B' ' 16' ' ' LYS . 8.4 mt-30 -106.6 141.12 38.4 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.551 ' HA ' ' CB ' ' B' ' 16' ' ' LYS . . . -91.47 135.53 33.77 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 122.004 0.907 . . . . 0.0 112.102 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.65 ' CG ' ' HB3' ' A' ' 20' ' ' TRP . 56.4 m-85 -119.57 153.21 35.78 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.794 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -118.32 147.58 21.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.743 ' NH2' ' HA2' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -93.64 107.68 19.51 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.678 -1.209 . . . . 0.0 110.405 -177.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.82 ' CD ' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -138.21 124.97 21.0 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.519 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.807 ' HA ' ' CB ' ' C' ' 8' ' ' ARG . 0.8 OUTLIER 60.97 45.84 9.03 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 176.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.743 ' HA2' ' NH2' ' A' ' 15' ' ' ARG . . . 61.37 14.75 42.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.643 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -137.15 164.25 28.9 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 117.983 0.892 . . . . 0.0 112.198 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.721 ' CZ2' HD12 ' A' ' 3' ' ' ILE . 81.4 m95 -93.11 116.2 28.81 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.188 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.924 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.4 m -107.04 128.25 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.717 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -52.21 121.86 7.6 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.985 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.978 HD22 HG11 ' B' ' 14' ' ' VAL . 15.8 tp -58.44 -44.97 89.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.508 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.406 ' HB2' HD12 ' A' ' 22' ' ' LEU . 4.9 m -48.08 -26.32 1.79 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.324 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -67.02 -18.84 65.55 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.489 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 1.249 ' O ' HD21 ' C' ' 27' ' ' LEU . 61.5 m-85 -98.75 -5.03 32.11 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.143 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.909 HD11 ' HB3' ' B' ' 26' ' ' PHE . 1.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.091 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . 0.604 ' CD1' ' HA ' ' A' ' 4' ' ' PRO . 2.7 m-85 -129.03 135.61 49.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.796 0.298 . . . . 0.0 111.345 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 5' ' ' GLU . 11.8 pt -86.97 155.84 55.25 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-O 120.993 0.425 . . . . 0.0 111.926 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.826 ' HD2' HH21 ' B' ' 15' ' ' ARG . 90.3 Cg_endo -86.93 154.25 8.53 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.427 2.752 . . . . 0.0 111.965 178.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 1.038 ' HA ' HG23 ' C' ' 3' ' ' ILE . 3.2 tt0 -58.48 143.46 45.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.592 ' HB2' ' CE2' ' B' ' 20' ' ' TRP . . . -86.9 158.16 53.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.12 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' B' ' 6' ' ' ALA . 19.0 Cg_endo -58.23 158.1 23.44 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.526 2.817 . . . . 0.0 113.106 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' C' ' 17' ' ' ASP . 1.3 mpp_? -112.22 74.6 0.87 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.294 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.41 8.24 10.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.698 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.735 ' O ' ' HE3' ' C' ' 16' ' ' LYS . . . 78.72 22.84 65.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.287 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.786 ' HB3' HD21 ' B' ' 22' ' ' LEU . 56.2 mt-30 -116.32 145.4 43.21 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' C' ' 14' ' ' VAL . . . -91.83 134.82 34.41 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.065 0.936 . . . . 0.0 111.503 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.695 ' CE1' HD23 ' B' ' 22' ' ' LEU . 52.2 m-85 -120.27 153.01 36.97 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.132 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.978 HG11 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -113.23 154.14 14.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 112.727 -2.033 . . . . 0.0 105.716 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.826 HH21 ' HD2' ' B' ' 4' ' ' PRO . 0.0 OUTLIER -106.22 100.63 10.15 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.257 1.027 . . . . 0.0 111.136 -176.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.799 ' HE3' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -134.66 126.71 29.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 113.347 -1.752 . . . . 0.0 110.847 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.774 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 38.4 t70 60.12 43.42 14.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.85 12.77 29.99 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.565 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.445 ' C ' ' NH1' ' B' ' 15' ' ' ARG . 28.0 mt-10 -128.56 160.03 33.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.09 0.945 . . . . 0.0 111.45 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' TRP . . . . . 0.82 ' CH2' ' HG2' ' B' ' 15' ' ' ARG . 81.9 m95 -95.14 116.19 28.41 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.301 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.968 ' O ' HG23 ' B' ' 14' ' ' VAL . 9.8 t -112.0 134.98 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.211 0 CA-C-O 121.746 0.784 . . . . 0.0 109.735 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.786 HD21 ' HB3' ' B' ' 11' ' ' GLN . 0.1 OUTLIER -52.71 124.94 15.15 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.821 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.791 HD21 ' CB ' ' C' ' 26' ' ' PHE . 18.2 tp -57.68 -38.35 75.01 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.256 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 25.6 t -62.66 -18.5 62.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.742 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 1.5 m -68.95 -17.88 64.01 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.909 ' HB3' HD11 ' A' ' 27' ' ' LEU . 81.4 m-85 -101.88 -12.69 18.06 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.673 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.781 HD13 ' O ' ' C' ' 26' ' ' PHE . 13.5 mt . . . . . 0 C--O 1.25 1.087 0 O-C-N 121.103 -0.998 . . . . 0.0 111.367 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.071 0 N-CA-C 112.815 -0.114 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' TYR . . . . . 0.582 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 3.7 m-85 -121.91 145.98 47.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.732 0.266 . . . . 0.0 111.344 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 1.038 HG23 ' HA ' ' B' ' 5' ' ' GLU . 3.8 pt -85.46 150.11 53.4 Favored Pre-proline 0 CA--C 1.514 -0.415 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.81 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 10.9 Cg_endo -81.89 150.41 16.2 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.817 1.678 . . . . 0.0 111.203 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.866 ' HA ' HG23 ' A' ' 3' ' ' ILE . 6.2 tt0 -58.04 142.39 46.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.503 -1.226 . . . . 0.0 113.102 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ALA . . . . . 0.646 ' HB2' ' CD2' ' C' ' 20' ' ' TRP . . . -88.57 165.06 29.79 Favored Pre-proline 0 C--O 1.231 0.127 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.873 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' PRO . . . . . 0.488 ' HD2' ' HB1' ' C' ' 6' ' ' ALA . 24.7 Cg_exo -59.06 146.22 95.03 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.525 2.15 . . . . 0.0 110.679 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' ARG . . . . . 0.807 ' CB ' ' HA ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -113.85 58.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.109 0.48 . . . . 0.0 111.5 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' ASP . . . . . 0.505 ' OD2' ' HB2' ' C' ' 11' ' ' GLN . 6.8 p-10 -104.27 21.84 15.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.387 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . 0.643 ' O ' ' HE3' ' A' ' 16' ' ' LYS . . . 78.88 12.7 83.89 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.226 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' GLN . . . . . 0.931 ' HB3' HD21 ' C' ' 22' ' ' LEU . 0.9 OUTLIER -113.02 143.05 44.97 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . 0.687 ' O ' HD23 ' C' ' 22' ' ' LEU . . . -90.6 138.26 31.7 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.948 0.88 . . . . 0.0 111.852 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.608 ' CG ' ' HB3' ' C' ' 20' ' ' TRP . 60.4 m-85 -118.33 150.35 39.64 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.572 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' VAL . . . . . 1.025 HG23 ' O ' ' C' ' 21' ' ' VAL . 0.3 OUTLIER -110.71 154.2 12.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.728 ' NH2' HG22 ' C' ' 3' ' ' ILE . 0.0 OUTLIER -105.73 108.13 19.49 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.651 -1.22 . . . . 0.0 109.944 -177.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.735 ' HE3' ' O ' ' B' ' 10' ' ' GLY . 0.0 OUTLIER -136.89 121.63 18.61 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.942 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' B' ' 8' ' ' ARG . 8.8 t70 58.56 45.75 15.8 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.562 ' HA2' ' NH2' ' C' ' 15' ' ' ARG . . . 63.97 15.71 58.6 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 115.064 0.786 . . . . 0.0 115.064 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -132.42 161.66 33.09 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.703 1.251 . . . . 0.0 112.118 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . 0.711 ' CH2' ' HG2' ' C' ' 15' ' ' ARG . 89.4 m95 -96.95 115.15 26.93 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.143 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 1.025 ' O ' HG23 ' C' ' 14' ' ' VAL . 2.4 m -114.67 131.83 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.139 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' LEU . . . . . 0.931 HD21 ' HB3' ' C' ' 11' ' ' GLN . 2.1 mt -51.48 127.31 19.71 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.235 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.681 HD22 HG11 ' A' ' 14' ' ' VAL . 3.5 tp -59.87 -44.01 94.42 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.677 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -65.63 -22.26 66.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.934 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 16.6 m -69.29 -18.41 63.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' PHE . . . . . 0.791 ' CB ' HD21 ' B' ' 23' ' ' LEU . 42.9 m-85 -97.19 -0.31 47.07 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.555 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 1.249 HD21 ' O ' ' A' ' 26' ' ' PHE . 1.7 tp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.007 179.382 . . . . . . . . 1 1 . 1 stop_ save_